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   Collagens	   are	   the	   major	   structural	   proteins	   in	   animal	   tissues.	   Their	  degradation	   is	   essential	   in	   embryogenesis	   and	   development,	  while	   unbalanced	  collagen	   breakdown	   is	   seen	   in	   diseases	   such	   as	   arthritis,	   atherosclerosis	   and	  cancer.	  	  Fibril-­‐forming	   collagens	   I,	   II	   and	   III	   consist	   of	   three	   polypeptide	   chains	  forming	   a	   triple	   helix,	   which	   is	   resistant	   to	   cleavage	   by	   most	   proteases.	  Collagenases	  of	  the	  matrix	  metalloproteinase	  family	  (MMP-­‐1,	  MMP-­‐8,	  and	  MMP-­‐13)	   degrade	   fibrillar	   collagens	   by	   locally	   unwinding	   the	   helix,	   followed	   by	  cleavage	   into	   ¼	   and	   ¾	   fragments.	   They	   comprise	   two	   domains,	   the	   catalytic	  (Cat)	   domain	   and	   the	   hemopexin	   (Hpx)	   domain,	   which	   are	   connected	   via	   a	  flexible	   linker.	  Both	  domains	  are	  essential	   for	  collagenolysis,	  but	  the	  exact	  sites	  of	   collagenase-­‐collagen	   interactions	   and	   how	   they	   unwind	   collagen	   remain	  elusive.	   This	   thesis	   addresses	   the	   roles	   of	   individual	   collagenase	   domains,	   and	  the	   sites	   in	   both	   the	   enzyme	   and	   the	   substrate	   that	   are	   involved	   in	   collagen	  binding	   and	   unwinding,	   focusing	   on	   the	   fibril-­‐forming	   collagens	   and	   human	  MMP-­‐1	  as	  a	  prototype.	  MMP-­‐1	  bound	  to	  immobilised	  collagen	  I	  with	  markedly	  higher	  affinity	  than	  its	  Hpx	  domain	  alone.	  The	  Cat	  domain	  alone	  failed	  to	  bind	  to	  collagen,	  but	  in	  the	  full-­‐length	   enzyme	   it	   participated	   in	   collagen	   binding.	   Above	   25	   °C	   the	   two-­‐domain	   binding	   involved	   the	   catalytic	   site	   cleft.	   Triple-­‐helical	   peptide	   (THP)	  Toolkits	   of	   collagens	   II	   and	   III	   were	   screened	   for	   MMP-­‐1	   binding,	   and	   the	  collagenase	   binding	   motif	   has	   been	   established.	   It	   contains	   two	   hydrophobic	  residues	   within	   a	   9	   residue	   distance.	   Finally,	   hydrogen/deuterium	   exchange	  mass	   spectrometry	   (H/DXMS)	   experiments	   indicated	   two	   potential	   collagen	  binding	   sites:	   285-­‐316	   and	   349-­‐365	   in	   the	   Hpx	   domain,	   and	   suggested	   a	  possibility	  of	  a	  dynamic	  interaction	  of	  the	  collagenase	  N-­‐terminus	  with	  collagen.	  These	  results	  imply	  that	  the	  two	  domains	  of	  collagenase	  bind	  to	  collagen	  in	  a	  cooperative	  manner.	  Based	  on	  the	  THP	  binding	  and	  H/DXMS	  data	  a	  3D	  model	  of	   collagenase-­‐collagen	   interaction	   has	   been	   proposed.	   It	   assumes	   that	  collagenase	   utilises	   hydrophobic	   interactions	   to	   unwind	   the	   collagen	   helix	   via	  perturbation	  of	  the	  hydrogen-­‐bond	  network	  which	  stabilises	  the	  helix.	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Collagens	  are	  the	  major	  proteins	  providing	  scaffolding	  for	  cells	  and	  tensile	  strength	  to	  animal	  tissues,	  and	  interstitial	  fibrillar	  collagens	  I,	  II	  and	  III	  are	  most	  abundant.	  Degradation	  of	  collagen	   is	  an	  essential	  part	  of	  physiology,	   i.e.	  during	  embryogenesis,	   organ	   morphogenesis,	   angiogenesis,	   development,	   tissue	  remodeling	   and	   wound	   healing,	   while	   unbalanced	   or	   insufficient	   collagen	  breakdown	   is	   seen	   in	   diseases	   such	   as	   arthritis,	   atherosclerosis,	   aneurysm,	  fibrosis,	  cirrhosis,	  nephritis,	  atherosclerosis,	  tissue	  ulcers,	  aneurysm,	  cancer	  and	  more	  (Woessner,	  1998).	  	  Enzymes	  of	  the	  matrix	  metalloproteinase	  (MMP)	  family	  are	  key	  endogenous	  proteinases	  that	  degrade	  collagen	  in	  vertebrates.	  Still,	  little	  is	  known	  about	  their	  mechanism	   of	   collagen	   cleavage.	   The	   goal	   of	   this	   thesis	   is	   to	   advance	   our	  understanding	  of	  the	  MMP-­‐dependent	  collagenolysis	  focusing	  on	  the	  archetypal	  interstitial	  collagenase	  MMP-­‐1	  and	  the	  major	  fibril-­‐forming	  collagens	  I,	  II	  and	  III.	  	  Collagen	  proteins	  compose	  the	  extracellular	  matrix	  (ECM)	  and	  interact	  with	  numerous	  ECM	  molecules.	  A	  brief	  description	  of	  the	  ECM	  will	  begin	  this	  chapter,	  and	  then	  details	  of	  the	  primary	  and	  higher	  order	  structures	  of	  fibrillar	  collagens	  will	   be	   outlined.	   The	   current	   knowledge	   about	   the	   structural	   basis	   of	  collagenolysis	  by	  MMPs	  will	  be	  discussed	  next,	  followed	  by	  an	  introduction	  to	  the	  hydrogen/deuterium	  exchange	  mass	   spectrometry	   (H/DXMS)	   technique,	  which	  was	  employed	  in	  this	  thesis	  work.	  	  	  
1.1.	  Extracellular	  matrix	  (ECM)	  
 The	   extracellular	   matrix	   (ECM)	   consists	   of	   assemblies	   of	   polymers	   and	  macromolecules	  that	  provide	  structural	  support	  for	  cells	  in	  tissues.	  Its	  function,	  however,	   extends	   from	   a	   passive	   framework	   to	   a	   bridge	   that	   signals	   from	   the	  environment	   to	   the	   cell.	   It	   sequesters	   cytokines,	   growth	   factors,	   and	   other	  signalling	  molecules	  serving	  as	  their	  reservoir.	  Those	  bioactive	  elements	  can	  be	  released	  from	  the	  ECM	  or	  derived	  directly	  from	  its	  constituent	  proteins	  through	  enzymatic	   degradation	   (Marneros	   &	   Olsen,	   2001;	   Marneros	   &	   Olsen,	   2005).	  Structural	   changes	   associated	  with	  ECM	   turnover	   can	  alone	  have	  an	   impact	  on	  cell	   behaviour	   as	   can	  mechanical	   forces	   occurring	  within	   the	   ECM	   (Califano	   &	  Reinhart-­‐King,	  2010;	  Vogel	  &	  Sheetz,	  2009).	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The	   main	   structural	   components	   of	   the	   ECM	   include:	   collagens;	  proteoglycans;	   noncollagenous	   glycoproteins	   (e.g.	   laminin,	   fibronectin	   and	  tenascin);	   and	   elastins.	   Different	   types	   and	   proportions	   of	   proteins	   from	   these	  families	   make	   up	   two	   distinct	   types	   of	   the	   ECM:	   (i)	   condensed	   matrix	   layers	  known	   as	   basement	   membranes,	   adjacent	   to	   cell	   sheets	   of	   epithelium	   and	  covering	  muscle	  cells,	  Schwann	  cells	  and	  adipocytes;	  and	  (ii)	   interstitial	  matrix,	  containing	   collagen	   fibrils,	   which	   may	   be	   anchored	   in	   basement	   membranes	  (Bosman	  &	  Stamenkovic,	  2003).	  	  Network-­‐forming	   collagen	   type	   IV	   is	   a	   defining	   feature	   of	   basement	  membranes	  (Yurchenco	  et	  al,	  2004).	  Multidomain	  laminins	  are	  linked	  to	  collagen	  IV	   by	   nidogen	   (Dziadek,	   1995)	   and	   interact	   with	   cells	   via	   integrin	   receptors	  (Horwitz	   et	   al,	   1985;	   Buck	   &	   Horwitz,	   1987).	   A	   large	   matrix	   proteoglycan	  perlecan	   is	   important	   for	   the	   basement	   membrane	   integrity	   and	   is	   also	  implicated	  in	  cartilage	  and	  pericellular	  matrices	  throughout	  the	  body	  (Iozzo	  et	  al,	  1994).	  	  In	   less	   cellular	   sites,	   i.e.	   connective	   tissues,	   the	   interstitial	   matrix	   is	  abundant.	  Major	  fibrillar	  networks	  are	  formed	  by	  interstitial	  collagens	  which	  will	  be	   extensively	   discussed	   further	   in	   this	   chapter.	   These	   fibrils	   and	   fibres	   are	  directly	  or	  indirectly	  connected	  to	  other	  collagens,	  noncollagenous	  regulatory	  or	  adaptor	   proteins,	   proteoglycans	   and	   cells.	   A	   range	   of	   multicomponent	  interrelations	   within	   the	   ECM	   is	   illustrated	   in	   Figure	   1,	   which	   schematically	  shows	  the	  arrangement	  of	  cartilage	  constituents.	  	  The	   most	   prevalent	   noncollagenous	   component	   of	   cartilage	   is	   the	   large	  proteoglycan	  aggrecan,	  organised	  in	  orderly	  aggregates	  along	  the	  polysaccharide	  hyaluronan	   (Hardingham	   &	   Muir,	   1972).	   It	   contains	   a	   number	   of	   negatively	  charged	  chondroitin	  sulfate	  and	  keratan	  sulfate	  glycosaminoglycan	  (GAG)	  chains	  which	  attract	  water,	   thereby	  keeping	   cartilage	  hydrated,	   and	   together	  with	   the	  collagen	   II	   scaffold	   ensuring	   compressibility	   (counteracting	   turgor)	   of	   load-­‐bearing	  articular	  cartilage.	  An	  additional	  collagen	  network	  of	  beaded	  filaments	  of	  collagen	  VI	  can	  be	  found	  in	  the	   ‘territorial’	  matrix	  close	  to	  the	  cells	  (Ayad	  et	  al,	  1989)	  (Figure	  1).	  Aggrecan	  can	  interact	  with	  fibrillins,	  associated	  with	  elastin	  in	  elastic	   tissues	   (e.g.	   vascular	   walls),	   fibulins	   and	   tenascins	   (Day	   et	   al,	   2004).	  Tenascin-­‐C	   forms	  hexamers	   and	   interacts	  with	   fibronectin,	   aggrecan	  and	  many	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more	   ECM	   molecules	   (Jones	   &	   Jones,	   2000).	   Tenascin-­‐X,	   on	   the	   other	   hand,	  deserves	   a	   mention	   as	   it	   facilitates	   collagen	   fibril	   packing	   (Minamitani	   et	   al,	  2004;	   Bristow	   et	   al,	   2005).	   Perlecan	   typical	   for	   basement	   membranes	   is	   also	  implicated	   in	   collagen	   fibre	   assembly	   in	   cartilage.	   Its	   heavily	   sulphated	  chondroitin	  sulphate	  chains	  have	  an	  ability	  to	  accelerate	  this	  process	  (Kvist	  et	  al,	  2006).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  One	  of	  the	  important	  collagen	  binding	  partners	  is	  fibronectin	  (FN)	  (Engvall	  et	   al,	   1978),	   a	   disulphide-­‐bonded	   dimer	   containing	   three	   types	   of	   repeating	  modules,	   of	   which	   types	   I	   and	   II	   interact	   with	   collagen.	   It	   also	   mediates	  
Figure	  1.	  Schematic	  depiction	  of	  the	  ECM	  protein	  networks.	  Large	  multimolecular	  assemblies	  of	  the	  
ECM	   constituents	   in	   cartilage	   are	   indicated	   in	   the	   territorial	  matrix	   (closer	   to	   the	   cells)	   and	   in	   the	  
interterritorial	  matrix	  (at	  a	  distance	  of	  the	  cells).	  Beaded	  filament	  networks	  of	  collagen	  VI,	  collagen	  II	  
and	  XI	   ‘thin’	  hybrid	  fibrils	  and	   ‘thick’	  collagen	   II	  homotypic	   fibrils	  are	  shown.	  Collagen	   IX	   in	  cartilage	  
binds	  to	  collagen	  II	  fibres	  (Eyre	  et	  al,	  2004;	  Wu	  et	  al,	  1992)	  in	  a	  way	  that	  allows	  interactions	  with	  other	  
matrix	   components	   via	   its	   NC4	   domain	   (Vaughan	   et	   al,	   1988).	   Collagen-­‐binding	   small	   leucine-­‐rich	  
repeat	   proteins	   such	   as	   decorin,	   fibromodulin,	   biglycan,	   thrombospondin	   5	   (cartilage	   oligomeric	  
matrix	  protein,	  COMP)	  are	  shown	  among	  other	  ECM	  molecules.	  Some	  cell-­‐matrix	  interactions	  are	  also	  
depicted.	  Redrawn	  after	  Heinegård	  (2009)	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interactions	   with	   other	   ECM	   components	   and	   cells	   through	   binding	   of	   cell-­‐surface	   integrins	   (Pierschbacher	   &	   Ruoslahti,	   1984;	   Hynes	   et	   al,	   1989)	   and	  heparan	   sulfate	   proteoglycans	   (e.g.	   syndecan	   (Saunders	   &	   Bernfield,	   1988;	  Elenius	   et	   al,	   1990)).	   The	   direct	   FN-­‐integrin	   interaction	   triggers	   FN	  polymerisation	  (Mao	  &	  Schwarzbauer,	  2005)	  and	  is	   involved	  in	  collagen	  matrix	  assembly	  (Kadler	  et	  al,	  2008).	  	  Small	  nonaggregating	  proteoglycans	  of	  the	  leucine-­‐rich	  repeat	  (LRR)	  family:	  fibromodulin,	  decorin,	  biglycan,	  asporin,	   lumican	  and	  chondroadherin,	   together	  with	   matrilins,	   thrombospondins	   (e.g.	   thrombospondin	   5	   or	   COMP	   –	   cartilage	  oligomeric	  matrix	  protein),	  and	  other	  multimeric	  proteins	  provide	  network	  links	  between	  collagen	  fibres,	  aggrecan	  and	  other	  ECM	  components,	  and	  regulate	  the	  accretion	  and	  stability	  of	  these	  assemblies	  (Heinegard,	  2009).	  	  Cells	   are	   attached	   to	   the	   matrix	   network	   via	   a	   number	   of	   cell	   surface	  receptors	   and	   adhesion	   molecules	   such	   as	   integrins,	   membrane-­‐associated	  heparan	   sulphate	   proteoglycans	   (i.e.	   syndecans	   and	   glypicans)	   and	  hyaluronan	  receptors	   (i.e.	   CD44	   (Peach	   et	   al,	   1993)),	   which	   are	   also	   involved	   in	   cell	  migration.	  	  Collagens	   are	   indeed	   linked	   to	   myriads	   of	   the	   multimolecular	   assemblies	  and	  cells.	  Some	  of	  the	  interactions	  associated	  with	  collagens	  will	  be	  discussed	  in	  a	  greater	  detail	  in	  the	  following	  sections.	  	  	  
1.2.	  Collagen	  
 Collagen	  means	   “glue	   former”	   from	   a	  Greek	  word	   ‘kolla’	  meaning	   ‘glue’.	  	  When	  tissues	  such	  as	  skin,	  bone,	  cartilage	  and	  tendon	  are	  boiled	  in	  water	  and	  the	  extracts	  are	  evaporated	  they	  indeed	  produce	  glue	  which	  was	  already	  known	  by	  the	  Romans	  (Weiss	  &	  Jayson,	  1982).	  Considering	  the	  body	  parts	  where	  collagen	  prevails	   it	   is	   not	   surprising	   that	   it	   is	   the	  most	   abundant	   protein	   in	   animals.	   In	  humans,	   it	   comprises	   one-­‐third	   of	   the	   total	   protein.	   It	   is	   also	   likely	   to	   be	   the	  oldest	  protein	  detected	  to	  date,	  as	  a	  fossil	  of	  a	  68	  million-­‐year-­‐old	  Tyrannosaurus	  
rex	  seemed	  to	  contain	  intact	  collagen	  (Asara	  et	  al,	  2007;	  Schweitzer	  et	  al,	  2007).	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1.2.1.	  Collagen	  polymorphism	  and	  functions	  	  For	   long	  collagen	  has	  been	  known	   to	   form	  highly	  ordered	  bundles,	  visible	  even	   under	   low	   magnification	   of	   a	   light	   microscope.	   These	   fibres,	   composed	  mainly	  of	  archetypal	  collagen	  type	  I,	  provide	  tendons	  with	  tensile	  strength,	  act	  as	  a	   scaffold	   filled	   with	  minerals	   in	   bone,	   and	   ensure	   firmness	   of	   the	   skin.	   More	  recently	  it	  has	  become	  clear	  that	  collagens	  are	  a	  large	  and	  widespread	  family	  of	  proteins.	   They	   not	   only	   exist	   as	   assemblies	   responsible	   for	   the	   structural	  integrity	  and	  mechanical	  characteristics	  of	  animal	  tissues	  (Brown	  &	  Timpl,	  1995;	  Kadler,	   1995),	   but	   in	   various	   forms	   they	   play	   important	   roles	   in	   cell	   adhesion	  and	   migration,	   angiogenesis,	   tissue	   morphogenesis	   and	   repair	   and	   in	   cancer.	  Moreover,	   they	   can	   be	   precursors	   of	   bioactive	   peptides	   that	   have	   paracrine	  functions	  (Kadler	  et	  al,	  2007).	  	  The	   collagen	   family	   encompasses	   at	   least	   29	   genetic	   types	   in	   vertebrates,	  numbered	  I-­‐XXIX	  (Myllyharju	  &	  Kivirikko,	  2001;	  Soderhall	  et	  al,	  2007).	  There	  are	  also	   a	   number	   of	   collagen-­‐like	   proteins,	   including	   the	   neurotransmitter	   acetyl	  cholinesterase,	   the	   C1q	   component	   of	   complement,	   adiponectin,	   ficolin,	  macrophage	   receptor	   and	   surfactant	   protein	   (Hulmes,	   1992).	   Various	   types	   of	  collagen	   have	   been	   grouped	   according	   to	   their	   distributions,	   structures	   and	  functions	  (Table	  1).	  	  
	  
Table	  1.	  Classification	  of	  collagens	  and	  their	  tissue	  distribution 
Collagen	  type	   Distribution	  /	  remarks	  
Fibril-­forming	  	  
I	   Non-­‐cartilaginous	  connective	  tissues,	  e.g.	  tendon,	  ligament,	  cornea,	  
bone,	  annulus	  fibrosis,	  skin	  
II	   Cartilage,	  vitreous	  humour	  and	  nucleus	  pulposus	  
III	   Co-­‐distributes	  with	  collagen	  I,	  especially	  in	  embryonic	  skin	  and	  hollow	  
organs	  
V	   Co-­‐distributes	  with	  collagen	  I,	  especially	  in	  embryonic	  tissues	  and	  in	  
cornea	  
XI	   Co-­‐distributes	  with	  collagen	  II	  
XXIV	   Shares	  sequence	  homology	  with	  the	  fibril-­‐forming	  collagens;	  has	  minor	  
interruptions	  in	  the	  triple	  helix;	  selective	  expression	  in	  developing	  
cornea	  and	  bone	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XXVII	   Shares	  sequence	  homology	  with	  the	  fibril-­‐forming	  collagens;	  has	  minor	  
interruptions	  in	  the	  triple	  helix;	  found	  in	  embryonic	  cartilage,	  developing	  
dermis,	  cornea,	  inner	  limiting	  membrane	  of	  the	  retina	  and	  major	  
arteries	  of	  the	  heart;	  restricted	  to	  cartilage	  in	  adults;	  found	  in	  fibrillar-­‐
like	  assemblies	  
Network-­forming	  
IV	   Basement	  membranes;	  important	  filtration	  function	  
VIII	   Descement’s	  membrane	  
X	   Hypertrophic	  cartilage	  
Beaded	  filament-­forming	  
VI	   Widespread,	  especially	  muscle	  
XXVI	   Also	  known	  as	  EMI	  domain-­‐containing	  protein	  2,	  protein	  Emu2,	  Emilin	  
and	  multimerin	  domain-­‐containing	  protein	  2	  
XXVIII	   A	  component	  of	  the	  basement	  membrane	  around	  Schwann	  cells;	  a	  von	  
Willebrand	  factor	  A	  domain-­‐containing	  protein	  with	  numerous	  
interruptions	  in	  the	  triple-­‐helical	  domain	  
Anchoring	  fibrils	  
VII	   Dermal-­‐epidermal	  junction	  
Fibril-­	  associated	  (FACIT*)	  
IX	   Co-­‐distributes	  with	  collagen	  II,	  especially	  in	  cartilage	  and	  vitreous	  
humour	  
XII	   Found	  with	  collagen	  I	  
XIV	   Found	  with	  collagen	  I	  
XVI	   Integrated	  into	  collagen	  fibrils	  and	  fibrillin-­‐1	  microfibrils	  
XIX	   Rare;	  localised	  to	  basement	  membrane	  zones;	  contributes	  to	  muscle	  
physiology	  and	  differentiation	  
XX	   Widespread	  distribution,	  most	  prevelant	  in	  corneal	  epithelium	  
XXI	   Widespread	  distribution	  
XXII	   Localised	  at	  tissue	  junctions	  –	  e.g.	  myotendinous	  junction,	  
cartilagesynovial	  fluid,	  hair	  follicle-­‐dermis	  
Transmembrane	  (MACIT*)	  
XIII	   Neuromuscular	  junctions,	  skin	  
XVII	   Also	  known	  as	  the	  bullous	  pemphigoid	  antigen	  2/BP180;	  localised	  to	  
epithelia;	  an	  epithelial	  adhesion	  molecule;	  ectodomain	  cleaved	  by	  
ADAM	  proteinases	  
XXIII	   Limited	  tissue	  distribution;	  exists	  as	  a	  transmembrane	  and	  shed	  form	  
XXV	   CLAC-­‐P	  –	  precursor	  protein	  for	  CLAC	  (collagenous	  Alzheimer	  amyloid	  
plaque	  component)	  
Ectodysplasin	  A	   Ectoderm	  














XV	   Located	  between	  collagen	  fibrils	  that	  are	  close	  to	  basement	  membranes;	  
found	  in	  the	  eye,	  muscle	  and	  microvessels;	  a	  close	  structural	  homologue	  
of	  collagen	  XVIII	  
XVIII	   Associated	  with	  basement	  membranes;	  endostatin	  is	  proteolytically	  
released	  from	  the	  C-­‐terminus	  of	  collagen	  XVIII;	  important	  for	  retinal	  
vasculogenesis	  
*FACIT	   and	   MACIT	   –	   fibril-­‐associated	   and	   membrane-­‐associated	   collagens,	   respectively,	   with	  
interrupted	  triple	  helices.	  Adapted	  and	  modified	  from	  (Gelse	  et	  al,	  2003;	  Kadler	  et	  al,	  2007).	  
 	  Over	   a	   1000	  mutations	   in	   different	   collagen	   genes	   are	   known	   for	   causing	  diseases.	  Their	  excellent	  description	  was	  provided	  by	  Myllyharju	  and	  Kivirikko	  (Myllyharju	  &	  Kivirikko,	  2001;	  Myllyharju	  &	  Kivirikko,	  2004)	  and	  is	  beyond	  the	  scope	   of	   this	   introduction.	   However,	   as	   the	   wide	   spectrum	   of	   collagen-­‐related	  disorders	   indicates	   the	   importance	   of	   collagen,	   some	   of	   these	   should	   be	  mentioned	  briefly:	  osteogenesis	   imperfecta	   (fragile,	  brittle	  bones)	   is	   associated	  with	  mutations	   in	   collagen	   I;	  Kniest	  dysplasia	   (dwarfism,	  problems	  with	  vision	  and	   hearing)	   –	   collagen	   II;	   arterial	   aneurysms	   –	   collagen	   III;	   Alport	   syndrome	  (kidney	   failure)	   –	   collagen	   IV;	   subtypes	   of	   Ehlers-­‐Danlos	   syndrome	   (joint	  hypermobility	  and	  skin	  laxity)	  –	  collagens	  I	  and	  V;	  Bethlem	  myopathy	  and	  Ulrich	  muscular	  dystrophy	  (muscle	  weakness,	   joint	  deformities)	  –	  collagen	  VI;	   certain	  subtypes	   of	   epidermolysis	   bullosa	   (skin	   blisters)	   –	   collagen	   VII;	   Knobloch	  syndrome	   (severe	   ocular	   anomalies,	   occipital	   scalp	   defect)	   –	   collagen	   XVIII;	  Stickler	   syndrome	   (facial	   abnormalities,	   eye	   problems,	   hearing	   loss,	   and	   joint	  problems)	  –	  collagens	   II,	   IX	  and	  XI;	  and	  some	  chondrodysplasias	  –	  collagens	   IX	  and	  XI.	  	  
	  
1.2.2.	  Collagen	  structure	  	  All	   collagens	  consist	  of	   three	  polypeptide	   (α)	  chains,	  which	  at	   least	   in	  one	  region	   of	   the	   protein	   fold	   into	   a	   unique	   triple	   helix.	   These	   three	   strands	   are	  identical	   in	   some	   collagen	   types	   (homotrimeric	   types)	   and	   different	   in	   others	  (heterotrimeric	   types).	   Moreover,	   the	   triple-­‐helical	   domain	   may	   be	   dominant	  with	  little	  or	  no	  imperfections,	  as	  in	  fibril-­‐forming	  collagens	  (e.g.,	  types	  I,	  II,	  III),	  or	   relatively	   minor	   (collagens	   XII	   and	   XIV),	   depending	   on	   the	   function	   and	  localisation	   of	   a	   given	   collagen	   type.	   Some	   collagens	   occur	   as	   trans-­‐membrane	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proteins	  (e.g.,	  types	  XIII	  and	  XVII)	  and	  have	  numerous	  interruptions	  in	  the	  triple	  helix.	   Others	   decorate	   fibril	   surfaces	   (collagen	   IX,	   XII	   and	   XIV)	   and	   comprise	  globular	   non-­‐collagenous	   (NC)	   domains.	   For	   example,	   collagen	   IX	   in	   cartilage	  binds	  covalently	  to	  collagen	  II	  fibres	  (Wu	  et	  al,	  1992;	  Eyre	  et	  al,	  2004)	  in	  a	  way	  that	   allows	   interactions	   with	   other	   matrix	   components	   via	   its	   NC4	   domain	  (Vaughan	   et	   al,	   1988)	   (Figure	   1).	   Nevertheless,	   most	   collagens	   associate	   into	  homo-­‐	   or	   heterotypic	   superstructures	   (Hulmes,	   2002).	   Collagen	   VI	   assembles	  into	  beaded	  filaments,	  found	  throughout	  the	  body,	  especially	  in	  muscle.	  Collagen	  types	  IV,	  VIII	  and	  X	  form	  networks,	  whereas	  the	  previously	  mentioned	  collagen	  IV	  interlaced	  network	  is	  a	  key	  constituent	  of	  the	  basement	  membrane	  (Kadler	  et	  al,	  2007).	  	  
1.2.2.1.	  Structure	  of	  the	  collagen	  triple	  helix	  	  The	   formation	   of	   a	   regular	   trimeric	   coil	   arises	   from	   a	   specific	   primary	  structure,	   where	   every	   third	   amino	   acid	   of	   each	   α-­‐chain	   is	   glycine	   (Gly),	   the	  smallest	  amino	  acid	  which	  perfectly	  fits	  the	  interior	  of	  the	  helix	  (Figure	  2).	  The	  other	  two	  positions	  of	  the	  Gly-­‐X-­‐Y	  repeating	  triplets	  are	  abundantly	  represented	  by	  proline	  and	  its	  derivative	  hydroxyproline,	  respectively,	  but	  can	  be	  any	  amino	  acid	  (Ramachandran	  &	  Kartha,	  1955;	  Fraser	  et	  al,	  1979).	  Such	  a	  configuration	  of	  imino	  acids	  imposes	  the	  conformation	  of	  a	  left-­‐handed	  polyproline	  II-­‐type	  (PPII)	  helix	   in	   the	   collagen	   α	   chains,	   which	   intertwine	   to	   form	   a	   right-­‐handed	  superhelix	   (Engel	   &	   Prockop,	   1991).	   All	   peptide	   bonds	   in	   the	   constituent	   PPII	  helices	   are	   in	   the	   trans	   conformation	   (Cowan	   et	   al,	   1955),	   which	   provides	   a	  structural	   constraint	   keeping	   the	   chains	  wound	   together	   (see	   next	   paragraph).	  Hydrogen	  bonds	   are	   formed	  between	   the	  neighbouring	  polypeptide	  backbones	  involving	  carbonyl	  groups	  between	  X-­‐Y	  doublets	  and	  peptide	  bond	  amides	  of	  Gly	  residues	   facing	   inward	   the	   helix	   (Kramer	   et	   al,	   2001)	   (Figure	   2).	   The	   three	  strands	   in	   the	  collagen	  coil	  are,	   therefore,	   staggered	   lengthwise	  by	  one	  residue	  and	   every	   triplet	   has	   a	   single	   interstrand	  N-­‐HGly∙∙∙O=CX	  hydrogen	  bond	   (Rich	  &	  Crick,	   1955;	   Rich	  &	   Crick,	   1961;	   Bella	   et	   al,	   1994;	   Brodsky	  &	   Persikov,	   2005).	  Another,	   although	   probably	   weaker	   interchain	   hydrogen	   bonding	   between	   Cα	  hydrogen	  from	  Gly	  or	  Y	  and	  C=O	  group	  of	  Gly	  and	  X,	  was	  proposed	  by	  Bella	  and	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1.2.2.2.	  Stability	  of	  the	  collagen	  triple	  helix	  	  Besides	   the	   ladder	   of	   hydrogen	   bonds	   along	   the	   collagen	   molecule	   the	  pyrrolidine	  rings	  of	  the	  imino	  acids	  in	  the	  X	  and	  Y	  positions	  promote	  the	  wound	  tertiary	  structure	  by	  preorganising	  individual	  α	  chains	  into	  a	  PPII	  conformation	  (Kramer	   et	   al,	   1999).	   Thus,	   the	   entropic	   cost	   for	   collagen	   folding	   is	   reduced	  (Cram,	   1988).	   Moreover,	   the	   Hyp	   in	   the	   Y	   position	   dramatically	   increases	   the	  thermal	  stability	  of	  triple	  helices	  (Berg	  &	  Prockop,	  1973;	  Rosenbloom	  et	  al,	  1973;	  Privalov,	   1982).	   It	   has	  been	  hypothesised	   that	   this	   stabilisation	   is	  mediated	  by	  hydrogen	  bonding	  of	   the	   side	   chain	  hydroxyl	   group	  with	   the	  exposed	   carbonyl	  group	   of	   the	   adjacent	   polypeptide	   backbone	   through	   a	   water	   molecule	  (Ramachandran	   et	   al,	   1973;	   Burjanadze,	   1992).	   Notably,	   the	   triple	   helices	   are	  surrounded	  by	  highly	  ordered	  hydration	  networks	  (Bella	  et	  al,	  1995),	  but	   their	  
Figure	  2.	  Collagen	  structure.	  Three	  α	  chains	  of	  collagen	  are	  indicated	  with	  three	  
different	  colours.	  (Top)	  sphere	  model.	  (Bottom)	  different	  views	  on	  sticks	  model	  in	  
the	   magnifying	   rectangles.	   The	   chain	   colours	   are	   maintained	   except	   glycines	  
which	   are	   shown	   in	   yellow.	   Other	   residues	   are	   labeled	   with	   relevant	   colours.	  
Hydrogen	   bonds	   are	   indicated	   with	   black	   dashed	   lines.	   The	   model	   image	   was	  
generated	  using	  Pymol	   software	   (DeLano	  Scientific	   LLC,	  San	  Francisco,	  CA,	  USA)	  
based	  on	  the	  pdb	  entry	  3AOA.	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contribution	  to	  the	  stability	  of	  the	  collagen	  fold	  is	  still	  under	  debate	  (Fukuda	  et	  al,	   2000;	   Ravikumar	   &	   Hwang,	   2008).	   Natural	   collagens,	   unlike	   a	   crystalline	  structures	  of	  collagen-­‐related	  peptides	  used	  in	  X-­‐ray	  diffraction	  studies	  (Bella	  et	  al,	  1995)	   lack	   long	  stretches	  of	  Gly-­‐X-­‐Hyp	   triads	   (Ramshaw	  et	  al,	  1998),	   so	   the	  extensive	   networks	   of	  water	   bridges	   stitching	   together	   coiled	   collagen	   strands	  cannot	  be	  formed	  (Shoulders	  &	  Raines,	  2009).	  Several	  studies	  denied	  the	  role	  of	  the	  specific	  water	  bridges	  in	  conferring	  stability	  to	  the	  collagen	  fold	  (Engel	  et	  al,	  1977;	  Holmgren	   et	   al,	   1998;	  Holmgren	   et	   al,	   1999).	  An	   alternative	   explanation	  for	   the	   stabilising	   role	   of	   Hyp	   in	   the	   Y	   position	   stems	   from	   the	   fundamental	  importance	  of	  the	  stereo-­‐configuration	  of	  the	  electronegative	  hydroxyl	  group	  at	  the	   Pro	   ring.	   It	   is	   only	   beneficial	   when	   installed	   as	   the	   4R	   and	   not	   the	   4S	  substituent	   (Inouye	   et	   al,	   1976).	   Accordingly,	   Hyp	   was	   shown	   to	   stabilise	   the	  collagen	  helix	  via	  a	  steric	  and	  stereoelectronic	  effect	  (Shoulders	  &	  Raines,	  2009)	  enforcing	  an	  advantageous	  Pro	  ring	  pucker,	  which	  in	  turn	  favours	  appropriate	  φ	  and	  ψ	  torsion	  angles	  for	  the	  triple-­‐helical	  arrangement.	  Arginine	  in	  the	  Y	  position	  was	   also	   found	   to	   stabilise	   the	   triple	   helix	   in	   a	   similar,	   stereospecific	   manner	  (Yang	  et	  al,	  1997).	  This	  inductive	  effect	  helps	  to	  maintain	  the	  trans	  conformation	  of	  all	  peptide	  bonds	  (Holmgren	  et	  al,	  1998)	  and	  may	  partly	  explain	  the	  tightness	  of	  the	  triple	  helix,	  in	  the	  presence	  of	  only	  two	  direct	  hydrogen	  bonds	  between	  its	  chains	  per	  each	  repeating	  triplet.	  Compared	  to	  secondary	  structures	   like	   the	  β-­‐sheet,	  which	  is	  stabilised	  by	  one	  hydrogen	  bond	  per	  each	  residue,	  the	  activation	  enthalpy	   for	  collagen	  denaturation	   is	  unusually	  high	  (Miles	  et	  al,	  1995;	  Miles	  &	  Burjanadze,	   2001).	   Still,	   the	   equilibrium	  melting	   temperature	   (Tm)	   of	   the	  main	  fibrillar	   collagen	   (type	   I)	   helix	   lies	   several	   degrees	   below	  body	   temperature	   in	  vertebrates	  (Leikina	  et	  al,	  2002)	  and	  is	  adjusted	  to	  be	  so	  in	  different	  species	  by	  Hyp	   content	   (Privalov,	   1982).	   How	   can	   stable	   tissue	   structures	   emerge	   from	  unstable	  building	  blocks?	  Clearly,	  collagen	  fibril	  formation	  has	  a	  stabilising	  effect	  on	  triple	  helices.	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1.2.3.	  Fibril-­‐forming	  collagens	  	  Collagen	  types	  I,	  II,	  III,	  V	  and	  XI	  build	  cross-­‐striated	  fibrils	  of	  a	  characteristic	  axial	  64-­‐67	  nm	  D-­‐periodicity	  (Kadler	  et	  al,	  1996;	  Ottani	  et	  al,	  2001)	  observed	  by	  transmission	  electron	  microscopy	  (TEM)	  images	  (Figure	  3).	  The	  diameter	  of	  the	  fibrils	   ranges	   from	   10	   to	   500	   nm	   (Flint	   et	   al,	   1984;	   Fleischmajer	   et	   al,	   1988),	  depending	  on	  tissue	  and	  its	  state	  of	  development,	  and	  the	   length	  of	   the	   fibril	   is	  essentially	   undefined,	   but	   was	   found	   to	   be	   up	   to	   1	   cm	   in	   tendon	   (Craig	   et	   al,	  1989).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Type	   I	   collagen	   is	   a	   heterotrimer,	   consisting	   of	   two	   α1(I)	   chains	   and	   one	  α2(I)	  chain,	  although	  a	  homotrimeric	   isoform	  ([α1(I)]3)	   is	   found	  in	  fetal	   tissues	  (Jimenez	   et	   al,	   1977)	   or	   pathologies,	   such	   as	   fibrosis	   or	   cancer	   (Rojkind	   et	   al,	  1979;	  Narayanan	   et	   al,	   1980;	   Shapiro	  &	  Eyre,	   1982;	   Pucci	  Minafra	   et	   al,	   1985;	  Makareeva	   et	   al,	   2010).	   Other	   major	   fibrillar	   collagens,	   types	   II	   and	   III	   are	  homotrimers,	   each	   composed	   of	   three	   identical	   α1(II)	   and	   α1(III)	   chains,	  respectively.	  Less	  prominent	  collagens	  V	  and	  XI	  are	  both	  heterotrimeric	  ([α1(V),	  
Figure	   3.	   Regular	   staggering	   of	   collagen	   triple	   helices	   in	   the	   D-­‐
periodic	   structure	   of	   the	   collagen	   fibril.	   (Top)	   Two-­‐dimensional	  
representation	  of	  the	  microfibril,	  showing	  gap	  and	  overlap	  regions	  
which	   together	   constitute	  one	  D-­‐period.	   (Bottom)	  TEM	   image	  of	  
the	   negatively	   stained	   collagen	   fibril	   aligned	   with	   the	   model	  
above.	   The	   broad	   dark	   and	   light	   zones	   are	   produced	   by	  
preferential	  stain	  (sodium	  phosphotungstic	  acid)	  penetration	  into	  
the	  gap	  regions.	  Redrawn	  and	  modified	  after	  (Kadler	  et	  al,	  1996)	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α2(V),	   α3(V)]	   or	   [{α1(V)}2,	   α2(V)]	   and	   [α1(XI),	   α2(XI),	   α3(XI)],	   respectively).	  Collagen	  I	  is	  widespread	  in	  the	  body,	  except	  cartilaginous	  tissues.	  Collagen	  II	  on	  the	  other	  hand	  is	  specific	  for	  cartilage	  (Canty	  &	  Kadler,	  2005).	  Type	  III	  collagen	  is	  present	  in	  elastic	  tissues,	  mainly	  in	  blood	  vessels	  and	  skin	  (Kielty	  et	  al,	  1993)	  and	  is	  often	  found	  at	  the	  periphery	  of	  type	  I	  collagen	  fibrils,	  especially	  in	  embryonic	  skin	   (Keene	  et	  al,	  1987).	   Indeed,	   collagen	   fibrils	  almost	  never	  contain	  only	  one	  collagen	   type.	   Also	   collagens	   V	   and	   XI	   co-­‐distribute	   with	   collagens	   I	   and	   II,	  respectively	  (Kypreos	  et	  al,	  2000;	  Eyre,	  2002;	  Wenstrup	  et	  al,	  2004a).	  	  Eventually,	   some	   collagen	   fibrils	   become	   organised	   into	   elaborate	  hierarchical	   arrays	   of	   parallel	   rope-­‐like	   fibres	   in	   tendons	   and	   ligaments,	  concentric	  layers	  in	  bones	  or	  orthogonal	  lattices	  in	  the	  cornea.	  In	  the	  latter,	  such	  an	  arrangement	  pertains	  to	  small	  diameter	  fibrils	  (~20	  nm)	  and	  is	  essential	  for	  optical	  transparency	  (Hulmes,	  2002).	  ‘Thin’	  fibrils	  (16	  nm)	  are	  also	  characteristic	  of	  cartilage,	  besides	  homotypic	  type	  II	  collagen	  ‘thick’	  (40	  nm)	  fibrils	  (Kadler	  et	  al,	   2008).	  Only	   the	   ‘thin’	   species	   are	  hybrids	  of	   collagen	   II	   and	  XI	   (Keene	   et	   al,	  1995).	  	  
1.2.3.1.	  Biosynthesis	  and	  fate	  of	  fibrillar	  collagen	  molecules	  	  Fibrillar	   collagens	   are	   synthesised	   primarily	   by	   fibroblasts,	   but	   also	  chondrocytes	  and	  osteoblasts,	  and	  to	  a	  lesser	  extent	  by	  epithelial	  cells	  or	  smooth	  muscle	  cells	  (Harkness,	  1961;	  Hulmes,	  2002)	  in	  the	  form	  of	  soluble	  procollagens.	  Before	  trimerisation	  and	  secretion,	  procollagen	  chains	  are	  assisted	  by	  a	  number	  of	   ER-­‐resident	   chaperones,	   including	   a	   collagen-­‐specific	   HSP47	   (Nagata,	   1998;	  Nagai	   et	   al,	   2000;	   Nagata,	   2003),	   and	   several	   post-­‐translationally	   modifying	  enzymes.	  These	  include:	  peptidylproline	  cis-­‐trans	  isomerase	  (PPI),	  necessary	  for	  converting	  every	  Pro	  residue	  to	  trans	  configuration	  (Bachinger,	  1987;	  Davis	  et	  al,	  1989);	  prolyl-­‐4-­‐hydroxylase	  (P4H),	  required	  to	  convert	  Pro	  to	  Hyp	  (Kivirikko	  &	  Myllyharju,	   1998);	   lysyl	   hydroxylases	   (Harwood	   et	   al,	   1974;	   Kellokumpu	   et	   al,	  1994;	   Mercer	   et	   al,	   2003);	   and	   two	   glycosyltransferases	   adding	   glucose	   and	  galactose	   moieties	   to	   hydroxylysines	   (Harwood	   et	   al,	   1975).	   Hydroxylysyl	  residues	  are	  essential	  for	  collagen	  crosslinking	  at	  a	  later	  stage.	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Procollagen	   travels	   from	   the	   rough	   ER	   through	   the	   Golgi	   to	   the	   plasma	  membrane	   as	   a	   folded,	   largely	   triple-­‐helical	   molecule.	   The	   N-­‐	   and	   C-­‐terminal	  propeptides	  flank	  short	  non-­‐helical	  extensions,	  named	  telopeptides,	  on	  each	  end	  of	   the	  300	  nm	  (~1000	  residue)	   long	  uninterrupted	   triple-­‐helix.	  The	  N-­‐terminal	  propeptides	   are	   variable	   among	   different	   fibrillar	   collagens.	   Most	   of	   them	  contain	   a	   cysteine-­‐rich	   domain	   and	   types	   V	   and	   XI	   carry	   additional	   large	   non-­‐triple-­‐helical	  domains	  at	  the	  N-­‐termini,	  such	  as	  proline-­‐	  and	  arginine-­‐rich	  (PARP)	  region	   and	   the	   variable	   domain	   (Brown	   &	   Timpl,	   1995).	   In	   addition,	   all	   N-­‐propeptides	   include	  an	  extra	  stretch	  of	   triple-­‐helix	  preceding	   the	  N-­‐telopeptide	  region,	  and	  the	  processing	  occurs	  at	  the	  junction	  between	  them	  (Figure	  4a).	  The	  C-­‐propeptides	  are	  highly	  conserved	  across	  fibrillar	  collagens,	  although	  they	  vary	  at	  one	  site	  of	  15	  residues	  which	  is	  known	  as	  the	  chain	  recognition	  region	  (Lees	  et	  al,	   1997).	   This	   site	   determines	   the	   correct	   chain	   stoichiometry	   during	  procollagen	   trimer	   assembly	  which	   proceeds	   in	   the	   C-­‐to-­‐N	   direction	   in	   the	   ER	  lumen	   (Engel	  &	  Prockop,	   1991;	  McLaughlin	  &	  Bulleid,	   1998;	  Khoshnoodi	   et	   al,	  2006).	  	  The	   collagen	   trafficking	   and	   secretion	  mechanism	   is	   not	   fully	   understood.	  Being	   large	   proteins,	   collagens	   are	   not	   transported	   through	   Golgi	   via	  conventional	   vesicle-­‐mediated	   mechanism	   (Bonfanti	   et	   al,	   1998;	   Trucco	   et	   al,	  2004).	  Their	  association	  into	  cross-­‐banded	  fibrils	  can	  begin	  even	  inside	  the	  cell	  (Canty	   et	   al,	   2004).	   Short	   fibrils	   are	   then	   extruded	   through	   distinctive	   narrow	  cellular	  recesses	  called	   fibripositors	  (Birk	  &	  Trelstad,	  1984;	  Yang	  &	  Birk,	  1986;	  Ploetz	  et	  al,	  1991;	  Canty	  et	  al,	  2004).	  Outside	  the	  cell,	   the	   fibrils	  remain	  closely	  attached	  to	  the	  fibripositor	  membrane	  infoldings	  (cell-­‐surface	  crypts)	  and	  can	  be	  propagated	   by	   addition	   of	   individual	   collagen	   molecules	   (Holmes	   et	   al,	   1992;	  Holmes	  et	  al,	  1998)	  or	  by	  end-­‐to-­‐end	  fusions	  with	  other	  short	  fibrils	  (Graham	  et	  al,	  2000)	  (Figure	  5).	  This	  is	  consistent	  with	  increasing	  evidence	  that	  cell-­‐surface	  proteins	  are	  implicated	  in	  fibrillogenesis	  in	  situ	  (see	  below).	  	  One	   must	   consider	   that	   fibrillogenesis	   requires	   processing	   of	   the	  procollagen.	   It	   has	   been	   generally	   accepted	   that	   collagen	   maturation	   to	   a	  fibrillogenesis-­‐competent	  molecule	  is	  an	  extracellular	  event,	  occurring	  within	  the	  plasma	   membrane	   channels	   of	   fibripositors.	   How	   then	   could	   fibril	   nucleation	  take	   place	   intracellularly?	   Canty	   et	   al	   (2004)	   observed	   that	   in	   case	   of	   chick	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embryo	  tendon,	  procollagen	  I	  can	  be	  processed	  in	  the	  secretory	  pathway,	  which	  explains	   the	   occurrence	   of	   specific	   short	   fibrils	   enclosed	   within	   intracellular	  membranes	  (Canty	  &	  Kadler,	  2005).	  Not	   only	   after,	   but	   also	   before	   processing,	   procollagen	   molecules	   have	   a	  tendency	   to	   aggregate	   (Hulmes	   et	   al,	   1983)	  which	  may	   delay	   their	   processing.	  Segment	   long	   spacing	   (SLS)	   crystallites	   of	   aligned	   procollagen	   molecules	   are	  present	  within	   fibroblasts	   in	  vivo	   and	  are	  secreted	   in	  cell	   cultures	   (Bruns	  et	  al,	  1979),	   together	  with	  the	  procollagen	  N-­‐	  and	  C-­‐proteinases	  (Kerwar	  et	  al,	  1973;	  Layman	   &	   Ross,	   1973)	   that	   cleave	   the	   N-­‐	   and	   C-­‐propeptides.	   Procollagen	   C-­‐proteinases	  are	  also	  known	  as	  bone	  morphogenetic	  protein-­‐1	   (BMP-­‐1)	  and	   the	  tolloid-­‐like	   zinc	   metalloproteinases	   (Kadler	   et	   al,	   2007).	   Procollagen	   N-­‐proteinases	   are	   members	   of	   the	   zinc-­‐dependent	   ADAMTS	   (a	   disintegrin	   and	  
metalloproteinase	  with	  thrombospondin	  motifs)	   family:	  ADAMTS-­‐2,	  ADAMTS-­‐3	  and	   ADAMTS-­‐14	   (Colige	   et	   al,	   2005),	   and	   are	   somewhat	   collagen-­‐type	   specific	  (Prockop	   et	   al,	   1998).	   Collagen	   V	   is	   exceptional,	   in	   that	   the	   N-­‐propeptide	   of	  proα1(V)	   chain	   is	   removed	   by	   BMP-­‐1,	   and	   the	   C-­‐propeptide	   by	   furin	   cleavage	  (Gopalakrishnan	  et	  al,	  2004).	  	  	  
1.2.3.1.	  Collagen	  fibrillogenesis	  	   After	   cleavage	   of	   the	   N-­‐	   and	   C-­‐propeptides	   the	   extrahelical	   telopeptide	  sequences	   are	   exposed.	   These	   are	   critical	   in	   collagen	   fibril	   assembly	   as	   they	  contain	   sites	   that	   interact	   with	   adjacently	   staggered	  molecules	   (Prockop	   et	   al,	  1998).	  In	  addition,	  assembly	  is	  stabilised	  by	  intermolecular	  crosslinks	  (Eyre	  et	  al,	  1984),	   occurring	   between	   a	   telopeptide	   and	   a	   neighbouring	   triple	   helix	   in	  nascent	   fibrils.	   This	   crosslinking	   is	   catalysed	   by	   lysyl	   oxidase	   and	   results	   in	  reducible	   and	   non-­‐reducible	   covalent	   bonds	   between	   ε-­‐amino	   groups	   of	   the	  lysine,	   hydroxylysine	   or	   glycosylated	   hydroxylisine	   residues.	   These	   crosslinks	  underlie	   the	   specific	   mechanical	   properties	   of	   collagen-­‐rich	   tissues,	   although	  excessive	   crosslinking,	   a	   common	   symptom	  of	   aging,	   results	   in	   brittle	   collagen	  fibrils	   (Buehler,	   2006).	   The	   N-­‐telopeptides	   fold	   into	   a	   hairpin	   conformation	  (Mould	  et	  al,	  1990;	  Holmes	  et	  al,	  1993)	  and	  similarly	  the	  C-­‐telopeptides	  adopt	  a	  bent-­‐back	  structure	  upon	  fibril	  formation	  (Orgel	  et	  al,	  2001).	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To	  initiate	  collagen	  assembly	  it	  is	  only	  necessary	  that	  the	  C-­‐propeptides	  are	  removed,	   as	   these	   are	   bulky	   and	   maintain	   high	   solubility	   of	   the	   molecules.	  Moreover,	   the	   fibrils	   are	   propagated	   from	   the	   C-­‐	   to	   N-­‐terminus	   (Kadler	   et	   al,	  1996).	   They	   can	   be	   unipolar	   (all	  molecules	   pointing	   at	   the	   same	   direction)	   or	  bipolar	   (with	   two	   ends	   extending	   in	   opposite	   directions	   from	  a	   single	   location	  along	  the	  fibril)	  (Thurmond	  &	  Trotter,	  1994)	  (Figure	  4b).	  Although	  the	  presence	  of	   the	   N-­‐propeptide	   does	   not	   prevent	   fibril	   formation,	   it	   influences	   the	   fibril	  diameter	   and	   shape.	   This	   is	   seen	   in	   heterotypic	   fibrils	   which	   include	   collagen	  type	  III,	  as	  its	  N-­‐terminal	  processing	  is	  relatively	  slow	  and	  causes	  accumulation	  of	  partially	  processed	  pN-­‐collagen,	  which	  lacks	  the	  C-­‐propeptide	  but	  retains	  the	  N-­‐propeptide.	  This	  may	  result	   in	  positioning	  of	  the	  partially	  processed	  collagen	  molecules	  at	  the	  surface	  and	  away	  from	  the	  center	  of	  the	  hybrid	  fibrils	  thereby	  limiting	   fibril	   growth	   (Chapman,	   1989;	   Linsenmayer	   et	   al,	   1993;	   Kadler	   et	   al,	  1996;	  Birk,	  2001).	  Also	  procollagens	  V	  and	  XI,	  which	  contain	  particularly	  large	  N-­‐propeptides,	  occur	  as	  a	  distribution	  of	  several	  processing	  intermediates	  (Moradi-­‐Ameli	  et	  al,	  1994)	  (their	  roles	  in	  fibrillogenesis	  in	  vivo	  have	  recently	  been	  better	  understood	  and	  will	  be	  discussed	  further	  in	  more	  detail).	  Thus,	  one	  level	  of	  fibril	  diameter	  control	  may	  be	  provided	  by	  heterotypic	  collagen	  interactions.	  Another	  mechanism	  regulating	  the	  fibril	  growth	  and	  fusion	  stems	  from	  the	  interactions	  of	  fibrillar	   collagens	  with	   other	  ECM	  proteins	   (Graham	  et	   al,	   2000)	   such	   as	   small	  leucine-­‐rich	   repeat	   proteoglycans	   (SLRPs),	   including	   decorin	   (Danielson	   et	   al,	  1997),	   biglycan	   (Schonherr	   et	   al,	   1995),	   lumican	   (Chakravarti	   et	   al,	   1998),	   and	  fibromodulin	   (Hedbom	   &	   Heinegard,	   1993)	   as	   well	   as	   the	   matrilins	   and	  thrombospondins	  (Halasz	  et	  al,	  2007),	  mentioned	  earlier	  (Figure	  1).	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction	  
 
 30	  
	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Mature	   collagen	   molecules,	   called	   tropocollagen	   (TC),	   can	   associate	   into	  fibrils	  spontaneously	  (Kadler	  et	  al,	  1996)	  (Figure	  4).	  This	  self-­‐polymerisation	  can	  be	   reconstituted	   in	   vitro	   from	   TC	   monomers	   or	   pN-­‐collagen	   monomers	  (Miyahara	  et	  al,	  1982;	  Kadler	  et	  al,	  1987;	  Kadler	  et	  al,	  1990).	  Even	  triple	  helices	  lacking	  the	  telopeptides	  can	  in	  vitro,	  albeit	  relatively	  slowly,	  assemble	  into	  fibrils	  with	  normal	  morphology,	  which	   suggests	   that	   the	   telopeptides	  have	  a	   catalytic	  function,	  but	  are	  not	  necessary	  at	  this	  stage	  (Kuznetsova	  &	  Leikin,	  1999).	  	  However,	   in	   situ,	   collagen	   fibril	   assembly	   does	   not	   appear	   to	   be	   a	  straightforward	  entropy-­‐driven	  process.	  First	  step	  in	  this	  process	  is	  considered	  a	  
Figure	   4.	   Collagen	   fibril	   formation.	   Procollagen	   consists	   of	   a	   300	   nm	   long	   triple-­‐helical	   domain	  	  
flanked	  by	  a	  trimeric	  globular	  C-­‐propeptide	  domain	  and	  a	  trimeric	  N-­‐propeptide	  domain.	  (a)	  After	  the	  
cleavage	  of	  the	  N-­‐	  and	  C-­‐propeptides	  by	  procollagen	  N-­‐	  and	  C-­‐proteinases,	  respectively,	  procollagen	  
is	   converted	   into	   collagen,	   in	   which	   the	   triple-­‐helical	   domain	   is	   flanked	   by	   non-­‐helical	   N-­‐	   and	   C-­‐
telopeptides.	   (b)	   The	   collagen	  molecules	   can	   spontaneously	   self-­‐assemble	   in	   vitro	   to	   unipolar	   and	  
bipolar	   fibrils	   that	   are	   stabilised	   by	   covalent	   cross-­‐links	   between	   the	   telopeptide	   regions	   and	   the	  
triple-­‐helical	  domains	  of	  the	  adjacent	  molecules.	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formation	   of	   a	   microfibril	   which	   occures	   spontanously	   after	   procollagen	  processing	  (Birk	  et	  al,	  1989).	  	  Microfibrils	  are	  segments	  containing	  5	  collagen	  molecules	   in	  cross	  section	  and	  are	  the	  minimum	  filamentous	  structures	  that	  account	  for	  the	  axial	  D	  repeat,	  as	  shown	  in	  Figure	  3	  using	  a	  two-­‐dimensional	  stack	  model.	  In	  Figure	  5	  a	  three-­‐dimensional	  model	  of	  a	  collagen	  microfibril	  is	  shown	  as	  well	  as	  its	  aggregation	  to	  higher	  order	  structures	  in	  situ.	  Collagen	  early	  fibrils	  deposited	  in	  the	  matrix	  grow	  by	  accretion	  or	  coupling	  of	  prearranged	  microfibrils	  (Birk	  et	  al,	  1989).	  These	  can	  fuse	  side-­‐by-­‐side	  or	  end-­‐to-­‐end	  (Birk	  et	  al,	  1995;	  Graham	  et	  al,	  2000)	  to	  increase	  the	   size.	   The	   inter-­‐	   and	   intra-­‐molecular	   crosslinks	   ‘cement’	   the	   whole	  construction	  in	  the	  tissue.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figure	  5.	  Collagen	  microfibril	  and	   fibril	  assembly	   in	   situ.	   (a)	  Schematic	  3D	   representation	  of	   the	  axial	  packing	  arrangement	  of	  collagen	  molecules	  in	  a	  microfibril	  (pentafibril),	  the	  smallest	  collagen	  
assembly	  that	  exhibits	   the	  D-­‐banded	  structure,	  and	  the	   largest	  spontaneously	  assembling	  fibrillar	  
collagen	   structure	   in	   situ.	   (b)	   The	  microfibril	   is	   a	   basic	   unit	   in	   collagen	   fibril	   assembly.	   Collagen	  
fibrils	  and	  fibres	  grow	  by	  lateral	  fusion	  with	  other	  fibrils	  or	  microfibrils	  and	  by	  end-­‐to-­‐end	  fusion	  of	  
individual	  fibrils. 
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Complex	  suprafibrillar	  collagen	  assemblies	  in	  vitro	  resemble	  different	  forms	  of	   liquid	  crystals	   (Giraud-­‐Guille,	  1996).	  A	   tantalising	  hypothesis	   is	   that	   through	  such	  ordering	  of	  the	  soluble	  precursors	  diverse	  patterns	  of	  collagen	  matrices	  in	  tissues	   might	   be	   pre-­‐established.	   Experiments	   by	   Martin	   et	   al	   (2000),	   using	  procollagen	  in	  a	  physiological	  buffer,	  support	  such	  possibility.	  Liquid	  crystalline	  ordering	   prior	   to	   procollagen	   processing	   may	   underlie	   some	   features	   of	   the	  naturally	   occurring	   insoluble	   fibrils	   as	   the	   preexisting	   architecture	   would	  simplify	   subsequent	   fibrillogenesis	   triggered	   by	   procollagen	   cleavage	   in	   the	  neighbourhood	   of	   the	   plasma	   membrane.	   Of	   note,	   crystallites	   of	   procollagen	  molecules	  were	  found	  in	  fibroblasts	  and	  the	  cell	  culture	  media	  (Bruns	  et	  al,	  1979;	  Hulmes	  et	  al,	  1983).	  A	  fact	  about	  nonspontaneous	  and	  heteronomous	  collagen	  fibrillogenesis	   in	  the	  physiological	  context	  is	  that	  the	  collagen	  I-­‐based	  fibrils	  cannot	  form	  without	  several	  noncollagenous	  proteins.	  These	  are:	  fibronectin	  (FN),	  fibronectin-­‐binding	  integrins	   and	   collagen-­‐binding	   integrins	   (McDonald	   et	   al,	   1982;	   Dzamba	   et	   al,	  1993;	   Li	   et	   al,	   2003).	   Clearly,	   cells	   in	   tissues	   tightly	   control	   the	   synthesis	   of	  collagen	  fibrils	  at	  the	  fibril	  assembly	  level.	  Kadler	  and	  coworkers	  (2008)	  refer	  to	  ~50	  known	  binding	  partners	  of	  fibrillar	  collagens	  in	  vivo	  (Di	  Lullo	  et	  al,	  2002),	  to	  indicate	  that	  individual	  collagen	  molecules	  or	  intermediate	  fibril	  segments	  could	  be	  kept	  separate	  through	  a	  plethora	  of	  competitive	  interactions	  in	  the	  absence	  of	  specific	  organisers	  of	  fibril	  assembly	  that	  cell-­‐surface	  integrins	  and	  FN	  appear	  to	  represent.	  How	  collagen	  fibrillogenesis	   is	  catalysed	  by	  these	  molecules	  remains	  obscure.	   It	   seems	   like	   the	   collagen	   and	   fibronectin	   matrices	   assemble	   in	   a	  concerted	  manner	   (Li	   et	   al,	   2003).	   The	   integrin	   involvement	   in	  both	  processes	  points	   to	   some	   common	   mechanistic	   elements.	   Indeed,	   procollagen	   and	   FN	  interactions	   may	   be	   established	   even	   before	   secretion,	   as	   they	   colocalise	   in	   a	  secretory	  pathway	  of	  cultured	  fibroblasts	  (Ledger	  et	  al,	  1980).	  	  Collagen	   I-­‐containing	   fibrils	   in	   vivo	   also	   do	   not	   form	   in	   the	   absence	   of	  collagen	  V.	  Mutations	  in	  collagen	  V	  genes	  are	  one	  of	  the	  causes	  of	  Ehlers-­‐Danlos	  syndrome	   (EDS)	   (Wenstrup	   et	   al,	   2004b).	   Electron	   microscope	   studies	   have	  shown	   that	   the	   triple-­‐helical	   domain	   of	   collagen	   V	   is	   located	   in	   the	   fibril	   core	  while	  its	  N-­‐terminal	  thrombospondin-­‐like	  and	  variable	  domains	  are	  at	  the	  fibril	  surface.	   Likewise,	   the	   ‘thin’	   collagen	   II-­‐containing	   fibrils	   do	   not	   form	   without	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collagen	   XI,	   which	   shares	   structural	   similarity	   with	   collagen	   V.	   Electron	  microscopy	  again	  helped	  to	  reveal	  the	  structure	  of	  heterotypic	  collagen	  II	  and	  XI	  fibrils	   (Holmes	   &	   Kadler,	   2006)	   (Figure	   6).	   They	   comprise	   14	   4-­‐nm-­‐diameter	  microfibrils,	  4	  of	  which	  make	  up	  the	  core	  of	  the	  fibril	  surrounded	  by	  the	  other	  10	  equally	   spaced;	   2	   of	   the	   4	  microfibrils	   in	   that	   core	   are	   collagen	  XI	  microfibrils	  (Figure	  6).	  The	  N-­‐prodomains	  of	   collagen	  XI	   are	   like	   those	  of	   collagen	  V	  at	   the	  fibril	  surface.	  In	  conclusion,	  collagens	  V	  and	  XI	  appear	  to	  have	  a	  similar	  function	  which	  is	  probably	  nucleation	  of	  collagen	  I	  and	  II-­‐containing	  fibrils,	  respectively.	  Their	  processing	  is	  similar	  and	  frequently	  occurs	  after	  the	  proline-­‐	  and	  arginine-­‐rich	  (PARP)	  region	  which	  is	  the	  first	  domain	  at	  their	  N-­‐termini	  (Moradi-­‐Ameli	  et	  al,	  1994;	  Rousseau	  et	  al,	  1996).	  This	  cleavage	  leaves	  collagen	  V	  and	  XI	  molecules	  with	  the	  additional	  N-­‐terminal	  short	  triple	  helix	  and	  a	  variable	  region	  that	  may	  help	  stabilise	  the	  fibril	  at	  its	  tip	  (Figure	  6).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  These	   N-­‐prodomains	  may	   at	   the	   same	   time	   constitute	   intrinsic	   limiters	   of	   the	  fibril	   diameter	   (preventing	   further	   accretion)	   (Hulmes,	   2002).	   Consistently,	  small-­‐diameter	   fibrils	   in	   cornea	   contain	   collagen	   I	   and	   V	   and	   so	   do	   the	   small-­‐
Figure	  6.	  Schematic	  model	  of	  a	  thin	  collagen	  fibril	  in	  cartilage.	  The	  fibril	  core	  comprises	  two	  
microfibrils	  of	  collagen	  XI	  and	   two	  microfibrils	  of	  collagen	   II.	  The	  core	   is	   surrounded	  by	  10	  
microfibrils	  of	  collagen	  II	   forming	  fibril	  surface.	  Collagen	  IX	   is	  covalently	  cross-­‐linked	  to	  the	  
fibril	   surface.	   The	   N-­‐terminal	   thrombospondin-­‐like	   domains	   of	   collagen	   XI	   are	   shown	  
extending	  from	  the	  core	  to	  the	  surface	  of	  the	  fibril.	  Redrawn	  after	  Dr	  D.	  Eyre	  (University	  of	  
Washington,	  Seattle)	  in	  (Kadler	  Canty-­‐Laird	  2008).	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diameter	  fibrils	  in	  cartilage,	  but	  not	  the	  ‘thick’	  ones,	  which	  contain	  collagen	  II	  and	  XI,	   as	   previously	   outlined	   (Andrikopoulos	   et	   al,	   1995;	   Marchant	   et	   al,	   1996;	  Blaschke	  et	  al,	  2000;	  Birk,	  2001).	  The	  collagen	  fibril	  packing	  model	  of	  Hulmes	  et	  al	  (1995)	  predicted	  such	  a	  possibility	  by	  the	   indication	  that	   the	   fibril	  surface	   is	  coated	  in	  molecular	  N-­‐terminal	  ends	  (Hulmes,	  2002).	  	  	  	  
1.2.4.	  Collagen	  fibril	  architecture	  	   The	  microfibrillar	  ~4-­‐nm-­‐diameter	  substructure	  is	  common	  for	  large-­‐	  and	  small-­‐diameter	   fibrils	   (Hulmes,	   2002).	   However,	   it	   is	   virtually	   impossible	   to	  isolate	  microfibrils	  from	  tissues	  in	  an	  intact	  form	  and	  therefore	  they	  are	  difficult	  to	   explore.	   Two	   aspects	   of	   the	   fibril	   architecture	   are	   puzzling:	   a)	   the	   exact	  arrangement	  of	  individual	  TC	  monomers	  within	  microfibrils,	  and	  b)	  the	  details	  of	  the	  three-­‐dimensional	  arrangement	  of	  microfibrils	  in	  the	  mature	  firbil.	  Hulmes	  et	  al	   (1995)	   established	   a	   comprehensive	   model	   of	   collagen	   fibril	   concentric	  packing	   through	   fibre	   diffraction	   and	   electron	   microscopy	   studies	   (Hulmes	   &	  Miller,	  1979;	  Hulmes	  et	  al,	  1981;	  Hulmes	  et	  al,	  1985).	  The	  model	  features	  a	  quasi-­‐hexagonal	   lateral	   unit	   cell	   of	   a	  microfibril	   (pentafibril)	   and	   assumes	   liquid-­‐like	  lateral	   disorder	   in	   some	   regions	   of	   the	   molecular	   packing.	   In	   this	   model	   all	  molecules	  are	  tilted	  with	  respect	  to	  the	  fibril	  surface	  by	  an	  angle	  depending	  on	  tisssue	   source,	   resulting	   in	   helicoidal	   organisation	   of	   the	   fibril.	   Such	   a	  characteristic	  of	  the	  collagen	  fibril	  structure	  was	  also	  observed	  and	  documented	  elsewhere	   (Ruggeri	   et	   al,	   1979;	   Holmes	   et	   al,	   2001;	   Ottani	   et	   al,	   2001)	   and	  confirmed	   by	   Orgel	   et	   al	   (Orgel	   et	   al,	   2001;	   Orgel	   et	   al,	   2006)	   who	   used	  synchrotron	   radiation	   to	   deliver	   the	   first	   electron-­‐density	   map	   of	   the	   type	   I	  collagen	  fibril	  (fibre	  diffraction	  study),	  with	  a	  medium	  resolution	  (axial:	  5.16	  Å;	  equatorial:	   11.1	   Å).	   The	   latter	   studies	   attempted	   to	   resolve	   the	   microfibril	  arrangement	   in	   the	   native	   collagen	   fibril.	   Through	   model	   fitting	   to	   the	   X-­‐ray	  diffraction	   data	   the	   microfibrils	   seem	   not	   only	   supertwisted	   but	   also	  interdigitated	  with	  adjacent	  microfibrils	  creating	  a	  formerly	  predicted	  spiral-­‐like	  global	   structure,	   also	   reported	   by	  Bozec	   et	   al	   (Bozec	   et	   al,	   2007)	   using	   atomic	  force	  microscopy	  (AFM).	  The	  nonhelical	   telopeptides	  participate	   in	  maintaining	  this	   structure	   (Orgel	   et	   al,	   2006)	   via	   crosslinks	   within	   and	   between	   the	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction	  
 
 35	  
microfibrils	   (Orgel	  et	  al,	  2000).	  Combining	   the	   interdigitation	  with	  crosslinking	  of	  the	  microfibrils	  explains	  why	  the	  resultant	  collagen	  fibrils	  are	  insoluble	  rather	  than	   liquid	   crystal-­‐like.	   It	   also	   explains	   the	   difficulty	   of	   isolating	   individual	  microfibrils	  from	  tissue	  samples.	  	  	  
1.3.	  Collagen-­‐degrading	  enzymes	  
 Non-­‐triple-­‐helical	   domains	   in	   collagens	   are	   relatively	   susceptible	   to	  proteolysis,	  but	   the	   triple-­‐helical	   fold	  of	  collagen	  makes	   it	  uniquely	  resistant	   to	  most	   proteolytic	   enzymes.	   Matrix	   metalloproteinases	   (MMPs)	   are	   the	   most	  prominent	   family	   of	   vertebrate	   endopeptidases	   in	   terms	   of	   processing	   of	  collagen	  and	  most	  of	  the	  ECM	  molecules.	  More	  importantly,	  however,	  members	  of	   the	   MMP	   family	   are	   the	   only	   endogenous	   enzymes	   capable	   of	   cleaving	  interstitial	   triple-­‐helical	   collagen	   at	   neutral	   pH.	   Cathepsin	   K	   also	   cleaves	   the	  collagen	  helix,	  but	  at	  acidic	  pH	  (Garnero	  et	  al,	  1998).	  
	  
1.3.1.	  Matrix	  metalloproteinases	  (MMPs)	  
 Collagenolysis	  during	  tadpole	  tissue	  metamorphosis	  was	  the	  first	  described	  process	   triggered	   by	   MMP	   activity	   (Gross	   &	   Lapiere,	   1962).	   This	   rapid	   ECM	  remodeling	   was	   catalysed	   by	   a	   zinc-­‐dependent	   endopeptidase	   named	  ‘collagenase’,	   which	   inaugurated	   the	   MMP	   family	   of	   proteinases,	   also	   called	  matrixins.	  The	  prototypic	  collagenase	  MMP-­‐1	  and	  22	  other	  matrixins	  were	  found	  to	   date	   in	   humans.	   They	   were	   studied	   extensively	   over	   the	   last	   decades	   and	  excellent	  reviews	  of	  this	  research	  (Overall,	  2002;	  Visse	  &	  Nagase,	  2003;	  Nagase	  et	   al,	   2006;	   Cauwe	   et	   al,	   2007;	   Murphy	   &	   Nagase,	   2008a)	   and	   a	   book	   by	   JF	  Woessner	  and	  H	  Nagase	  are	  available	  (Woessner	  &	  Nagase,	  2000).	  	  Collectively	   MMPs	   can	   degrade	   most	   if	   not	   all	   the	   ECM	   proteins.	  Nonetheless,	   their	   substrate	   specificities	   extend	   far	  beyond	  matrix	  destruction.	  More	  recent	  studies	  have	  shown	  that	  MMPs	  are	  capable	  of	  cleaving	  an	  array	  of	  bioactive	   molecules	   such	   as	   cytokines	   (e.g.	   interleukin	   1α	   (Ito	   et	   al,	   1996)	   or	  tumor	   necrosis	   factor	   α	   (Amour	   et	   al,	   1998)),	   apoptotic	   ligands	   (Fas	   ligand)	  (Powell	   et	   al,	   1999)	   or	   adhesion	   molecules	   (E-­‐cadherin)	   (Lochter	   et	   al,	   1997;	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Thomasset	  et	  al,	  1998),	  to	  mention	  only	  a	  few.	  Overall,	  they	  are	  now	  recognised	  as	  key	  players	  in	  tissue	  morphogenesis,	  remodeling	  and	  repair	  (wound	  healing),	  modulation	   of	   growth	   factors,	   cytokine	   and	   chemokine	   bioavailability	   and	   cell	  surface	   signaling.	   In	   consequence,	   they	   greatly	   influence	   cell	   differentiation,	  proliferation	   and	   apoptosis	   (Sternlicht	   &	   Werb,	   2001;	   Nagase	   et	   al,	   2006;	  Murphy	  &	  Nagase,	  2008a).	  MMPs	   function	   in	  various	   locations,	  being	  produced	  by	   many	   cell	   types,	   including	   epithelial	   cells,	   stromal	   cells,	   chondrocytes,	  osteoblasts	   and	   leukocytes	   (Sternlicht	   &	   Werb,	   2001)	   and	   their	   dysregulated	  activity	  is	  implicated	  in	  many	  diseases	  such	  as	  arthritis,	  tissue	  ulcers,	  cancer	  and	  cardiovascular	   diseases	   (Milner	   &	   Cawston,	   2005;	   Newby,	   2005;	   Burrage	   &	  Brinckerhoff,	  2007).	  	  A	  few	  genetic	  disorders	  associated	  with	  Mmp	  genes	  have	  been	  described	  in	  humans.	   Multicentric	   osteolysis	   or	   ‘vanishing’	   bone	   syndrome	   is	   a	   recessive	  autosomal	   disorder	   resulting	   from	   inactivating	   mutations	   in	   the	   Mmp2	   gene	  (Martignetti	   et	   al,	   2001).	   An	   autosomal	   dominant	   disorder,	  spondyloepimetaphyseal	   dysplasia,	   Missouri	   type,	   is	   caused	   by	   a	   missense	  mutation	   in	   the	   Mmp13	   gene.	   It	   is	   characterised	   by	   defective	   growth	   and	  remodeling	  of	  long	  bones	  (Kennedy	  et	  al,	  2005).	  A	  mutation	  in	  the	  intron	  6	  splice	  acceptor	   site	   in	   the	   Mmp20	   gene	   probably	   reduces	   MMP-­‐20	   expression	   or	  impairs	   Hpx	   domain	   function.	   It	   leads	   to	   recessive	   autosomal	   pigment	  hypomaturation	  amelogenesis	  imperfecta	  (Kim	  et	  al,	  2005).	  
 
1.3.1.1.	  MMP	  classification,	  subdivision	  and	  domain	  structure	  
 MMPs	  belong	  to	  the	  metzincin	  superfamily	  characterised	  by	  the	  active	  site	  zinc-­‐binding	   motif:	   HEXXHXXGXXH	   (where	   X	   means	   any	   amino	   acid)	   and	   a	  methionine	   eight	   residues	   downstream	   forming	   the	   Met-­turn	   region,	   which	  stabilises	   the	   catalytic	   site	   cleft	   (Visse	   &	   Nagase,	   2003).	   A	   criterion	   for	  membership	   of	   the	   MMP/matrixin	   family,	   classified	   by	   the	   MEROPS	  (http://merops.sanger.ac.uk)	   database	   as	  M10,	   is	   sequence	   homology	  with	   the	  catalytic	  (Cat)	  domain	  of	  MMP-­‐1.	  Matrixins	  are	  also	  unified	  by	  similarities	  in	  the	  domain	  structure	  presented	  schematically	  in	  Figure	  7.	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Based	  on	  the	  domain	  organisation	  as	  well	  as	  substrate	  preference	  MMPs	  are	  traditionally	   grouped	   into	   collagenases,	   gelatinases,	   stromelysins,	   matrilysins,	  membrane-­‐type	  MMPs	  and	  members	  not	  catalogued	  into	  any	  of	  those	  categories	  (Table	  2	  and	  Figure	  7).	  A	  list	  of	  human	  MMPs	  grouped	  according	  to	  their	  trivial	  names	   is	   shown	   in	  Table	  2.	   It	   includes	   their	   example	   substrates	   and	  biological	  activities.	  Their	  general	  structure	  and	  biochemical	  hallmarks	  within	  certain	  MMP	  subgroups	  are	  next	  discussed	  briefly.	  	  	  	  
Table	  2.	  Mammalian	  MMPs	  and	  their	  substrates	  
MMP	   Names	   ECM	  substrates	   Other	  substrates	   Bioactivity	  
Collagenases	  





Collagens	  I,	  II,	  III,	  VII,	  












Active	  IGF	  and	  soluble	  
TNFα	  release;	  self-­‐





MMP-­‐8	   Collagenase	  2;	  
Neutrophil	  
collagenase	  
Collagens	  I,	  II,	  III;	  
aggrecan	  




angiotensin	  I	  and	  II;	  
bradykinin;	  plasmin;	  
C1-­‐inhibitor	  
Soluble	  active	  TNFα	  
release;	  self-­‐activation	  
MMP-­‐13	   Collagenase	  3	   Collagens	  I,	  II,	  III,	  IV,	  











Soluble	  active	  TNFα	  
release;	  self-­‐activation	  
and	  MMP-­‐9	  activation;	  
osteoclast	  activation	  
Gelatinases	  
MMP-­‐2	   Gelatinase	  A	   Collagens	  I,	  II,	  III,	  IV,	  














factor	  receptor	  1);	  
serum	  amyloid	  A;	  




Active	  IGF,	  IL-­‐1β,	  TGFβ	  
and	  soluble	  TNFα	  
release;	  self-­‐activation,	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MMP-­‐9	   Gelatinase	  B	   Collagens	  IV,	  V,	  XI,	  









proIL-­‐8;	  substance	  P;	  














MMP-­‐3	   Stromelysin	  1	   Collagens	  III,	  IV,	  V,	  


























Active	  IL-­‐1β,	  	  
E-­‐cadherin	  
ectodomain,	  
angiostatin	  and	  soluble	  
TNFα	  release;	  self-­‐
activation,	  MMP-­‐1,	  -­‐7,	  
-­‐8,	  -­‐9,	  13	  activation,	  
cell	  migration;	  
mammary	  epithelial	  










proMMP-­‐1,	  -­‐7,	  -­‐8,	  	  
-­‐9;	  
Self-­‐activation,	  MMP-­‐
1,	  -­‐7,	  -­‐8	  and	  -­‐9	  
activation	  










Active	  IGF	  release	  
Matrilysins	  
MMP-­‐7	   Matrilysin	  1	  
Pump-­‐1	  

















soluble	  TNFα	  release;	  
self-­‐activation,	  MMP-­‐1,	  
-­‐2	  and	  -­‐9	  activation;	  
adipocyte	  
differentiation	  


























ProMMP-­‐2,	  -­‐13;	  	  
α2-­‐Macroglobulin;	  
proTNFα;	  fibrinogen;	  
factor	  XII,	  fibrin;	  
CD44;	  tissue	  
transglutaminase;	  	  
CD44	  and	  active	  
soluble	  TNFα	  release;	  











Soluble	  active	  TNFα	  
release;	  MMP-­‐2	  
activation	  







Soluble	  active	  TNFα	  
release;	  MMP-­‐2	  
activation	  













Soluble	  active	  TNFα	  
release	  
MMP-­‐25	   MT6-­‐MMP	  
Leukolysin	  










MMP-­‐12	   Metalloelastase;	  
Macrophage	  
elastase	  










proTNFα;	  factor	  XII;	  
plasminogen	  
Angiostation	  and	  
soluble	  active	  TNFα	  
release	  








MMP-­‐20	   Enamelysin	   Amelogenin;	  
aggrecan;	  COMP	  
Autolytic	   	  
MMP-­‐21	   -­‐	   Gelatin	   Casein	   	  
MMP-­‐23	   CA-­‐MMP	   Gelatin	   	   	  
MMP-­‐27	   -­‐	   Gelatin	   Autolytic;	  casein	   	  
MMP-­‐28	   Epilysin	   	   Casein	   	  
Adapted	  and	  modified	  after	  Visse	  &	  Nagase	  (2003),	  Nagase	  et	  al	  (2006)	  and	  Overall	  (2002).	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  All	   MMPs	   are	   synthesized	   as	   pre-­‐proenzymes.	   The	   signal	   peptides	   are	  removed	   at	   translation	   and	   inactive	   zymogens	   are	   generated	   (Nagase	   et	   al,	  2006).	  An	  80	  amino	  acid	  prodomain	   (Pro)	   is	  attached	  at	   the	  N-­‐terminus	  of	   the	  catalytic	   (Cat)	   domain	   and	   ensures	   the	   latency	   of	   the	   enzyme	   by	   folding	   the	  
cysteine	  switch	  motif	  PRCGXPD	  (X,	  any	  amino	  acid)	   into	  the	  active	  site.	  The	  Cys	  residue	   in	   that	  motif	  occupies	   the	   fourth	  coordination	  site	  on	   the	  catalytic	  zinc	  ion	   kept	   in	   the	   Cat	   domain	   by	   the	   His	   triad	   of	   the	   conserved	   HEXXHXXGXXH	  motif.	   In	   consequence,	   the	   water	   molecule	   essential	   for	   substrate	   hydrolysis	  cannot	   bind	   to	   the	   zinc.	   Next	   to	   the	   signature	   metalloproteinase	   Cat	   domains	  
Figure	  7.	  Domain	  structure	  of	  MMPs.	  The	  domains	  are	  as	  follows:	  S,	  signal	  peptide	  (grey);	  Pro,	  
prodomain	   (blue);	   Cat,	   catalytic	   domain	   (orange);	   Hpx,	   hemopexin	   domain	   (pale	   orange);	   Fn,	  
fibronectin	   domain	   (green);	   V,	   vitronectin	   insert	   (only	   in	   XMMP);	   I,	   type	   I	   transmembrane	  
domain;	  II,	  type	  II	  transmembrane	  domain;	  Red	  ruffled	  structure	  embedded	  in	  plasma	  membrane	  
(PM)	  is	  GPI	  anchor;	  Ct,	  cytoplasmic	  tail;	  Cr,	  cysteine	  rich	  region;	  and	  Ig,	  IgG-­‐like	  domain.	  The	  furin	  
(Fu)	   cleavage	   site	   is	   depicted	   by	   the	   black	   arrows.	   The	   coordination	   of	   Cys	   from	   the	   cysteine	  
switch	  region	  with	  the	  active	  site	  zinc	  (dashed	  lines)	  and	  the	  disulphide	  bridge	  in	  the	  Hpx	  domain	  
(solid	  lines)	  are	  indicated.	  Collagenolytic	  MMPs	  are	  highlighted	  in	  yellow.	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(~170	   amino	   acids)	   the	   most	   widespread	   among	   MMPs	   are	   the	   C-­‐terminal	  hemopexin	  (Hpx)	  domains	  (~200	  amino	  acids),	  connected	  to	  the	  Cat	  domains	  via	  the	   linker	  peptides	  of	   a	   variable	   length.	  Despite	  distinct	   amino	  acid	   sequences,	  these	  domains	  share	  an	  identical	  global	  fold	  across	  the	  family.	  At	  the	  start	  and	  at	  the	  end	  of	  the	  Hpx	  domain	  are	  Cys	  residues	  that	  form	  a	  disulphide	  bridge	  (Figure	  8).	  Gelatinases	   (MMP-­‐2	  and	  MMP-­‐9)	   contain	  6	   additional	  disulphide	  bridges	   in	  the	  three	  repeats	  of	  fibronectin	  type	  II	  module	  (FNII)	  inserted	  in	  the	  Cat	  domain.	  	  The	  differences	   in	  primary	  structure,	  and	   the	  presence	  or	  absence	  of	  non-­‐catalytic	  and	  extra-­‐catalytic	  domains,	  underlie	  diverse	  substrate	  specificities	  and	  degrees	   of	   catalytic	   proficiency	   among	   MMPs	   (Hirose	   et	   al,	   1993;	   Nagase	   &	  Fields,	  1996;	  Smith	  et	  al,	  1999).	  Particularly	  divergent	   in	  sequence	  are	  the	  Hpx	  domains	  (Piccard	  et	  al,	  2007).	  The	  Hpx	  domains	  in	  most	  MMPs	  and	  FNII	  domains	  in	   gelatinases	   provide	   exosites	   that	   assist	   in	   the	   binding	   of	   various	  macromolecular	   substrates	   (reviewed	   in	   (Overall,	   2002))	   including	   collagen	  (Clark	  &	  Cawston,	  1989;	  Murphy	  et	  al,	  1992;	  Knäuper	  et	  al,	  1993;	  Knäuper	  et	  al,	  1997a;	  Patterson	  et	  al,	  2001).	  	  Gelatinase	  A	  and	  B	   (MMP-­‐2	  and	   -­‐9,	   respectively)	  have	  almost	  overlapping	  specificities	   for	   a	   number	   of	   ECM	   proteins	   that	   they	   digest,	   except	   that	   only	  MMP-­‐2	   can	   cleave	   fibrillar	   collagens	   I,	   II	   and	   III.	   MMP-­‐9,	   on	   the	   other	   hand,	  deserves	  a	  mention	  for	   its	  unusually	   long	  (54	  amino	  acids)	   linker	  region	  which	  seems	   to	  confer	  profound	  conformational	   flexibility	   to	   the	  enzyme	  (Rosenblum	  et	  al,	  2007).	  Only	   matrilysins	   (MMP-­‐7	   and	   MMP-­‐26)	   do	   not	   have	   the	   Hpx	   domains	  (Nagase	  et	  al,	  2006).	  Perhaps	  for	  this	  reason	  MMP-­‐7	  (matrilysin	  1)	  seems	  to	  be	  the	   least	   ‘matrix’	   metalloproteinase	   as	   it	   cleaves	   many	   non-­‐ECM	   bioactive	  molecules	   such	   as	   cell	   surface	   pro-­‐α-­‐defensins,	  making	   them	   bactericidal,	   pro-­‐tumor	   necrosis	   factor	   (TNF)α	   and	   Fas-­‐ligand	   (Nagase	   et	   al,	   2006).	   MMP-­‐26	  (matrilysin	   2)	   is	   unique	   in	   that	   it	   is	   stored	   intracellularly	   unlike	   other	   MMPs	  (Marchenko	  et	  al,	  2004).	  	  	  	   Stromelysin	  1	  (MMP-­‐3)	  and	  stromelysin	  2	  (MMP-­‐10)	  are	  related	  to	  each	  other,	   whereas	   stromelysin	   3	   (MMP-­‐11)	   is	   more	   divergent	   and	   has	   a	   weak	  activity	  against	  ECM	  components	  (Murphy	  et	  al,	  1993).	  MMP-­‐11	  is	  not	  secreted	  as	   inactive	   proenzyme	   like	   the	   other	   two	   stromelysins	   because	   it	   contains	   the	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proprotein	  convertase	  (furin)	  recognition	  sequence	  RX[R/K]R	  directly	  preceding	  the	   Cat	   domain	   and	   is	   processed	   intracellularly	   (Pei	   &	   Weiss,	   1995).	   All	  stromelysins	  are	  similar	  to	  collagenases,	  but	  cannot	  cleave	  interstitial	  collagens	  in	  triple-­‐helical	  domains,	  except	  collagen	  III	  in	  the	  case	  of	  MMP-­‐3.	  	  	   Among	  MMPs	  are	  also	  membrane-­‐anchored	  (membrane-­‐type)	  MT-­‐MMPs.	  Four	   of	   these	   (MMP-­‐14,	   -­‐15,	   -­‐16,	   and	   -­‐24)	   contain	   a	   type	   I	   transmembrane	  domain	  after	  the	  Hpx	  domain	  and	  before	  a	  short	  cytoplasmic	  tail	  (Ct).	  These	  MT-­‐MMPs	  also	  contain	  a	  so-­‐called	  MT-­loop	  formed	  by	  8	  residues	  between	  β-­‐strand	  II	  and	   III	   in	   the	   Cat	   domain.	   The	   two	   other	   MT-­‐MMPs	   (MMP-­‐17	   and	   -­‐25)	   are	  glycosylphosphatidylinositol	   (GPI)-­‐anchored	   at	   the	   C-­‐terminus	   of	   the	   Hpx	  domain.	   All	   transmembrane	   species	   and	   one	   GPI-­‐anchored	  MMP	   (-­‐25	   or	  MT6-­‐MMP)	  participate	  in	  activation	  of	  proMMP-­‐2	  (English	  et	  al,	  2000).	  These	  was	  the	  first	  discovered	  role	  of	  MMP-­‐14	  (MT1-­‐MMP)	  (Sato	  et	  al,	  1994).	  For	  it	  to	  activate	  proMMP-­‐2	   the	   MT-­loop	   is	   critical	   (English	   et	   al,	   2001).	   All	   MT-­‐MMPs	   are	  activated	  intracellularly	  by	  furin.	  Seven	  matrixins	  (MMP-­‐12,	  -­‐19,	  -­‐20,	  -­‐21,	  -­‐23,	  -­‐27	  and	  -­‐28)	  do	  not	  belong	  to	  any	   conventional	   categories.	   The	  most	   structurally	   unique	  MMP-­‐23	   contains	   a	  transmembrane	   type	   II	   domain	   at	   the	   N-­‐terminus	   of	   the	   prodomain,	   but	   it	   is	  processed	   intracellularly	  by	   furin,	   like	  MT-­‐MMPs,	   and	   released	   in	   the	  activated	  form	   (Pei	   et	   al,	   2000).	  Moreover,	   the	   prodomain	   of	  MMP-­‐23	   lacks	   the	   cysteine	  
switch	  region	  and	  instead	  of	  the	  Hpx	  domain	  has	  unique	  C-­‐terminal	  cysteine-­‐rich	  (Cr)	  and	  immunoglobulin-­‐like	  (Ig)	  domains	  (Figure	  7).	  MMP-­‐21	  (epilysin)	  is	  also	  processed	  by	  furin	  and	  is	  unique,	  for	  it	  has	  the	  Hpx	  domain	  linked	  immediately	  after	  the	  C-­‐terminus	  of	  the	  Cat	  domain,	  without	  the	  linker	  peptide.	  The	  Xenopus	  homologue	  of	  MMP-­‐21	  (XMMP)	  has	  additional	  vitronectin-­‐insert	  (V)	  sequence	  in	  its	  prodomain	  (Figure	  7).	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1.3.1.2.	  General	  aspects	  of	  (pro)MMP	  activation	  	  
 The	   Zn2+	   coordination	   with	   SH	   of	   the	   cysteine	   switch	   motif	   needs	   to	   be	  disrupted	  to	  allow	  a	  water	  molecule	  to	  occupy	  this	  site.	  The	  glutamic	  acid	  of	  the	  conserved	  HEXXHXXGXXH	  motif	  polarises	  this	  water	  molecule	  when	  a	  substrate	  binds	   to	   the	   active	   site	   Zn2+,	   thereby	   catalysing	   nucleophilic	   attack	   of	   the	  hydroxyl	   group	   on	   the	   carbonyl	   carbon	   of	   the	   substrate	   scissile	   bond	   (Visse	  &	  Nagase,	  2003).	  Mutation	  of	  the	  active	  site	  Glu	  residue	  to	  Ala	  renders	  the	  enzyme	  essentially	  inactive	  (Chung	  et	  al,	  2004).	  	  A	   number	   of	   3D	   structures	   of	   proMMPs	  have	  been	   solved	   and	   the	   overall	  folds	  of	  prodomains	  are	  essentially	  superimposable	  between	  them,	  as	  in	  the	  case	  of	   other	   domains	   (Maskos,	   2005).	   The	   prodomain	   consists	   of	   three	   α-­‐helices	  connected	   by	   unstructured	   loops.	   The	   proteinase	   susceptible	   bait	   region	  between	   the	   first	   and	   the	   second	   helix	   is	   flexible	   and	   is	   missing	   from	   the	  proMMP-­‐1	   crystal	   structure	   (Jozic	   et	   al,	   2005)	   shown	   in	  Figure	  10A	   (page	  63).	  Host	   tissue	  and	  plasma	  proteinases	   as	  well	   as	  bacterial	  proteinases	   cleave	   this	  region,	   partially	   activating	   an	   MMP	   zymogen.	   The	   complete	   removal	   of	   the	  prodomain	   is	   conducted	  either	  by	  self-­‐cleavage	  of	   the	  MMP	   intermediate	  or	  by	  other	  MMPs	  (Nagase	  et	  al,	  2006).	  Such	  stepwise	  activation	  applies	  to	  13	  secreted	  proMMPs	   in	   mammals,	   which	   do	   not	   possess	   a	   proprotein	   convertase	   (furin)	  recognition	  sequence	  (Nagase	  et	  al,	  1990;	  Woessner	  &	  Nagase,	  2000)	  (Figure	  7).	  The	  other	  10	  proMMPs	  are	  most	  likely	  processed	  in	  the	  Golgi	  by	  furin,	  as	  shown	  for	   proMMP-­‐14	   (Stawowy	   et	   al,	   2005)	   or	   proMMP-­‐23	   (Pei	   et	   al,	   2000),	   and	  secreted	   or	   anchored	   on	   the	   cell	   surface	   as	   active	   enzymes.	   It	   has	   also	   been	  shown	  that	  oxidants	  such	  as	  HOCl	  and	  ONOO-­‐	  react	  with	   the	  SH	  of	   the	  cysteine	  
switch	   and	  disrupt	   its	   interaction	  with	   the	   catalytic	   zinc	   ion,	   thereby	  activating	  proMMPs.	  This	  activation	  pathway	  is	  likely	  to	  occur	  during	  inflammatory	  states	  (Peppin	  &	  Weiss,	  1986;	  Gu	  et	  al,	  2002).	  Many	  MMPs,	  including	  the	  collagenolytic	  ones,	  can	  be	  efficiently	  activated	  in	  the	   laboratory	   using	   mercurial	   compounds	   such	   as	   p-­‐aminophenyl	   mercuric	  acetate	  (APMA),	  SH	  and	  chaotropic	  agents,	  which	  probably	  cause	  a	  perturbation	  of	   the	   structure	   around	   the	   active	   site	   (Nagase	   et	   al,	   1990).	   Activation	   of	  collagenolytic	  MMPs	  will	  be	  described	  in	  a	  greater	  detail	  below.	  	  	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction	  
 
 44	  
1.3.1.3.	  MMPs	  with	  triple	  helicase	  activity	  (‘collagenolytic’	  MMPs)	  
	   	   Enzymes	   referred	   to	   as	   collagenolytic	   cleave	   triple-­‐helical	   structures	   in	  collagens	   I,	   II	   and	   III.	   Collagenolytic	   MMPs	   in	   mammals	   include	   four	   soluble	  enzymes	   (MMP-­‐1,	   -­‐2,	   -­‐8	   and	   -­‐13)	   and	   one	   membrane-­‐anchored	   enzyme	  MT1-­‐MMP	  (MMP-­‐14)	  (Visse	  &	  Nagase,	  2003).	  All	  of	  them	  cleave	  interstitial	  collagens	  at	  the	  same	  (Q/L)G#(I/L)(A/L)	  (#	  indicates	  the	  scissile	  bond)	  segment	  ¾	  away	  from	  the	  N-­‐terminus	  (Miller	  et	  al,	  1976)	  and	  all	  are	  considered	  to	  have	  an	  ability	  to	   unwind	   the	   collagen	   triple	   helix,	   as	   the	   MMP	   catalytic	   site	   cleft	   in	   solution	  (NMR)	  and	  crystal	   (X-­‐ray)	  structures	  (Bode	  &	  Maskos,	  2003)	  appears	  not	  wide	  enough	   (~0.5	   nm	   or	   5	   Å)	   to	   accommodate	   the	   native	   collagen	   molecule	   of	  approximately	  1.5	  nm	  (15	  Å)	  diameter	  (Bode	  et	  al,	  1994;	  Borkakoti	  et	  al,	  1994)	  (Figure	   9,	   page	   59).	  Moreover,	   the	   scissile	   bond	   is	  masked	   in	   the	   triple-­‐helical	  conformation	   of	   the	   substrate.	   The	   triple	   helicase	   mechanisms	   seem	   to	   be	  different	   in	   different	   MMPs;	   e.g.	   MMP-­‐8	   and	   the	   ectodomain	   of	   MT1-­‐MMP	  catalyse	  relatively	  limited	  helix	  unwinding	  compared	  to	  MMP-­‐2	  at	  37	  °C	  (Gioia	  et	  al,	  2007),	  but	  human	  collagenases	  (MMP-­‐1,	  -­‐8	  and	  -­‐13)	  probably	  share	  a	  similar	  mechanism,	   due	   to	   their	   common	   3D	   structures.	   Nevertheless,	   distinct	  preferences	   for	   different	   fibrillar	   collagens	   are	   seen	   among	   them	   (see	   below).	  Stromelysins	   (MMP-­‐3	   and	   MMP-­‐10),	   on	   the	   other	   hand,	   are	   unable	   to	   cleave	  collagen	   types	   I	   and	   II,	   despite	   showing	   the	   level	   of	   structural	   similarity	   to	  collagenase	  almost	  equal	   to	   that	  which	  collagenases	  share	  between	   themselves	  (Woessner	   &	   Nagase,	   2000).	   The	   molecular	   determinants	   of	   MMP	   substrate	  specificity	   and	   collagen-­‐degrading	   specificity	   in	   particular	   are	   still	   poorly	  understood.	  	  	  
1.3.1.3.1.	  Collagenases	  (MMP-­‐1,	  MMP-­‐8	  and	  MMP-­‐13)	  	  Three	   MMPs	   in	   mammals	   are	   classified	   as	   collagenases:	   collagenase	   1	   or	  fibroblast	  collagenase	   (MMP-­‐1),	   collagenase	  2	  or	  neutrophil	   collagenase	   (MMP-­‐8)	   and	   collagenase	   3	   (MMP-­‐13).	   A	   fourth	  MMP	   collagenase,	  MMP-­‐18,	   has	   been	  identified	  in	  Xenopus	  (Stolow	  et	  al,	  1996),	  but	  it	  has	  no	  human	  equivalent.	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Collagenases	  cleave	  many	  collagen	  types	  and	  other	  matrix	  and	  non-­‐matrix	  proteins	  (Table	  2)	  but	  their	  key	  activity	  is	  a	  characteristic	  breakdown	  of	  fibrillar	  collagens	  (I,	  II	  and	  III)	  to	  ¾	  and	  ¼	  fragments	  with	  different	  preference	  for	  each	  collagen	  type	  (Woessner	  &	  Nagase,	  2000).	  	  
1.3.1.3.1.1.	  Collagen	  type	  preference	  of	  collagenases	  	  	   MMP-­‐1	   and	   MMP-­‐8	   cleave	   in	   order	   of	   preference	   collagen	   III	   (bovine)	   >	  collagen	   I	   (guinea	   pig)	   >	   collagen	   II	   (bovine)	   (Tominga,	   Visse,	   Nagase,	  unpublished	  results).	  MMP-­‐13	  seems	   to	  have	  highest	  preference	   for	   collagen	   II	  and	  is	  thought	  to	  be	  one	  of	  the	  major	  cartilage	  degrading	  enzymes	  in	  rheumatic	  diseases	  (Mitchell	  et	  al,	  1996).	  However,	   fully	  activated	  MMP-­‐1	  (see	  below)	  has	  similar	  activity	  on	  collagen	  II	  as	  MMP-­‐13,	  and	  greater	  activity	  for	  collagens	  I	  and	  III	  than	  MMP-­‐13	  (H.	  Nagase	  &	  R.	  Visse,	  personal	  communication).	  	  
1.3.1.3.1.2.	  Three-­‐dimensional	  structure	  and	  activation	  of	  collagenases	  	   The	  3D	  structure	  of	  collagenases	  is	  discussed	  using	  the	  representative	  full-­‐length	   human	   collagenase	   1	   crystal	   structure	   (Iyer	   et	   al,	   2006)	   presented	   in	  Figure	  8A.	  The	  Cat	  domain	  consists	  of	  a	  5-­‐stranded	  β-­‐sheet,	  three	  α-­‐helices	  and	  connective	   loops.	   It	   is	   divided	   into	   two	   parts	   by	   the	   active	   site	   cleft	   running	  across.	   The	   upper	   part	   is	   liganded	   by	   three	   stabilising	   calcium	   ions	   and	   one	  structural	   zinc	   ion.	   The	   catalytic	   zinc	   ion	   is	   located	   in	   the	   middle	   and	   at	   the	  bottom	   of	   the	   active	   site	   cleft.	   To	   the	   right	   of	   this	   zinc	   ion	   is	   an	   important	  substrate	   binding	   site	   called	   the	   S1’	   pocket	   according	   to	   the	   subsite	  nomenclature	   by	   Schechter	   and	   Berger	   (Schechter	   &	   Berger,	   1967).	   It	   is	  hydrophobic	   in	   nature	   in	   all	   collagenases	   and	  most	   other	  MMPs,	   but	   its	   depth	  varies	   across	   MMPs,	   constituting	   one	   of	   the	   factors	   that	   determine	   their	  substrate	   specificity.	   The	   linker	   peptide	   contains	   a	   number	   of	   prolines	   and	  adopts	   a	  pseudo-­‐helical	   conformation.	   It	   connects	   the	  Cat	  domain	   and	   the	  Hpx	  domain	  and	  is	  considered	  to	  act	  as	  a	  hinge	  between	  them,	  as	  illustrated	  in	  Figure	  10.	  The	  Hpx	  domain	  has	  a	  four-­‐bladed	  β-­‐propeller	  structure	  and	  contains	  the	  one	  and	  only	  disulphide	  bond	  of	  the	  enzyme,	  between	  the	  first	  and	  the	  last	  blade	  of	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the	  β-­‐propeller.	  Each	  blade	  has	  a	  similar	  scaffold	  made	  up	  of	  four	  antiparallel	  β-­‐strands.	  In	  the	  centre	  of	  the	  propeller	  there	  is	  a	  fourth	  Ca2+	  ion	  of	  the	  collagenase.	  The	  highly	  symmetrical	  propeller	  structure	  provides	  a	  large	  disc-­‐shaped	  surface	  for	  potential	  interactions	  with	  protein	  substrates.	  In	  the	  case	  of	  MT1-­‐MMP,	  not	  a	  classical	   collagenase,	   but	   sometimes	   referred	   to	   as	   a	   plasma	   membrane	  collagenase,	   it	   also	   enables	   a	   dimerisation	   and	   possibly	   further	   aggregation	  essential	   for	   the	   function	  of	   the	  enzyme	  (Itoh	  et	  al,	  2001;	   Itoh	  et	  al,	  2006)	  (see	  below).	  	  The	   procollagenase	   activation	   pathway	   significantly	   regulates	  collagenolysis.	  The	   collagenolytic	   activity	  of	  MMP-­‐1	  or	  MMP-­‐8	  varies	  up	   to	  10-­‐fold,	  depending	  on	  the	  final	  processing	  site.	  After	  cleavage	  in	  the	  bait	  region	  the	  partially	   activated	   MMP-­‐1	   autocleaves	   the	   Phe100-­‐Val101	   or	   Val101-­‐Leu102	  bond	  (pre-­‐proenzyme	  numeration)	  (Figure	  8B).	  Suzuki	  and	  coworkers	  (Suzuki	  et	  al,	   1990)	   discovered	   that	   these	   forms	   exhibit	   only	   10-­‐20%	   of	   collagenolytic	  activity	   compared	   to	   the	   form	  generated	  by	  MMP-­‐3	   cleavage	   at	  Gln99-­‐Phe100,	  which	   has	   a	   maximum	   collagenolytic	   activity.	   The	   fully	   active	   MMP-­‐1	   with	   N-­‐terminal	   Phe100	   can	   also	   be	   generated	   with	   a	   help	   of	   MMP-­‐2,	   -­‐7	   and	   -­‐10.	  Analogously,	  MMP-­‐8	  needs	  a	  Phe99	  residue	  at	  the	  N-­‐terminus	  to	  be	  fully	  active	  and	  for	  this	  a	  cleavage	  by	  MMP-­‐3	  or	  -­‐10	  is	  required	  (Knäuper	  et	  al,	  1996b).	  In	  the	  case	  of	  MMP-­‐1	  and	  MMP-­‐8	  the	  N-­‐terminal	  Phe	  forms	  a	  salt	  bridge	  with	  Asp252	  (Reinemer	  et	  al,	  1994;	  Iyer	  et	  al,	  2006).	  Any	  longer	  or	  shorter	  N-­‐terminus	  fails	  to	  form	   this	   bond	   and	   remains	   highly	   flexible	   (Figure	   8B).	   Full	   activation	   of	   the	  MMP-­‐13	   precursor	   is	   attained	   by	   autolysis	   after	   MMP-­‐2,	   MMP-­‐14	   or	   plasmin	  cleavage	   in	   the	   bait	   region,	   and	   the	   fully	   active	   MMP-­‐13	   starts	   with	   Tyr104	  (Knäuper	  et	  al,	  1996a;	  Knäuper	  et	  al,	  1996c)	  (Figure	  8B),	  which	  may	  form	  a	  salt	  bridge	  similar	  to	  the	  one	  seen	  in	  MMP-­‐1	  (e.g.	  2D10.pdb)	  (Kohno	  et	  al,	  2006),	  but	  some	  crystal	  structures	  (e.g.	  1XUC.pdb)	  show	  this	  N-­‐terminus	  as	  free	  (Engel	  et	  al,	  2005).	   The	   mechanistic	   role	   of	   the	   N-­‐terminal	   salt	   bridge	   in	   collagenolysis	   is	  therefore	  difficult	  to	  deduce.	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1.3.1.3.2.	  Gelatinase	  A	  (MMP-­‐2)	  	  
 MMP-­‐2	  was	  originally	  characterised	  as	  a	  gelatin	  degrading	  enzyme	  (Collier	  et	   al,	   1988),	   like	   the	   other	   gelatinase	   (gelatinase	   B,	   MMP-­‐9),	   and	   the	   three	  fibronectin	   type	   II	   repeats	   (FNII	   domain)	   were	   known	   as	   the	   gelatin	   binding	  domain.	  It	  was	  later	  found	  to	  cleave	  triple-­‐helical	  collagens	  I,	  II	  and	  III	  similar	  to	  collagenases,	   ¾	   away	   from	   the	   N-­‐terminus	   (Aimes	   &	   Quigley,	   1995),	   and	   the	  fibronectin	  modules	  were	  named	   the	   collagen	  binding	  domain	   (CBD),	   although	  they	  bind	  collagen	   less	   tightly	   than	  gelatin	   (Steffensen	  et	  al,	  1995).	   In	  addition,	  the	  main	   binding	   site	   for	   the	   CBD	   is	   the	   telopeptide	   region	   and	  not	   the	   triple-­‐helical	  region.	  At	  body	  temperature	  the	  cleaved	  collagen	  fragments	  can	  denature	  and	  MMP-­‐2	  may	  serve	  as	  a	  potent	  partner	  for	  other	  collagenolytic	  enzymes	  as	  it	  can	  readily	  cleave	  denaturing	  collagen	  chains	  (Murphy	  et	  al,	  1985).	  
Figure	  8.	  Collagenase	  structure	  and	  activation	  variants.	   (A)	  The	  3D	  ribbon	  structure	  of	  an	  active	  
human	   MMP-­‐1	   (pdb	   code:	   2CLT)	   consists	   of	   the	   catalytic	   domain	   (Cat,	   cyan),	   the	   linker	   region	  
(Linker,	  yellow)	  and	  the	  hemopexin	  domain	  (Hpx,	  marine).	  Four	  blades	  of	  the	  Hpx	  β-­‐propeller	  are	  
numbered.	  The	  Cat	  domain	  contains	  two	  zinc	  ions	  (orange	  spheres),	  the	  catalytic	  zinc	  ion	  is	  in	  the	  
active	  site	  cleft	  (line),	  and	  the	  structural	  zinc	  ion	  stabilises	  the	  upper	  part	  of	  the	  domain	  together	  
with	   three	   calcium	   ions	   (magenta	   spheres).	   The	   fourth	   calcium	   ion	   is	   in	   the	  middle	   of	   the	   Hpx	  
domain	  propeller.	  The	  N-­‐terminus	  is	  anchored	  on	  the	  third	  α-­‐helix	  (circled)	  and	  the	  Cys278	  in	  blade	  
1	  forms	  a	  disulphide	  bridge	  (red)	  with	  Cys466	  in	  blade	  4	  (circled).	  (B)	  Cat	  domains	  of	  MMP-­‐13	  (pdb	  
code:	  1XUC)	  and	  two	  activation	  variants	  of	  MMP-­‐1	  (violet:	  1CGE.pdb;	  cyan	  2CLT.pdb)	  with	  different	  
N-­‐terminal	   residues	   shown	   with	   sticks	   (red,	   oxygen;	   grey,	   hydrogen;	   dark	   blue,	   nitrogen)	  
superimposed	   on	   the	   common	   parts.	   Only	   MMP-­‐1	   with	   with	   N-­‐terminal	   Phe100	   forms	   an	  
intramolecular	  salt	  bridge	  with	  Asp252	  (circled).	  Images	  were	  made	  with	  Pymol.	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1.3.1.3.2.1.	  MT1-­‐MMP-­‐dependent	  activation	  of	  proMMP-­‐2	  
 ProMMP-­‐2	  has	  a	  unique	  activation	  mechanism	  occurring	  on	  the	  cell	  surface.	  For	  this	  a	  tetramolecular	  complex	  is	  formed	  between	  proMMP-­‐2,	  tissue	  inhibitor	  of	  metalloproteinases	  2	  (TIMP-­‐2)	  and	  an	  MT1-­‐MMP	  dimer	  (Sato	  et	  al,	  1994;	  Itoh	  et	   al,	   2006).	   The	  Hpx	   domain	   of	   proMMP-­‐2	   is	   tightly	   bound	   by	   the	   C-­‐terminal	  domain	   of	   the	   TIMP	   protein	   (Fridman	   et	   al,	   1992),	   which	   is	   bound	   to	   the	   Cat	  domain	  of	  MT1-­‐MMP	  via	  its	  inhibitory	  N-­‐terminal	  domain.	  Then,	  the	  prodomain	  of	   the	  gelatinase	   zymogen	   is	  presented	   to	   the	  neighbouring	   free	  MT1-­‐MMP	   for	  the	   partially	   activating	   cleavage	   of	   the	   Asn66-­‐Leu67	   bond.	   Subsequent	  autocleavage	   of	   the	   Asn109-­‐Tyr110	   bond	   completes	   the	   activation	   (Will	   et	   al,	  1996).	  Fully	  activated	  MMP-­‐2	  can	  be	   inhibited	  by	  TIMP-­‐2	   (Itoh	  et	  al,	  1998),	   so	  the	  participation	  of	  MMP-­‐2	  in	  pericellular	  collagenolysis	  is	  regulated	  extensively	  by	  TIMP-­‐2.	  	  
1.3.1.3.2.2.	  Collagenolytic	  properties	  of	  MMP-­‐2	  	  Gelatinase	   A,	   besides	   the	   Cat	   and	   Hpx	   domains,	   has	   the	   collagen-­‐binding	  FNII	  domain	  located	  in	  the	  loop	  between	  the	  fifth	  β-­‐strand	  and	  the	  third	  α-­‐helix	  of	   the	   Cat	   domain,	   and	   likely	   utilises	   a	   different	   mechanism	   than	   typical	  collagenases	  (MMP-­‐1,	  -­‐8	  and	  -­‐13)	  to	  cleave	  the	  collagen	  helix	  (Overall,	  2002;	  Tam	  et	   al,	   2004;	   Gioia	   et	   al,	   2007).	   The	   removal	   of	   the	   FNII	   domain	   reduces	   the	  collagenolytic	   activity	   of	   the	   enzyme	   by	   50%	   at	   25	   °C	   (Patterson	   2001).	   It	   is	  likely	   that	   the	   FNII	   domain	   enhances	   collagen	   unwinding	   by	   stabilising	   the	  unwound	   state	   of	   collagen,	   as	   it	   binds	   to	   the	   triple-­‐helical	   region	   of	   collagen	  when	   it	   is	  denatured	  (Steffensen	  et	  al,	  1995).	  Accordingly,	  Gioia	  and	  colleagues	  (Gioia	   et	   al,	   2007)	   observed	   the	   stabilisation	   of	   the	   relaxed	   triple	   helicity	   of	  collagen	  I	  by	  a	  low	  molecular	  weight	  inhibitor-­‐inactivated	  MMP-­‐2	  at	  37	  °C	  using	  circular	   dichroism	   (CD)	   spectroscopy.	   The	   same	   study	   has	   shown	   that	  MMP-­‐2	  cleaves	  the	  α1(I)	  chain	  5-­‐times	  more	  readily	  than	  the	  α2(I)	  chain	  at	  37	  °C,	  unlike	  MMP-­‐8	   and	   the	   ectodomain	   of	   MT1-­‐MMP	   which	   cleaved	   those	   chains	   almost	  simultaneously.	   This	   suggests	   that	   individual	   collagen	   strands	   are	   cleaved	  independently	   by	  MMP-­‐2,	  when	   the	   collagen	   can	   be	   readily	   unwound	   at	   37	   °C	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with	  the	  help	  of	  the	  FNII	  domain.	  In	  the	  study	  using	  THPs,	  gelatinase	  A	  appeared	  incapable	   of	   cleaving	  more	   thermally	   stable	   triple	   helices,	   which	   were	   readily	  processed	  by	  the	  collagenases	  (Minond	  et	  al,	  2006).	  	  
1.3.1.3.3.	  A	  unique	  triple	  helicase	  activity	  of	  membrane-­‐type	  1	  MMP	  
(MMP-­‐14)	  and	  pericelullar	  collagenolysis.	  	   Apart	  from	  triggering	  and	  mediating	  the	  pericellular	  proteolysis	  by	  MMP-­‐2,	  MT1-­‐MMP	   itself	   is	   a	   key	   enzyme	   responsible	   for	   pericellular	   collagenolysis	  (Ohuchi	  et	  al,	  1997).	  To	  digest	  triple-­‐helical	  collagen	  it	  needs	  to	  dimerise	  on	  the	  plasma	   membrane	   (Itoh	   et	   al,	   2006),	   like	   for	   proMMP-­‐2	   activation.	   This	  dimerisation	   and	   perhaps	   oligomerisation	   is	   mediated	   via	   an	   interaction	  between	   the	   adjacent	   Hpx	   domains.	   The	   role	   of	   the	   dimerisation	   in	   the	   triple	  helicase	   mechanism	   of	   MT1-­‐MMP	   is	   not	   known.	   It	   may	   be	   required	   due	   to	  restricted	   movement	   of	   the	   enzyme	   on	   the	   plasma	   membrane.	   Consistently,	  MMP-­‐13	   lost	   the	   collagenolytic	   activity	   when	   it	   was	   engineered	   to	   be	   a	  transmembrane	   enzyme,	   but	  when	   it	  was	   fused	  with	   the	  Hpx	   domain	   of	  MT1-­‐MMP	  it	  dimerised	  and	  cleaved	  solid	  phase	  collagen	  (Itoh	  et	  al,	  2006).	  	  MT1-­‐MMP	   is	   critically	   important	   for	  cell	  migration	   (Sabeh	  et	  al,	  2004).	  By	  digesting	  the	  surrounding	  collagen	  MT1-­‐MMP	  specifically	  localised	  at	  the	  leading	  edge	  of	   the	  cell	  makes	  way	   through	  dense	  extracellular	  matrix	   (ECM).	  Collagen	  fibrils	   fragmented	   by	   MT1-­‐MMP	   of	   human	   fibroblasts	   are	   phagocytosed	   for	  further	   degradation	   (Lee	   et	   al,	   2006)	   conducted	   intracellularly	   by	   cathepsin	   K	  (Everts	   et	   al,	   2003).	   Also	   secreted	   collagenases	   such	   as	   MMP-­‐1	   may	   be	  facultatively	  localised	  on	  the	  cell	  membrane,	  docking	  via	  integrins	  (Dumin	  et	  al,	  2001),	  or	  an	   immunoglobulin	   superfamily	   receptor	  EMMPRIN	  (CD147)	   (Guo	  et	  al,	  2000),	  and	  can	  provide	  focal	  pericellular	  collagenolytic	  activity	  (Stricker	  et	  al,	  2001).	   The	   lack	   of	   MT1-­‐MMP-­‐dependent	   collagenolysis	   is	   the	   most	   probable	  cause	  of	  skeletal	  abnormalities	  during	  post-­‐natal	  development	  in	  MT1-­‐MMP	  null	  mice	  (Holmbeck	  et	  al,	  1999).	  	  	  	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction	  
 
 50	  
1.3.2.	  Non-­‐MMP	  enzymes	  degrading	  interstitial	  triple-­‐helical	  collagens	  
	  
1.3.2.1.	  Cathepsin	  K	  	   Besides	   collagenolytic	  MMPs,	   there	   is	  only	   cathepsin	  K	   that	   cleaves	   triple-­‐helical	   collagen,	   and	   it	   is	   active	   exclusively	   in	   acidic	   pH	   (Garnero	   et	   al,	   1998;	  Kafienah	   et	   al,	   1998).	   It	   is	   a	   cysteine	   proteinase	   expressed	   mainly	   by	   bone-­‐resorbing	   osteoclasts,	   but	   also	   to	   a	   lesser	   extent	   in	   fibroblasts	   and	   other	   cell	  types.	  	  Collagen	  I	  in	  the	  bone	  is	  the	  main	  target	  of	  the	  enzyme	  (Garnero	  et	  al,	  1998).	  Activated	  osteoclasts	  attach	  to	  the	  bone	  forming	  a	  sealing	  zone.	  Sealed	  areas	  turn	  into	  cavities	  due	  to	  the	  digestion	  of	  the	  underlying	  bone.	  Cathepsin	  K	  is	  secreted	  into	   this	   so-­‐called	   resorptive	   pit,	  where	   the	   osteoclast	   proton	   pumps	   generate	  highly	   acidic	   conditions.	   Deficiency	   in	   cathepsin	   K	   activity	   is	   associated	   with	  pycnodystosis,	   a	   hereditary	   osteopetrotic	   desease	   (Gelb	   et	   al,	   1996).	   Patients	  with	  pycnodystosis	  have	  enhanced	  bone	  density	  and	  dwarfism	  (Fratzl-­‐Zelman	  et	  al,	  2004).	  Knockout	  of	   the	  cathepsin	  K	  gene	   in	  mice	  also	   leads	   to	  osteopetrotic	  phenotype	   (Saftig	   et	   al,	   1998).	   In	   the	   case	   of	   soft	   connective	   tissue	   fibroblasts	  cathepsin	   K	   does	   not	   leave	   the	   lysosomes	   but	   functions	   inside	   them	   to	   digest	  phagocytosed	  collagen	  fragments	  (Everts	  et	  al,	  2003).	  	  Cathepsin	  K	  cleaves	  collagens	  I	  and	  II	  at	  multiple	  sites,	  primarily	  near	  their	  N-­‐termini	   (Garnero	   et	   al,	   1998;	   Kafienah	   et	   al,	   1998),	   and	   it	   requires	  glycosaminoglycans	   for	   efficient	   collagenolysis	   (Li	   et	   al,	   2000;	   Li	   et	   al,	   2002).	  Chondroitin	  4-­‐sulfate	  (C4-­‐S)	  is	  most	  effective.	  It	  serves	  as	  a	  cosine-­‐wave	  shaped	  template	  for	  the	  enzyme	  (Li	  et	  al,	  2002),	  which	  binds	  at	  the	  maxima	  and	  minima	  of	  the	  wave,	  forming	  a	  ‘beads-­‐on-­‐a-­‐string’	  arrangement	  (Li	  et	  al,	  2008).	  	  The	  triple	  helical	  peptidase	  mechanism	  of	  cathepsin	  K	  is	  not	  known.	  It	  may	  be	  hypothesised	  that	  two	  adjacent	  cathepsin	  K	  molecules	  on	  the	  C4-­‐S	  chain	  may	  cooperate	  in	  cleavage	  of	  the	  collagen	  triple	  helix.	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1.3.2.2.	  Non-­‐vertebrate	  collagenases	  
1.3.2.2.1.	  Bacterial	  collagenase	  
 Collagenolytic	   activity	   was	   first	   discovered	   in	   the	   culture	   filtrates	   of	   an	  anaerobic,	   gas	   gangrene	   bacterium	   Clostridium	   histolyticum	   (Jennison,	   1947).	  Two	  types	  of	  bacterial	  collagenases	  were	  purified	  and	  characterised	  (Mandl	  et	  al,	  1953;	   Matsushita,	   1999):	   (i)	   Class	   I	   collagenases	   (ColG)	   consisting	   of	   a	  metalloproteinase	  domain,	  one	  polycystic	  kidney	  disease	  domain	  and	  two	  copies	  of	   a	   collagen-­‐binding	   domain	   (CBD),	   and	   (ii)	   Class	   II	   collagenases	   (ColH)	  with	  two	   copies	   of	   polycystic	   kidney	   disease	   domain,	   and	   one	   CBD	   domain.	   They	  belong	  to	  the	  gluzincin	  metalloproteinase	  superfamily	  (Jung	  et	  al,	  1999),	  because	  the	   catalytic	   domain	   contains	   a	   zinc	   binding	  motif	   415-­‐HEYTH-­‐419,	   providing	  two	   zinc-­‐binding	   His	   residues,	   and	   Glu447	   serves	   as	   a	   third	   zinc	   ligand.	   The	  homologous	   CBDs	   (~110	   amino	   acids)	   bind	   to	   triple	   helical	   regions	   of	   various	  collagen	   types,	   but	   not	   to	   gelatins	   (Matsushita	   et	   al,	   2001;	   Toyoshima	   et	   al,	  2001).	  	  Bacterial	   collagenases	   cleave	   triple	   helices	   of	   insoluble	   collagen	   at	  numerous	   sites,	  with	   a	   preference	   for	  Gly	   in	   the	  P1’	   and	  P3	   subsites,	   aromatic	  residues	  in	  P1,	  and	  Pro	  or	  Ala	  in	  the	  P2	  and	  P2’	  subsites	  (Van	  Wart	  &	  Steinbrink,	  1985).	  The	  CBD	  is	  required	  for	  native	  collagen	  cleavage,	  but	  is	  not	  necessary	  to	  cleave	   denatured	   collagen	   (gelatin).	   Calcium	   ions	   in	   physiological	   solution	  stimulate	   collagen	   binding	   via	   the	   CBD	   by	   facilitating	   a	   conformational	   change	  between	  this	  domain	  and	  the	  12	  residue	  long	  linker.	  The	  linker	  adopts	  an	  α-­‐helix	  which	   in	   the	   absence	   of	   Ca2+	   form	   a	   β-­‐sheet	   sandwich	   fold	  with	   the	   CBD.	   The	  addition	   of	   Ca2+	   unwinds	   the	   linker	   and	  makes	   it	   form	   a	   new	   β-­‐strand	   at	   the	  distal	   side	   of	   the	   sandwich.	   This	   helix-­‐to-­‐sheet	   structural	   rearrangement	  removes	   the	   N-­‐terminus	   from	   the	   collagen-­‐binding	   face	   (Wilson	   et	   al,	   2003).	  More	   important	   in	   collagenase-­‐collagen	   interactions	   are,	   however,	   the	   three	  conserved	  Tyr	  residues	  (Tyr970,	  944	  and	  996).	  Tyr944	  is	  considered	  to	  form	  a	  hydrogen	   bond	   with	   the	   collagen	   backbone	   and	   to	   be	   a	   ‘hot-­‐spot’	   of	   this	  interaction	  (Wilson	  et	  al,	  2003).	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Since	   the	   3D	   structures	   of	   the	  metalloproteinase	   domains	   have	   so	   far	   not	  been	  solved,	  it	  remains	  obscure	  how	  bacterial	  collagenase	  cleaves	  collagen	  triple	  helices	  at	  several	  sites.	  	  
1.3.2.2.2.	  Crab	  collagenase	  	   Decapod	  crustacea	  such	  as	  crab,	  shrimp,	  krill,	  crayfish	  and	  lobster	  secrete	  in	  their	   hepatopancreas	   serine,	   trypsin-­‐like	   proteinases	   that	   have	   triple	   helical	  peptidase	  activity.	  These	  enzymes	  are	  known	  as	  brachyurins	  and	  their	  probable	  role	  is	  digestion	  of	  food.	  Three	  types	  of	  brachyurins	  are	  recognised:	  type	  Ia	  with	  broad	  specificity,	  similar	  to	  trypsin,	  chymotrypsin	  and	  elastase	  specificities;	  type	  Ib	   with	   broad	   specificity	   but	   less	   similar	   to	   trypsin;	   and	   type	   II	   with	   strictly	  trypsin-­‐like	  specificity	  (Welgus	  et	  al,	  1982).	  	  Fiddler	  crab	  collagenases	  belong	  to	  type	  Ia	  and	  Ib.	  They	  cleave	  collagens	  I-­‐V	  at	   multiple	   sites	   at	   25	   °C	   (Welgus	   et	   al,	   1982;	   Welgus	   &	   Grant,	   1983).	  Interestingly,	   the	  predominant	  cleavages	  occurr	  at	   the	  proximal	  site	  C-­‐terminal	  to	  the	  MMP	  collagenase	  cleavage	  site,	  where	  the	  helical	  structure	  is	  looser	  (Tsu	  et	   al,	   1994).	   According	   to	   the	   3D	   structure	   of	   crab	   collagenase	   solved	   in	   a	  complex	  with	  the	  E.	  coli	  serine	  proteinase	  inhibitor	  ecotin	  (Perona	  et	  al,	  1997),	  it	  has	  a	  similar	  fold	  to	  that	  of	  vertebrate	  trypsins	  with	  conservation	  of	  the	  double	  β-­‐barrel	  core	  and	  the	  catalytic	  triad	  (His57,	  Asp102	  and	  Ser195).	  The	  differences	  are	  seen	  in	  several	  connecting	  loops	  which	  create	  an	  extended	  S7-­‐S4’	  substrate	  binding	   site.	   This	   structural	   feature	   may	   be	   decisive	   for	   collagen	   recognition.	  However,	   the	   affinity	   of	   MMP-­‐1	   for	   collagen	   I	   is	   greater	   than	   that	   of	   the	   crab	  collagenase	  (Welgus	  et	  al,	  1982).	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1.4.	  Collagenolysis	  by	  MMPs	  in	  health	  and	  disease	  	  Collagen	  turnover	  throughout	  animal	  life	  is	  normally	  very	  slow.	  However,	  it	  accelerates	  dramatically	   in	  physiological	  processes	  of	  growth	  and	  development	  and	  in	  pathologies	  associated	  with	  tissue	  destructive	  diseases.	  	  Collagen	   breakdown	   (collagenolysis)	   is	   a	   major	   event	   during	   tissue	  remodelling	   processes	   such	   as	   bone	   and	   growth	   plate	   remodelling,	   embryonic	  development,	  post-­‐partum	  involution	  of	  the	  uterus,	  ovulation	  and	  wound	  healing	  (reviewed	   by	   (Woessner,	   1991)).	   It	   is	   usually	   initiated	   by	   collagenases.	  Collagenase	   activity	   can	   also	   indirectly	   alter	   cell	   behaviour.	   Collagen	   I	  degradation	   by	   MMP-­‐1	   initiates	   bone	   resorption	   by	   activating	   cathepsin	   K	  producing	   osteoclasts	   (Sakamoto	   &	   Sakamoto,	   1988;	   Holliday	   et	   al,	   1997),	  stimulating	   keratinocyte	   migration	   during	   reepithelialisation	   (Pilcher	   et	   al,	  1997),	  and	  accompanying	  apoptosis	  of	  amnion	  epithelial	  cells	  before	  the	  onset	  of	  labour	  (Lei	  et	  al,	  1996).	  	  It	   is	  not	  surprising	   that	  collagenolytic	  enzymes,	   causing	  destruction	   to	   the	  framework	  of	   their	  host	  organism,	  require	  a	  strict	  activity	  control.	  This	   is	  done	  by	   several	   means	   such	   as	   regulation	   of	   expression	   and	   secretion,	   multistep	  activation,	  and	   inhibition	  by	  multiple	  endogenous	   inhibitors.	  Collagenases	  may,	  however,	   escape	   the	   activity	   control	   under	   pathological	   conditions.	   Aberrant	  collagenolysis	   is	  greatly	  manifested	  during	   joint	  destruction	   in	  rheumatoid	  and	  osteoarthritis.	   MMP-­‐1	   and	   MMP-­‐13	   are	   produced	   by	   synovial	   fibroblasts,	  macrophages	  and	  chondrocytes	  (Hollander	  et	  al,	  1994;	  Wu	  et	  al,	  2002).	  MMP-­‐8	  (neutrophil	  collagenase)	  is	  also	  expressed	  in	  synovial	  joints,	  but	  its	  contribution	  to	   cartilage	   collagen	   degradation	   is	   unclear.	   Unbalanced	   collagenolysis	   is	   also	  seen	  in	  tumor	  growth	  and	  invasion	  (Liotta	  et	  al,	  1983;	  Salo	  et	  al,	  1985;	  Cockett	  et	  al,	   1998)	   or	   atherosclerotic	   plaque	   formation	   and	   rupture	   (Busti	   et	   al,	   2010;	  Wang	   et	   al,	   2010).	  MMP-­‐1	   and	  MMP-­‐13	   are	   upregulated	   in	   the	   later	   stages	   of	  vascular	   diseases	   and	   facilitate	   the	   transition	   from	   matrix	   turnover	   to	   matrix	  destruction	  (Chase	  &	  Newby,	  2003).	  In	  a	  mouse	  model,	  overexpression	  of	  MMP-­‐1	  caused	  functional	  heart	  defects	  due	  to	  the	  reduction	  in	  collagen	  (Kim	  et	  al,	  2000).	  MMP-­‐1	   is	  also	  one	  of	  several	  MMPs	   implicated	   in	  osteoporosis	  (Andersen	  et	  al,	  2004).	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1.4.1.	  Inhibition	  of	  MMP-­‐dependent	  collagenolysis	  
 Collagenolytic	   activity	   of	   MMPs	   is	   tightly	   controlled	   by	   endogenous	  inhibitors.	   In	   the	   fluid	  phase	  α2-­‐macroglobulin	   (α2-­‐M)	   is	  mainly	  responsible	   for	  regulating	  MMP	  activity.	  The	  MMP-­‐α2M	  complex	  is	  rapidly	  cleared	  by	  low	  density	  lipoprotein	   receptor-­‐related	   protein-­‐1-­‐mediated	   endocytosis	   (Strickland	   et	   al,	  1990).	   In	   a	   tissue	   context,	   the	   most	   potent	   are	   the	   tissue	   inhibitors	   of	  metalloproteinases	   (TIMPs)	   (Brew	   &	   Nagase,	   2010).	   For	   potential	   therapeutic	  application,	   many	   synthetic	   matrixin	   inhibitors	   have	   also	   been	   designed,	   and	  recent	  strategies	  for	  their	  development	  have	  become	  promising	  (see	  below).	  
 
 
1.4.1.1.	  Tissue	  inhibitors	  of	  metalloproteinases	  (TIMPs)	  
 TIMPs	  were	   first	  discovered	  as	   collagenase	   inhibitors	   in	   serum	  and	   in	   the	  conditioned	   media	   from	   fibroblast	   cultures	   (Vater	   et	   al,	   1979;	   Welgus	   et	   al,	  1979).	  They	  bind	  to	  MMPs	  with	  a	  1:1	  stochiometry.	  There	  are	  four	  members	  of	  the	   family:	  TIMP-­‐1,	   -­‐2,	   -­‐3	  and	   -­‐4.	  They	   inhibit	  all	  MMPs	  with	  various	  efficacies,	  but	   among	   collagenolytic	   members	   MT1-­‐MMP	   is	   poorly	   inhibited	   by	   TIMP-­‐1	  (Baker	  et	  al,	  2002).	  Studies	  of	  TIMP	  knockouts	  (Fata	  et	  al,	  2001;	  Leco	  et	  al,	  2001)	  indicate,	  that	  TIMP-­‐3	  is	  a	  major	  regulator	  of	  metalloproteinase	  activities	  in	  vivo.	  TIMP-­‐3	   is	   also	   unique	   for	   its	   ability	   to	   adhere	   to	   ECM	   components	   (Lee	   et	   al,	  2007).	   Under	   pathological	   conditions	   caused	   by	   unbalanced	   collagenolysis,	  changes	   in	  TIMP	  bioavailability	  are	   considered	   to	  be	  essential	   for	   they	  directly	  downregulate	  the	  level	  of	  collagenolytic	  activity.	  
 
 
1.4.1.2.	  Synthetic	  inhibitors	  of	  MMPs	  
	   Initially,	  synthetic	  inhibitors	  of	  MMPs	  were	  developed	  based	  on	  the	  peptide	  sequence	  recognised	  by	  the	  targeted	  proteinase,	  with	  addition	  of	  a	  zinc-­‐chelating	  moiety,	   such	   as	   hydroxamic	   acid.	   Several	   potent	   non-­‐peptidic	   inhibitors	   were	  generated,	  however,	  their	  selectivity	  among	  MMPs	  was	  poor.	  This	  is	  due	  to	  a	  high	  conservation	   of	   the	   active	   site	   architecture	   in	   MMPs.	   It	   therefore	   poses	   a	  challenge	   to	   develop	   highly	   specific	   active	   site-­‐directed	   inhibitors	   of	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metalloproteinases,	   discriminating	   members	   of	   the	   matrixin	   family,	   despite	  knowledge	   of	   the	   3D	   structure	   of	   their	   Cat	   domains.	   One	   of	   the	   ways	   to	   gain	  selectivity	  would	  be	  by	  targeting	  the	  exosites	  participating	  in	  binding	  of	  various	  substrates,	   if	   only	   those	   were	   better	   known.	   In	   animal	   models,	   the	   first	  generations	   of	   synthetic	   MMP	   inhibitors	   proved	   successful	   in	   preventing	   the	  progression	   of	   early	   cancer,	   but	   were	   ineffective	   in	   the	   advanced	   disease	  (Coussens	   et	   al,	   2002).	   Numerous	   clinical	   trials	   of	   synthetic	   MMP	   inhibitors	  failed	  with	  cancer	  patients,	  principally	  due	  to	  the	  lack	  of	  efficacy	  and	  side-­‐effects	  such	   as	  musculoskeletal	   pain	   and	   in	   some	   cases	   tendonitis	   (Milner	  &	  Cawston,	  2005).	   Those	   trials	   usually	   involved	   the	   inhibitors	   as	   single	   therapeutic	   agents	  for	  patients	  with	  advanced	  disease.	  New	  generations	  of	  hydroxamate	  MMP	   inhibitors,	  which	  display	  relatively	  higher	  specificity,	  are	  being	  evaluated	  (Fisher	  &	  Mobashery,	  2006).	  Tetracycline-­‐based	  inhibitors	  appear	  to	  have	  some	  efficacy,	  despite	  their	  weak	  MMP	  binding.	  Possibly,	  they	  may	  act	  on	  MMP	  synthesis	  (Murphy	  &	  Nagase,	  2008a).	  Also	  thiol-­‐,	  hydroxypyrone-­‐	  and	  barbiturate-­‐based	   inhibitors	  are	  being	  explored	  as	  well	  as	  phosphinates	  which	  act	  as	  transition	  state	  analogues	  (Murphy	  &	  Nagase,	  2008a).	  Phosphinates	   are	   also	   being	   employed	   in	   combination	   with	   triple-­‐helical	  structures	   by	   incorporation	   into	   THPs.	   This	   gives	   rise	   to	   a	   new	   class	   of	  potentially	   selective	   inhibitors,	   which	   can	   interact	   with	   both	   prime	   and	  nonprime	   active	   site	   subsites	   (Lauer-­‐Fields	   et	   al,	   2007).	   Recently	  MMP-­‐13	   has	  been	   targeted	   for	   selective	   inhibition,	   as	   it	   is	   a	  major	   effector	   in	   arthritis	   and	  periodontitis.	  Some	  approaches	  are	  targeting	  the	  depth	  of	  the	  S1’	  pocket	  (Devel	  et	   al,	   2010;	   Gao	   et	   al,	   2010).	   Some	   potent	   and	   selective	   carboxylic-­‐acid	   based	  inhibitors	   of	  MMP-­‐13	  have	   also	   been	  discovered	   (Monovich	   et	   al,	   2009).	  Many	  novel	  relatively	  selective	  MMP-­‐13	  inhibitors	  proved	  successful	  in	  various	  animal	  trials	   (Baragi	   et	   al,	   2009;	   Jungel	   et	   al,	   2010;	   Settle	   et	   al,	   2010)	   and	   seem	  promising	  as	  future	  therapeutic	  agents.	  	  Novel	  approaches	  to	  MMP	  inhibition	  include	  phage	  library	  screens	  (Overall	  &	   Lopez-­‐Otin,	   2002).	   Inhibitory	   proteins	   derived	   from	   this	   strategy	   could	   be	  especially	   useful	   for	   defining	   and	   targeting	   the	   substrate-­‐specific	   exosites	   on	  MMPs.	   For	   example,	   the	   Hpx	   domain	   of	   MT1-­‐MMP	   determines	   its	   binding	   to	  CD44	   (Suenaga	   et	   al,	   2005).	   On	   the	   other	   hand,	   this	   domain	   mediates	   the	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clustering	  of	  MT1-­‐MMP	  required	  for	  collagen	  degradation	  and	  MMP-­‐2	  activation.	  The	  collagenolytic	  activity	  of	  MT1-­‐MMP	  is	  a	  key	  regulator	  of	  cell	  migration	  (Itoh,	  2006),	   and	   MMP-­‐2	   participates	   in	   pericellular	   collagenolysis,	   helping	   cells	   to	  penetrate	  the	  stroma	  and	  force	  their	  way	  through	  basement	  membranes	  to	  enter	  the	   circulation.	   Selective	   pharmacological	   blockage	   of	   MT1-­‐MMP	   clustering	  combined	  with	  an	  appropriate	  administration	  of	  the	  drug	  could	  perhaps	  prevent	  tumor	  metastasis.	  	  
1.5.	  Structural	  and	  mechanistic	  aspects	  of	  collagenolysis	  by	  MMP	  
collagenases	  	   There	   is	   an	   ongoing	   debate	   on	   how	   collagenases	   deal	   with	   structural	  complexity	  of	  collagen,	  both	  at	  the	  level	  of	  fibril	  organisation	  and	  at	  the	  level	  of	  unwinding	  of	  individual	  triple	  helices.	  	  
	  
1.5.1.	  Degradation	  of	  collagen	  fibrils	  
	   A	  recent	  investigation	  of	  the	  collagen	  I	  microfibrillar	  arrangement	  (Perumal	  et	  al,	  2008)	  was	  focused	  on	  the	  fibrillar	  collagen	  degradation	  enigma.	  It	  has	  been	  thought	   that	   fibrillar	   collagen	   degradation	   was	   usually	   initiated	   by	   the	   MMP	  family	   members,	   particularly	   collagenases.	   However,	   the	   MMP	   cleavage	   site	  appears	   to	   be	   concealed	   by	   the	   C-­‐telopeptide	   of	   a	   neighbouring	   collagen	  molecule	  in	  the	  established	  3D	  architecture	  of	  the	  fibril.	  Hence,	  proteolysis	  of	  the	  C-­‐terminal	   telopeptides	  was	   suggested	   to	   be	   required	   for	   the	   fibrillar	   collagen	  breakdown	  by	  MMP	  collagenases	  (Perumal	  et	  al,	  2008).	  	  Reconstituted	  acid	  soluble	  collagen	  I	  fibrils	  are	  less	  readily	  cleaved	  by	  MMP-­‐1,	  compared	  to	  TC	  monomers.	  Consequently,	  the	  activation	  energy	  (EA)	  value	  for	  solubilised	   and	   fibril-­‐assembled	   collagens	   comes	   to	   49.2	   and	   101.05	  Kcal/mol,	  respectively	  (Welgus	  et	  al,	  1981b).	  Interestingly,	  expansion	  of	  buffer	  volume	  did	  not	  affect	  the	  collagen	  fibril	  lysis	  by	  collagenase,	  suggesting	  that	  the	  enzyme	  does	  not	  dissociate	  from	  the	  fibril	  during	  the	  processing	  but	  rather	  stays	  in	  a	  constant	  close	   association	   (Welgus	   et	   al,	   1981b).	   Reconstituted	   fibrils,	   however,	   do	   not	  necessarily	   exhibit	   the	   same	   packing	   arrangement	   as	   collagen	   fibrils	   in	   vivo.	  Furthermore,	  the	  reconstituted	  fibrils	  lack	  the	  plethora	  of	  small	  collagen-­‐binding	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proteins	   such	   as	   SLRPs	  mentioned	   earlier.	   It	   is	   likely,	   that	   proteinases	   bearing	  telopeptidase	   activity	   such	   as	  MMP-­‐1,	  MMP-­‐3,	  MMP-­‐13,	   cathepsins	   B,	   G	   and	   L,	  and	   neutrophil	   elastase	   (HNE)	   are	   important	   components	   of	   collagen	   fibril	  digestion	   in	  vivo.	  Cleavage	  of	  C-­‐telopeptides	  would	  not	  only	   remove	   the	  spatial	  hindrance,	  but	  also	  cross	  linking	  sites	  from	  the	  fibrils	  (Wu	  et	  al,	  1991),	  bringing	  about	   relaxation	   or	   local	   decomposition	   of	   the	   fibril.	   Thinner	   fibrils	   generated	  this	   way	   or	   due	   to	   mechanical	   damage	   could	   have	   more	   exposed	   collagenase	  cleavage	   sites	   and	   be	   more	   readily	   processed.	   Soluble	   collagenases	   might	  therefore	  provide	  some	  sort	  of	  clean-­‐up	  mechanism	  at	  the	  sites	  of	  injury.	  	  Saffarian	  et	  al	  (Saffarian	  et	  al,	  2004)	  found	  that	  active	  MMP-­‐1	  moves	  in	  one	  direction	   on	   reconstituted	   collagen	   fibrils,	   like	   a	   molecular	   ratchet	   driven	   by	  proteolysis.	   This	   is	   consistent	   with	   the	   collagen	   fibril	   structure	   proposed	   by	  Orgel.	  After	  C-­‐telopeptide	  removal,	  collagenase	  can	  remove	  the	  C-­‐terminal	  ¼	  of	  the	  exposed	  collagen	  molecule	  together	  with	  its	  C-­‐telopeptide,	  thereby	  exposing	  another	  cleavage	  site.	  Then	  it	  may	  shift	  to	  that	  newly	  exposed	  cleavage	  site	  and	  so	  forth	  (proposed	  by	  R.	  Visse	  &	  H.	  Nagase,	  personal	  communication).	  	  Such	   directional	   collagenase	   action	   may	   be	   associated	   with	   directional	  movement	   of	   the	   cells	   expressing	   MT1-­‐MMP	   or	   the	   cells	   with	   soluble	  collagenases	   attached	   to	   the	   plasma	   membrane	   via	   integrins	   or	   Emmprin	  (Basigin	  or	  CD147)	  (Guo	  et	  al,	  2000).	  The	  directional	  cell	  movement	  on	  collagen	  fibrils	  has	  been	  reported	  during	  pericellular	  collagen	  fibril	  degradation	  by	  MT1-­‐MMP	   (Wolf	   et	   al,	   2007).	   According	   to	   Orgel’s	  model	   integrin	   binding	   sites	   are	  also	   blocked	   by	   the	   neighbouring	   collagen	   molecules	   (Sweeney	   et	   al,	   2008).	  Collagenolysis	  may	  therefore	  be	  necessary	  to	  make	  those	  sites	  available	  to	  cells.	  	  	  	  
1.5.2.	  Current	  insights	  into	  the	  mechanism	  of	  collagen	  cleavage	  by	  
MMP	  collagenase	  	   Ways	   in	   which	   the	   MMP	   collagenases	   may	   gain	   access	   to	   the	   fibril-­‐assembled	  collagen	  molecules	  have	  been	  proposed,	  although	  further	  research	  is	  needed	  to	  validate	  certain	  assumptions.	  Not	   fully	  understood	  also	   is	  the	  way	  in	  which	   collagenases	   overcome	   the	   proteolytically	   resistant	   triple-­‐helical	   fold	   to	  cleave	   individual	   α	   chains.	   Regions	   of	   collagenase-­‐collagen	   interaction	   are	   of	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particular	  importance	  in	  the	  elucidation	  of	  the	  mechanism	  of	  collagenase	  activity.	  So	  far,	  a	  few	  insights	  into	  this	  mechanism	  have	  been	  provided.	  	  	  
1.5.2.1.	  Participation	  of	  non-­‐catalytic	  domains	  (linker	  and	  Hpx)	  in	  
collagen	  processing	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1.5.2.2.	  Collagen	  unwinding	  	  
 Figure	  9	  shows	  a	  collagen	  triple	  helix	  based	  on	  a	  THP	  structure	  determined	  by	  Kramer	  (Kramer	  et	  al,	  1999),	  aligned	  to	  the	  catalytic	  site	  cleft	  of	  MMP-­‐1.	  This	  cleft	   is	   sufficiently	   wide	   to	   accept	   only	   a	   single	   polypeptide	   chain	   in	   a	   linear	  conformation.	  In	  a	  helical	  conformation	  a	  polypeptide	  could	  not	  be	  fitted	  into	  the	  substrate	   binding	   subsites,	   and	   effective	   peptide	   hydrolysis	   by	   MMPs	   engages	  multiple	   subsites	   within	   the	   cleft	   (Nagase,	   2001).	   In	   the	   case	   of	   the	   collagen	  triple-­‐helix	   the	  distance	  between	   the	   catalytic	   site	   zinc	   and	   the	   closest	   peptide	  bond	   is	   ~7Å.	   Thus	   possibilities	   are	   that	   the	   catalytic	   domain	   needs	   to	   change	  shape	  prior	  to	  cleavage	  or	  that	  the	  collagen	  triple	  helix	  needs	  to	  be	  unwound.	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  In	   2004,	   Chung	   and	   coworkers	   (Chung	   et	   al,	   2004)	   experimentally	  demonstrated	   that	   the	   collagen	   strands	   are	   locally	   unwound	   prior	   to	   peptide	  bond	  hydrolysis	   by	  MMP-­‐1.	   They	   used	   an	   active	   site	  mutant	   of	   the	   enzyme,	   in	  which	  Glu200	  was	  substituted	  to	  Ala	  (MMP-­‐1(E200A)),	  together	  with	  an	  enzyme	  such	  as	  the	  Cat	  domain	  of	  MMP-­‐1	  (MMP-­‐1Cat)	  or	  neutrophil	  elastase,	  capable	  of	  
Figure	   9.	   Collagenase	   active	   site	   cleft	   is	   too	   narrow	   to	   accommodate	   the	   collagen	   triple	   helix.	  A	  
fragment	  of	  the	  triple-­‐helical	  peptide	  containing	  native	  collagen	  III	  sequence	  (Col,	  red)	  (Kramer	  et	  al,	  
1999;	  pdb	  code:	  1BKV)	  is	  manually	  aligned	  with	  the	  active	  site	  cleft	  of	  MMP-­‐1	  (pdb	  code:	  2CLT;	  Cat,	  
light	   cyan;	   Hpx,	   blue),	   shown	   as	   a	   ribbon	  with	   transparent	   van	   der	  Waals	   surface.	   The	   active	   site	  
Zn2+	  is	  shown	  as	  a	  yellow	  sphere.	  Water	  molecules	  of	  the	  hydration	  network	  around	  the	  triple-­‐helical	  
peptide	  crystal	  structure	  are	  shown	  as	  red	  dots.	  Images	  were	  made	  with	  Pymol.	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cleaving	   collagen	   chains	   only	  when	   they	   are	   unwound.	   Nonetheless,	   the	   triple	  helicase	  mechanism	  and	  precise	   intra-­‐	   and	   intermolecular	   interaction	   sites	   are	  still	   enigmatic,	   despite	   the	   abundance	   of	   mutagenesis	   and	   domain	   exchange	  studies	  mentioned	  above.	  	  A	  number	  of	  scenarios	  have	  been	  proposed,	  including	  collagen	  sandwiching	  between	  the	  Hpx	  domain	  folded	  over	  the	  Cat	  domain	  (collagen	  trapping	  model)	  (Gomis-­‐Rüth	   et	   al,	   1996)	   and	  α	   chain	   intercalation	  with	   the	  proline-­‐rich	   linker	  (proline	   zipper	   model)	   (De	   Souza	   et	   al,	   1996),	   but	   without	   experimental	   data	  (reviewed	  in	  (Overall,	  2002)).	  Stultz	  and	  colleagues	  (Stultz,	  2002;	  Nerenberg	  et	  al,	  2008),	  on	  the	  other	  hand,	  claim	  that	  the	  localised	  collagen	  micro-­‐unfolding	  in	  the	   vicinity	   of	   the	   collagenase	   cleavage	   site	   occurs	   spontaneously	   via	   thermal	  structural	   fluctuations,	   and	   generates	   a	   proteolytically	   vulnerable	   state,	   which	  does	   not	   require	   ‘active’	   involvement	   of	   the	   enzyme.	   This	   theory	   is	   proposed	  based	   on	   the	   fact	   that	   collagenase	   action	   is	   not	   accompanied	   by	   any	   external	  energy	   supply	   (e.g.	   ATP	   hydrolysis),	   and	   the	   computational	   simulation	   (Stultz,	  2002)	   showing	   that	   the	   triple	   helix	   is	   conformationally	   unstable	   at	   the	  collagenase-­‐susceptible	  region.	  Thermal	   fluctuations	   in	   the	   triple-­‐helical	   structural	   arrangement	   are	   not	  evenly	  distributed	  along	  the	  entire	  collagen	  molecule,	  which	  is	  consistent	  with	  a	  single	  collagenase-­‐cleavage	  site.	  There	  are	  segments	  (domains)	  of	  various	  imino-­‐acid	  contents,	  and	  hence,	  various	  backbone	  motilities	  (Steplewski	  et	  al,	  2004b).	  Poor	  imino-­‐acid	  content	  in	  the	  vicinity	  of	  collagenase	  cleavage	  site	  was	  noted	  by	  Brown	  et	  al	  (Brown	  et	  al,	  1977).	  This	  finding	  substantiated	  the	  early	  hypothesis	  of	   local	   thermolability	   of	   the	   triple	   helix	   in	   that	   region	   (Gross	  &	  Nagai,	   1965).	  Later,	  the	  collagenase-­‐susceptible	  sites	  in	  various	  fibrillar	  collagens	  were	  found	  to	  be	  loose	  imino-­‐poor	  regions	  preceded	  by	  tightly	  helical	  conformations	  of	  low	  side-­‐chain	   volumes	   (Fields,	   1991).	   More	   recent	   studies	   also	   suggested	   that	  collagen	  is	  conformationally	  labile	  at	  the	  site	  of	  collagenase	  cleavage	  (Fiori	  et	  al,	  2002),	  including	  in	  silico	  molecular	  dynamics	  simulations	  of	  collagen-­‐like	  model	  peptides	  (Stultz,	  2002).	  In	  addition,	  the	  study	  by	  Leikina	  et	  al	  (2001)	  showed	  that	  the	   energetically	   preferred	   conformation	   of	   collagen	   at	   physiological	  temperature	  is	  a	  random	  coil	  rather	  than	  a	  triple	  helix.	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The	  Stultz’s	  hypothesis	  was	  recently	  challenged	  by	  R.	  Visse	  and	  H.	  Nagase	  (unpublished	   data)	   by	   measuring	   the	   cutter	   activity	   (an	   activity	   to	   cleave	  unwound	   collagen	   chains)	   of	   various	   MMP-­‐1Cat	   mutants	   in	   the	   presence	   of	  MMP-­‐1(E200A),	   and	   their	   collagenolytic	   activities.	   The	   latter	   activities	   showed	  only	   small	   variability	   between	   the	   mutants	   (60-­‐120%	   of	   the	   wild-­‐type	   MMP-­‐1Cat),	  whereas	  the	  cutter	  activities	  varied	  extensively	  (4.5-­‐58	  fold	  in	  relation	  to	  the	   wild-­‐type	   MMP-­‐1Cat).	   These	   results	   suggest	   that	   considerable	   structural	  changes	  are	  induced	  by	  collagenase	  interaction	  with	  collagen.	  If	  MMP-­‐1(E200A)	  were	  to	  passively	  capture	  and	  only	  extend	  the	  lifetime	  of	  the	  vulnerable	  state	  of	  collagen	   the	   collagenolytic	   activities	   of	   the	   Cat	   domain	  mutants	   would	   exhibit	  similar	   fold	   of	   increase	   upon	  MMP-­‐1(E200A)	   addition.	   It	   has	   also	   been	   found,	  that	   the	   α1(I)	   homotrimers	   are	   resistant	   to	   collagenases	   due	   to	   less	   efficient	  unwinding	   (Han	   et	   al,	   2010),	  which	   suggests	   that	   unwinding	   activity	   is	   one	   of	  rate-­‐limiting	   steps	   in	   collagenolysis.	   This	   is	   consistent	  with	   the	  high	  Arrhenius	  activation	  energy	  (EA)	  (Welgus	  et	  al,	  1981b)	  associated	  with	  energetically	  costly	  displacement	   of	   the	   organised	   water	   network	   upon	   triple	   helix	   perturbation.	  Such	  water	  molecules	  surrounding	  a	  THP	  structure	  are	  shown	  in	  Figure	  9	  as	  red	  dots.	  	  Using	  the	  system	  where	  unwinding	  and	  cutting	  activities	  of	  collagenases	  are	  decoupled,	  R.	  Visse	  and	  H.	  Nagase	  also	  found	  that	  collagenase	  mutants	  showing	  several-­‐fold	  higher	  unwinding	  or	  cutting	  activity	  than	  MMP-­‐1	  do	  not	  necessarily	  exhibit	   greater	   collagenolytic	   activity	   (unpublished	   data).	   Conversely,	   some	   of	  them	  showed	  10%	  of	  that	  activity,	  suggesting	  that	  the	  triple	  helicase	  mechanism	  comprises	  several	  steps,	  one	  of	  which	  would	  be	  presentation	  of	  the	  unwound	  α	  chains	   to	   the	   active	   site	   of	   the	   enzyme.	   Impairment	   of	   any	   of	   the	   following:	  collagen	  recognition;	  unwinding;	  active	  site	  positioning	  of	  unwound	  α	  chain	  and	  hydrolysis	   of	   peptide	   bonds	   affects	   the	   overall	   collagenolytic	   activity	   of	   the	  enzyme.	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1.5.2.3.	  Conformational	  freedom	  as	  an	  important	  element	  of	  
collagenase-­‐collagen	  interactions	  
 Comparison	  of	  the	  crystal	  structure	  of	  proMMP-­‐1	  reported	  in	  2005	  (Jozic	  et	  al,	  2005)	  with	  the	  structures	  of	  activated	  MMP-­‐1	  (Li	  et	  al,	  1995;	  Iyer	  et	  al,	  2006)	  supported	  a	   speculation	   that	   the	   flexibility	   in	   the	  hinge	   (linker)	   region	  enables	  changes	   in	   relative	   orientation	   of	   the	   Cat	   and	   the	  Hpx	  domains,	  which	  may	  be	  triggered	  upon	  substrate	  binding	  (Figure	  10).	  The	  prodomain	  holds	  the	  Cat	  and	  Hpx	   domains	   together	   by	   direct	   interaction	   with	   the	   Hpx	   domain.	   Upon	  activation,	  the	  Hpx	  domain	  can	  swing	  aside	  widening	  the	  space	  between	  the	  two	  domains	   (Figure	   10)	   and	   can	   probably	   fluctuate	   in	   other	   directions	   to	   some	  degree.	   This	   suggests	   that	   at	   least	   two	   states	   of	   MMP-­‐1	   can	   be	   distinguished:	  ‘open’	   and	   ‘closed’	   state.	   It	   is	   hypothesised	   that	   the	   ‘open’	   state	   facilitates	  collagen	  binding	  and	  subsequent	  unwinding	  may	  be	  exerted	  by	  conformational	  transition	  to	  the	  ‘closed’	  state	  (Jozic	  et	  al,	  2005).	  This	  or	  other	  mode	  of	  a	  putative	  intramolecular	   transition	   is	   probably	   impeded	   in	   temperatures	   lower	   than	  physiological	  (37	  °C),	  as	  the	  unwinding	  activity	  of	  MMP-­‐1	  against	  type	  I	  collagen	  was	  shown	  to	  decrease	  with	  temperature	  and	  was	  almost	  completely	  abolished	  below	  10	  °C	  (Chung	  et	  al,	  2004).	  In	  this	  low	  temperature	  the	  enzyme	  could	  only	  bind	  the	  substrate	  (form	  an	  early	  complex),	  but	  was	  unable	  to	  unwind	  its	  triple	  helical	  structure	  (form	  a	  transition	  complex).	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  Conformational	  flexibility	  may	  be	  a	  common	  feature	  of	  MMPs	  as	  concluded	  from	   the	   wide	   array	   of	   conformations	   that	   MMP-­‐9	   (gelatinase	   B)	   can	   adopt	  (Rosenblum	   et	   al,	   2007).	   	   Intramolecular	   plasticity	   demonstrated	   with	   this	  example	   sheds	   some	   light	   on	   how	   MMPs	   may	   flex	   to	   deal	   with	   structurally	  inaccessible	   folds	   such	   as	   triple	   helical	   collagen.	   The	   blockade	   of	   flexibility	  imposed	   by	   the	   prodomain	   may	   explain	   the	   biochemical	   observation	   that	  proMMP-­‐1	  and	  proMMP-­‐8	  do	  not	  bind	  to	  collagen	  I	  (Welgus	  et	  al,	  1985b;	  Murphy	  et	  al,	  1992;	  Knäuper	  et	  al,	  1993).	  However,	  proMMP-­‐13	  binds	  to	  collagen	  I	  with	  slightly	   lower	  affinity	   than	   its	  active	  counterpart	   (Knäuper	  et	  al,	  1997a),	  which	  suggests	   that	   the	   Hpx	   domain	   of	   MMP-­‐13	   can	   bind	   to	   collagen	   independently	  from	  the	  active	  site	  cleft	  of	  the	  enzyme.	  	  
	  
 
Figure	  10.	  Collagenase	   interdomain	   flexibility	  exemplified	  by	  pro-­‐	  and	  mature	  MMP-­‐1	   structures.	  
(A)	   The	   ribbon	   structure	   of	   human	   proMMP-­‐1	   (pdb	   code:	   1SU3),	   with	   numbered	   α-­‐helices	   in	   the	  
prodomain.	   The	   Cat	   domain	   is	   shown	   in	   cyan	   and	   the	   pro-­‐	   and	  Hpx	   domains	   as	  well	   as	   linker	   are	  
shown	   in	   green.	   The	   prodomain	   interacts	   with	   the	   Hpx	   domain	   resulting	   in	   a	   compact	   reciprocal	  
arrangement	  of	  the	  Cat	  and	  the	  Hpx	  domains.	  (B)	  Superimposition	  of	  human	  MMP-­‐1	  (orange	  linker-­‐
Hpx	  domain),	  porcine	  MMP-­‐1	  (navy	  blue	  linker-­‐Hpx	  domain)	  (pdb	  codes:	  2CLT	  and	  1FBL,	  respectively)	  
and	  the	  proMMP-­‐1	  via	  the	  Cat	  domains,	  showing	  the	  wider	  space	  between	  the	  Cat	  and	  Hpx	  domain	  in	  
the	  active	  forms	  of	  MMP-­‐1.	  This	  demonstrates	  the	  pivoting	  potential	  of	  the	  Hpx	  domain	  in	  relation	  to	  
the	  Cat	  domain	  in	  MMP-­‐1.	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1.5.2.4.	  Sites	  of	  collagenase	  involved	  in	  interactions	  with	  collagen	  
 Little	  is	  known	  about	  the	  regions	  of	  collagenase	  which	  make	  contacts	  with	  collagen	   during	   collagenolysis.	   Most	   likely	   some	   regions	   governing	   substrate	  specificity	   are	   distinct	   from	   the	   sites	   responsible	   for	   the	   catalytic	   activity	   in	  collagenases.	   Taking	   into	   account	   the	   importance	   of	   the	   Hpx	   domain	   and	   the	  likely	  structural	   flexibility	   those	  regions	  may	  be	  distal	   to	   the	  catalytic	  centre	  of	  the	   enzyme.	   Interactions	   occurring	   via	   exosites	   in	   the	   Hpx	   domain	   may	   even	  drive	  active	  site	  positioning	  according	  to	  (Overall	  &	  Butler,	  2007).	  An	  attempt	  to	  identify	   those	   sites	   that	   interact	   with	   a	   collagen-­‐like	   synthetic	   triple-­‐helical	  peptide	  (THP)	  by	  hydrogen/deuterium	  exchange	  mass	  spectrometry	  (H/DXMS),	  indicated	  regions	  285-­‐295,	  302-­‐316	  and	  437-­‐457	  of	   the	  Hpx	  domain	  of	  MMP-­‐1	  (Lauer-­‐Fields	   et	   al,	   2009).	   The	   Ile290	   and	  Arg291	   residues	  were	   confirmed	   to	  contribute	  to	  recognition	  of	  collagen	  I	  by	  mutagenesis	  (Lauer-­‐Fields	  et	  al,	  2009).	  However,	  the	  participation	  of	  the	  437-­‐457	  region	  in	  collagenolysis	  has	  not	  been	  proven,	  and	  due	   to	   its	   location	   in	   the	  3D	  structure	  (back	  of	   the	  Hpx	  blade	  4)	   it	  seems	   unlikely	   to	   be	   a	   catalytically	   relevant	   collagen	   binding	   site.	   In	   addition,	  recent	  studies	  by	  R.	  Visse	  and	  H.	  Nagase	  have	  suggested	  that	  blades	  1	  and	  2	  of	  the	  Hpx	  domain	  are	  important	  for	  collagen	  unwinding	  (unpublished	  data).	  In	   the	   Cat	   domain	   of	   MMP-­‐1	   the	   202-­‐RWTNNFREY-­‐210	   loop	   located	  between	  the	  fifth	  β-­‐strand	  and	  the	  second	  α-­‐helix	  was	  shown	  to	  be	  essential	  for	  the	  expression	  of	   triple	  helicase	  activity	  by	  MMP-­‐1/MMP-­‐3	  chimeras	  (Chung	  et	  al,	   2000).	   The	   Tyr210	   residue	   in	   that	   region	   is	   particularly	   crucial.	   A	   single	  mutation	  of	  this	  residue	  to	  Thr,	  the	  corresponding	  residue	  in	  MMP-­‐3,	  caused	  a	  4-­‐fold	  reduction	  in	  collagenolytic	  activity.	  In	  other	  MMPs	  the	  corresponding	  region	  is	   highly	   variable	   in	   sequence,	   but	   all	   collagenolytic	   MMPs,	   except	   MT1-­‐MMP,	  have	  Tyr	  in	  the	  corresponding	  positions.	  Glu209	  and	  Tyr210	  form	  an	  unusual	  cis	  peptide	   bond.	   The	   corresponding	   Tyr209	  	   Phe	   mutation	   in	   MMP-­‐8	   has	   a	  similar	   effect	   on	   collagenolytic	   activity	   (Pelman	   et	   al,	   2005).	   R.	   Visse	   in	   our	  laboratory	  showed	  that	  the	  replacement	  of	  the	  upper	  part	  of	  the	  catalytic	  domain	  of	   MMP-­‐1	   by	   the	   corresponding	   sequence	   from	   MMP-­‐3	   enhances	   collagen	  unwinding	   activity	   (unpublished	   data)	   compared	   to	   the	   wild-­‐type	   MMP-­‐1.	  However,	   these	   MMP-­‐3/MMP-­‐1	   chimeras	   (LC3,	   LC4)	   (Chung	   et	   al,	   2000)	   are	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relatively	   poor	   collagenases.	   It	   has	   been	   concluded	   that	   these	   chimeras	   form	  nonproductive	  unwound	  complexes.	  Another	   collagenase	   residue	   important	   for	   functional	   interactions	   with	  collagen	  has	  been	  revealed	  by	  mutation	  of	  Gly233	  in	  the	  Cat	  domain,	  3	  residues	  before	  the	  conserved	  Met	  of	  the	  catalytic	  site	  cleft,	  to	  Glu	  (corresponding	  residue	  in	   MMP-­‐9).	   This	   single	   mutation	   almost	   completely	   abolished	   collagenolytic	  activity	  (0.13%	  remained),	  but	  did	  not	  affect	  the	  gelatinolytic	  activity	  (O'Farrell	  et	   al,	   2006).	   It	   is	   thought,	   that	   this	   Gly	   provides	   a	   necessary	   flexibility	   for	   a	  collagen	  binding-­‐induced	  fit	  of	  the	  enzyme	  to	  collagen	  substrate.	  	  	  
1.6.	  Experimental	  approach	  to	  mapping	  of	  collagenase-­‐collagen	  
interaction	  sites	  	  Site-­‐directed	  mutagenesis,	  domain	  swap	  mutants	  and	  domain	  chimeras	  are	  always	   burdened	   with	   a	   possibility	   of	   structure	   perturbation	   and	   a	   loss	   of	  function	  that	  cannot	  be	  unequivocally	  attributed	  to	  the	  altered	  interaction	  of	  the	  mutated	   segment	   with	   the	   substrate.	   The	   direct	   proof	   for	   the	   collagenase-­‐collagen	  interaction	  sites	  mentioned	  above	  is	  lacking	  to	  date.	  One	  way	  to	  tackle	  this	   problem	  would	   be	   an	   X-­‐ray	   diffraction	   study	   of	   a	   crystal	   structure	   of	   the	  collagenase-­‐THP	   complex.	   Technically	   this	   is	   challenging,	   as	   it	   depends	   on	  crystallisation	  of	  the	  complex	  and	  it	  has	  not	  been	  successful	  so	  far.	  An	  alternative	  method	   offering	   high-­‐resolution	   identification	   of	   protein-­‐protein	   interaction	  sites	  is	  hydrogen/deuterium	  exchange	  mass	  spectrometry	  (H/DXMS).	  	  An	  important	  part	  of	  this	  work	  was	  aimed	  at	  determining	  the	  sites	  of	  MMP	  collagenase	  involved	  in	  collagen	  binding	  and	  unwinding	  and	  H/DXMS	  technique	  was	  adapted	  for	  this	  purpose.	  	  	  
1.6.1.	  Hydrogen/deuterium	  exchange	  mass	  spectrometry	  (H/DXMS):	  
methodology	  overview	  
 Hydrogen/deuterium	   exchange	   mass	   spectrometry	   (H/DXMS)	   is	   a	  powerful	  technique	  for	  investigating	  protein-­‐protein	  interactions	  (Ehring,	  1999;	  Zawadzki	   et	   al,	   2003).	   It	   takes	   advantage	   of	   the	   fact	   that	   covalently	   bound	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hydrogen	  (H)	  on	  the	  surface	  of	  macromolecules	  exchanges	  with	  the	  one	  from	  the	  environment.	   In	   a	  deuterated	   solution	   (D2O)	   these	  protons	  will	   be	   replaced	  by	  twice	  as	  heavy	  deuterons	  (D)	  in	  a	  solvent	  exposure-­‐dependent	  manner.	  Peptide	  amide	  hydrogen	  acts	  as	  a	  string	  of	  sensors	  of	  solvent	  exposure	  along	  polypeptide	  chains.	  The	  specific	  mass	  increments	  caused	  by	  deuterium	  incorporation	  into	  the	  protein	   backbone	   can	   be	   measured	   by	   mass	   spectrometry	   (MS).	   The	   sites	  protected	  by	  ligand	  binding	  can	  be	  identified	  based	  on	  the	  lack	  of	  the	  mass	  shift.	  Such	   deuterium	   labeling	   is	   not	   associated	   with	   any	   chemical	   change	   (no	  destabilising	   or	   steric	   effects)	   and	   is	   not	   restricted	   by	   sequence,	   allowing	   high	  resolution	  mapping	  of	   interaction	  sites.	  The	  use	  of	   the	  H	  exchange	  principle	   is,	  however,	  technically	  demanding.	  The	  experimental	  procedure,	  with	  a	  number	  of	  technical	   requirements,	   and	   the	   approach	   to	   complex	   data	   analyses	   will	   be	  outlined	  in	  this	  section.	  	  According	   to	   Englander	   (Englander	   et	   al,	   1997;	   Englander,	   2006)	   the	  modern	  H/DXMS	   is	   a	   legacy	   of	   Linderstrøm-­‐Lang	   and	   coworkers,	  who	   did	   the	  pioneering	  studies	  on	  hydrogen	  exchange	  in	  the	  1950s	  (Hvidt	  &	  Nielsen,	  1966).	  Those	  days	  MS	  techniques	  were	  not	  developed	  enough	  to	  be	  employed	  for	  such	  measurements,	  so	  the	  use	  of	  tritium	  and	  NMR	  were	  initially	  more	  popular	  with	  H	  exchange	   analyses.	   The	   fundamental	   findings	   of	   that	   research	   provided	   the	  ground	  work	  for	  developing	  H/DXMS	  as	  a	  tool	   for	  exploring	  protein	  structures,	  dynamics	  and	  interactions.	  Hydrogen	   bonding	   or	   a	   steric	   obstruction	   stabilizes	   protons	   and	   protects	  them	   from	   being	   exchanged.	   The	   intrinsic	   rate	   of	   exchange	   for	   each	   H	   in	   a	  protein	  may	   be	   different,	   depending	   on	   its	  microenvironment.	   H	   buried	   in	   the	  hydrophobic	   core	   of	   folded	   protein	  will	   essentially	   not	   exchange	   at	   all,	   unless	  structural	   fluctuations	  are	  present.	  Also	  atoms	  to	  which	  H	  is	  covalently	  bonded	  and	  neighbouring	  residues	  are	  decisive	  for	  its	  rate	  of	  exchange.	  In	  H/DXMS,	  only	  the	   peptide	   amide	   H/D	   exchange	   is	   analysed.	   Protons	   associated	   with	   the	  reactive	   groups	   of	   amino	   acid	   side	   chains	   are	   exchanging	   too	   rapidly	   to	   be	  measured	  with	  available	   instrumentation	  and	  the	  ones	  associated	  with	  carbons	  do	  not	  exchange	  at	  all	  within	  the	  available	  time	  scale.	  	  	  	  The	   rate	   of	   H/D	   exchange	   changes	   10-­‐fold	   with	   each	   pH/D	   unit	   and	   is	  sensitive	  to	  temperature	  variations	  (Smith	  et	  al,	  1997).	  These	  characteristics	  are	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction	  
 
 67	  
used	   for	   quenching	   the	   exchange	   reaction	   by	   acidification	   to	   pH2.5	   and	  temperature	   reduction	   to	   0	   °C	   (Wagner	   &	   Wuthrich,	   1979).	   Under	   such	  quenching	  conditions	  the	  half-­‐life	  of	  D	  label	   is	  about	  1h	  for	  an	  average	  peptide.	  This	   puts	   serious	   time	   constraints	   on	   the	   H/DXMS	   application.	   Moreover,	  interaction	  site	  mapping	  necessitates	  fragmentation	  of	  the	  D	  labeled	  protein	  and	  analysis	   of	   the	  mass	   change	   in	   resultant	   peptides.	   This	   needs	   to	   be	   performed	  rapidly	  under	  H/D	  exchange	  quenching	  conditions,	  to	  prevent	  the	  loss	  of	  label	  by	  back	   exchange,	   and	   the	   fragments	   should	   ideally	   be	   small	   and	   overlapping	   for	  high	   resolution	   of	   the	   mapping.	   Therefore,	   only	   broad	   specificity	   proteases,	  active	  at	  0	  °C	  and	  pH2.5	  can	  be	  applied.	  Pepsin	  proved	  to	  be	  the	  best	  enzyme	  for	  this	  purpose	  so	  far.	  To	  enhance	  the	  resolution	  of	  mapping,	  additional	  peptidases	  such	  as	  aspergillopepsin	  from	  Aspergillus	  saitoi	  can	  be	  used	  (Takahashi	  &	  Chang,	  1976;	  Cravello	  et	  al,	  2003;	  Del	  Mar	  et	  al,	  2005;	  Englander,	  2006).	  The	  fragments,	  however,	  cannot	  be	  too	  small	  due	  to	  the	  background	  signals	  in	  MS.	  Depending	  on	  the	   instrument,	   the	  methodological	   limitation	   is	   about	  5	  amino	  acids	   in	   length.	  The	  H/D	  exchange	  rate	  at	  various	  protein	  regions	  is	  determined	  by	  monitoring	  a	  mass	  buildup	  in	  the	  corresponding	  peptides	  over	  time.	  This	  requires	  separation	  of	   the	   peptides,	   which	   is	   most	   conveniently	   done	   by	   reversed-­‐phase	   high-­‐performance	   liquid	   chromatography	   (RP-­‐HPLC),	   as	   it	   can	   be	   coupled	   to	   the	  electrospray	   ionisation	   (ESI)	   mass	   spectrometer	   for	   direct	   peptide	   mass	  measurement	  and	  identification.	  In	  summary,	  samples	  of	  H/D	  exchange	  reaction	  are	  quenched	  at	  different	   time	  points,	   rapidly	  digested	  and	  analysed	  by	  LC-­‐MS.	  The	   aim	   is	   to	   complete	   the	   procedure	   in	   the	   shortest	   possible	   time	   after	  quenching	  H/D	  exchange,	  due	  to	  the	  short	  half-­‐life	  of	  the	  D	  label	  on	  the	  protein	  amides.	  The	  H/DXMS	  workflow	  scheme	  is	  shown	  in	  Figure	  11.	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1.6.2.	  Mass	  spectrometry	  application	  to	  mapping	  of	  H/D	  exchange	  in	  
proteins	  	   All	   mass	   spectrometers	   comprise	   three	   fundamental	   modules:	   an	   ion	  source,	  mass	  analyser	   and	   ion	  detector,	   and	  enables	  determination	  of	  mass-­‐to-­‐charge	  ratio	  (m/z).	  At	  present,	  two	  ionisation	  techniques	  are	  in	  common	  use	  for	  protein	   and	   peptide	   analyses:	   electrospray	   ionisation	   (ESI)	   (Fenn	   et	   al,	   1989)	  and	  matrix-­‐assisted	   laser	   desorption/ionisation	   (MALDI)	   (Karas	  &	  Hillenkamp,	  1988).	  The	  ESI	  technique	  is	  based	  on	  ionisation	  with	  a	  high	  voltage	  (2-­‐5	  kV).	  The	  sample	  flowing	  through	  a	  fine	  capillary	  is	  dispersed	  as	  an	  ionic	  cloud	  due	  to	  the	  electric	  potential	  applied.	  This	  allows	  introducing	  liquid	  phase	  samples	  into	  the	  instrument.	  The	  ESI	  usually	  results	  in	  multiply	  charged	  ions.	  The	  MALDI	  method	  employs	  a	  laser	  beam	  to	  ionise	  only	  solid	  phase	  samples,	  which	  are	  mixed	  with	  a	  special	   matrix,	   such	   as	   α-­‐cyanohydroxycinnamic	   acid	   (αCHCA)	   that	   easily	  absorbs	  laser	  energy.	  This	  energy	  is	  transferred	  from	  the	  matrix	  to	  the	  analysed	  compounds,	   charging	   them	  usually	  +1	  and	   sometimes	  +2.	  Both	  ESI	   and	  MALDI	  can	   be	   combined	  with	   different	  mass	   analysers,	   such	   as	   a	   time-­‐of-­‐flight	   (TOF)	  analyser	   (most	   common	   for	   MALDI)	   or	   a	   quadrupole	   (Q)	   analyser.	   These	   and	  other	   mass	   analysers	   can	   also	   be	   found	   in	   combination,	   i.e.	   Q-­‐TOF.	   Both	  ionisation	   techniques	   can	  be	   used	   for	   peptide	  mass	   determination	   in	  H/DXMS.	  
Figure	   11.	   Schematic	   diagram	   of	  
H/DXMS	  workflow.	  Enzyme	  alone	  (E)	  
or	  bound	  to	  substrate	  (S)	  is	  subjected	  
to	   the	   multistep	   experimental	  
procedure	   and	   the	   	   results	   are	  
compared	   to	   identify	   the	   sites	  
protected	   from	   H/D	   exchange	  
(concealed)	   upon	   substrate	   binding.	  
Labeling	   is	   performed	   at	   the	   pH	  
optimal	   for	   enzyme-­‐substrate	   (ES)	  
interactions.	   	  For	  quenching	  the	  H/D	  
exchange	  the	  temperature	  is	  lowered	  
to	  0°C	  and	   the	  pH	   is	   lowered	   to	  2.5.	  
After	   the	   quenching	   step	   the	  
procedure	  must	  be	  conducted	  as	  fast	  
as	   possible	   to	   reduce	  postquenching	  
exchange	  of	  D	  to	  H.	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The	  peptides	  can	  be	  eluted	  directly	  from	  the	  reversed-­‐phase	  column	  into	  the	  ESI	  mass	  spectrometer	  or	  fractionated	  and	  dried	  for	  MALDI	  mass	  analyses.	  H/D	  exchange	  measured	  by	  MS	  in	  pepsin-­‐generated	  peptides	  needs	  to	  be	  mapped	  to	  the	  parent	  protein	  sequence.	  Identification	  of	  the	  peptides	  is	  done	  by	  two	   rounds	   of	   mass	   spectrometry,	   referred	   to	   as	   tandem	   mass	   spectrometry	  (MS/MS).	  In	  order	  to	  sequence	  a	  peptide	  it	  needs	  to	  be	  fragmented	  after	  the	  first	  MS	  round,	  called	  a	  survey	  scan.	  One	  fragmentation	  method	  relies	  on	  collisions	  of	  the	  peptide	  chosen	  from	  the	  survey	  scan	  (parent	  ion)	  with	  atoms	  of	  a	  neutral	  gas	  such	   as	   argon	   or	   nitrogen	   (collision	   induced	   dissociation,	   CID).	   The	   resultant	  fragments	   of	   various	   lengths,	   called	   product	   ions	   or	   daughter	   ions,	   are	   then	  subjected	  to	  another	  round	  of	  MS	  analyses.	  Mass	  spectra	  obtained	  this	  way	  allow	  for	  peptide	  sequence	  identification.	  The	  sequence	  is	  deciphered	  through	  the	  set	  of	  fragment	  masses.	  
 
1.6.3.	  H/DXMS	  spectra	  analyses	  
 Mass	   spectrometers	   are	   capable	   of	   easily	   resolving	   individual	   ions	   that	  differ	  by	  a	  single	  atomic	  unit	  (1	  u	  or	  1	  Da,	  a	  mass	  of	  a	  proton);	  hence,	  molecules	  containing	  different	  isotopes	  can	  be	  distinguished.	  Due	  to	  the	  natural	  abundance	  of	  stable	  carbon	  isotopes	  (98.9%	  of	  C12	  and	  1.1%	  of	  C13),	  peptides	  are	  seen	  in	  MS	   spectra	   as	   multiple	   peaks,	   representing	   isotope	   distributions	   (isotopic	  patterns).	  The	  first	  peak	  in	  such	  a	  cluster	  (with	  the	  lowest	  m/z	  value)	  represents	  the	  monoisotopic	  mass	  M	   (C12	   only)	   (Figure	   12).	   The	   isotopic	   pattern	   can	   be	  interpreted	  as	  a	  probability	  distribution	  of	  the	  amount	  of	  C13	  incorporation	  into	  a	   given	   peptide.	   For	   longer	   peptides	   the	   likelihood	   of	   C13	   incorporation	  increases,	  which	   results	   in	   increasing	   intensities	  of	  peaks	  M+1,	  M+2,	  M+3,	   etc.,	  with	  respect	  to	  the	  monoisotopic	  peak	  M.	  Beyond	  a	  certain	  peptide	  length,	  peak	  intensities	  show	  Gaussian	  distribution.	  	  The	   effect	   of	   deuterium	   incorporation	   on	   a	   peptide	   mass	   spectrum	  appearance	   is	   illustrated	   in	   Figure	   12.	   Exchange	   of	   H	   to	   D	   causes	   the	   same	  peptide	  mass	  increment	  as	  substitution	  of	  C12	  by	  C13,	  equal	  1	  Da.	  It	  is	  therefore	  manifested	   in	   the	  mass	   spectrum	   in	   the	   same	  way	  as	  C13	   isotopic	  enrichment.	  Depending	  on	   the	  extent	  of	  D	   incorporation	   the	  natural	   isotopic	  pattern	   is	   first	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Figure	   12.	   Manifestation	   of	  	  
H/D	  exchange	  in	  a	  peptide	  mass	  
spectrum.	   (Top	   panel)	   Set	   of	  
peaks	   (a-­‐e)	   related	   to	   ions	  with	  
the	   same	   chemical	   formula	   but	  
containing	   different	   isotopes	  
(natural	   isotopic	   pattern)	  
represents	   one	   approximately	  
20	   amino	   acid	   long	   example	  
peptide	   P	   of	   the	   monoisotopic	  
mass	   M.	   The	   properties	   of	   an	  
isotopic	   pattern	   are	   explained.	  
(Middle	  panel)	  H/D	  exchange	   in	  
a	   peptide	   results	   in	   an	   array	   of	  
differently	   exchanged	   species.	  
For	   simplicity	   of	   illustration	  
assumptions	   were	   made,	   that	  
after	   some	   time	   (t)	   of	   H/D	  
exchange	  the	   indicated	  portions	  
of	   total	   peptide	   P	   population	  
exchanged	  specified	  amounts	  of	  
H	   for	   D.	   This	   is	   illustrated	   by	  
peak	   clusters	   shifting	   on	   the	  
mass/z	   axis	   by	   multiples	   of	   1	  
mass/z	   unit,	   and	   showing	  
amplitudes	   proportional	   to	   the	  
represented	  peptide	  
deviated,	   so	   that	   the	  most	   abundant	  mass	   (so-­‐called	  base	  peak	  assigned	  100%	  intensity)	  changes	  to	  one	  of	  higher	  m/z	  value,	  and	  is	  then	  shifted	  on	  the	  m/z	  axis.	  Combined	  H/DXMS	  spectra	  including	  vast	  numbers	  of	  peptides	  are	  complicated	  and	  difficult	  to	  evaluate	  without	  specific	  computer	  programs.	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
populations	  (maintaining	  intensity	  ratios	  within	  clusters).	  (Bottom	  panel)	  In	  the	  real	  mass	  spectrum	  all	  
the	  populations	  of	  peptides	  are	  superimposed,	  causing	  change	  in	  the	  isotopic	  pattern	  appearance.	  
 
	  
1.6.4.	  H/DXMS	  design	  	   There	   are	   many	   examples	   of	   protein-­‐protein	   interaction	   studies	   using	  H/DXMS.	  Often	  columns	  with	  immobilised	  pepsin	  are	  used	  for	  protein	  digestion,	  and	   RP-­‐HPLC	   combined	   with	   ESI-­‐MS	   is	   then	   used	   for	   peptide	   separation	   and	  analyses	   (Ehring,	   1999;	   Englander	   et	   al,	   2003;	   Zhu	   et	   al,	   2004;	   Del	   Mar	   et	   al,	  2005;	  Garcia	  et	  al,	  2005).	  Some	  studies	  successfully	  employed	  pepsin	  in	  solution	  for	  protein	   fragmentation.	  An	  example	  of	   this	  approach	  comes	   from	  Zhang	  and	  Smith’s	  work	  on	  rabbit	  muscle	  aldolase	  (Zhang	  &	  Smith,	  1993;	  Smith	  et	  al,	  1997).	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H/D	   exchange	   followed	   by	   automated	   on-­‐line	   in	   solution	   pepsin	   cleavage	  followed	  by	  ESI-­‐MS	  was	   successfully	   applied	   for	   analysis	   of	   protein	   aggregates	  using	   amyloid	   fibrils	   (Kheterpal	   et	   al,	   2006).	   MALDI	   was	   used	   in	   a	   limited	  number	  of	  H/DXMS	  approaches,	  despite	  several	  advantages	  including	  sensitivity,	  relatively	   low	   back	   exchange	   levels	   and	   MS	   spectra	   simplification	   due	   to	   a	  predominance	   of	   singly	   charged	   ions.	   An	   example	   is	   HET-­‐s	   prion	   aggregates	  studies	  (Nazabal	  &	  Schmitter,	  2006).	  However,	  ESI-­‐MS/MS	  was	  required	  in	  that	  study	   to	  establish	  a	  complete	  peptide	  mass	   fingerprint	  of	   the	  protein.	  Different	  H/DXMS	  setups	  have	  been	  evaluated	  by	  Zhu	  and	  coworkers	  (2004)	  by	  looking	  at	  fatty-­‐acid	  carboxylate	  binding	  properties	  of	  intestinal	  fatty-­‐acid-­‐binding	  protein	  (IFABP)	  and	  its	  D34A	  mutant.	  They	  used	  pepsin	  either	   in	  solution	  or	  on	  a	  solid	  support,	  either	  on-­‐	  or	  off-­‐	  line,	  coupled	  to	  LC-­‐ESI-­‐MS	  or	  MALDI-­‐MS.	  According	  to	  their	   assessment,	   a	   home-­‐made	   pepsin	   column	   followed	   by	   LC-­‐ESI-­‐MS	   and	  MS/MS	  gave	   the	  best	  outcome	  of	   sequence	   coverage	  and	  experimental	   control.	  MMP-­‐7	  interactions	  with	  doxycycline	  were	  explored	  in	  a	  similar	  way	  (Garcia	  et	  al,	   2005).	   In	   conclusion,	   an	   optimal	   H/DXMS	   setup	   needs	   to	   be	   designed	   for	  every	   protein-­‐protein	   interaction	   system	   to	   be	   studied.	   This	   optimisation	   is	  absolutely	  crucial	  for	  a	  successful	  H/DXMS	  application.	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1.7.	  Aims	  of	  project	  	   The	   purpose	   of	   this	   research	   was	   to	   gain	   insight	   into	   the	   mechanism	  	  of	   interstitial	   triple-­‐helical	   collagen	   processing	   by	   MMP-­‐1,	   an	   archetypal	  interstitial	   collagenase,	   focusing	  on	   structural	   aspects	   of	   two	  principal	   steps	   of	  collagenolysis:	   (i)	   enzyme	   binding,	   and	   (ii)	   the	   triple	   helix	   unwinding	   at	   the	  cleavage	   site,	   which	   precede	   sequential	   hydrolysis	   of	   collagen	   chains.	   This	  included:	  	  	  
• Determination	  of	  the	  roles	  of	  individual	  domains	  of	  MMP-­‐1	  and	  the	  role	  of	  temperature	  in	  MMP-­‐1	  interaction	  with	  collagen	  I	  	  
• Establishing	  the	  structural	  principle	  of	  collagenase-­‐collagen	  binding,	  by	  mapping	  the	  sites	  where	  MMP-­‐1	  binds	  in	  type	  II	  and	  III	  collagens	  	  













Materials	  and	  Methods	  




2.1.1.	  Protein	  production	  reagents	  
 Materials	   were	   purchased	   from	   the	   following	   sources:	   BL21	  E.	   coli	   strain	  from	  Invitrogen	  (Paisley,	  UK);	  isopropyl-­‐β-­‐D-­‐thiogalactopyranoside	  (IPTG)	  from	  Biogene	   (Kimbolton,	   UK);	   urea,	   dithiothreitol	   (DTT),	   β-­‐mercaptoethanol,	  ethylenediaminotetraacetic	   acid	   (EDTA)	   and	   Triton	   X-­‐100	   from	   BDH/VWR	  (Lutterworth,	  UK);	  lysozyme	  and	  chymotrypsin	  from	  Sigma-­‐Aldrich	  (Dorset,	  UK);	  phenylmethanesulfonyl	   fluoride	   (PMSF)	   and	   p-­‐aminophenyl	   mercuric	   acetate	  (APMA)	   from	   ICN	   Biochemicals	   (Cleveland,	   OH,	   USA).	  MMP-­‐3	   catalytic	   domain	  (MMP-­‐3Cat)	  was	  expressed	   in	  E.	   coli	   and	  purified	   in	   this	   laboratory	  by	  Toyoko	  Nakamura,	  using	  a	  hydroxamate	  affinity	  column	  according	  to	  (Moore	  &	  Spilburg,	  1986).	  	  
 
2.1.2.	  SDS-­‐PAGE	  and	  Western	  blotting	  materials	  
 Materials	   were	   purchased	   from	   the	   following	   sources:	   30%	   (w/v)	  acrylamide/bisacrylamide	  (ratio:	  37.5/1)	   from	  Severn	  Biotech	  (Worcestershire,	  UK);	  2-­‐amino-­‐2-­‐methyl-­‐1,3-­‐propanediol	   (ammediol)	  and	  bovine	  serum	  albumin	  (BSA)	   from	   Sigma-­‐Aldrich	   (Dorset,	   UK);	   pre-­‐stained	   Precision	   Protein	  StandardsTM	   from	   BioRad	   (Hemel	   Hempstead,	   UK)	   and	   PageRuler	   Plus	   Pre-­‐stained	   Protein	   LadderTM	   from	   Fermentas	   (York,	   UK);	   polyvinylidene	   fluoride	  (PVDF)	  membrane	  from	  GE	  Healthcare	  (Bucks,	  UK);	  streptavidin	  conjugated	  with	  alkaline	  phosphatase	  (Streptavidin-­‐AP)	  and	  Western	  Blue®	  Stabilised	  Substrate	  for	  AP	  from	  Promega	  (Southampton,	  UK).	  
 
2.1.3.	  Collagen	  and	  triple-­‐helical	  peptide	  (THP)	  binding	  assay	  reagents	  
 Type	   I	   collagen	   was	   provided	   by	   Dr	   Robert	   Visse	   in	   this	   laboratory.	   The	  collagen	  was	  extracted	  from	  guinea-­‐pig	  skin	  essentially	  as	  described	  in	  (Miller	  &	  Rhodes,	   1982)	   and	   it	   was	   pepsin-­‐treated	   during	   the	   procedure.	   Mouse	   skin	  collagen	   and	   its	   non-­‐cleavable	   version	   (Liu	   et	   al,	   1995)	  were	   a	   gift	   from	   Prof.	  Stephen	  M.	  Krane	  from	  Harvard	  Medical	  School,	  Massachusetts,	  USA.	  Active	  site-­‐
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directed	   zinc-­‐chelating	   hydroxamate	   inhibitor	   GM6001	   was	   purchased	   from	  Elastin	  Products,	  EPC	  (Owensville,	  MO,	  USA)	  and	  Marimastat	  was	  a	  gift	  from	  Dr	  Peter	   Brown	   (British	   Biotech).	   Other	   chemicals	   were	   purchased	   from	   the	  following	  sources:	  N-­‐Cyclohexyl-­‐2-­‐aminoethanesulfonic	  acid	  (CHES)	  and	  Tween	  20	  from	  Sigma-­‐Aldrich	  (Dorset,	  UK);	  EZ-­‐Link	  Sulfo-­‐NHS-­‐LC-­‐Biotin	  from	  Thermo	  Fisher	   Scientific	   (Cramlington,	   UK);	   streptavidin	   conjugated	   with	   horseradish	  peroxidase	  (Streptavidin-­‐HRP)	  from	  R&D	  Systems	  (Abingdon,	  UK);	  and	  3,3',5,5'-­‐tetramethylbenzidine	  (TMB)	  2-­‐Component	  Microwell	  Peroxidase	  Substrate	  KitTM	  from	  KPL	  (Wembley	  Middlesex,	  UK).	  
 
2.1.3.1.	  THP	  Toolkits	  of	  collagens	  II	  and	  III	  
 Human	   collagen	   II	   and	   III	   THP	   Toolkits	   as	   well	   as	   mutant	   THPs	   were	  supplied	  by	  the	  collaborating	  laboratory	  of	  Prof.	  Richard	  W.	  Farndale,	  University	  of	   Cambridge,	   UK.	   The	   synthesis	   of	   Toolkit	   peptides	   has	   been	   described	   in	  (Raynal	  et	  al,	  2006;	  Konitsiotis	  et	  al,	  2008).	  The	  host	  sequences	  of	  the	  peptides	  in	  the	  Toolkits	  are	  shown	  in	  Table	  3.	  	  
Table	  3.	  Host	  sequences	  of	  Toolkit	  peptides	  
 
Toolkit	  II	   Toolkit	  III	  
THP	  	  	  	  	  	  Sequence	   THP	  	  	  	  	  	  	  Sequence	  
II-­‐1	  	  	  	  	  	  GPMGPMGPRGPOGPAGAOGPQGFQGNO	  	   III-­‐1	  	  	  	  	  	  GLAGYOGPAGPOGPOGPOGTSGHOGSO	  
II-­‐2	  	  	  	  	  	  GPQGFQGNOGEOGEOGVSGPMGPRGPO	  	   III-­‐2	  	  	  	  	  	  GTSGHOGSOGSOGYQGPOGEOGQAGPS	  
II-­‐3	  	  	  	  	  	  GPMGPRGPOGPOGKOGDDGEAGKOGKA	  	   III-­‐3	  	  	  	  	  	  GEOGQAGPSGPOGPOGAIGPSGPAGKD	  
II-­‐4	  	  	  	  	  	  GEAGKOGKAGERGPOGPQGARGFOGTO	  	   III-­‐4	  	  	  	  	  	  GPSGPAGKDGESGROGROGERGLOGPO	  
II-­‐5	  	  	  	  	  	  GARGFOGTOGLOGVKGHRGYOGLDGAK	  	   III-­‐5	  	  	  	  	  	  GERGLOGPOGIKGPAGIOGFOGMKGHR	  
II-­‐6	  	  	  	  	  	  GYOGLDGAKGEAGAOGVKGESGSOGEN	  	   III-­‐6	  	  	  	  	  	  GFOGMKGHRGFDGRNGEKGETGAOGLK	  
II-­‐7	  	  	  	  	  	  GESGSOGENGSOGPMGPRGLOGERGRT	  	   III-­‐7	  	  	  	  	  	  GETGAOGLKGENGLOGENGAOGPMGPR	  
II-­‐8	  	  	  	  	  	  GLOGERGRTGPAGAAGARGNDGQOGPA	  	   III-­‐8	  	  	  	  	  	  GAOGPMGPRGAOGERGROGLOGAAGAR	  
II-­‐9	  	  	  	  	  	  GNDGQOGPAGPOGPVGPAGGOGFOGAO	  	   III-­‐9	  	  	  	  	  	  GLOGAAGARGNDGARGSDGQOGPOGPO	  
II-­‐10	  	  	  	  GGOGFOGAOGAKGEAGPTGARGPEGAQ	  	   III-­‐10	  	  	  	  GQOGPOGPOGTAGFOGSOGAKGEVGPA	  
II-­‐11	  	  	  	  GARGPEGAQGPRGEOGTOGSOGPAGAS	  	   III-­‐11	  	  	  	  GAKGEVGPAGSOGSNGAOGQRGEOGPQ	  
II-­‐12	  	  	  	  GSOGPAGASGNOGTDGIOGAKGSAGAO	   III-­‐12	  	  	  	  GQRGEOGPQGHAGAQGPOGPOGINGSO	  
II-­‐13	  	  	  	  GAKGSAGAOGIAGAOGFOGPRGPOGPQ	   III-­‐13	  	  	  	  GPOGINGSOGGKGEMGPAGIOGAOGLM	  
II-­‐14	  	  	  	  GPRGPOGPQGATGPLGPKGQTGEOGIA	  	   III-­‐14	  	  	  	  GIOGAOGLMGARGPOGPAGANGAOGLR	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II-­‐15	  	  	  	  GQTGEOGIAGFKGEQGPKGEOGPAGPQ	  	   III-­‐15	  	  	  	  GANGAOGLRGGAGEOGKNGAKGEOGPR	  
II-­‐16	  	  	  	  GEOGPAGPQGAOGPAGEEGKRGARGEO	   III-­‐16	  	  	  	  GAKGEOGPRGERGEAGIOGVOGAKGED	  
II-­‐17	  	  	  	  GKRGARGEOGGVGPIGPOGERGAOGNR	  	   III-­‐17	  	  	  	  GVOGAKGEDGKDGSOGEOGANGLOGAA	  
II-­‐18	  	  	  	  GERGAOGNRGFOGQDGLAGPKGAOGER	  	   III-­‐18	  	  	  	  GANGLOGAAGERGAOGFRGPAGPNGIO	  
II-­‐19	  	  	  	  GPKGAOGERGPSGLAGPKGANGDOGRO	  	   III-­‐19	  	  	  	  GPAGPNGIOGEKGPAGERGAOGPAGPR	  
II-­‐20	  	  	  	  GANGDOGROGEOGLOGARGLTGROGDA	  	   III-­‐20	  	  	  	  GAOGPAGPRGAAGEOGRDGVOGGOGMR	  
II-­‐21	  	  	  	  GLTGROGDAGPQGKVGPSGAOGEDGRO	  	   III-­‐21	  	  	  	  GVOGGOGMRGMOGSOGGOGSDGKOGPO	  
II-­‐22	  	  	  	  GAOGEDGROGPOGPQGARGQOGVMGFO	   III-­‐22	  	  	  	  GSDGKOGPOGSQGESGROGPOGPSGPR	  
II-­‐23	  	  	  	  GQOGVMGFOGPKGANGEOGKAGEKGLO	  	   III-­‐23	  	  	  	  GPOGPSGPRGQOGVMGFOGPKGNDGAO	  
II-­‐24	  	  	  	  GKAGEKGLOGAOGLRGLOGKDGETGAA	  	   III-­‐24	  	  	  	  GPKGNDGAOGKNGERGGOGGOGPQGPO	  
II-­‐25	  	  	  	  GKDGETGAAGPOGPAGPAGERGEQGAO	  	   III-­‐25	  	  	  	  GGOGPQGPOGKNGETGPQGPOGPTGPG	  
II-­‐26	  	  	  	  GERGEQGAOGPSGFQGLOGPOGPOGEG	  	   III-­‐26	  	  	  	  GPOGPTGPGGDKGDTGPOGPQGLQGLO	  
II-­‐27	  	  	  	  GPOGPOGEGGKOGDQGVOGEAGAOGLV	  	   III-­‐27	  	  	  	  GPQGLQGLOGTGGPOGENGKOGEOGPK	  
II-­‐28	  	  	  	  GEAGAOGLVGPRGERGFOGERGSOGAQ	  	   III-­‐28	  	  	  	  GKOGEOGPKGDAGAOGAOGGKGDAGAO	  
II-­‐29	  	  	  	  GERGSOGAQGLQGPRGLOGTOGTDGPK	  	   III-­‐29	  	  	  	  GGKGDAGAOGERGPOGLAGAOGLRGGA	  
II-­‐30	  	  	  	  GTOGTDGPKGASGPAGPOGAQGPOGLQ	  	   III-­‐30	  	  	  	  GAOGLRGGAGPOGPEGGKGAAGPOGPO	  
II-­‐31	  	  	  	  GAQGPOGLQGMOGERGAAGIAGPKGDR	  	   III-­‐31	  	  	  	  GAAGPOGPOGAAGTOGLQGMOGERGGL	  
II-­‐32	  	  	  	  GIAGPKGDRGDVGEKGPEGAOGKDGGR	  	   III-­‐32	  	  	  	  GMOGERGGLGSOGPKGDKGEOGGOGAD	  
II-­‐33	  	  	  	  GAOGKDGGRGLTGPIGPOGPAGANGEK	   III-­‐33	  	  	  	  GEOGGOGADGVOGKDGPRGPTGPIGPO	  
II-­‐34	  	  	  	  GPAGANGEKGEVGPOGPAGSAGARGAO	  	   III-­‐34	  	  	  	  GPTGPIGPOGPAGQOGDKGEGGAOGLO	  
II-­‐35	  	  	  	  GSAGARGAOGERGETGPOGPAGFAGPO	   III-­‐35	  	  	  	  GEGGAOGLOGIAGPRGSOGERGETGPO	  
II-­‐36	  	  	  	  GPAGFAGPOGADGQOGAKGEQGEAGQK	   III-­‐36	  	  	  	  GERGETGPOGPAGFOGAOGQNGEOGGK	  
II-­‐37	  	  	  	  GEQGEAGQKGEAGAOGPQGPSGAOGPQ	  	   III-­‐37	  	  	  	  GQNGEOGGKGERGAOGEKGEGGPOGVA	  
II-­‐38	  	  	  	  GPSGAOGPQGPTGVTGPKGARGAQGPO	   III-­‐38	  	  	  	  GEGGPOGVAGPOGGSGPAGPOGPQGVK	  
II-­‐39	  	  	  	  GARGAQGPOGATGFOGAAGRVGPOGSN	  	   III-­‐39	  	  	  	  GPOGPQGVKGERGSOGGOGAAGFOGAR	  
II-­‐40	  	  	  	  GRVGPOGSNGNOGPOGPOGPSGKDGPK	  	   III-­‐40	  	  	  	  GAAGFOGARGLOGPOGSNGNOGPOGPS	  
II-­‐41	  	  	  	  GPSGKDGPKGARGDSGPOGRAGEOGLQ	  	   III-­‐41	  	  	  	  GNOGPOGPSGSOGKDGPOGPAGNTGAO	  
II-­‐42	  	  	  	  GRAGEOGLQGPAGPOGEKGEOGDDGPS	  	   III-­‐42	  	  	  	  GPAGNTGAOGSOGVSGPKGDAGQOGEK	  
II-­‐43	  	  	  	  GEOGDDGPSGAEGPOGPQGLAGQRGIV	  	   III-­‐43	  	  	  	  GDAGQOGEKGSOGAQGPOGAOGPLGIA	  
II-­‐44	  	  	  	  GLAGQRGIVGLOGQRGERGFOGLOGPS	  	   III-­‐44	  	  	  	  GAOGPLGIAGITGARGLAGPOGMOGPR	  
II-­‐45	  	  	  	  GFOGLOGPSGEOGKQGAOGASGDRGPO	  	   III-­‐45	  	  	  	  GPOGMOGPRGSOGPQGVKGESGKOGAN	  
II-­‐46	  	  	  	  GASGDRGPOGPVGPOGLTGPAGEOGRE	  	   III-­‐46	  	  	  	  GESGKOGANGLSGERGPOGPQGLOGLA	  
II-­‐47	  	  	  	  GPAGEOGREGSOGADGPOGRDGAAGVK	   III-­‐47	  	  	  	  GPQGLOGLAGTAGEOGRDGNOGSDGLO	  
II-­‐48	  	  	  	  GRDGAAGVKGDRGETGAVGAOGAOGPO	  	   III-­‐48	  	  	  	  GNOGSDGLOGRDGSOGGKGDRGENGSO	  
II-­‐49	  	  	  	  GAOGAOGPOGSOGPAGPTGKQGDRGEA	  	   III-­‐49	  	  	  	  GDRGENGSOGAOGAOGHOGPOGPVGPA	  
II-­‐50	  	  	  	  GKQGDRGEAGAQGPMGPSGPAGARGIQ	   III-­‐50	  	  	  	  GPOGPVGPAGKSGDRGESGPAGPAGAO	  
II-­‐51	  	  	  	  GPAGARGIQGPQGPRGDKGEAGEOGER	   III-­‐51	  	  	  	  GPAGPAGAOGPAGSRGAOGPQGPRGDK	  
Chapter	  2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Materials	  and	  Methods	  
 77	  
II-­‐52	  	  	  	  GEAGEOGERGLKGHRGFTGLQGLOGPO	   III-­‐52	  	  	  	  GPQGPRGDKGETGERGAAGIKGHRGFO	  
II-­‐53	  	  	  	  GLQGLOGPOGPSGDQGASGPAGPSGPR	   III-­‐53	  	  	  	  GIKGHRGFOGNOGAOGSOGPAGQQGAI	  
II-­‐54	  	  	  	  GPAGPSGPRGPOGPVGPSGKDGANGIO	   III-­‐54	  	  	  	  GPAGQQGAIGSOGPAGPRGPVGPSGPO	  
II-­‐55	  	  	  	  GKDGANGIOGPIGPOGPRGRSGETGPA	   III-­‐55	  	  	  	  GPVGPSGPOGKDGTSGHOGPIGPOGPR	  
II-­‐56	  	  	  	  GPRGRSGETGPAGPOGNOGPOGPOGPO	  	   III-­‐56	  	  	  	  GPIGPOGPRGNRGERGSEGSOGHOGQO	  
	  	  -­‐	   III-­‐57	  	  	  	  GERGSEGSOGHOGQOGPOGPOGAOGPC	  
    
 
2.1.4.	  Reagents	  used	  in	  the	  H/DXMS	  study	  
 Reagents	   were	   purchased	   from	   the	   following	   sources:	   N-­‐2-­‐hydroxyethyl-­‐piperazine-­‐N’-­‐2-­‐ethanesulfonic	   acid	   (HEPES),	   3-­‐(N-­‐morpholino)propanesulfonic	  acid	   (MOPS),	   porcine	   pepsin,	   aspergillopepsin	   (Type	   XIII	   protease),	   pepstatin,	  sodium	  cyano-­‐borohydride	  (NaCNBH3)	  and	  sodium	  acetate	   from	  Sigma-­‐Aldrich	  (Dorset,	   UK);	   MS	   grade	   formic	   acid	   and	   acetonitrile	   (ACN)	   from	   VWR	  (Lutterworth,	  UK)	  
2.2.	  Expression	  and	  purification	  of	  recombinant	  human	  MMPs	  and	  
their	  individual	  domains	  
 Human	  MMP	  mutants	  such	  as	  proMMP-­‐1(E200A)	  and	  its	  separate	  domains	  (Hpx	  and	  proCat(E200A)),	  active	  MMP-­‐1Cat,	  proMMP-­‐13(E200A),	  proMMP-­‐1-­‐1-­‐13(E200A),	  proLC3Cat	  and	  proLC3(Y191T)Cat	  were	  generated	  according	  to	  the	  methods	   described	   by	   (Chung	   et	   al,	   2000).	   They	   were	   overexpressed	   from	  	  a	  pET3a	  vector	  in	  E.	  coli	  BL21	  (DE3).	  Transformed	  cells	  were	  grown	  to	  OD600	  ~	  0.4,	   then	   induced	  with	  0.5	  mM	   IPTG,	   and	  harvested	   after	   4	   h.	   Inclusion	  bodies	  were	   collected	   by	   lysing	   the	   cells	   in	   0.05	  M	   Tris-­‐HCl	   pH	   8,	   0.1	  M	   NaCl,	   1	  mM	  EDTA,	  0.26	  mg/ml	   lysozyme,	  0.5%	  Triton-­‐X100,	   and	  dissolved	   in	  8	  M	  Urea,	  50	  μM	   ZnCl2,	   20	   mM	   Tris-­‐HCl,	   pH	   8.6,	   20	   mM	   DTT.	   This	   was	   passed	   over	  	  a	  Macroprep	  HighQ	  ion-­‐exchange	  column	  (BioRad),	  equilibrated	  in	  8	  M	  Urea,	  50	  μM	   ZnCl2,	   20	   mM	   Tris-­‐HCl,	   pH	   8.6,	   1	   mM	   DTT	   and	   eluted	   with	   a	   linear	   salt	  gradient	   (0-­‐0.5	  M	  NaCl).	  The	   fractions	  were	  run	  on	  SDS-­‐PAGE	  and	   the	  relevant	  protein	  fractions	  were	  pooled,	  diluted	  with	  50	  mM	  Tris-­‐HCl,	  pH	  8.6,	  6	  M	  Urea,	  1	  mM	  DTT,	  150	  mM	  NaCl,	  5	  mM	  CaCl2,	  100	  μM	  ZnCl2,	  0.02	  %	  NaN3	  to	  A280	  <	  0.3,	  supplemented	  with	  20	  mM	  cystamine	  and	  refolded	  by	  dialyses	  at	  4	  °C	  against	  4	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volumes	   of	   renaturation	   buffer	   (50	  mM	  Tris-­‐HCl,	   pH	   8.6,	   150	  mM	  NaCl,	   5	  mM	  CaCl2,	  100	  μM	  ZnCl2,	  5	  mM	  β-­‐mercaptoethanol,	  1	  mM	  2-­‐hydroxyethyl	  disulphide,	  0.02	  %	  NaN3)	  for	  24	  h,	  and	  then	  10	  volumes	  of	  the	  same	  buffer	  for	  another	  24	  h,	  then	  against	  10	  volumes	  of	  the	  same	  buffer	  without	  β-­‐mercaptoethanol	  for	  24h,	  and	   finally	   against	   4	   volumes	   of	   50	  mM	   Tris-­‐HCl,	   pH	   8.6,	   5	  mM	   CaCl2,	   50	   μM	  ZnCl2,	  0.02	  %	  NaN3,	  for	  24	  h.	  Refolded	  protein	  was	  purified	  using	  Green	  A	  affinity	  column	  (Amicon),	  equilibrated	  with	  50	  mM	  Tris-­‐HCl	  pH	  7.5,	  75	  mM	  NaCl,	  5	  mM	  CaCl2,	  0.02	  %	  NaN3,	  and	  eluted	  with	  linear	  salt	  gradient	  (0-­‐1	  M	  NaCl).	  	  ProMMPs	   were	   activated	   with	   MMP-­‐3Cat	   in	   50:1	   molar	   ratio	   and	   1	   mM	  APMA	  in	  TNC	  buffer	  (50	  mM	  Tris-­‐HCl	  pH	  7.5,	  150	  mM	  NaCl,	  10	  mM	  CaCl2,	  0.02	  %	  NaN3)	   for	   60-­‐120	  min	   at	   37	   °C,	   except	   proLC3(Y191T)Cat	   (35	   μM)	  which	  was	  activated	  with	  2	  μg/ml	  chymotrypsin	  in	  TNC	  buffer,	  stopped	  with	  10	  mM	  PMSF	  after	   40	   min	   incubation	   at	   37	   °C.	   The	   mature	   forms	   were	   next	   purified	   by	  Sephacryl	  S200	  gel	  filtration	  (GE	  Healthcare)	  in	  TNC	  buffer.	  	  All	  preparative	  chromatography	  steps	  were	  performed	  using	  an	  AKTA	  FPLC	  system	   (GE	   Healthcare).	   The	   final	   yields	   were	   between	   10-­‐50	   mg	   from	   1	   L	  bacterial	  culture.	  
2.3.	  Protein	  biotinylation	  
 To	  avoid	  the	  presence	  of	  primary	  amines,	  the	  TNC	  buffer	  in	  which	  proteins	  were	  stored	  was	  exchanged	  using	  Sephadex	  G-­‐25M	  PD-­‐10	  desalting	  columns	  (GE	  Healthcare)	   into	  50	  mM	  CHES	  buffer	  pH	  8.8,	   supplemented	  with	  200	  mM	  NaCl	  and	  10	  mM	  CaCl2.	  Then,	  10	  mM	  biotin	  solution	  in	  distilled	  water	  was	  added	  at	  1:2	  protein-­‐biotin	  molar	  ratio	  and	  incubated	  for	  1	  h	  at	  room	  temperature.	  Proteins	  were	   next	   passed	   over	   another	   PD-­‐10	   column	   equilibrated	   in	   TNC	   buffer	   to	  remove	  excess	  biotin	  and	  the	  biotinylated	  proteins	  were	  stored	  in	  TNC.	  
2.4.	  SDS-­‐PAGE	  analyses	  
 SDS-­‐PAGE	  was	  performed	  using	  a	  modification	  of	  the	  ammediol-­‐glycine	  gel	  and	  buffer	  system	  (Wyckoff	  et	  al,	  1977;	  Bothe	  et	  al,	  1985)	  for	  proteins	  up	  to	  150	  kDa	   in	   mass	   and	   the	   Tris-­‐tricine	   system	   (Schagger	   &	   von	   Jagow,	   1987)	   for	  peptides	  down	  to	  1	  kDa	  in	  mass.	  Protein	  or	  peptide	  samples	  were	  mixed	  with	  an	  equal	   volume	   of	   the	   reducing	   ammediol	   loading	   mix	   (42	   mM	   ammediol-­‐HCl	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pH7.5,	  0.01	  %	  (w/v)	  sodium	  azide,	  2	  %	  (w/v)	  SDS,	  50	  %	  (w/v)	  glycerol,	  1	  %	  β-­‐mercapto-­‐ethanol	   and	  a	   few	  grains	  of	  bromophenol	  blue),	   supplemented	  when	  necessary	  with	  20	  mM	  EDTA	  to	  quench	  MMP	  activity,	  or	  the	  tricine	  sample	  buffer	  (125	  mM	  Tris-­‐HCl	  pH	  7.5,	  20	  %	  (v/v)	  glycerol,	  4%	  (w/v)	  SDS,	  50	  mM	  DTT	  and	  a	  few	  grains	  of	  bromophenol	  blue),	  heated	  up	  briefly	  and	  loaded	  into	  the	  wells	  of	  the	  upper	  (stacking)	  polyacrylamide	  gel	   (4	  %	  total	  acrylamide	   in	  each	  system).	  The	  lower	  (separating)	  ammediol	  polyacrylamide	  gels	  were	  made	  with	  7.5	  or	  10	  %	   and	   the	   Tris-­‐tricine	   ones	   with	   15	  %	   total	   acrylamide.	   Ammediol	   gels	   were	  typically	  run	  for	  60	  min	  at	  150	  V;	  whereas	  Tris-­‐tricine	  gels	  were	  run	  at	  100	  V	  in	  stacking	  gel	  and	  130	  V	   in	  separating	  gel	  untill	   the	  bromophenol	  blue	  dye	   front	  reached	  the	  bottom	  of	  the	  separating	  gel.	  Proteins	  in	  the	  gels	  were	  stained	  with	  Coomassie	  Brilliant	  Blue	  R-­‐250	  or	  silver.	  
2.5.	  Coomassie	  blue	  gel	  staining	  
 SDS-­‐PAGE	  gels	  were	  stained	  for	  30	  min	  in	  0.1	  %	  Coomassie	  Brilliant	  Blue	  R-­‐250,	  50	  %	  (v/v)	  methanol	  and	  20	  %	  (v/v)	  acetic	  acid,	  and	  then	  destained	  with	  30	  %	  (v/v)	  methanol	  and	  1	  %	  (v/v)	  acetic	  acid	  multiple	   times,	   for	  at	   least	  30	  min	  each	   time,	   to	   reduce	   the	   background	   stain	   and	   increase	   the	   intensity	   of	   the	  protein	  bands.	  
2.6.	  Silver	  gel	  staining	  
 SDS-­‐PAGE	  gels	  were	  first	  incubated	  in	  the	  fix	  solution	  (50	  %	  (v/v)	  methanol	  and	  5%	  (v/v)	  acetic	  acid)	  for	  20	  min	  and	  then	  washed	  in	  50	  %	  methanol	  for	  10	  min.	  This	  was	   followed	  by	  10	  min	  washing	   in	  distilled	  water	   repeated	  3	   times.	  The	  gels	  were	  next	  incubated	  in	  sensitiser	  (0.02	  %	  sodium	  thiosulfate)	  for	  1	  min,	  washed	  twice	  in	  distilled	  water	  for	  1	  min	  and	  incubated	  with	  the	  silver	  reagent	  (0.1	  %	  silver	  nitrate)	  at	  4	  °C	  for	  20	  min.	  After	  that,	  the	  gels	  were	  washed	  twice	  in	  distilled	  water	  for	  1	  min	  and	  developed	  by	  adding	  2	  %	  (w/v)	  sodium	  bicarbonate	  solution	  freshly	  supplemented	  with	  0.04	  %	  formalin.	  The	  precipitation	  of	  silver	  on	   the	  protein	  bands	  was	  stopped	  with	  10	  %	  (v/v)	  acetic	  acid	  when	  the	  visual	  band	  intensity	  signal-­‐to-­‐background	  noise	  ratio	  started	  decreasing.	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2.7.	  Western	  blot	  analysis	  
 SDS-­‐PAGE	  gels	  were	  transferred	  onto	  a	  PVDF	  membrane	  at	  constant	  voltage	  of	  25	  V	  for	  90	  min	  in	  transfer	  buffer	  (20	  %	  (v/v)	  methanol,	  12.6	  mM	  Tris,	  96	  mM	  glycine	  and	  0.1	  %	  SDS).	  The	  membrane	  was	  then	  blocked	  using	  5	  %	  BSA	  in	  TNC-­‐T	  for	  1	  h	  at	  room	  temperature.	  After	  blocking,	  the	  membrane	  was	  washed	  for	  10	  min	   in	   TNC-­‐T	   and	   incubated	   with	   Streptavidin-­‐AP	   (diluted	   according	   to	   the	  manufacturers’	   instructions)	   in	   1	  %	   BSA/TNC-­‐T	   for	   1	   h	   at	   room	   temperature.	  The	  membrane	  was	   finally	  washed	  3	   times	   for	  10	  min	   in	  TNC-­‐T	  and	   incubated	  with	  the	  AP	  substrate	  until	  clear	  bands	  appeared.	  
2.8.	  SDS-­‐PAGE	  and	  Western	  blot	  image	  acquisition	  and	  processing	  
 The	   gels	   and	   the	  membranes	  were	   scanned	   using	   ImageScannerTM	   III	   (GE	  Healthcare)	   for	   densitometric	   applications.	   The	   protein	   band	   images	   were	  quantified	  using	  Phoretix	  1D	  software	  (TotalLab).	  
2.9.	  Solid	  phase	  binding	  assays	  
 
2.9.1.	  Collagen	  binding	  assay	  
 Costar®	  High	  Binding	  96-­‐well	  microtiter	  plates	  (Corning,	  London,	  UK)	  were	  coated	  with	  50	  μl	  of	  20	  μg/ml	  native	  type	  I	  collagen	  in	  TNC	  buffer	  overnight	  at	  room	  temperature.	  They	  were	  washed	  3-­‐times	  with	  200	  μl	  TNC	  containing	  0.05	  %	   Tween	   20	   (TNC-­‐T)	   and	   blocked	   with	   200	   μl	   of	   3	   %	   BSA	   for	   2	   h	   at	   room	  temperature.	   After	   washing	   as	   previously,	   biotinylated	   proteins	   at	   increasing	  concentrations	  were	  added	  in	  50	  μl	  TNC	  buffer	  and	  incubated	  in	  Inca	  Microplate	  incubators	   (Jencons/VWR)	   for	   1-­‐24	   h	   at	   4-­‐40	   °C.	   	   The	   wells	   were	   washed	   as	  previously	   at	   the	   temperature	   of	   incubation	   and	   then	   fixed	   with	   3	   %	   p-­‐formaldehyde	  for	  30	  min.	  After	  another	  triple	  wash	  in	  TNC-­‐T,	  streptavidin-­‐HRP	  was	  added	  at	  the	  manufacturers’	  (R&D)	  recommended	  dilution	  and	  incubated	  for	  1	   h	   at	   room	   temperature.	   The	   level	   of	   binding	   was	   determined	   using	   a	  chromogenic	  reaction	  with	  TMB	  substrate	  developed	  for	  about	  1-­‐3	  min,	  stopped	  with	   addition	   of	   6	   %	   sulphuric	   acid	   and	   measured	   by	   absorption	   at	   450	   nm	  wavelength.	  All	   samples	  were	  analysed	   in	   triplicate	  and	  compared	  assays	  were	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always	   developed	   simultaneously.	   All	   experiments	   were	   repeated	   at	   least	   3	  times.	  	  
2.9.2.	  Triple-­‐helical	  peptide	  binding	  assay	  
 The	  Costar	  plates	  were	  coated	  with	  a	  5	  μg/ml	  THP	  solution	  in	  10	  mM	  acetic	  acid	  for	  2	  h	  at	  room	  temperature	  followed	  by	  overnight	  incubation	  at	  4	  °C.	  They	  were	   washed	   and	   blocked	   the	   same	   way	   as	   in	   the	   collagen	   binding	   assay.	  Biotinylated	  proteins	  at	  1	  μM	  concentration	  in	  50	  μl	  TNC	  buffer	  were	  added	  and	  incubated	  1-­‐2	  h	  at	  room	  temperature.	  Next	  they	  were	  washed	  and	  developed	  as	  in	  the	  collagen	  binding	  assay,	  but	  without	  the	  fixing	  step.	  The	  experiments	  were	  carried	  out	  in	  triplicate.	  	  
2.10.	  Optimisation	  of	  MMP-­‐1(E200A)	  proteolytic	  fragmentation	  for	  
H/DXMS	  
 
2.10.1.	  MMP-­‐1(E200A)	  digestion	  in	  solution	  
 Porcine	  pepsin	  or	  aspergillopepsin	  (100-­‐400	  nM)	  was	  added	  to	  3	  μM	  MMP-­‐1(E200A)	   in	  acidified	  MOPS-­‐NC	  buffer	  (25	  mM	  MOPS	  pH2.5,	  0.8	  %	  formic	  acid,	  100	   mM	   NaCl,	   10	   mM	   CaCl2)	   on	   ice.	   For	   SDS-­‐PAGE	   analyses	   samples	   were	  collected	  at	   the	   indicated	   time	  points	  and	  added	   to	  an	  equal	  volume	  of	   loading	  mix	   or	   sample	   buffer	   pre-­‐alkalised	   by	   addition	   of	   1	   μl	   1	  M	   sodium	   hydroxide,	  which	   irreversibly	   inactivated	   the	   acidic	   proteases.	   For	   the	   nano-­‐LC-­‐MS/MS	  analyses	   samples	   were	   supplemented	   with	   20	   μM	   pepstatin	   to	   stop	   the	  proteolysis.	  	  	  
 
2.10.2.	  Preparation	  of	  pepsin	  columns	  (PCs)	  
 Porcine	  pepsin	  at	  a	  concentration	  of	  10	  mg/ml	  (PC1),	  0.1	  mg/ml	  (PC1/100),	  or	  0.01	  mg/ml	  (PC1/1000	  and	  its	  5-­‐times	  shorter	  version	  PC1/1000S)	  in	  0.8	  ml	  coupling	  buffer	  (50	  mM	  sodium	  acetate	  pH4.0,	  0.5	  M	  NaCl)	  were	  mixed	  with	  50	  mg	  of	  POROS	  AL20	  media	  (Applied	  Biosystems,	  Warrington,	  UK)	  and	  0.2	  ml	  of	  5	  mg/ml	  NaCNBH3,	   and	   incubated	   for	  12	  h	  at	   room	   temperature,	   gently	   shaking.	  Next,	   the	   solid	   support	   was	   washed	   10-­‐times	   with	   1	   ml	   coupling	   buffer.	   The	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coupling	  reaction	  was	  quenched	  by	  addition	  of	  0.4	  ml	  of	  0.2	  M	  Tris-­‐HCl	  pH	  5.0	  and	   0.1	  ml	   of	   5	  mg/ml	   NaCNBH3	   and	   incubated	   for	   2	   h	   at	   room	   temperature,	  shaking.	   The	   pepsin-­‐coupled	   POROS	   AL20	   support	   was	   washed	   as	   before	   and	  packed	  manually	  into	  HPLC-­‐grade	  2.1	  mm	  internal	  diameter	  (id)	  and	  50	  mm	  long	  peek	  column	  case	  from	  VICI	  JOUR	  (Thames	  Restek,	  Bucks,	  UK)	  	  
 
2.10.3.	  Off-­‐line	  MMP-­‐1(E200A)	  digestion	  on	  pepsin	  columns	  
 One	   hundred	   microliters	   of	   3	   μM	   MMP-­‐1(E200A)	   acidified	   MOPS-­‐NC	  solution	  (pH	  2.5)	  was	  passed	  at	  a	   flow	  rate	  of	  0.02-­‐6	  ml/min	   through	  different	  PCs	  equilibrated	   in	  0.1	  %	  cold	   formic	  acid.	  The	   columns	  were	   immersed	   in	   ice	  and	  operated	  by	  an	  Ettan	  LC	  system	  (GE	  Healthcare).	  	  
2.11.	  Mapping	  of	  MMP-­‐1(E200A)	  peptic	  fragments	  
 
2.11.1.	  Off-­‐line	  RP-­‐HPLC	  peptide	  separation	  
 MMP-­‐1(E200A)	   peptic	   digests	   from	   the	   PC	   flowthrough	   fractions	   were	  applied	   to	   a	   2.1	   mm	   id,	   5	   μm	   particle	   size	   and	   25	   cm	   long	   C18	   column	  (Grace/Vydac,	   Mikrolab	   Aarhus,	   DK)	   equilibrated	   in	   0.1	   %	   formic	   acid	   and	  connected	  to	  an	  Ettan	  LC	  (GE	  Healthcare)	  system.	  The	  peptides	  were	  eluted	  from	  the	  column	  at	  25	  °C	  across	  a	   linear	  12-­‐48	  %	  ACN	  gradient	   in	  0.1	  %	  formic	  acid	  over	  4.5	  ml	  at	  the	  flow	  rate	  of	  200	  μl/min.	  The	  UV	  trace	  was	  recorded	  at	  214	  and	  230	  nm	  wavelengths	  and	  fractions	  of	  200	  μl	  were	  collected.	  	  
2.11.2.	  Nano-­‐LC-­‐ESI	  MS/MS	  
	   Tandem	  mass	   spectra	   (MS/MS)	  were	   recorded	   using	   a	   Q-­‐TOF	   Ultima	   API	  spectrometer	   (Micromass/Waters,	   Manchester,	   UK)	   interfaced	   to	   a	   Micromass	  CapLC	  capillary	  chromatography	  or	  an	  EASY-­‐nLCTM	  (Thermo	  Scientific/Proxeon	  Biosystems,	  Odense,	   DK)	   system.	  Off-­‐line	  RP-­‐HPLC	   fractions	   of	  MMP-­‐1(E200A)	  peptic	  peptides	  were	  loaded	  (2-­‐6	  µl)	  onto	  a	  300	  µm	  id,	  0.5	  cm	  long	  Pepmap	  C18	  column	  (LC	  Packings,	  Amsterdam,	  NL),	  and	  washed	  for	  3	  min	  with	  0.1	  %	  formic	  acid	   (with	   the	   stream	  select	  valve	  diverting	   the	   column	  effluent	   to	  waste).	  The	  flow	  rate	  was	  then	  reduced	  to	  1	  µl/min,	  the	  stream	  select	  valve	  was	  switched	  to	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the	   data	   acquisition	   position,	   and	   the	   peptides	   were	   eluted	   into	   the	   mass	  spectrometer	   with	   an	   ACN/0.1	   %	   formic	   acid	   gradient	   (5-­‐70	   %	   ACN	   over	   20	  min).	  The	  capillary	  voltage	  was	  set	  to	  3500	  V.	  A	  survey	  scan	  over	  the	  m/z	  range	  200-­‐1300	  was	  used	  to	  identify	  protonated	  peptides	  with	  charge	  states	  of	  2,	  3	  or	  4,	   which	  were	   automatically	   selected	   for	   data-­‐dependent	  MS/MS	   analysis,	   and	  fragmented	  by	  collision	  with	  argon.	  The	  resulting	  product	  ion	  spectra	  from	  each	  precursor	  mass	   were	   averaged,	   smoothed,	   background	   subtracted,	   centroided,	  transformed	  onto	  a	   singly	   charged	  m/z	   axis	  using	  a	  maximum	  entropy	  method	  (MaxEnt3,	   Waters)	   and	   saved	   in	   peak	   list	   format	   (pkl)	   using	   the	   MassLynx	  processing	   routine	   peptideauto	   (Waters).	   The	   PKL	   files	  were	   searched	   against	  the	   SwissProt	   database	   using	   the	   publicly	   available	   version	   of	   Mascot	  (www.matrixscience.com).	   No	   enzyme	   specificity	  was	   applied,	   and	   the	   peptide	  and	  ion	  tolerances	  were	  1.2	  and	  0.6	  Da,	  respectively.	  	  	  
2.11.3.	  MALDI	  MS/MS	  
 Tandem	  MALDI	  mass	   spectra	   were	   obtained	   using	   the	   Q-­‐TOF	   Ultima	   API	  instrument,	   fitted	   with	   a	   MALDI	   ionisation	   source	   and	   a	   nitrogen	   laser.	   The	  matrix	   was	   α-­‐cyano-­‐2-­‐hydroxycinnamic	   acid	   (Sigma)	   prepared	   at	   a	  concentration	  of	  10	  mg/ml	   in	  50	  %	  acetonitrile/0.1	  %	  formic	  acid.	  Off-­‐line	  RP-­‐HPLC	  fractions	  of	  MMP-­‐1(E200A)	  peptic	  peptides	  were	  concentrated	  (essentially	  dried)	   using	   a	   SpeedVac	   system	   (Thermo	   Scientific).	   The	   samples	   were	  recovered	   from	   the	   vessel	  walls	   using	   2	   μl	   of	  matrix	   solution.	   They	  were	   then	  deposited	  on	  the	  stainless	  steel	  target	  and	  air-­‐dried.	  The	  laser	  energy	  was	  14	  μJ.	  The	  user-­‐controlled	  survey	  scans	  were	  acquired	  over	  the	  mass	  range	  800-­‐3000	  Da,	   and	  MS/MS	   scans	  were	   collected	   between	  masses	   3000	   and	   100	   Da.	   Data	  were	   smoothed	   and	   centroided	   as	   before,	   and	   were	   converted	   into	   mascot	  generic	  format	  (mgf).	  The	  mgf	  files	  were	  submitted	  to	  Mascot	  for	  searching	  using	  the	  parameters	  described	  above.	  	  
2.12.	  Optimisation	  of	  the	  peptide	  Trap	  column	  for	  H/DXMS	  
 For	   the	   reversed-­‐phase	   peptide	   Trap	   columns,	   POROS	   R1	   20	   (Applied	  Biosystems)	  and	  C18	   (Vydac)	  materials	  were	  self-­‐packed	   into	  2.1	  mm	   id	  and	  2	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cm	  long	  stainless	  steel	  column	  cases	  (Upchurch	  Scientific,	  Mikrolab	  Aarhus,	  DK).	  Each	  Trap	   column	  was	   connected	   in-­‐line	  after	   the	  PC1.	  This	   column	  setup	  was	  connected	   to	   the	  Ettan	  microLC	  system	  (GE	  Healthcare)	   in	  a	  cooling	  cabinet	   (1	  °C)	  and	  100	  μl	  of	  3	  μM	  MMP-­‐1(E200A)	  was	  passed	  at	  a	  flow	  rate	  of	  200	  μl/min	  through	   the	   columns	   equilibrated	   in	   0.1	   %	   formic	   acid,	   followed	   by	   2	   min	  washing.	  The	  PC1	  was	  removed	  and	  the	  peptides	  trapped	  on	  the	  RP	  peptide	  Trap	  columns	  were	  eluted	  at	  1	  °C	  using	  a	  linear	  gradient	  from	  0	  to	  65	  %	  ACN	  in	  0.1	  %	  formic	   acid	   over	   5	   min	   and	   constant	   65	   %	   	   ACN/0.1	   %	   formic	   acid	   over	  additional	  3	  min	  at	  a	  flow	  rate	  of	  50	  μl/min.	  The	  UV	  trace	  was	  recorded	  at	  214	  nm	  wavelength.	  	  
2.13.	  H/DXMS	  experiment	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3.1.	  Introduction	  
	   As	  described	   in	   Chapter	   1,	   it	   is	   generally	   known	   that	  MMP-­‐1	   involves	   the	  
exosite	  regions	  to	  recognise	  and	  process	  collagen.	  Those	  sites	  are	  present	  in	  the	  Hpx	  domain	  of	  MMP-­‐1	   (Clark	  &	  Cawston,	   1989;	  Murphy	   et	   al,	   1992),	   but	   their	  contribution	   to	   the	   overall	   collagen	   binding	   affinity	   of	   MMP-­‐1	   has	   never	   been	  investigated.	  It	  is	  also	  known	  that	  the	  collagenolytic	  activity	  of	  MMP-­‐1	  is	  severely	  affected	   at	   10	   °C,	   because	   of	   impaired	   collagen	   unwinding	   at	   the	   cleavage	   site	  (Chung	   et	   al,	   2004).	   The	   nature	   of	   this	   is	   unclear,	   since	   the	   triple	   helicase	  mechanism	   of	   MMP-­‐1	   is	   not	   known.	   Nevertheless,	   the	   collagen	   helix	  conformation	   is	   affected	   by	   temperature	   (Leikina	   et	   al,	   2002;	   Steplewski	   et	   al,	  2004b),	   especially	   at	   the	   C-­‐terminal	   side	   of	   collagenase	   cleavage	   site	   region	  (Fields,	  1991;	  Fiori	  et	  al,	  2002;	  Stultz,	  2002).	  This	  poses	  an	  important	  question,	  whether	   the	   collagen	  binding	  affinity	  of	  MMP-­‐1	  depends	  on	   the	  helical	   state	  of	  collagen.	  How	  are	  the	  three:	  collagen	  binding	  affinity;	  local	  helix	  unwinding;	  and	  thermal	   stability	   of	   the	   helix	   interrelated?	   The	   less	   ordered	   helix	   expected	   at	  temperatures	   over	   25	   °C	  will	   here	   be	   referred	   to	   as	   looser	   helix	   and	   a	   tighter	  helix	  at	  temperatures	  below	  10	  °C	  will	  be	  referred	  to	  as	  compactly	  folded	  helix.	  To	   gain	   a	   more	   comprehensive	   understanding	   of	   collagen	   binding	   and	  unwinding	  by	  the	  prototypic	  collagenase	  1	  (MMP-­‐1),	  we	  developed	  a	  solid	  phase	  binding	   assay	   allowing	   a	   simple	   and	   robust	   assessment	   of	   a	   relative	   protein	  binding	   strength	   (Leitinger,	   2003).	   In	   this	   adaptation	   of	   the	   enzyme-­‐linked	  immunosorbent	   assay	   (ELISA)	   concept,	  we	   took	   advantage	   of	   the	   streptavidin-­‐horseradish	  peroxidise	  system	  to	  detect	  proteins	  biotinylated	  at	  a	  low	  level	  (<	  2	  biotins	  per	  molecule)	  that	  bound	  to	  immobilised	  collagen.	  The	  biotinylation	  had	  no	  effect	  on	  collagenase	  activity	  (data	  not	  shown).	  We	  studied	  the	  roles	  and	  the	  relation	  between	  the	  Cat	  and	  Hpx	  domains	  of	  MMP-­‐1	   in	   triple-­‐helical	   collagen	   binding	   and	   unwinding,	   and	   the	   influence	   of	  temperature	  on	  collagen	  binding	  by	  MMP-­‐1.	  In	  this	  chapter	  we	  demonstrate	  that	  MMP-­‐1	   has	   a	   higher	   affinity	   to	   collagen	   in	   a	   loose	   rather	   then	   tight	   helical	  conformation	  and	  that	  this	  high-­‐affinity	  interaction	  can	  only	  be	  achieved	  by	  the	  cooperative	   binding	   of	   both	   collagenase	   domains	   linked	   together.	   Further,	  evidence	   is	   presented	   that	   the	   Cat	   domain	   participates	   in	   this	   cooperative	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collagen	  binding	   via	   a	   region	  proximal	   to	   the	   active	   centre	   of	   the	   enzyme.	  The	  cooperative	   high-­‐affinity	   collagen	   binding	   of	   MMP-­‐1	   induces	   the	   collagen	  unwinding	  event	  which	  leads	  to	  the	  cleavage	  of	  individual	  collagen	  strands.	  
3.2.	  Results	  
	  
3.2.1.	  The	  catalytic	  and	  the	  hemopexin	  domain	  of	  collagenase	  1	  (MMP-­‐
1)	  gain	  a	  high	  affinity	  to	  collagen	  only	  when	  linked	  to	  each	  other	  
 To	   investigate	   the	   role	   of	   the	   Hpx	   exosite	   binding	   to	   collagen,	   we	   first	  compared	   the	   abilities	   of	   each	   domain	   of	   MMP-­‐1(E200A)	   to	   bind	   to	   native	  collagen	   I.	   	  MMP-­‐1(E200A)	   is	   unable	   to	   cleave	   collagen,	   but	   it	   retains	   collagen	  binding	  and	  unwinding	  properties	  of	  the	  wild-­‐type	  enzyme	  (Chung	  et	  al,	  2004).	  	  As	   shown	   in	  Figure	  13A,	   the	   full-­‐length	  enzyme	  bound	   to	   collagen	   I	  much	  tighter	   than	   the	  Hpx	  domain.	  The	  Cat(E200A)	  domain	  and	   the	  wild-­‐type	  MMP-­‐1Cat	  (not	  shown)	  showed	  no	  detectable	  collagen	  binding,	  even	  in	  the	  presence	  of	  the	   Hpx	   domain	   at	   a	   12-­‐fold	   molar	   excess	   (Figure	   13A,	   bottom	   panel).	   This	  showed	   that	   the	   separated	   Hpx	   domain	   cannot	   induce	   the	   binding	   of	   the	   Cat	  domain	   and	   that	   the	   Hpx	   domain	   does	   not	   exhibit	   high	   affinity	   to	   the	   native	  collagen	   on	   its	   own.	   The	   effective	   high-­‐affinity	   interaction	   of	   the	   full-­‐length	  enzyme	  with	   collagen	   is,	   therefore,	   ensured	   by	   cooperative	   binding	   of	   several	  low-­‐affinity	   binding	   subsites	   distributed	   across	   both	   domains	   and	   perhaps	  facilitated	  by	  conformational	  changes	  caused	  upon	  binding.	  	  From	   the	   complete	   absence	   of	   collagen	   binding	   by	   the	   collagenase	   Cat	  domain	  we	  considered	  the	  possibility	  that	  the	  native	  triple-­‐helical	  conformation	  of	  collagen	  is	  inaccessible	  to	  the	  Cat	  domain.	  We	  therefore	  tested	  the	  Cat(E200A)	  domain	   for	   collagen	   binding	   in	   the	   presence	   of	   collagenolytically	   inactive	  collagen	   unwinders,	   such	   as	   MMP-­‐1(E200A)	   and	   MMP-­‐13(E204A),	   but	   no	  collagen	  binding	  by	  Cat(E200A)	  was	  observed	  (Figure	  13A,	  bottom	  panel).	  The	  binding	  of	  MMP-­‐1(E200A)	  to	  collagen	  I	  was	  competed	  by	  itself,	  but	  not	  by	  the	  Hpx	  or	  the	  Cat	  domain	  (Figure	  13B).	  On	  the	  other	  hand,	  the	  binding	  of	  the	  Hpx	  domain	  to	  collagen	  I	  was	  dose-­‐dependently	  inhibited	  by	  MMP-­‐1(E200A)	  or	  by	   itself,	   suggesting	   that	   the	   full-­‐length	   enzyme	   and	   the	   Hpx	   domain	   share	   a	  common	  collagen	  binding	  site.	  	  

































3.2.2.	  The	  Hpx	  domain	  can	  partially	  stabilise	  collagen	  unwinding	  
 To	   further	   investigate	   the	   nature	   of	   the	   Hpx	   domain	   interaction	   with	  collagen	   we	   examined	   its	   influence	   on	   collagen	   degradation	   by	   the	   active	   Cat	  domain	   in	   the	   presence	   or	   absence	   of	   the	   full-­‐length	   MMP-­‐1(E200A).	   In	   the	  presence	  of	  1	  μM	  MMP-­‐1(E200A),	  3	  μM	  Cat	  domain	  cleaves	  collagen	  I	  into	  ¾	  and	  ¼	  fragments	  at	  25	  °C	  (Figure	  14a).	  The	  addition	  of	  the	  Hpx	  domain	  to	  this	  system	  did	   not	   interfere	   with	   collagen	   unwinding	   by	   MMP-­‐1(E200A).	   Conversely,	   it	  slightly	  enhanced	   the	  collagen	  degradation.	  This	  observation	  was	  confirmed	  by	  
Figure	   13.	   Collagen	   binding	   of	   MMP-­‐1(E200A)	   and	   its	   separate	   domains.	   Immobilised	   type	   I	  
collagen	  binding	  assays	  were	  carried	  out	  at	  approximately	  22°C	  using	  biotinylated	  proteins	  (marked	  
with	  *).	  (A)	  Top,	  Dose	  dependent	  binding	  of	  full-­‐length	  MMP-­‐1(E200A)	  (MMP-­‐1EA),	  the	  hemopexin	  
domain	  of	  MMP-­‐1	  (Hpx)	  and	  the	  catalytic	  domain	  of	  MMP-­‐1(E200A)	  (CatEA)	  to	  collagen	  I.	  Bottom,	  
Collagen	  binding	  of	  CatEA	  at	  1μM	   in	   the	  presence	  of	  up	   to	  12-­‐fold	  excess	  Hpx,	   full-­‐length	  MMP-­‐
1(E200A)	   and	   MMP-­‐13(E204A)	   (MMP-­‐13EA).	   None	   of	   the	   components	   stimulated	   the	   CatEA	  
binding	  to	  collagen	  I.	  (B)	  Top,	  MMP-­‐1(E200A)	  (1	  μM)	  binding	  competition	  with	  the	  CatEA,	  Hpx	  and	  
MMP-­‐1(E200A)	  itself.	  Bottom,	  Competition	  of	  the	  Hpx	  domain	  (1	  μM)	  with	  MMP-­‐1(E200A)	  and	  the	  
Hpx	  domain	   itself.	   Separate	  domains	  of	   the	  MMP-­‐1(E200A)	  do	  not	  affect	   the	  collagen	  binding	  of	  
the	  full-­‐length	  enzyme,	  whereas,	  the	  full-­‐length	  enzyme	  effectively	  competes	  with	  the	  Hpx	  domain	  
in	  the	  collagen	  binding.	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incubating	  the	  collagen	  (5	  μM	  at	  25	  °C)	  with	  4	  μM	  Hpx	  and	  3	  μM	  Cat	  domain	  in	  the	  absence	  of	  MMP-­‐1(E200A),	  which	   resulted	   in	  marked	  collagen	  degradation	  above	  the	  background	  level	  produced	  by	  3	  μM	  Cat	  alone	  (Figure	  14).	  From	  these	  data	  we	  conclude	   that	  either	   the	  Hpx	  domain	  displays	  some	  ability	   to	  promote	  the	  unwound	  state	  of	  collagen,	  or	  that	  the	  two	  domains	  transiently	  interact	  and	  form	   a	   productive	   enzyme-­‐substrate	   complex.	   Nonetheless,	   the	   collagen	  unwinding	  efficacy	  of	  separated	  Hpx	  domain	  is	  much	  weaker	  than	  that	  of	  the	  full-­‐length	   enzyme.	   It	   follows	   that	   the	   ability	   of	   full-­‐length	   MMP-­‐1(E200A)	   and	  separate	  Hpx	  domain	  to	  promote	  the	  unwound	  state	  of	  collagen	  corresponds	  to	  their	  collagen	  binding	  strength	  estimated	  earlier	  (Figure	  13A).	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
Figure	  14. Roles	  of	  the	  individual	  MMP-­‐1	  domains	  in	  triple-­‐helical	  collagen	  degradation.	  The	  top	  and	  
the	  bottom-­‐left	  panels	  show	  7.5%	  SDS-­‐PAGE	  analyses	  of	  type	  I	  collagen	  (5	  μM)	  degradation	  to	  ¾	  and	  ¼	  
fragments	   over	   time	   (0-­‐30	   h)	   at	   25°C	   in	   the	   presence	   of	   3	   μM	  MMP-­‐1	   catalytic	   domain	   (Cat)	   in	   the	  
presence	  of:	  	  (a)	  1	  μM	  MMP-­‐1(E200A);	  (b)	  1	  μM	  MMP-­‐1(E200A)	  and	  5	  μM	  hemopexin	  domain	  of	  MMP-­‐
1	  (Hpx);	  (c)	  1	  μM	  MMP-­‐1(E200A)	  and	  10	  μM	  Hpx;	  (d)	  Hpx	  (4	  μM)	  and	  (e)	  none.	  (CONTROLS)	  From	  the	  
left:	   5	   μM	  Hpx,	   nothing	   added,	   1	   μM	  MMP-­‐1(E200A).	   The	   extent	   of	   collagen	   degradation	   in	   various	  
mixtures	  was	  quantified	  using	  Phoretix	  1D	  software	  (TotalLab)	  (bottom-­‐right	  graph).	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3.2.3.	  MMP-­‐1	  shows	  higher	  affinity	  for	  the	  unwound	  collagen	  helix	  
than	  the	  compactly	  folded	  one	  
 Collagenase	  cleavage	  of	  a	  native	  collagen	  is	  highly	  temperature-­‐dependent,	  whereas	   cleavage	   of	   denatured	   α-­‐chains	   is	  much	   less	   sensitive	   to	   temperature	  (Welgus	   et	   al,	   1981b;	   Chung	   et	   al,	   2004).	   Furthermore,	   collagenase	   has	   much	  higher	   activity	   against	   native	   collagen	   than	   against	   gelatin	   at	   25-­‐37	   °C.	   This	  indicates	   that	   the	   conformational	   state	   of	   the	   triple-­‐helical	   structure	   has	  significant	   influence	  on	  collagenase	  action.	  We	  postulated	   that	   the	   collagenase-­‐collagen	  binding	  affinity	  would	  be	  affected	  as	  a	   function	  of	   temperature,	  which	  alters	  the	  backbone	  motility	  of	  the	  triple-­‐helical	  substrate.	  	  We	   therefore	   performed	   the	   collagen	   binding	   assays	   at	   temperatures	  ranging	  from	  4	  °C	  to	  40	  °C	  (Figure	  15A).	  The	  full-­‐length	  MMP-­‐1(E200A)	  showed	  an	   increase	   in	   collagen	   I	   binding	   affinity	  with	   temperature	   up	   to	   30	   °C.	   In	   the	  range	   of	   30-­‐37	   °C,	   where	   the	   collagen	   structure	   would	   be	   more	   relaxed,	   but	  probably	  still	  not	  denatured	  in	  the	  time	  frame	  of	  the	  experiment	  (~2h)	  (Leikina	  et	  al,	  2002),	  the	  binding	  affinity	  of	  MMP-­‐1(E200A)	  was	  maximal.	  However,	  at	  40	  °C	  the	  binding	  strength	  was	  severely	  reduced.	  Based	  on	  these	  observations,	  we	  conclude	   that	   the	   loosely	   folded	   collagen	   helix	   is	   favoured	   for	   the	   interaction	  with	   MMP-­‐1(E200A),	   but	   not	   above	   a	   critical	   point	   over	   37	   °C	   in	   which	   the	  degree	  of	  disorder	  in	  the	  helix	  is	  probably	  excessive	  and	  collagen	  denatures.	  The	  strength	  of	  the	  MMP-­‐1(E200A)	  binding	  to	  gelatin	  and	  cleaved	  collagen	  (¾	  and	  ¼	  fragments)	  resembled	  the	  binding	  at	  40	  °C	  (data	  not	  shown).	  	  Hpx	   domain	   binding	   to	   collagen	   I	   increased	   slightly	   at	   the	   temperature	  between	   20	   °C	   and	   30	   °C,	   but	   the	   Hpx	   domain	   did	   not	   seem	   to	  maintain	   high	  collagen	  binding	  ability	  at	  37	  °C	  (Figure	  15A,	  bottom	  panel).	  This	  indicates	  that	  the	  change	  in	  the	  triple	  helix	  flexibility	  does	  not	  affect	  the	  binding	  affinity	  of	  the	  Hpx	   domain	   as	   much	   as	   that	   of	   MMP-­‐1(E200A).	   This	   is	   consistent	   with	   the	  previous	  observation	  (Figure	  14),	  suggesting	  that	  the	  Hpx	  domain	  alone	  could	  be	  a	  poor	  promoter	  of	   collagen	  unwinding,	  perhaps	  causing	  only	  small	  unwinding	  amplitude	  compared	  to	  the	  full-­‐length	  enzyme.	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Figure	   15.	   The	   effect	   of	   temperature	   and	   active	   site	   inhibitors	   on	   MMP-­‐1(E200A)	   binding	   to	  
collagen.	  Immobilised	  type	  I	  collagen	  binding	  assays.	  Detected	  biotinylated	  proteins	  are	  marked	  with	  
*	   (A)	   Temperature-­‐dependent	   collagen	   binding	   of	   the	   full-­‐length	   MMP-­‐1(E200A)	   (top)	   and	   the	  
hemopexin	  domain	  of	  MMP-­‐1	  (Hpx)	  (bottom).	  (B)	  MMP-­‐1(E200A)	  binding	  to	  collagen	  in	  the	  presence	  
of	  10	  μM	  Marimastat	  (top)	  or	  GM6001	  (bottom)	  at	   increasing	  temperatures;	  data	  from	  (A)	  kept	  for	  
reference	  in	  grey.	  (C)	  Binding	  of	  1	  μM	  MMP-­‐1(E200A)	  (top)	  and	  1μM	  Hpx	  domain	  of	  MMP-­‐1	  (bottom)	  
to	   collagen	   in	   the	   presence	   of	   various	   concentrations	   of	  Marimastat	   (left)	   and	   GM6001	   (right)	   at	  
increasing	  temperatures.	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3.2.4.	  The	  Cat	  domain	  of	  MMP-­‐1	  participates	  in	  the	  cooperative	  
binding	  of	  collagen	  via	  its	  catalytic	  site	  
 To	  further	  investigate	  the	  participation	  of	  the	  Cat	  domain	  in	  cooperative	  collagen	   binding	   of	   the	   full-­‐length	  MMP-­‐1(E200A)	  we	   tested	   two	   different	   low	  molecular	   weight	   synthetic	   active	   site-­‐directed	   MMP	   inhibitors,	   GM6001	   and	  Marimastat.	  As	   shown	   in	  Figure	  15B	  and	  C,	   the	  binding	  of	  MMP-­‐1(E200A)	  was	  affected	   by	   both	   inhibitors,	   most	   prominently	   at	   higher	   temperatures,	  particularly	   at	   above	   25	   °C.	   Marimastat	   did	   not	   have	   any	   effect	   on	   MMP-­‐1(E200A)	  collagen	  binding	  up	  to	  20	  °C	  (Figure	  15B	  and	  C).	  In	  addition,	  the	  Hpx	  domain	   binding	   was	   not	   significantly	   affected	   by	   the	   inhibitors	   regardless	   of	  temperature	   (Figure	   15C).	   The	   inhibitor	   dose-­‐dependent	   reduction	   in	   MMP-­‐1(E200A)	  binding	  to	  collagen	  I	  showed	  saturation	  at	  1:1	  enzyme-­‐inhibitor	  ratio	  (Figure	  15C,	   top	  panels).	  This	  specific	  blockage	  of	  the	  active	  site	  dampened	  the	  MMP-­‐1(E200A)	  collagen	  binding,	  but	  not	  below	  the	  binding	  level	  seen	  at	  10	  °C.	  At	  this	  temperature	  collagen	  unwinding	  does	  not	  take	  place	  (Chung	  et	  al,	  2004),	  and	   as	   expected,	   the	   inhibitors	   had	   no	   significant	   influence	   on	   the	   collagen	  binding	  by	  MMP-­‐1(E200A)	  at	  10	  °C	  and	  below	  (Figure	  15B	  and	  C).	  Remarkably,	  at	   temperatures	   of	   20-­‐30	   °C	   the	   collagen	   binding	   level	   of	   MMP-­‐1(E200A)	   at	  saturation	   of	   the	   active	   site	   by	   either	   inhibitor	   was	   higher	   than	   at	   35-­‐37	   °C,	  indicating	   that	   sites	   other	   than	   the	   active	   site	  were	  more	   involved	   in	   collagen	  binding	  at	  those	  lower	  temperatures.	  At	  temperatures	  closer	  to	  the	  physiological	  temperature,	   where	   the	   collagen	   helicity	   is	   less	   tight	   and	   the	   triple	   helix	  unwinding	   is	   thermodynamically	   favoured	   (Leikina	   et	   al,	   2002),	   the	   active	   site	  region	  was	  more	  involved	  in	  the	  interaction	  with	  collagen.	  The	  same	  was	  true	  at	  40	   °C,	   however,	   the	   overall	   binding	   level	   at	   this	   temperature	  was	  much	   lower,	  most	  likely	  due	  to	  progressive	  loss	  of	  triple	  helicity	  in	  collagen.	  	  Those	  results	  suggested	  that	  the	  preferred	  interaction	  of	  MMP-­‐1(E200A)	  with	  collagen	  at	  physiological	   temperature	   is	  associated	  with	   the	  unwinding	  of	  the	  substrate,	  in	  which	  the	  active	  site	  region	  participates.	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3.2.5.	  The	  effect	  of	  the	  active	  Cat	  domain	  on	  the	  binding	  of	  MMP-­‐
(E200A)	  to	  collagen	  












 	  	  	  	  	  
Figure	   16.	   Stimulation	   of	   MMP-­‐1(E200A)	  
binding	   to	   collagen	   by	   the	   active	   Cat	  
domain	   of	   MMP-­‐1.	   Biotinylated	   MMP-­‐
1(E200A)(*)	  at	  the	  concentration	  of	  0.5	  μM	  
was	   incubated	   with	   immobilised	   collagen	  
type	   I	   in	   the	   presence	   of	   increasing	  
concentration	   of	   the	   active	   Cat	   domain	   of	  
MMP-­‐1	   (0-­‐5	   μM)	   at	   25°C	   and	   the	   bound	  
fraction	   was	   detected	   after	   increasing	  
incubation	   times	   (1-­‐24	   h)	   (top).	   The	   same	  
experiment	   was	   carried	   out	   at	   increasing	  
temperatures	   after	   1.5	   h	   incubation	  
(bottom).	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To	   understand	   the	   mechanism	   of	   the	   collagen	   binding	   enhancement	   of	   MMP-­‐1(E200A)	  by	  the	  active	  Cat	  domain,	  we	  employed	  other	  MMP	  catalytic	  domains	  of	  different	  cutting	  efficacies.	  Alongside	  the	  Cat	  domain	  of	  MMP-­‐1,	  we	  used:	  (a)	  the	   LC3Cat	   domain,	   which	   is	   an	   MMP-­‐3/MMP-­‐1	   chimera,	   known	   in	   our	  laboratory	   for	   a	   higher	   cutting	   activity	   than	   the	  Cat	   domain	   of	  MMP-­‐1;	   (b)	   the	  Tyr-­‐210	  	  Thr	  mutant	  of	  this	  chimera	  (LC3YTCat),	  activity	  of	  which	  is	  severely	  abolished;	  and	  (c)	  the	  catalytic	  domain	  of	  MMP-­‐3	  (MMP-­‐3Cat),	  which	  is	  another	  relatively	   poor	   cutter	   proteinase	   (Dr.	   R.	   Visse,	   unpublished	   data).	   Results	  presented	   in	   Figure	   17A	   show	   the	   strongest	   collagen	   binding	   stimulation	   of	  MMP-­‐1(E200A)	  by	  the	  most	  proficient	  cutter	  enzyme	  LC3Cat.	  As	  expected,	  MMP-­‐1Cat	   showed	   moderate	   effect	   and	   LC3YTCat	   and	   MMP-­‐3Cat	   showed	   no	  stimulation	  of	  MMP-­‐1(E200A)	  binding	  to	  collagen,	  exactly	  as	  seen	  in	  the	  case	  of	  the	   inactive	   Cat(E200A)	   (Figure	   13B,	   top	   graph).	   Based	   on	   these	   results,	   the	  stimulation	   of	   MMP-­‐1(E200A)	   binding	   to	   collagen	   increases	   with	   the	   cutting	  activity.	   This	   suggests	   that	   the	   collagen	  binding	   affinity	   of	  MMP-­‐1(E200A)	  was	  enhanced	  due	  to	  the	  cleavage	  at	  the	  unwound	  collagen.	  	  We	  investigated	  this	  possibility	  by	  varying	  the	  collagen	  unwinding	  efficacy	  this	  time.	  Besides	  MMP-­‐1(E200A),	  we	  examined	  two	  additional	  enzymes,	  MMP-­‐13(E204A)	   and	   the	   MMP-­‐1-­‐1-­‐13(E200A)	   chimera,	   which	   consists	   of	   the	   Cat	  domain	  and	  the	  linker	  of	  MMP-­‐1	  and	  the	  Hpx	  domain	  of	  MMP-­‐13.	  These	  species	  vary	  in	  collagen	  unwinding	  properties	  as	  shown	  in	  Figure	  17B	  (top	  panel).	  MMP-­‐13(E204A)	   was	   the	   most	   potent	   collagen	   unwinder,	   MMP-­‐1(E200A)	   was	  intermediary	  and	  the	  MMP-­‐1-­‐1-­‐13(E200A)	  chimera	  was	  the	  poorest	  unwinder	  in	  this	   group.	   Next,	   all	   three	   enzymes	   where	   biotinylated	   and	   subjected	   to	   solid	  phase	  collagen	  binding	  analyses	  in	  the	  presence	  of	  active	  Cat	  domain	  of	  MMP-­‐1	  (Figure	   17B,	   bottom	   graph).	   The	   collagen	   binding	   enhancement	   was	   most	  prominent	   for	   the	  most	   proficient	  unwinder	  MMP-­‐13(E200A).	   Accordingly,	   the	  binding	  of	  MMP-­‐1(E200A)	  was	  less,	  and	  the	  binding	  of	  MMP-­‐1-­‐1-­‐13(E200A)	  was	  least	  stimulated.	  	  In	   conclusion,	   the	   stimulatory	   effect	   of	   the	   active	   Cat	   domain	   on	   collagen	  binding	   by	   the	   unwinder	   enzymes	   is	   directly	   correlated	   with	   their	   collagen	  unwinding	   efficacies.	   This	   further	   supports	   the	   notion	   that	   a	   cleavage	   in	   the	  complex	   of	   MMP-­‐1(E200A)	   with	   unwound	   collagen	   is	   responsible	   for	   the	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Figure	   17. Enhancement	   of	   the	   collagenase	   binding	   results	   from	   the	   cleavage	   in	   the	   unwound	  
collagen-­‐collagenase	  complex.	  Biotinylated	  entities	  detected	  in	  solid	  phase	  assays	  or	  Western	  blots	  are	  
marked	  with	  *.	  (A)	  The	  effect	  of	  different	  Cat	  domains	  (MMP-­‐1Cat,	  LC3Cat,	  LC3(Y191T)Cat,	  and	  MMP-­‐
3Cat)	  on	  MMP-­‐1(E200A)	  (0.5	  μM)	  binding	  to	  immobilised	  collagen	  at	  20°C	  after	  1	  h	  incubation.	  (B)	  Top,	  
collagen	  unwinding	  assay	  were	   carried	  out	  by	   SDS-­‐PAGE	  analyses	  of	   collagen	   (4.5	  μM)	   cleavage	  over	  
time	  (0-­‐26	  h)	  in	  the	  presence	  of	  3	  μM	  MMP-­‐1Cat	  and	  MMP-­‐1(E200A),	  MMP-­‐13(E204A)	  and	  biotinylated	  
MMP-­‐1-­‐1-­‐13(E204A)	   at	   1	   μM.	   Bottom,	   immobilised	   collagen	   binding	   enhancement	   of	  MMP	   variants	  
mentioned	  above	  (0.5	  μM	  each)	  by	  the	  MMP-­‐1Cat	  at	  20°C	  after	  1	  h	  incubation,	  normalised	  taking	  the	  
highest	  relative	  binding	  enhancement	  value	  as	  100%.	  (C)	  0.5	  μM	  MMP-­‐1(E200A)	  binding	  to	  immobilised	  
wild-­‐type	  collagen	  I	  from	  g.	  pig	  skin,	  mouse	  skin	  and	  engineered	  non-­‐cleavable	  mouse	  collagen	  I	  for	  1	  h	  
at	   30°C	   in	   the	   presence	   of	   MMP-­‐1Cat	   (0-­‐5	   μM).	   (D)	   Western	   blot	   analyses	   of	   the	   cleavage	   of	   the	  
immobilised	  type	  I	  collagen	  after	  24	  h	  co-­‐incubation	  at	  approximately	  22°C	  with	  0.5	  μM	  MMP-­‐1(E200A)	  
and	   various	   amounts	   of	   the	   MMP-­‐1Cat	   (top)	   and	   the	   deposition	   of	   the	   MMP-­‐1(E200A)	   on	   the	  
immobilised	  collagen	  after	  6	  h	  incubation	  under	  the	  same	  conditions	  (bottom). 
* 
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3.2.6.	  Collagen	  unwinding	  occurs	  upon	  cooperative	  binding	  of	  the	  two	  
domains	  of	  collagenase	  
 To	  confirm	  that	  the	  collagen	  unwinding	  is	  indeed	  occurring	  upon	  binding	  of	  MMP-­‐1(E200A),	  we	  aimed	  to	  directly	  demonstrate	  that	  the	  cleavage	  in	  a	  collagen	  chain	  is	  the	  driving	  factor	  of	  the	  observed	  increased	  collagen	  binding	  affinity	  of	  MMP-­‐1(E200A)	  in	  the	  presence	  of	  the	  cutter	  activity.	  As	   shown	   in	  Figure	  17C,	  we	   immobilised	   a	  mouse	   collagen	   I	   in	  which	   the	  collagenase	   cleavage	   site	   was	   mutated	   rendering	   it	   non-­‐cleavable	   (Liu	   et	   al,	  1995),	  alongside	  wild-­‐type	  mouse	  collagen	  I	  and	  the	  usual	  guinea-­‐pig	  collagen	  I.	  The	  human	  MMP-­‐1(E200A)	  showed	  a	  lower	  affinity	  to	  the	  mouse	  collagen	  than	  to	   the	  guinea-­‐pig	   collagen	  and	   the	   lowest	  affinity	   to	   the	  non-­‐cleavable	   collagen	  variant.	   Importantly,	  however,	  the	  MMP-­‐1(E200A)	  binding	  to	  the	  non-­‐cleavable	  collagen	  was	   insensitive	   to	   the	  presence	  of	   the	  Cat	  domain	  of	  MMP-­‐1,	  unlike	   in	  the	  case	  of	  the	  control	  native	  collagens,	  where	  the	  characteristic	  Cat-­‐dependent	  binding	  stimulation	  was	  observed.	  	  	  We	  also	  attempted	  to	  visualise	  cleaved	  collagen	  α	  chains.	  In	  this	  respect,	  we	  co-­‐incubated	   MMP-­‐1(E200A)	   with	   increasing	   amounts	   of	   MMP-­‐1Cat	   and	  immobilised	  collagen	  over	  24	  h	  at	  approximately	  22	  °C.	  Instead	  of	  developing	  the	  assay	  in	  a	  usual	  ELISA	  format,	  the	  material	  was	  scraped	  from	  the	  plate	  with	  SDS	  sample	   buffer	   after	   a	   thorough	  wash	  with	   TNC	   buffer,	   separated	   by	   SDS-­‐PAGE	  and	  detected	  by	  Western	  blot	  (Figure	  17D,	  top	  panel).	  The	  same	  was	  done	  with	  biotinylated	  MMP-­‐1(E200A),	  but	  the	  incubation	  time	  was	  reduced	  to	  6	  h	  (Figure	  17D,	   bottom	   panel).	   We	   managed	   to	   identify	   the	   cleavage	   of	   α	   chains	   and	  observed	   increasing	   amount	   of	   bound	   MMP-­‐1(E200A)	   corresponding	   to	   the	  increasing	  concentration	  of	  the	  active	  Cat	  domain.	  	  These	   results	   support	   the	   hypothesised	  mechanism	   of	   the	   Cat-­‐stimulated	  collagen	  binding	  of	  MMP-­‐1(E200A).	  The	  cleavage	   in	  the	  exposed	  collagen	  chain	  seemed	  to	  allow	  MMP-­‐1(E200A)	  to	  accommodate	  a	  tighter	  fit	  with	  the	  remaining	  chains	  as	  the	  tension	  in	  the	  helix	  is	  eased.	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3.3.	  Discussion	  
 In	   this	   chapter	  we	  have	  demonstrated	   that	   the	   interaction	  of	  MMP-­‐1	  with	  collagen,	  which	  leads	  to	  a	  specific	  local	  unwinding	  of	  the	  triple	  helix,	  relies	  on	  a	  cooperative	   interaction	   of	   several	  moieties	   linked	   together.	   Neither	   of	   the	   two	  MMP-­‐1	   domains	   displayed	   high	   collagen	   binding	   affinity	   when	   split.	   The	   Cat	  domain	   alone	   showed	   no	   collagen	   binding	   detectable	   in	   our	   assay,	   but	   it	  substantially	  contributed	  to	  the	  overall	  enzyme	  binding	  when	  linked	  to	  the	  Hpx	  domain,	  which	  likewise	  showed	  only	  relatively	  weak	  binding	  alone.	  The	  physical	  connection	  between	  the	  domains	  is	  required	  for	  the	  functional	  collagen	  binding	  as	  the	  addition	  of	  Hpx	  separately	  did	  not	  make	  the	  Cat	  domain	  bind	  to	  collagen.	  Such	  gain	  of	  binding	  strength	  through	  a	  coupling	  of	  two	  low-­‐binding	  components	  is	  not	  surprising,	  especially	   if	  structural	  changes	   in	  the	  complex	  are	  considered	  (Jencks,	   1981).	   It	   appears,	   that	   the	   isolated	   Cat	   domain	   interacts	   with	   single	  collagen	  strands	  very	  dynamically,	  as	   it	  cleaves	  them	  with	  the	  help	  of	  unwinder	  enzyme	   but	   does	   not	   remain	   bound,	   even	   in	   a	   catalytically	   disabled	   form	  Cat(E200A).	  Triple-­‐helical	   collagen	   is	   one	   of	   the	   extreme	   examples	   of	   resistance	   to	  proteolysis.	  The	  turnover	  number	  (kcat)	  of	  MMP-­‐1	  is	  only	  22.5	  h-­‐1	  for	  the	  solution	  form	   of	   guinea-­‐pig	   type	   I	   collagen	   (Welgus	   et	   al,	   1981a).	   This	   extremely	   slow	  turnover	  rate	  among	  enzyme-­‐catalysed	  reactions	   is	   in	  this	  case	  associated	  with	  large	  energetic	  cost	  of	  displacing	  the	  water	  shell	  upon	  local	  perturbation	  of	  the	  triple	  helix.	  Thus,	  high	  activation	  energy	  (EA)	  corresponding	  to	  high	  temperature	  dependence	   of	   the	   enzymatic	   reaction	   is	   one	   of	   the	   hallmarks	   of	   the	   native	  collagen	  degradation	  by	  MMP	  collagenase	   (Welgus	  et	   al,	   1981b).	  For	  each	  2	   °C	  increase	   in	   temperature,	   MMP-­‐1	   activity	   against	   native	   collagen	   increases	   ~3-­‐fold,	   whereas	   for	   nearly	   all	   reported	   enzymatic	   reactions,	   including	   MMP-­‐1	  processing	  of	  other	  substrates,	   their	  velocity	  changes	  up	  to	  3-­‐fold	  per	  10	  °C.	   In	  theory,	  such	  striking	  temperature	  dependence	  could	  result	  from	  large	  structural	  flexibility	  of	  either	  the	  enzyme	  or	  the	  substrate.	  The	  first	  possibility	  is	  ruled	  out	  in	  this	  case,	  since	  the	  catalytic	  activity	  of	  MMP-­‐1	  towards	  linear	  substrates,	  such	  as	   denatured	   α	   chains,	   lacks	   the	   temperature	   sensitivity	   characteristic	   for	   the	  native	   collagen	   cleavage	   (Chung	   et	   al,	   2004).	   Consequently,	   the	   EA	   value	   for	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gelatin	   is	  13.9	  kcal/mol,	  which	  follows	  a	  typical	  enzyme-­‐catalysed	  reaction,	  but	  for	   soluble	   or	   fibril-­‐assembled	   collagen	   it	   comes	   to	   49.2	   and	   101.05	   kcal/mol,	  respectively	   (Welgus	   et	   al,	   1981b).	   The	   unique	   temperature	   dependence	   of	  collagen	   cleavage	   by	   MMP	   collagenase	   is,	   therefore,	   attributable	   to	   the	  uniqueness	   of	   the	   substrate,	   which	   loses	   compactness	   of	   the	   helix	   as	   the	  temperature	   is	   raised	   (Shanmugam	   &	   Polavarapu,	   2009).	   The	   melting	  temperatures	   (Tm)	   of	   different	   collagen	   types	   and	   origins	   depend	   vastly	   on	  hydroxyproline	  content	  (Jenkins	  et	  al,	  2003;	  Xu	  et	  al,	  2003)	  and	  are	  usually	  close	  to	   or	   below	   37	   °C	   for	   soluble	   collagen	   molecules	   (Leikina	   et	   al,	   2002).	   For	  example,	   type	   I	   collagen	   was	   reported	   to	   be	   thermally	   unstable	   at	   body	  temperature,	   as	   it,	   albeit	   slowly,	   denatured	   at	   37	   °C	   over	   several	   days,	   as	  measured	  by	  ultra-­‐slow	  scanning	  calorimetry	  and	  isothermal	  circular	  dichroism	  (Leikina	  et	  al,	  2002).	  These	  observations	  lend	  credence	  to	  speculations	  that	  the	  independent	   mobility	   of	   collagen	   helices	   in	   fibres	   is	   essential	   for	   various	  physiological	  functions	  (Steplewski	  et	  al,	  2004a),	  besides	  conferring	  elasticity	  to	  the	  fibres.	  	  Catalytically	  inactive	  MMP-­‐1(E200A)	  presents	  essentially	  the	  same	  mode	  of	  interaction	  with	  collagen	  as	  the	  native	  MMP-­‐1	  (Chung	  et	  al,	  2004).	  Since	  it	  lacks	  the	  ability	  to	  cleave	  collagen,	  the	  relative	  collagen	  binding	  strength	  of	  the	  enzyme	  could	   be	   easily	   measured	   at	   different	   temperatures.	   We	   found	   that	   the	  collagenase-­‐susceptible	   site	   in	   type	   I	   collagen	   is	   bound	   by	   MMP-­‐1	   in	   a	   highly	  temperature-­‐dependent	   manner.	   Clearly,	   a	   looser	   conformation	   of	   collagen	  triple-­‐helix	  corresponding	  to	  the	  temperatures	  of	  30-­‐37	  °C	  produced	  the	  highest-­‐affinity	   fit	   between	   the	   enzyme	   and	   the	   substrate.	   This	  was	   further	   confirmed	  using	   the	   collagenase	   Cat	   domain,	   capable	   of	   cleaving	   only	   unfolded	   collagen	  chains,	  that	  the	  complexes	  of	  the	  highest	  binding	  affinity	  represent	  the	  unwound	  state	  of	  collagen.	  The	  cleavage	  by	  the	  Cat	  domain	  increased	  the	  affinity	  between	  MMP-­‐1(E200A)	   and	   collagen,	   but	   the	  Hpx	   domain	   binding	   to	   collagen	  was	   not	  influenced	   by	   the	   Cat	   domain,	   confirming	   that	   this	   domain	   cannot	   efficiently	  promote	  collagen	  unwinding	  on	   its	  own.	  The	  active	  Cat	  domain	  effect	  on	  MMP-­‐1(E200A)	   binding	   to	   collagen	   followed	   exactly	   the	   temperature	   dependence	   of	  this	  binding.	  It	  was	  most	  pronounced	  at	  the	  30-­‐37	  °C	  temperature	  range,	  with	  a	  severe	  drop	  at	  40	   °C,	  which	  can	  be	  explained	  by	   the	  excessive	  unfolding	  of	   the	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collagen	  helix	  making	  it	  no	  longer	  optimal	  for	  the	  enzyme	  binding	  (Km	  values	  of	  gelatin	  I	  are	  4-­‐7	  μM	  for	  MMP-­‐1,	  and	  those	  of	  collagen	  I	  are	  about	  1	  μM	  	  (Welgus	  et	  al,	  1985a)).	  Forming	  the	  high-­‐affinity	  unwound	  collagen-­‐collagenase	  complex	  is,	  therefore,	  energetically	  favoured	  close	  to	  physiological	  temperature	  of	  37	  °C,	  at	  which	  the	  thermolabile	  C-­‐terminal	  side	  of	  the	  collagenase	  cleavage	  site	  is	  most	  relaxed	   (Fields,	   1991;	   Fiori	   et	   al,	   2002),	   but	   the	   overall	   triple	   helicity	   of	   the	  substrate	   is	   maintained.	   This	   consideration	   is	   very	   important	   since	   many	  investigators	  have	  addressed	  the	  mechanistic	  enigma	  of	  collagenolysis	  by	  MMP	  collagenases,	  especially	  regarding	  the	  energetic	  aspect	  of	  the	  process.	  Among	  the	  proposed	  theories,	  several	   forces	  have	  been	  hypothesised,	   including:	  (a)	   lateral	  compression	   (clamping)	   (Bode,	   1995;	   Gomis-­‐Rüth	   et	   al,	   1996);	   (b)	   α	   chain	  intercalation	  with	  the	  proline-­‐rich	   linker	  (De	  Souza	  et	  al,	  1996);	   (c)	  bending	  or	  (d)	   axial	   rotation	   of	   the	   helix	   (Overall,	   2002).	   All	   those	   mechanisms	   would	  require	  high	  energy	  of	  the	  coordinated	  domain	  motions.	  Since	  the	  collagenolysis	  does	  not	  involve	  any	  external	  energy	  source,	  such	  as	  ATP	  hydrolysis,	  it	  is	  unlikely	  that	  the	  enzyme	  could	  exert	  such	  profound	  effects	  on	  collagen.	  Stultz	  et	  al	  (Stultz,	  2002;	   Nerenberg	   et	   al,	   2008)	   argue	   an	   alternative	   theory,	   that	   sufficiently	  unwound	   states	   are	   spontaneously	   occurring	   at	   the	   conformationally	   unstable	  collagenase-­‐cleavage	   site	   region	   and	   that	   collagenolysis	   relies	   on	   capturing	   the	  unwound	   conformation.	   This	   seems	   possible	   in	   the	   light	   of	   the	   less	   thermally	  stable	   triple	   helicity	   of	   the	   collagenase	   cleavage	   site.	   A	   trypsin-­‐like	   crab	  collagenase,	   for	   example,	   cleaves	   native	   collagen	   C-­‐terminal	   to	   the	  mammalian	  collagenase	   cleavage	   site.	   Still,	   it	   is	   unlikely,	   that	   even	   the	   most	   prominent	  thermal	  breathing	  of	  collagen	  in	  the	  neighbourhood	  of	  the	  collagenase-­‐cleavage	  site,	  would	  stochastically	  generate	  an	  unwound	  state	  of	  collagen	  which	  is	  optimal	  for	   collagenase	   cleavage,	   as	   the	   Cat	   domain	   of	   MMP-­‐1	   and	   other	   gelatinolytic	  enzymes	   (neutrophil	   elastase	   or	   trypsin)	   are	   essentially	   non-­‐collagenolytic	  (Clark	  &	  Cawston,	  1989;	  Chung	  et	  al,	  2004).	  Although	  some	  ‘vulnerable’	  partially	  unwound	  state	  does	  occur	  spontaneously,	  since	  extremely	  high	  concentration	  of	  the	   active	   Cat	   domain	   (3	   μM	   Cat	   per	   5	   μM	   collagen)	   produced	   some	   collagen	  degradation	   over	   30	  hours.	  Here,	   it	   is	   postulated	   that	   the	   local	   thermal	  micro-­‐unfolding	   of	   the	   collagen	   molecule	   ¾	   away	   from	   the	   N-­‐terminus	   is	   only	   a	  prerequisite	   for	   collagenase	   action,	   as	   illustrated	   in	   Figure	   18.	   Some	   of	   the	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stochastically	   sampled	   conformers	   of	   the	   collagenase-­‐susceptible	   region	   are	  recognised	   by	   the	   enzyme,	   which	   in	   turn	   induces	   the	   catalytically	   relevant	  unwound	  state	  of	  the	  substrate.	  As	  we	  demonstrated,	  the	  enzyme	  has	  the	  highest	  affinity	   to	   that	   unwound	   state,	   which	   means,	   that	   collagen	   unwinding	   is	  thermodynamically	   favoured	   within	   the	   microenvironment	   of	   the	   enzyme.	  Therefore,	   no	   energy	   input	   other	   than	   heat	   is	   required	   in	   the	   process.	   The	  collagen	   unwinding	   can	   be	   realised	   upon	   the	   enzyme	   two-­‐domain	   cooperative	  binding,	  because	   it	  provides	  at	   least	  a	  two-­‐point	  (two-­‐domain)	   interaction	  with	  collagen,	  enabling	  physical	  distortion	  in	  the	  substrate.	  Thermally	  labile	  collagen	  strands	  anchored	  at	  spatially	  independent	  sites	  of	  the	  enzyme	  may	  engage	  with	  the	   thermal	   movements	   of	   the	   enzyme,	   which	   may	   in	   turn	   lead	   to	   the	   local	  opening/melting	   of	   the	   helix.	   Our	   hypothesis	   agrees	   well	   with	   the	   lack	   of	  collagenolysis	  by	  MMP-­‐1	  at	  10	  °C	  and	  below,	  which	  results	  from	  the	  suppression	  of	  collagen	  unwinding	  (Chung	  et	  al,	  2004)	  as	  thermal	  fluctuations	  in	  collagen	  and	  perhaps	   in	   the	   enzyme	   are	   quenched.	   Consistently,	   at	   these	   temperatures	   we	  observed	   a	   significant	   decrease	   in	   the	   collagen	   binding	   affinity	   of	   MMP-­‐1(E200A),	  and	  that	  low	  affinity	  binding	  was	  insensitive	  to	  the	  presence	  of	  either	  low	  molecular	  weight	  active	  site-­‐directed	  inhibitor	  (no	  binding	  inhibition)	  or	  the	  active	   Cat	   domain	   (no	   binding	   enhancement),	   which	   is	   indicative	   of	   a	   lack	   of	  collagen	  unwinding.	  When	  collagen	  is	  more	  flexible,	  it	  is	  more	  prone	  to	  unwind,	  thus	  collagenase-­‐collagen	  interaction	  accelerates	  as	  the	  temperature	  rises	  up	  to	  around	  the	  collagen	  melting	  point	  (Tm)	  close	  to	  37	  °C.	  	  Conversely,	   both	   GM6001	   and	  Marimastat,	   significantly	   affected	   the	   high-­‐affinity	  binding	  associated	  with	  collagen	  unwinding	  at	  temperatures	  above	  25	  °C.	  Moderate	  or	  no	   inhibitor	  effect	  was	  seen	  at	  20	  °C	  or	  below.	  From	  these	  results	  we	   can	   define	   at	   least	   two	   different	   binding	   modes.	   One	   represents	   collagen	  unwinding	   in	   which	   a	   region	   located	   at	   the	   active	   site	   cleft	   of	   the	   enzyme	  participates,	  and	  the	  weaker	  binding	  of	  the	  compactly	  folded	  triple	  helix	  which	  is	  independent	  on	  the	  active	  site	  region	  (Figure	  18).	  So	  apart	  from	  the	  two	  or	  more	  initial	   collagen	   anchoring	   points,	   the	   additional	   collagen	   anchoring	   point	   is	  satisfied	  by	   the	   catalytic	   site	   region,	  which	  helps	   to	  provide	   the	   energy	   for	   the	  collagen	  strand	  movement	  during	  the	  unwinding	  step.	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Those	   results	   also	   explained	   the	   nature	   of	   active	   site	   inhibitor-­‐dependent	  blockage	   of	   collagen	   unwinding	   by	   MMP-­‐1.	   In	   a	   previous	   report	   (Chung	   et	   al,	  2004),	  GM6001	  prevented	  collagen	  unwinding	  by	  MMP-­‐1(E200A).	  To	  date	  it	  was	  not	  known,	  however,	   if	  GM6001	  affects	  only	   the	  unwinding	  mechanism	  or	  also	  the	  binding.	   In	  our	  experiments	   it	  became	  clear,	   that	  these	  two	  elements	  of	  the	  MMP-­‐1	   mechanism	   are	   inseparable.	   The	   establishment	   of	   the	   productive	  unwound	   collagen-­‐collagenase	   complex	   is	   determined	   by	   the	   high-­‐affinity	  binding	  in	  which	  the	  active	  site	  cleft	  is	  involved.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  In	   our	   hands	   the	   Hpx	   domain	   facilitated	   some	   unwound	   state	   of	  collagenase-­‐susceptible	  region	  in	  the	  presence	  of	  the	  Cat	  domain	  of	  MMP-­‐1	  as	  it	  enhanced	  collagenolysis	  by	  the	  latter.	  However,	  addition	  of	  the	  active	  Cat	  did	  not	  enhance	   the	  Hpx	   interaction	  with	   collagen,	   proving	   its	   poor	   unwinding	   ability.	  This	   agrees	   with	   the	   identification	   of	   the	   two	   modes	   of	   MMP-­‐1	   binding	   to	  collagen,	   one	   of	   which	   does	   not	   accommodate	   the	   unwound	   state	   of	   collagen.	  Chung	  et	  al	  (2004)	  shed	  some	  light	  on	  the	  structural	  aspects	  of	  MMP-­‐1	  binding	  to	  collagen	   I	   by	   demonstrating	   preferential	   interaction	   of	   the	   active	   site	   of	   the	  
Figure	   18.	   Modes	   of	   collagenase	  
binding	  to	  collagen.	  (10°C)	  Collagenase	  
binds	   to	   compactly	   folded	   collagen	  
triple	   helix	   (Scompact)	   and	   forms	   an	  
enzyme-­‐substrate	  complex	  of	  relatively	  
low	   affinity.	   The	   collagen	   does	   not	  
undergo	   unwinding	   and	   its	   cleavage	   is	  
not	   possible.	   (37°C)	   Collagenase	   binds	  
to	   loose	   collagen	   triple	   helix	   (Sloose)	  
which	   leads	   to	   formation	   of	   the	  
unwound	   collagen-­‐collagenase	   high-­‐
affinity	   complex	   (ESunwound)	   with	   the	  
α2(I)	   chain	   bound	   inside	   the	   catalytic	  
site	   cleft	   of	   the	   enzyme.	   The	   Hpx	  
domain	  may	   interact	   with	   α1(I)	   chains	  
via	   blades	   1	   and	   2.	   Next	   collagen	   is	  
degraded	   to	   ¾	   and	   ¼	   fragments	   (P¼,	  
P¾).	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enzyme	  with	  the	  α2(I)	  chain.	  This	  chain	   is	  more	  hydrophobic	  and	  contains	   less	  imino-­‐acids	   than	   the	   homologous	   α1(I)	   chains	   (Prockop	  &	  Kivirikko,	   1995).	   In	  addition,	   recent	   mutagenesis	   studies	   from	   our	   laboratory	   indicated	   that	   the	  blades	  1	  and	  2	  of	  the	  Hpx	  domain	  are	  essential	  in	  collagen	  degradation	  (R.	  Visse	  &	  H.	  Nagase,	  unpublished	  data).	  	  Based	   on	   this	   set	   of	   experimental	   observations	  we	   propose	   a	  mechanism	  illustrated	   in	   Figure	   18.	   The	   interaction	   of	   the	  Hpx	   domain	  with	   collagen	  may	  splay	  the	  α	  chains	  to	  some	  extent.	  At	  physiological	  conditions,	  when	  the	  motility	  of	   the	   triple	   helix	   is	   sufficient,	   the	   α2(I)	   chain	   can	   then	   be	   positioned	   into	   the	  active	   site	   cleft,	   since	   the	   active	   site	   region	   of	   MMP-­‐1	   was	   found	   to	   interact	  preferentially	  with	  α2(I)	  (Chung	  et	  al,	  2004).	  In	  other	  words,	  if	  the	  Hpx	  domain	  binding	  at	  the	  C-­‐terminal	  side	  of	  the	  collagenase	  cleavage	  site	  (see	  Chapter	  4)	  can	  cause	   or	   stabilise	   some	   alteration	   in	   the	   collagen	   chain	   conformation,	   this	  conformational	   change	  may	   be	   propagated	   further	   towards	   the	   N-­‐terminus.	   A	  nine	   residue	   segment	   202-­‐RWTNNFREY-­‐210	   located	   in	   a	   loop	   near	   the	   S3’	  subsite	  of	  the	  active	  site	  groove	  of	  MMP-­‐1,	  which	  was	  reported	  as	  critical	  for	  the	  expression	  of	  collagenolytic	  activity	  (Chung	  et	  al,	  2000),	  may	  be	  involved	  in	  this	  step,	   e.g.	   by	   accepting	   the	   altered	   conformation.	   Under	   artificial	   conditions,	   in	  which	   the	   collagen	   unwinding	   is	   prevented	   (e.g.	   the	   active	   site	   is	   occupied	   by	  inhibitor	  or	  the	  helix	  is	  thermostable)	  the	  α2(I)	  chain	  would	  remain	  bound	  at	  a	  lower	  affinity	  site.	   It	   is	   justified	   to	  see	   this	  mode	  of	  binding	  as	  an	   intermediate	  state	   towards	   the	   unwound	   collagen	   binding,	   with	   a	   lifetime	   which	   would	   be	  strongly	  dependent	  on	  the	  reaction	  temperature.	  Under	  physiological	  conditions,	  however,	   the	   presented	   protein-­‐protein	   interaction	   mechanism,	   although	  described	   as	   a	   sequence	   of	   events,	   should	   be	   considered	   rather	   as	   an	   almost	  simultaneous	  cooperative	  action	  of	  both	  collagenase	  domains.	  After	  cleavage	  of	  the	  α2(I)	  chain	  the	  enzyme-­‐substrate	  complex	  is	  probably	  destabilised	  allowing	  the	  enzyme	  to	  position	  the	  other	  two	  α	  chains	  in	  the	  active	  site	  and	  cleave	  them	  one	  by	  one,	   	  as	   they	  are	  now	  exposed	  and	  spatially	  close	   to	   the	  enzyme.	  When	  collagen	   upon	   interaction	   with	   MMP-­‐1(E200A)	   is	   partially	   cleaved	   by	   the	   Cat	  domain	  introduced	  externally,	  it	  is	  one	  of	  the	  α1(I)	  chains	  that	  is	  cleaved	  (Chung	  et	   al,	   2004),	  which	   seems	   to	  be	  opposite	   to	   the	  natural	   cleavage.	  This	   cleavage	  does	  not	  break	  the	  interaction	  of	  the	  α2(I)	  chain	  with	  the	  active	  site	  region	  of	  the	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4.1.	  Introduction	  	   In	   the	   previous	   chapter	   the	   cooperative	   nature	   of	   the	   interaction	   of	  collagenase	  domains	  with	  collagen	  has	  been	  shown.	  Different	  modes	  of	  collagen	  binding	  by	  collagenase,	  depending	  on	  the	  structural	  properties	  of	   the	  substrate	  at	   different	   temperatures,	   were	   indicated,	   but	   the	   structural	   basis	   of	   those	  complexes	  was	  not	  elucidated.	  	  	  This	  chapter	  presents	  a	  solid	  phase	  binding	  assay	  approach	  to	  identification	  of	   the	  sites	  on	  collagen	   that	  are	  recognised	  by	  MMP-­‐1.	  A	  series	  of	   triple-­‐helical	  peptides	   (THP	   Toolkits)	   that	   collectively	   represent	  whole	  molecules	   of	   human	  collagens	   II	   and	   III	  were	   used	   to	   characterise	   the	   nature	   of	  MMP-­‐1	   binding	   to	  collagen.	   Every	   THP	   in	   each	   Toolkit	   contains	   27	   amino	   acids	   (aa)	   of	   host	  sequence,	  with	  a	  9	  aa	  overlap	  between	  the	  neighbouring	  peptides,	   flanked	  by	  5	  GPP	  repeats	  and	  a	  GPC	  knot.	  These	  Toolkits	  were	  generated	  at	  Prof.	  R.	  Farndale's	  laboratory	  at	  the	  University	  of	  Cambridge,	  and	  were	  utilised	  to	  map	  the	  binding	  of	   a	   number	   of	   proteins	   to	   collagens	   II	   and	   III,	   including	   discoidin	   domain	  receptors,	  DDR1	  and	  DDR2	   (Konitsiosis	   et	   al,	   2008),	   bacterial	   collagen	  binding	  protein	   YadA	   (Leo	   et	   al),	   immune	   inhibitory	   receptor	   LAIR-­‐1	   (Lebbink	   et	   al,	  2009;	  Brondijk	  et	  al),	  platelet	  receptors	  (Herr	  &	  Farndale,	  2009),	  glycoprotein	  VI	  (Jarvis	  et	  al,	  2008)	  and	  von	  Willebrand	  factor	  (Farndale	  et	  al,	  2008).	  	  In	  our	  study,	   the	  sites	  of	  human	  collagenase	  1	  (MMP-­‐1)	  and	  stromelysin	  1	  (MMP-­‐3)	  binding	  in	  collagens	  II	  and	  III	  were	  investigated.	  In	  summary,	  the	  MMP-­‐1	   binding	   motif	   in	   collagens	   II	   and	   III	   has	   been	   established.	   Collagenase	  recognition	   relied	   on	   two	   hydrophobic	   clusters	   at	   P1’	   and	   P10’	   subsites	   in	  collagen,	   formed	   by	   Leu-­‐	   and/or	   Ile-­‐containing	   tripeptides	   separated	   by	   two	  other	   tripeptides,	   as	   follows	   G#(L/I)(A/L)-­‐GXY-­‐GXY-­‐GL(O/A)	   (O	   is	  hydroxyproline).	   Non-­‐collagenolytic	   MMP-­‐3	   showed	   different	   collagen	   binding	  specificity.	   A	  model	   of	   the	   collagenase-­‐collagen	   interaction	   is	   proposed,	  where	  the	  P10’	  hydrophobic	  cluster	   is	   thought	  to	  perturb	  the	  hydrophobic	   interaction	  between	   the	   two	   collagenase	   domains,	   enabling	   flexible	   alignment	   of	   the	   Cat	  domain	  to	  collagen	  around	  the	  P1’	  hydrophobic	  cluster	  next	  to	  the	  cleavage	  site	  in	   the	   collagen	   molecule.	   Such	   two-­‐site	   hydrophobic	   interaction	   is	   a	   likely	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4.2.1.	  Screening	  of	  collagen	  II	  and	  III	  THPs	  for	  the	  binding	  of	  proMMP-­‐
1(E200A),	  mature	  MMP-­‐1(E200A)	  and	  their	  Cat(E200A)	  and	  Hpx	  
domains	  
 To	  determine	  the	  sites	  in	  collagen	  II	  and	  III	  that	  are	  bound	  by	  collagenase	  1	  and	  to	  elucidate	  the	  collagen	  binding	  interface	  of	  the	  enzyme,	  we	  used	  the	  pro-­‐	  and	  the	  activated	  (full-­‐length)	  form	  of	  biotinylated	  MMP-­‐1(E200A),	  as	  well	  as	  its	  separate	   Hpx	   and	   Cat(E200A)	   domains	   to	   screen	   the	   collagen	   II	   and	   III	   THP	  Toolkits.	  	  As	  presented	  in	  Figure	  19,	  Toolkit	  II	  screening	  showed	  only	  one	  high	  affinity	  binding	   THP	   for	   MMP-­‐1(E200A).	   This	   is	   peptide	   II-­‐44,	   which	   starts	   with	   the	  collagenase	   cleavage	   site	   sequence	   G#LAGQR.	   The	   Hpx	   domain	   showed	   2-­‐fold	  lower	  binding	  to	  peptide	  II-­‐44	  compared	  to	  the	  mature	  enzyme	  and	  both	  the	  Cat	  domain	  alone	  and	  the	  pro-­‐form	  of	  the	  enzyme	  showed	  no	  significant	  binding.	  In	  addition,	  peptide	  II-­‐7	  seems	  to	  be	  weakly	  bound	  by	  MMP-­‐1(E200A)	  and	  its	  Hpx	  domain.	  Peptide	  II-­‐43,	  which	  contains	  the	  collagenase	  cleavage	  site	  region	  at	  the	  C-­‐terminal	   end,	   is	   not	   recognised	   by	   the	   enzyme.	   This	   suggests	   that	   the	  collagenase	  binding	  domain	   in	  collagen	   is	   located	  on	   the	  C-­‐terminal	   side	  of	   the	  cleavage	  site.	  	  Toolkit	  III	  screening	  revealed	  the	  highest	  binding	  affinity	  of	  MMP-­‐1(E200A)	  to	  the	  cleavage	  site	  peptide	  III-­‐44,	  and	  weaker	  binding	  to	  peptide	  III-­‐40.	  The	  Hpx	  domain	   alone	  binds	   to	  peptides	   III-­‐40	   and	   III-­‐44	  with	   similar	   affinity,	  which	   is	  about	  5	  times	  lower	  than	  the	  full-­‐length	  enzyme	  binding	  to	  III-­‐44.	  No	  binding	  of	  these	  peptides	  was	  observed	   for	   the	  Cat	  domain	  alone.	  The	  proMMP-­‐1(E200A)	  bound	   to	   peptide	   III-­‐44,	   which	   suggests	   that	   some	   region	   of	   the	   Hpx	   domain	  away	   from	   the	   cleft	   around	   the	   Cat-­‐Hpx	   interface	   has	   a	   high	   affinity	   to	   this	  peptide.	  Some	  other	  Toolkit	  III	  peptides,	  i.e.	  III-­‐7,	  III-­‐19,	  III-­‐30	  and	  III-­‐32	  showed	  weaker	  interaction	  with	  different	  MMP-­‐1(E200A)	  constructs.	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Figure	   19.	   Idenditifcation	  of	  MMP-­‐1	  binding	   sites	   in	   collagens	   II	   and	   III.	  Triple-­‐helical	   peptide	   (THP)	  
libraries	  of	  collagens	  II	  and	  III	   (Toolkit	   II	  and	  Toolkit	   III)	  were	  screened	  for	  the	  binding	  of	  pro-­‐	  and	  the	  
activated	  form	  of	  MMP-­‐1(E200A)	  and	  its	  separate	  domains	  (Cat(EA)	  and	  Hpx).	  Peptides	  II-­‐44	  and	  III-­‐44	  
exhibited	   the	   highest-­‐affinity	   binding	   to	   various	   MMP-­‐1(E200A)	   constructs,	   except	   the	   Cat	   domain	  
alone.	  These	  peptides	  contain	  the	  collagenase	  cleavage	  site	  (black	  arrow).	  MMP-­‐1(E200A)	  and	  its	  Hpx	  
domain	  alone	  also	  bound	  to	  peptide	  III-­‐40.	  Similar	  sequence	  strings	  in	  all	  high-­‐affinity	  binding	  peptides	  
are	  boxed.	  These	  sites	  contain	  tripeptides	  with	  hydrophobic	  residues	  at	  10-­‐residue	  distance	  (red).	  The	  
experiment	  was	  carried	  out	  in	  triplicate.	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From	  this	  observation	  we	  identified	  a	  common	  sequence	  pattern	  in	  all	  high-­‐affinity	   binding	  peptides	   (Figure	  19).	   Two	  GXY	   tripeptides	  with	   a	   hydrophobic	  amino	   acid,	   such	   as	   Leu	   or	   Ile	   at	   position	   X,	   are	   separated	   by	   two	   other	  tripeptides.	   We	   hypothesised	   that	   those	   ‘hydrophobic	   tripeptides’	   were	  important	   for	   interaction	   with	   the	   enzyme.	   Peptide	   III-­‐40,	   weakly	   bound	   by	  MMP-­‐1(E200A),	  has	  a	  similar	  sequence	  motif,	  except	  that	  Ala	  substitutes	  Leu/Ile	  of	   the	   first	   tripeptide.	   Ala	   side	   chains	   are	   probably	   too	   small	   to	   account	   for	  effective	   interaction	   with	   the	   full-­‐length	   enzyme.	   The	   Hpx	   binding	   was	   not	  affected	  by	  this	  alteration	  in	  sequence,	  suggesting	  that	  the	  second	  ‘hydrophobic	  tripeptide’	  of	  the	  motif	  interacts	  with	  the	  sites	  on	  the	  Hpx	  domain,	  whereas	  the	  first	  one	  may	   interact	  with	   the	  Cat	  domain,	  but	   the	  Cat	  domain	  alone	  does	  not	  bind	  to	  peptides	  II-­‐44	  or	  III-­‐44.	  It	  is	  also	  possible,	  that	  the	  separate	  Hpx	  domain	  binds	   to	   collagen	   in	   a	   different	   manner,	   as	   even	   the	   proenzyme	   showed	   high	  binding	  affinity	  to	  peptide	  III-­‐44.	  Those	  hypotheses	  were	  subsequently	  tested	  by	  mutagenesis.	  	  
4.2.2.	  Determination	  of	  the	  MMP-­‐1	  binding	  motif	  in	  collagen	  
 To	   precisely	   pinpoint	   the	   residues	   in	   fibrillar	   collagens	   that	   mediate	  interaction	  with	  collagenase,	  we	  examined	  an	  array	  of	  peptide	  II-­‐44	  mutants	  that	  are	  available	  at	  Prof.	  R.	  Farndale’s	  laboratory	  at	  the	  University	  of	  Cambridge.	  We	  varied	  the	  length	  of	  the	  peptide	  and	  employed	  a	  set	  of	  Ala	  substitutions	  to	  X	  and	  Y	  positions	  in	  the	  DB133	  peptide,	  spanning	  the	  P4-­‐P17’	  subsites	  (4	  amino	  acids	  towards	   the	  N-­‐terminus	   and	   17	   amino	   acids	   towards	   the	   C-­‐terminus	   from	   the	  collagenase	   cleavage	   site;	   nomenclature	   according	   to	   (Schechter	   &	   Berger,	  1967)).	   The	   results	   are	   presented	   in	   Figure	   20.	   Clearly,	   each	   peptide	   variant	  lacking	   the	   first	   (and	   in	   one	   case	   the	   second)	   of	   the	   two	   Leu-­‐containing	  tripeptides	  (DB108,	  DB123,	  DB124,	  DB125,	  DB126,	  NR373)	  showed	  profoundly	  reduced	  binding	  of	  MMP-­‐1(E200A)	  and	  its	  Hpx	  domain	  (Figure	  20,	  marked	  with	  asterisks).	   This	   was	   confirmed	   by	   the	   DB135	   and	   DB141BIS	   mutants,	   where	  those	   Leu	   residues	   were	   replaced	   with	   Ala	   at	   the	   P1’	   and	   P10’	   subsites,	  respectively	  (Figure	  20,	  arrows).	  The	  truncations	  that	  did	  not	  delete	  any	  of	   the	  two	   ‘hydrophobic	   tripeptides’	   resulted	   in	   relatively	  minor	   reductions	   of	  MMP-­‐
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1(E200A)	  affinity.	  Mutation	  of	  Arg	  at	   the	  P5’	  subsite,	  Gln	  at	   the	  P13’	  subsite	  or	  Glu	  at	  the	  P16’	  subsite	  to	  Ala	  (peptides	  DB138,	  DB143	  and	  DB145,	  respectively)	  caused	  markedly	  increased	  affinity	  between	  the	  THP	  and	  MMP-­‐1(E200A).	  These	  residues	  in	  the	  collagen	  II	  sequence	  therefore	  seem	  to	  have	  a	  negative	  influence	  on	   collagenase	   1	   binding.	   Arginines	   at	   position	   Y	   of	   the	   two	   C-­‐terminal	  tripeptides	   of	   DB133	   (P14’	   and	   P17’	   subsites),	   on	   the	   other	   hand,	   seem	   to	   be	  somewhat	  beneficial	  for	  the	  MMP-­‐1(E200A)	  binding,	  as	  their	  substitution	  to	  Ala	  (peptides	  DB144	  and	  DB150)	  had	  a	  slight	  negative	  effect	  on	  the	  MMP-­‐1(E200A)	  binding.	  These	  results	  confirmed	  the	  importance	  of	  the	  hydrophobic	  residues	  at	  the	  P1’	  and	  P10’	  subsites	  for	  MMP-­‐1(E200A)	  binding.	  In	  the	  triple-­‐helical	  structural	  arrangement	   these	   hydrophobic	   residues	   form	   hydrophobic	   clusters	   of	  considerable	   side	   chain	   volumes.	   They	   may	   be	   therefore	   described	   as	  ‘hydrophobic	  rings’.	  The	  first	  hydrophobic	  ring	  is	  formed	  at	  the	  P1’	  subsite	  and	  the	  second	  one	  at	  the	  P10’	  subsite	  of	  the	  cleavage	  site	  peptides	  II-­‐44	  and	  III-­‐44.	  The	   Y	   residue	   in	   the	   first	   hydrophobic	   ring	   tripeptide	   is	   Ala	   (P2’)	   and	   in	   the	  second	   one	   it	   is	   Hyp	   or	   Ala	   (P11’).	   Clearly,	   the	   presence	   of	   both	   hydrophobic	  rings	  in	  the	  specific	  P1’-­‐P10’	  distance	  is	  a	  prerequisite	  for	  collagenase	  binding.	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Figure	  20.	  Determination	  of	  the	  MMP-­‐1	  binding	  motif	  by	  mutations	  in	  peptide	  II-­‐44.	  Solid	  phase	  
binding	  analyses	  using	  the	  collagen	  II	  Toolkit	  (top)	  and	  peptide	  II-­‐44	  derivatives	  (left)	  indicated	  that	  
the	   lack	  of	  one	  of	  the	  two	  Leu-­‐containing	  tripeptides	  abolishes	  full-­‐length	  MMP-­‐1(E200A)	  binding	  
and	   diminishes	   the	   MMP-­‐1	   Hpx	   domain	   binding	   to	   THPs	   (indicated	   with	   asterisks).	   This	   was	  
confirmed	  by	  alanine	  mutations	   (DB133	  ALaScan).	   Two	   Leu	   residues	  at	  P1’	   and	  P10’	   subsites	   are	  
crucial	   for	   collagenase	   binding	   (pointed	   by	   arrows).	   The	   subsite	   nomenclature	   of	   Schechter	   and	  
Berger	  (1967)	  is	  indicated	  below	  the	  THP	  sequences.	  The	  experiments	  were	  carried	  out	  in	  triplicate	  
repeats.	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The	   DB133	   variant,	   which	   has	   an	   additional	   GPQ	   tripeptide	   on	   the	   N-­‐terminus	  and	  lacks	  3	  host	  sequence	  tripeptides	  on	  the	  C-­‐terminus	  with	  respect	  to	  peptide	   II-­‐44,	   showed	   reduced	   binding	   of	   the	   full-­‐length	   MMP-­‐1(E200A)	  compared	   to	   original	   peptide	   II-­‐44,	   and	   particularly	   poor	   binding	   of	   the	   Hpx	  domain,	  whereas	  peptide	  DB122,	  that	  differs	  from	  DB133	  only	  by	  the	  lack	  of	  the	  GPQ	   sequence	  before	   the	   cleavage	   site	  GLA	  motif	   at	   the	  N-­‐terminus,	   or	  NR393	  which	  has	  a	  triplet	  missing	  at	  each	  end	  compared	  to	  DB133,	  showed	  essemtially	  equal	   binding	   of	  MMP-­‐1(E200A)	   and	   the	  Hpx	   domain.	   It	   seems	   puzzling,	   as	   to	  what	   is	   responsible	   for	   the	   marked	   difference	   in	   the	   Hpx	   domain	   binding	  between	  these	  two	  peptides,	  especially	  as	  the	  hypothesised	  Hpx	  binding	  region	  at	   the	   P10’	   hydrophobic	   ring	   was	   intact	   in	   both	   of	   them.	   This	   can	   likely	   be	  explained	  as	   follows.	  Each	  of	   the	  hydrophobic	   ring	   tripeptides	  determining	   the	  collagenase	   binding	   site	   is	   followed	   by	   the	   identical	   GQR	   tripeptide	   in	   these	  THPs.	  It	  is	  likely,	  that	  in	  the	  absence	  of	  the	  Cat	  domain,	  the	  Hpx	  domain	  can	  bind	  to	  both	  hydrophobic	  ring	  regions,	  but	  not	  in	  the	  case	  of	  peptide	  DB133,	  where	  an	  additional	  GPQ	   tripeptide	   is	   present	   at	   the	  N-­‐terminus.	  The	  Gln	   residue	   at	   this	  site	  may	  cause	  a	  clash	  for	  the	  Hpx	  interaction	  as	  the	  residue	  preceding	  the	  P10’	  hydrophobic	  ring	   tripeptide	  (which	   likely	   interacts	  with	   the	  Hpx	  domain	   in	   the	  case	  of	  the	  full-­‐length	  enzyme	  binding)	  in	  native	  collagens	  is	  always	  hydrophobic	  (collagens	  I	  and	  II)	  or	  basic	  (collagen	  III),	  unlike	  Gln	  in	  the	  GPQ	  sequence	  (Figure	  24).	  This	  observation	  is	  supported	  by	  the	  reduced	  Hpx	  domain	  binding	  of	  NR394	  peptide	   compared	   to	   NR393	   (Figure	   20).	   The	   former	   peptide	   lacks	   the	   GQR	  tripeptide	  after	  the	  P10’	  hydrophobic	  ring	  which	  indicates,	  that	  the	  GQR	  motif	  at	  this	  location	  is	  beneficial	  for	  the	  Hpx	  domain	  binding.	  The	  significance	  of	  the	  Arg	  residue	  in	  that	  site	  (P14’)	  was	  confirmed	  by	  the	  Ala	  mutation	  (peptide	  DB144),	  which	   resulted	   in	   reduced	   MMP-­‐1(E200A)	   binding	   (Figure	   20).	   Another	   Arg	  residue	   at	   P17’	   subsite	   seems	   to	   have	   a	   positive	   influence	   on	   the	   full-­‐length	  MMP-­‐1(E200A)	  binding.	   The	   contribution	  of	   these	  Arg	   residues	  may	   also	   arise	  from	  increased	  tightness	  they	  confer	  to	  the	  triple-­‐helix	  (Yang	  et	  al,	  1997).	  After	   analysing	   all	   the	   peptides	  which	  were	   somewhat	   bound	   by	   the	  Hpx	  domain	   alone,	   a	   sequence	   motif	   probably	   recognised	   by	   the	   domain	   could	   be	  deduced	   (Table	   4),	   consistent	  with	   the	   previous	   observation	   (Figure	   20).	   This	  motif	  contains	  two	  adjacent	  tripeptides,	  where	  a	  hydrophobic	  residue	  is	  strongly	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preferred	  at	  position	  X	  and	  a	  hydroxyl	  group-­‐containing	  residue	  at	  position	  Y	  in	  the	  first	  tripeptide	  and	  a	  strongly	  basic	  residue	  (preferably	  Arg)	  at	  position	  Y	  in	  the	  second	  tripeptide.	  This	  confirms	  that	  the	  Hpx	  domain	  of	  MMP-­‐1	  may	  bind	  to	  THPs	   in	   a	   slightly	   different	   manner	   when	   alone	   and	   when	   linked	   to	   the	   Cat	  domain.	  
       
 
	  	  	  	  	  	  	  	  	  Table	  4.	  Collagen	  sequence	  motif	  preferably	  bound	  by	  the	  Hpx	  domain	  of	  MMP-­‐1	  
 
 
	  	  	  	  	  	  	  	  	  	  	  	  
4.2.3.	  Determination	  of	  a	  different	  collagen	  binding	  principle	  for	  
collagenase	  and	  stromelysin	  	  
 We	   next	   analysed	   the	   binding	   of	   Toolkit	   II	   and	   III	   THPs	   by	   different	  stromelysin	   1	   (MMP-­‐3)	   constructs.	   This	   was	   done	   to	   compare	   the	   mode	   of	  collagen	  binding	  of	  two	  structurally	  similar	  MMPs	  of	  which	  only	  one	  is	  a	  potent	  collagenolytic	   enzyme.	   MMP-­‐3(E202A)	   and	   its	   pro-­‐form	   showed	   multiple	  binding	  sites	  in	  both	  collagens	  II	  and	  III	  (Figure	  21).	  Probably	  most	  of	  these	  sites	  are	  recognised	  by	  the	  Hpx	  domain	  of	  MMP-­‐3.	  The	  separate	  Cat	  domain	  of	  MMP-­‐3	  was	  unable	  to	  bind	  any	  site	  in	  collagen	  II,	  like	  the	  Cat	  domain	  of	  MMP-­‐1(E200A),	  but	  it	  bound	  to	  two	  sites	  of	  collagen	  III,	  in	  THPs	  III-­‐7	  and	  III-­‐30.	  The	   collagen	   binding	   behaviour	   exhibited	   by	   MMP-­‐3(E200A)	   does	   not	  resemble	  that	  of	  MMP-­‐1(E200A).	  The	  common	  motif	  of	  the	  THPs	  most	  strongly	  
Analysis	  of	  a	  number	  of	  THPs	  
which	   showed	   significant	  
binding	   to	   MMP-­‐1	   Hpx	  
domain	   reveal	   a	   common	  
motif	   (boxed)	   which	   may	  
account	   for	   the	   Hpx	   domain	  
binding	  affinity.	  Hydrophobic	  
residues	   are	   grey,	   hydroxyl	  
group-­‐containing	   residues	  
are	   red,	   and	   basic	   residues	  
are	  blue.	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bound	  by	  MMP-­‐3(E200A)	   is	  a	   sequence	  string	  of	   two	  adjacent	  GXY	   tripeptides,	  where	  the	  X	  is	  preferentially	  a	  hydrophobic	  residue	  (usually	  Pro,	  Phe	  or	  Ala)	  and	  the	  Y	  is	  obligatorily	  Hyp	  or	  another	  residue	  with	  a	  hydroxyl	  group.	  As	  expected,	  the	   MMP	   cleavage	   site	   peptide	   II-­‐44	   was	   not	   bound	   by	   any	   of	   the	   MMP-­‐3	  constructs,	   but	   III-­‐44	   was	   bound	   by	   the	   full-­‐length	   MMP-­‐3(E200A).	   This	   was	  expected,	   as	   collagen	   III	   is	   the	   only	   fibrillar	   collagen	   cleaved	   by	   MMP-­‐3	  (Woessner	  &	  Nagase,	  2000).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Figure	  21.	  Idenditifcation	  of	  MMP-­‐3	  binding	  sites	  in	  collagens	  II	  and	  III.	  Triple-­‐helical	  peptide	  (THP)	  libraries	  of	  collagens	  II	  and	  III	  (Toolkit	  II	  and	  Toolkit	  III)	  were	  screened	  for	  the	  binding	  of	  pro-­‐	  and	  the	  activated	  form	  of	  MMP-­‐3(E202A)	  and	  its	  Cat	  domain.	  A	  number	  of	  peptides	  exhibited	  binding	  mostly	  
to	  the	  pro-­‐	  and	  mature	  MMP-­‐3(E202A)	  with	  various	  affinities.	  The	  separate	  Cat	  domain	  of	  MMP-­‐3	  
bound	   to	   peptides	   III-­‐7	   and	   III-­‐30	   only.	   Similar	   sequence	  motifs	   in	   several	   highest-­‐affinity	   binding	  
peptides	  are	  boxed.	  The	  more	  conserved	  sequences	  are	  shown	  in	  the	  larger	  box	  and	  the	  most	  similar	  
motifs	   were	   indicated	   in	   boldface	   and	   colours:	   grey	   for	   hydrophobic	   residues;	   red	   for	   hydroxyl	  
group-­‐containing	   residues.	   The	  MMP	   cleavage	   site	   peptide	   of	   collagen	   III	   is	   recognized	   by	  MMP-­‐
3(E202A),	  unlike	  the	  one	  of	  collagen	  II.	  The	  experiment	  was	  carried	  out	  in	  triplicate.	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4.3.	  Discussion	  	  So	   far,	  most	   thoroughly	   researched	  were	   the	   interactions	  of	   collagenolytic	  MMPs	  with	  THP	  substrates	  of	  various	  sequences	  (Lauer-­‐Fields	  et	  al,	  2001;	  Lauer-­‐Fields	   et	   al,	   2003;	   Minond	   et	   al,	   2004;	   Minond	   et	   al,	   2006;	   Lauer-­‐Fields	   et	   al,	  2009).	  Those	  studies	  provided	   insights	   into	  how	  different	  residues	  at	  several	  P	  subsites	   of	   the	   collagenase	   cleavage	   site	   influence	   collagenolysis	   by	   various	  MMPs.	   However,	   due	   to	   the	   short	   length	   of	   the	   THPs,	   their	   interaction	   with	  MMPs	   might	   have	   not	   adequately	   resembled	   the	   interaction	   with	   the	   native	  collagen.	   The	   study	   of	   Chung	   et	   al	   (2004),	   using	   native	   type	   I	   collagen,	  demonstrated	   that	   local	   unwinding	   of	   the	   collagen	   helix	   takes	   place	   at	   the	  collagenase	   cleavage	   site	   region	   upon	   collagenase	   binding.	   This	   report	  confirmed,	   contrary	   to	   the	   classical	   concept,	   that	   the	   primary	   sequence	   of	   the	  substrate	   is	   not	   the	   sole	   principle	   in	   determining	   collagenolytic	   specificity	   of	  MMPs	  (Fields,	  1991).	  Accordingly,	  the	  scissile	  bond	  segment	  (Q/L)G#(I/L)(A/L)	  (#	  indicates	  the	  cleaved	  bond)	  of	  all	  fibrillar	  collagens	  is	  located	  within	  an	  imino-­‐poor	  region	  prone	  to	  destabilisation	  (Brown	  et	  al,	  1977;	  Highberger	  et	  al,	  1979;	  Fields,	   1991;	   Fiori	   et	   al,	   2002;	   Stultz,	   2002).	   Without	   collagen	   unwinding	  collagenolysis	   by	   MMPs	   would	   not	   be	   possible,	   as	   the	   active	   site	   cleft	   of	  collagenase	   is	   only	  wide	   enough	   to	   accommodate	   a	   single	   α	   chain	   (Bode	   et	   al,	  1994;	   Borkakoti	   et	   al,	   1994;	   Chung	   et	   al,	   2004).	   So	   far,	   however,	   it	   was	   not	  known	  which	  residues	  in	  collagen	  make	  contact	  with	  the	  enzyme.	  Our	   results	   explain	   the	   principle	   that	   guides	   binding	   of	   the	   prototypic	  collagenase	   MMP-­‐1	   to	   fibrillar	   collagen.	   We	   demonstrated	   that	   hydrophobic	  residues	  at	  P1’	  and	  P10’	  subsites	  are	  crucial	  for	  this	  binding.	  In	  the	  triple-­‐helical	  structure,	   the	  hydrophobic	  side	  chains	   in	  each	  cluster	  point	  outwards	   the	  helix	  forming	  hydrophobic	  rings	  of	  relatively	   large	  volume.	  Such	  a	   two-­‐hydrophobic-­‐ring	  motif	   is	  recognised	  by	  MMP-­‐1.	  The	  THPs	  used	  as	  collagenase	  substrates	   in	  the	   previous	   studies	   (Minond	   et	   al,	   2006)	   spanned	   P4-­‐P8’	   subsites	   (4	  tripeptides).	  Hence,	   they	   did	   not	   extend	   far	   enough	   towards	   the	   C-­‐terminus	   of	  the	   native	   collagen	   sequence	   to	   appreciate	   the	   importance	   of	   the	   hydrophobic	  cluster	   at	   the	  P10’	   subsite	   (P10’	  hydrophobic	   ring).	  Based	  on	   these	   results,	  we	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propose	   a	  model	   of	   the	   collagenase-­‐collagen	   interaction	   (Figure	   22),	   using	   the	  crystal	  structure	  of	   the	  active	   form	  of	  human	  MMP-­‐1	  (Iyer	  et	  al,	  2006)	  and	   the	  THP	   structure,	   which	   contains	   the	   GIT-­‐GAR-­‐GLA-­‐GPO	   sequence	   of	   human	  collagen	  III	  (Kramer	  et	  al,	  1999),	  present	  in	  peptide	  III-­‐44.	  Docking	  of	  the	  THP	  to	  MMP-­‐1	  was	  directed	  by	  the	  hydrophobic	  patches	   	  on	  the	  surface	  of	  the	  enzyme	  (Figure	  22,	  Sites	  1	  and	  2)	  and	  regions	  285-­‐295	  and	  302-­‐316	  in	  the	  Hpx	  domain	  blade	  1	  (Figure	  22,	  Site	  3)	  determined	  by	  an	  H/DXMS	  study	  using	  a	  THP	  (Lauer-­‐Fields	   et	   al,	   2009)	   and	   our	   H/DXMS	   experiments	   using	   native	   collagen	   type	   I	  (Chapter	  5).	  The	  first	  (P1’)	  hydrophobic	  ring	  potentially	  binds	  in	  the	  cavity	  at	  the	  front	  of	  the	  Cat	  domain	  (Site	  1),	  but	  outside	  the	  active	  site	  cleft,	  and	  the	  second	  (P10’)	   hydrophobic	   ring	   at	   the	  Cat-­‐Hpx	   interface	   (Site	   2).	   This	   is	   an	   important	  assumption,	  since	  the	  Cat	  and	  the	  Hpx	  domains	  are	  potentially	  flexible	  via	  hinge-­‐bending	  motion	  of	  the	  linker.	  The	  hydrophobic	  interaction	  between	  Ile232	  in	  the	  Cat	  domain	  and	  Phe301,	  Leu314	  and	  Phe316	  in	  the	  Hpx	  domain	  at	  the	  Site	  2	  may	  hold	  the	  two	  domains	  close	  to	  each	  other	  (Figure	  22C).	  Upon	  insertion	  of	  Leu	  of	  the	   P10’	   ring	   this	   hydrophobic	   interaction	  may	   be	   perturbed,	   rearranging	   the	  Cat-­‐Hpx	   interface.	   This	  may	   in	   turn	   allow	  unconstrained	  positioning	  of	   the	  Cat	  domain	  facilitating	  enzyme-­‐substrate	  interaction	  and	  perhaps	  causing	  structural	  change	  around	  the	  P1’	  ring	  in	  collagen.	  Slightly	  altered	  reciprocal	  orientation	  of	  the	  Cat	   and	  Hpx	  domains	  was	   found	   in	   the	   crystal	   structure	   of	  mature	  MMP-­‐1	  compared	  to	  proMMP-­‐1	  (Jozic	  et	  al,	  2005;	  Iyer	  et	  al,	  2006),	  marking	  considerable	  conformational	  changes	  within	   the	  enzyme	  as	  a	   likely	  scenario	   for	  binding	   to	  a	  macromolecular	   substrate	   such	   as	   collagen.	   Extensive	   conformational	   freedom	  between	  the	  two	  domains	  of	  MMP-­‐1	  was	  confirmed	  by	  NMR	  and	  small	  angle	  X-­‐ray	  scattering	  experiments	  and	  similarly	  for	  MMP-­‐12	  (Bertini	  et	  al,	  2009).	  More	  pronounced	  intramolecular	  plasticity	  was	  seen	  for	  MMP-­‐9,	  which	  has	  the	  longest	  (52	   aa)	   linker	   within	   the	   family	   (Rosenblum	   et	   al,	   2007).	   This	   suggests	   that	  conformational	  freedom	  is	  a	  common	  property	  of	  MMPs	  (Overall	  &	  Butler,	  2007).	  Because	   collagenases	   have	   the	   shortest	   linkers	   among	   MMPs	   (16	   aa),	   it	   is	  possible	   that	   the	   disruption	   of	   the	   Cat-­‐Hpx	   interface	   upon	   collagen	   binding	  triggers	  conformational	   freedom	  between	  the	  domains,	  which	  may	  be	  a	  driving	  force	  of	  the	  triple	  helicase	  mechanism.	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  Our	   model	   also	   addresses	   other	   issues	   of	   the	   collagenase-­‐collagen	  interaction	   riddle.	   It	  has	  always	  been	  mystifying	  how	   the	  enzyme	  overcomes	  a	  barrier	   of	   ordered	   water	   networks	   surrounding	   collagen	   to	   unwind	   its	   chains	  prior	   to	   cleavage.	   The	   hypothesised	   two-­‐point	   hydrophobic	   interaction	   may	  constitute	   a	   mechanism	   for	   expelling	   this	   water	   shell,	   thereby	   locally	  destabilising	   the	  collagen	   triple	  helix.	  This	   is	  an	  energetically	  costly	  step	  which	  may	   help	   to	   separate	   the	   collagen	   backbone	   chains	   that	   are	   held	   by	   hydrogen	  bonds.	  It	  is	  therefore	  rate-­‐limiting	  and	  it	  underlies	  high	  temperature	  dependence	  of	   MMP	   collagenolytic	   activity	   (high	   activation	   energy)	   (Welgus	   et	   al,	   1981b).	  Upon	   complex	   formation,	   in	   the	   presence	   of	   thermal	   structural	   fluctuations	  around	  the	  destabilised	  cleavage	  site	  region,	  a	  single	  α	  chain	  may	  migrate	  inside	  the	   catalytic	   site	   groove	   and	   fit	   the	   P1’	   hydrophobic	   residue	   into	   the	   deep	   S1’	  hydrophobic	  pocket.	  This	  hypothesis	  is	  consistent	  with	  our	  earlier	  results,	  where	  we	  demonstrated,	  that	  the	  binding	  of	  MMP-­‐1(E200A)	  to	  collagen	  is	  temperature	  dependent	   (Chapter	   3).	   The	   complex	   of	   MMP-­‐1(E200A)	   with	   the	   locally	  unwound	   collagen	   (above	   25	   °C)	   is	   profoundly	   tighter	   than	   the	   one	   with	  compactly	   folded	   collagen	   (below	   10	   °C).	   Blocking	   the	   active	   site	   with	   small	  inhibitors	   (GM6001	   or	   Marimastat)	   reduces	   only	   the	   temperature-­‐enhanced	  collagen	  binding.	  Importantly,	  the	  Cat	  domain	  alone	  can	  bind	  to	  neither	  collagen	  nor	  gelatin,	  and	  the	  Hpx	  domain	  alone	  binds	  to	  collagen	  only	  weakly	  compared	  to	  the	  full-­‐length	  enzyme.	  The	  cooperation	  between	  the	  two	  collagenase	  domains	  is	   therefore	   required	   for	   high-­‐affinity	   interaction	   with	   collagen,	   which	   occurs	  upon	  collagen	  unwinding	  involving	  the	  catalytic	  site	  cleft	  of	  the	  enzyme.	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   The	   hypothesis	   presented	   herein	   is	   consistent	   with	   previous	   studies	  dissecting	  the	  role	  of	  different	  MMP-­‐1	  regions	  in	  the	  expression	  of	  collagenolytic	  activity	   (Table	   5).	   The	   202-­‐210	   (V-­‐B)	   loop	   in	   the	   Cat	   domain	   is	   essential	   in	  collagenolysis,	   and	   the	   Tyr210	   residue	   in	   that	   site	   was	   found	   to	   be	   critical	  (Chung	   et	   al,	   2000).	   However,	   the	   importance	   of	   Tyr210	  may	   result	   from	   the	  hydrophobic	   interaction	   with	   Leu181,	   which	   is	   potentially	   necessary	   for	  
Figure	  22.	  Potential	  mode	  of	  collagenase-­‐collagen	  interaction.	  (A)	  Hydrophobic	  patches	  (orange)	  on	  
MMP-­‐1	   (structure	  by	   Iyer	  et	  al	   (2006),	  pdb	  code:	  2CLT)	  van	  der	  Waals	  surface	  were	  determined	  by	  
highlighting	   Leu,	   Ile,	   Ala,	  Met,	   Trp,	   Val	   and	   Phe	   residues.	   Candidate	   collagen	   interaction	   sites	   are	  
labeled	  1,	  2	  and	  3.	  Site	  3	  was	  determined	  by	  H/DXMS	  ((Lauer-­‐Fields,	  2009)	  and	  chapter	  5)	  (B)	  Docking	  
of	  triple	  helical	  collagen-­‐like	  peptide	  structure	  (green)	  determined	  by	  Kramer	  et	  al	  (1999)	  (pdb	  code:	  
1BKV)	  to	  hydrophobic	  patches	  on	  MMP-­‐1	  and	  the	  Site	  3.	  Hydrophobic	  rings	  at	  P1’	  (Pro	  in	  this	  peptide)	  
and	  P10’	  (Leu)	  subsites	  are	  shown	  in	  yellow.	  (C)	  The	  Cat	  and	  the	  Hpx	  domains	  are	  potentially	  flexible	  
via	   the	  hinge-­‐bending	  connection	   (Linker).	  Hydrophobic	   interactions	  among	   Ile232,	  Phe301,	  Leu314	  
and	  Phe316	  (circled)	  may	  keep	  the	  domains	  close	  together.	  The	  insertion	  of	  P10’Leu	  may	  perturb	  the	  
hydrophobic	   interaction	   within	   the	   Cat-­‐Hpx	   interface	   (Site	   2)	   (close-­‐ups	   in	   squares)	   and	   allow	  
positioning	   of	   the	   Cat	   domain	   around	   the	   P1’	   ring.	   (D)	   After	   conformational	   adjustment,	   in	   the	  
presence	   of	   localized	   thermal	   fluctuations	   of	   the	   helix,	   a	   single	   α	   chain	  may	   be	   pulled	   inside	   the	  
hydrophobic	  (S1’)	  pocket,	  near	  the	  active	  site	  of	  the	  enzyme	  (arrow).	   Images	  were	  generated	  using	  
Pymol.	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structural	   integrity	   of	   the	   Cat	   domain.	  Moreover,	   Tyr210	   forms	   a	   collagenase-­‐characteristic	  cis	  peptide	  bond	  with	  Glu209	  in	  MMP-­‐1	  (Asn208-­‐Tyr209	  in	  MMP-­‐8,	   as	   originally	   identified	   (Brandstetter	   et	   al,	   2001))	   which	   is	   crucial	   for	  appropriate	  conformation	  of	  the	  loop.	  Analysis	  of	  THP	  processing	  by	  the	  MMP-­‐1	  Tyr210-­‐to-­‐Ala	  mutant	  indicated	  that	  this	  residue	  does	  not	  function	  in	  hydrolysis	  of	  triple	  helices	  of	  increasing	  thermal	  stabilities	  (Minond	  et	  al,	  2006).	  Tyr210	  is	  indeed	   relatively	   distant	   to	   the	   collagen	   binding	   axis	   predicted	   in	   our	   model	  (Table	   5).	   Other	   studies	   showed	   Gly233	   to	   be	   necessary	   for	   conformational	  flexibility	  of	  the	  active	  site	  (O'Farrell	  et	  al,	  2006)	  and	  suggested	  that	  Gly	  272	  in	  the	   linker	   is	   essential	   for	   its	   bending	   (Tsukada	   &	   Pourmotabbed,	   2002).	   One	  should	  also	  consider	  that	  a	  Gly	  mutation	  may	  have	  a	  profound	  effect,	  because	  Gly	  has	   a	   unique	   conformational	   freedom	   in	   the	   polypeptide	   backbone.	   Recently,	  mutagenesis	  of	  Ile290	  and	  Arg291	  from	  the	  THP-­‐binding	  285-­‐295	  region	  in	  the	  Hpx	  domain	  showed	  that	  these	  residues	  are	  critically	  important	  for	  collagen,	  but	  not	   gelatin	   hydrolysis	   (Lauer-­‐Fields	   et	   al,	   2009).	   Moreover,	   the	   287-­‐295	  sequence	   is	   highly	   conserved	   across	  MMP	   collagenases	   (Maskos,	   2005).	   These	  residues	  make	  contacts	  with	  collagen	  according	  to	  our	  model	  (Table	  5).	  Finally,	  the	  replacement	  of	  the	  MMP-­‐1	  sequence	  coded	  for	  by	  exon	  5,	  spanning	  the	  lower	  part	  of	  the	  catalytic	  domain,	  with	  the	  corresponding	  MMP-­‐3	  sequence	  (Table	  5),	  caused	  a	  drop	  of	  collagenolytic	  activity	  to	  2.2%	  of	  the	  wild-­‐type	  MMP-­‐1	  activity	  (Knäuper	  et	  al,	  2001).	  This	   is	   consistent	  with	  our	  model,	   as	   in	   the	  chimera	   the	  Ile232	   residue	   restraining	   the	   interdomain	   motility	   and	   generating	   the	  hypothesised	  hydrophobic	  collagen	  binding	  Site	  2	  (Figure	  22C)	  was	  replaced	  by	  Thr	  (Table	  5).	  Nonetheless,	  a	  number	  of	  other	  residues	  at	  the	  Cat-­‐Hpx	  interface	  were	   mutated	   in	   this	   chimera.	   Thus,	   the	   loss	   of	   function	   in	   this	   case	   cannot	  unequivocally	  be	  ascribed	  to	  the	  mutated	  residues,	  as	  it	  may	  also	  arise	  from	  the	  incorrect	   domain-­‐domain	   interaction.	   Interestingly,	   exchanging	   different	  portions	   of	   the	   upper	   part	   of	   the	   Cat	   domain	   of	   MMP-­‐1	   to	   the	   corresponding	  MMP-­‐3	  region	  enhanced	  the	  collagen	  unwinding	  activity	  compared	  to	  wild-­‐type	  MMP-­‐1	   (R.	   Visse	   &	   H.	   Nagase,	   in	   preparation).	   At	   the	   same	   time,	   these	   MMP-­‐3/MMP-­‐1	   chimeras	   (LC3,	   LC4)	   are	   relatively	   poor	   collagenases	   (Chung	   et	   al,	  2000).	   It	   has	   been	   concluded	   that	   they	   form	   non-­‐productive	   unwound	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complexes,	   suggesting	   that	   the	   active	   site	   positioning,	   probably	   governed	   by	  substrate	  specificity,	  is	  an	  important	  part	  of	  the	  collagenase	  mechanism	  of	  action.	  
	  
 
    Table	  5.	  MMP-­‐1-­‐collagen	  binding	  hypothesis	  in	  light	  of	  previous	  reports.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Research	   on	   other	   human	   collagenases	   also	   produced	   useful	   insights	   into	  the	   collagenolysis	  mechanism	  agreeing	  with	   the	  proposed	   collagenase-­‐collagen	  interaction	   model.	   Brandstetter	   et	   al	   (2001)	   revealed	   a	   possibility	   for	  rearrangement	  in	  the	  active	  site	  region	  of	  MMP-­‐8,	  using	  a	  barbiturate	  active	  site	  inhibitor	   that	   mimics	   hydroxyprolines	   (induced	   fit	   mechanism).	   They	   also	  noticed	   that	   in	   MMP-­‐3,	   competing	   stabilising	   interactions	   at	   the	   relevant	  segment	  hinder	  a	  similar	  rearrangement.	  Hirose	  et	  al	  (1993)	  pointed	  out	  that	  the	  linker	   of	   MMP-­‐8	   was	   a	   key	   element	   for	   its	   ability	   to	   hydrolyse	   triple-­‐helical	  collagen,	  by	  replacing	  its	  hinge	  sequence	  motif	  with	  the	  one	  of	  MMP-­‐3.	  This	  was	  confirmed	  by	  alanine	  scanning	  mutagenesis	  (Knäuper	  et	  al,	  1997b).	  Besides	  the	  
Mutagenesis	  and	  hydrogen/deuterium	  exchange	  mass	  spectrometry	  (H/DXMS)	  studies	  indicated	  a	  
number	  of	  sites	  in	  MMP-­‐1	  which	  are	  essential	  in	  collagenolysis.	  Mutation	  of	  the	  MMP-­‐1	  sequence	  
coded	  for	  by	  exon	  5	  (bottom)	  to	  corresponding	  sequence	  in	  MMP-­‐3	  resulted	  in	  the	  232Ile-­‐to-­‐Thr	  
mutation.	   This	   Ile	   contributes	   to	   the	   Cat-­‐Hpx	   interface	   and	   is	   particularly	   essential	   for	   collagen	  
binding	   at	   Site	   2	   according	   to	   our	   model.	   Leu181	   (indicated	   in	   orange)	   interacts	   with	   the	  
hydrophobic	  ring	  of	  Tyr210.	  Mutation	  to	  Ala	  (Chung,	  2000)	  at	  this	  site	  may	  have	  caused	  improper	  
folding	  of	  the	  enzyme	  around	  that	  region.	  Residues	  implicated	  in	  the	  MMP-­‐1-­‐collagen	  interaction	  
and	   the	   active	   site	   zinc	   are	   located	   along	   the	   hypothesized	   collagen	   binding	   axis	   (dashed	   line).	  
MMP-­‐1	  structure	  (pdb	  code:	  2CLT)	  images	  were	  generated	  using	  Pymol. 
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linker	   region,	   a	   specific	   Cat	   and	   Hpx	   domain	   combination	   is	   required	   for	   the	  expression	  of	  collagenolytic	  activity.	  A	  chimeric	  MMP	  containing	  the	  Cat	  domain	  of	  MMP-­‐1,	  connected	  to	  the	  Hpx	  domain	  of	  stromelysin	  2	  (MMP-­‐10)	  by	  the	  MMP-­‐1	  linker,	  was	  not	  collagenolytic	  (Sanchez-­‐Lopez	  et	  al,	  1993),	  which	  demonstrated	  a	   requirement	   of	   a	   specific	   Hpx	   domain	  with	   respect	   to	   triple-­‐helical	   collagen	  cleavage.	  The	  importance	  of	  the	  Hpx	  domain	  in	  this	  respect	  was	  also	  reported	  for	  MMP-­‐13	  (Knäuper	  et	  al,	  1997a).	   It	   is	  not	  possible,	  on	  the	  other	  hand,	   to	  simply	  bring	   collagenolytic	   activity	   to	   a	   non-­‐collagenolytic	   MMP	   by	   replacing	   its	   Hpx	  domain	  with	  one	  from	  a	  collagenolytic	  MMP,	  as	  shown	  by	  Murphy	  et	  al	  (1992)	  by	  engineering	   MMP-­‐3	   and	   MMP-­‐1.	   Sites	   responsible	   for	   the	   expression	   of	  collagenolytic	  activity	  are	   therefore	   located	   in	  both	  domains,	  which	  need	  to	  act	  jointly	  via	  specifically	  structured	  linker.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  23.	  Hydrophobic	  and	  
electrostatic	   surfaces	   of	  
different	   MMP	   Cat	  
domains.	   Hydrophobic	  
patches	   in	   compared	  
enzymes	   were	   determined	  
by	   highlighting	   Leu,	   Ile,	   Ala,	  
Met,	   Trp,	   Val	   and	   Phe	  
residues	   (orange).	   The	  
distribution	   of	   electrostatic	  
potentials	   computed	   using	  
Pymol	   (excluding	   inorganic	  
ions	   and	   solvent),	   are	  
indicated	   by	   colour	   scales:	  
negative	   (red),	   positive	  
(blue)	   and	   neutral	   (white).	  
All	   collagenases	   and	   MMP-­‐
12,	   but	   not	   MMP-­‐3,	   have	  
similar	   localization	   of	  
hydrophobic	   regions.	   The	  
S1’	   pocket	   of	   MMP-­‐12,	  
however,	   is	   not	  
hydrophobic.	   Electrostatic	  
potentials	   are	   similarly	  
distributed	   across	   all	  
enzymes,	   except	   MMP-­‐1,	  
which	  shows	  positive	  charge	  
in	   the	   S1’	   pocket.	   The	   type	  
of	   crystal	   (with	   or	   without	  
ligand)	   and	   PDB	   codes	   are	  
indicated.	   Images	   were	  
generated	  using	  Pymol.	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The	  collagen	  binding	  principle	  of	  MMP-­‐3	  proved	  to	  be	  different	  from	  MMP-­‐1,	   consistent	   with	   distinct	   substrate	   specificities	   of	   these	   enzymes.	   The	  identification	   of	   multiple	   stromelysin	   1	   binding	   sites	   of	   different	   affinities	  explains	  the	  previous	  finding	  of	  essentially	  unsaturable	  collagen	  binding	  of	  MMP-­‐3	  (Murphy	  et	  al,	  1992).	  The	  collagenase	  cleavage	  site	  peptide	  III-­‐44,	  but	  not	  II-­‐44,	  showed	   significant	   binding	   to	   MMP-­‐3.	   This	   was	   expected,	   as	   of	   all	   fibrillar	  collagens	   MMP-­‐3	   is	   capable	   of	   cleaving	   only	   collagen	   type	   III,	   and	   it	   shares	   a	  common	   cleavage	   site	   with	   collagenases	   (Woessner	   &	   Nagase,	   2000).	  Considering	   hydrophobic	   regions	   on	   the	   surface	   of	   the	   enzyme	   as	   critically	  important	   for	   collagen-­‐degrading	   specificity,	   we	   compared	   the	   distribution	   of	  hydrophobic	   patches	   and	   electrostatic	   potentials	   in	   the	   Cat	   domains	   of	  collagenases	   (MMP-­‐1,	   -­‐8	   and	   -­‐13)	   and	   structurally	   similar	   non-­‐collagenolytic	  MMPs	   (MMP-­‐3,	   -­‐10	   and	   -­‐12)	   (Figure	   23).	   Roughly	   estimated	   electrostatic	  potentials	   (excluding	   inorganic	   ions)	   seem	   to	   be	   similarly	   distributed	   in	   all	  compared	   enzymes,	   except	   that	   MMP-­‐1	   exhibits	   a	   positive	   charge	   in	   the	   S1’	  subsite.	   Hydrophobic	   patches,	   on	   the	   other	   hand,	   show	   more	   distinct	  distributions.	  All	  the	  Cat	  domains	  of	  collagenases	  have	  a	  similar	  overall	  layout	  of	  hydrophobic	   patches,	   which	   is	   different	   from	   that	   in	   stromelysins.	  Metalloelastase	   (MMP-­‐12)	   shows	   a	   similar	   pattern	   of	   hydrophobic	   patches	   to	  collagenases,	   except	   that	   its	   S1’	   subsite	   is	   not	   hydrophobic.	   This	   supports	   the	  notion,	   that	   the	   hydrophobic	   interactions	   are	   key	   determinants	   of	   collagen-­‐degrading	  properties.	  	  We	   also	   checked	   how	   often	   regions	   consisting	   of	   two	   hydrophobic	   rings,	  similar	   to	   the	   identified	   collagenase	   recognition	   motif	   G#(L/I)(A/L)-­‐GXY-­‐GXY-­‐GL(O/A)	   (O	   is	   hydroxyproline),	   occur	   in	   fibrillar	   collagens	   (Figure	   24).	   In	  heterotrimeric	  collagen	  I	  there	  is	  only	  one	  site	  where	  this	  motif	   is	  present.	   It	   is	  the	   collagenase	   cleavage	   site	  ¾	  away	   from	   the	  N-­‐terminus.	   In	   collagen	   II	   there	  are	   two	  more	   sites	  with	   Leu	   residues	   positioned	   as	   in	   the	   collagenase	   binding	  motif.	  They	  are	   in	  peptides	   II-­‐24	  (host	  sequence:	  GKA-­‐GEK-­‐GLO-­‐GAO-­‐GLR-­‐GLO-­‐GKD-­‐GET-­‐GAA)	   and	   II-­‐52	   (host	   sequence:	   GEA-­‐GEO-­‐GER-­‐GLK-­‐GHR-­‐GFT-­‐GLQ-­‐GLO-­‐GPO)	   (underlined	   residues),	   but	   they	   are	   not	   bound	   by	   MMP-­‐1(E200A).	  Contrary	   to	   the	   collagenase	   binding	   motif,	   peptide	   II-­‐24	   contains	   Hyp	   in	   the	  position	  Y	  by	  the	  first	  hydrophobic	  ring,	  where	  the	  Cat	  domain	  could	  be	  expected	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to	   bind.	   This	   may	   cause	   increased	   stability	   of	   the	   triple	   helix	   at	   this	   site	  compared	   to	   the	   original	   binding	   motif	   in	   peptide	   II-­‐44.	   As	   shown	   by	  temperature	  dependent	  collagen	  binding	  of	  MMP-­‐1(E200A),	  the	  tightness	  of	  the	  helix	   is	  unfavourable	   for	   collagenase	  binding.	  Peptide	   II-­‐52,	   on	   the	  other	  hand,	  contains	   Lys	   and	   Glu	   at	   the	   Y	   positions	   next	   to	   the	   Leu	   residues	   of	   the	  hydrophobic	   rings.	   Lys	   and	   Glu	   have	   large	   side	   chains	   with	   hydrophilic	   ends.	  Strongly	  basic	  Lys	  in	  the	  first	  Leu-­‐containing	  tripeptide	  probably	  prevents	  MMP-­‐1(E200A)	   binding,	   as	   in	   all	   bound	   sites	   the	   respective	   Y	   position	   in	   the	   first	  hydrophobic	   ring	   tripeptide	   is	   occupied	   by	   small	   hydrophobic	   Ala	   or	   Leu.	  Another	   feature	   common	   for	   peptides	   II-­‐24	   and	   II-­‐52	   is	   that	   the	   first	   Leu-­‐containing	  tripeptides	  are	  preceded	  by	  strongly	  basic	  Lys	  and	  Arg,	  respectively.	  In	  the	  sites	  of	  collagenase	  binding	  they	  are	  never	  preceded	  by	  positively	  charged	  residues,	  which	   suggests	   that	   a	   neutral	   or	   negatively	   charged	   residue	   at	   the	   Y	  position	  of	  the	  tripeptide	  preceding	  the	  first	  (P1’)	  hydrophobic	  ring	  may	  also	  be	  a	  characteristic	  of	  the	  collagenase	  binding	  motif.	  In	  collagen	  III	  the	  site	  contained	  in	   peptide	   III-­‐44	   is	   the	   only	   region	   of	   Ile	   and/or	   Leu	   positioned	   as	   in	   the	  collagenase	  binding	  motif.	  However,	  there	  seem	  to	  be	  more	  sites	  bound	  solely	  via	  the	  Hpx	  domain,	  than	  in	  collagen	  II.	  We	  deduced	  that	  the	  Hpx	  domain	  of	  MMP-­‐1	  may	   individually	   bind	   to	   a	   motif	   other	   than	   the	   collagenase	   recognition	  motif	  bound	  cooperatively	  by	  both	  MMP-­‐1	  domains.	  This	  motif	  contains	  two	  adjacent	  tripeptides,	  where	  a	  hydrophobic	  residue	  is	  strongly	  preferred	  at	  position	  X	  and	  a	   hydroxyl	   group-­‐containing	   residue	   at	   position	   Y	   in	   the	   first	   tripeptide	   and	   a	  strongly	   basic	   residue	   (preferably	   Arg)	   at	   position	   Y	   in	   the	   second	   tripeptide.	  Mutliple	   ‘nonspecific’	   MMP-­‐8	   binding	   sites	   were	   also	   observed	   on	   collagen	  molecules,	   but	   cleavage	   always	   took	  place	   at	   the	   unique	   site	   (Sun	   et	   al,	   2000).	  Interestingly,	   there	  are	  sites	  which	  are	  not	  bound	  by	  the	  Hpx	  domain,	  although	  they	  do	  seem	  to	  satisfy	  the	  deduced	  sequence	  requirement	  (e.g.	  GIPGAK,	  GIAGFK,	  GFOGPK,	   GIAGPK,	   etc.).	   Those	   questions	   could	   only	   be	   solved	   by	   additional	  mutagenesis	  studies.	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Figure	   24.	   Occurrence	   of	   the	  
Leu/Ile	   residues	   and	   collagenase	  
binding	  motifs	   in	   the	   triple-­‐helical	  
domains	   of	   collagens	   I-­‐III.	   Boxed	  
sequences	   indicate	   Leu	   and/or	   Ile	  
residues	   separated	   by	   8	   residues,	  
the	   arrangement	   seen	   in	  
collagenase	   binding	   site.	   Cleavage	  
site	   motifs	   are	   indicated	   with	  
arrows.	   In	   collagen	   I	   the	   cleavage	  
site	   is	   the	   only	   region	   where	   the	  
indicated	   residues	   clusterise	   in	   the	  
triple	  helix.	   In	   collagen	   II	   there	  are	  
three	   sequences	   similar	   to	  
collagenase	   recognition	   motif.	  
None	   of	   them	   is	   bound,	   probably	  
due	   to	   conformational	  
arrangement	   of	   the	   helix	   and	   the	  
influence	  of	  neighbour	   residues.	   In	  
collagen	   III	   there	   is	   no	   other	  
sequence	   region	   with	   Leu/Ile	  
arrangement	   resembling	   the	  
collagenase	  binding	  motif.	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5.1.	  Introduction	  	  In	  the	  previous	  chapter	  the	  sites	  on	  collagen	  molecules	  that	  are	  essential	  in	  the	   interaction	   with	   collagenase	   were	   established.	   Based	   on	   those	   data,	   a	  putative	  mode	  of	  MMP-­‐1	  binding	  to	  triple-­‐helical	  collagen	  has	  been	  proposed.	  In	  this	  chapter,	  the	  sites	  on	  MMP-­‐1	  which	  mediate	  the	  interaction	  with	  collagen	  are	  addressed.	  	  To	  gather	  evidence	  as	  to	  where	  those	  sites	  reside	  and	  prove	  or	  disprove	  the	  collagen	   binding	   hypothesis,	   the	   H/DXMS	  method	   was	   optimised.	   Site-­‐specific	  differences	  in	  deuterium	  (D)	  incorporation	  were	  measured	  over	  time	  across	  80%	  of	   the	  MMP-­‐1	  backbone.	   Collagen	  binding	   affected	  D	   incorporation	   to	   the	  285-­‐316	   region	   in	   blade	   1	   and	   349-­‐365	   region	   in	   blade	   2	   of	   the	   Hpx	   domain.	   The	  region	  in	  blade	  1	  corresponds	  to	  a	  THP-­‐binding	  site	  identified	  by	  Lauer-­‐Fields	  et	  al	   (2009).	   In	  addition,	   the	  N-­‐terminus	  of	  MMP-­‐1	   (100-­‐FVLTEGNPRWEQTHLTY-­‐114),	   which	   is	   anchored	   to	   the	   lower	   part	   of	   the	   Cat	   domain	   by	   the	   Phe100-­‐Asp252	   salt	   bridge,	   showed	   a	   variable	   H\D	   exchange	   pattern	   in	   the	   collagen-­‐bound	  enzyme,	  suggesting	  a	  possibility	  of	  a	  dynamic	  interaction	  of	  this	  segment	  with	  the	  bound	  collagen	  and	  a	  possible	  role	  in	  collagen	  unwinding.	  The	  regions	  in	   which	   altered	   H/D	   exchange	   in	   the	   presence	   of	   collagen	   was	   detected	   are	  predicted	   to	   interact	   with	   collagen	   in	   the	   collagen	   binding	   model	   of	   MMP-­‐1	  presented	  in	  the	  previous	  chapter.	  
5.2.	  Results	  
 
5.2.1.	  Optimisation	  of	  H/DXMS	  for	  the	  mapping	  of	  the	  sites	  of	  
interaction	  between	  MMP-­‐1(E200A)	  and	  collagen	  I	  
	  
5.2.1.1.	  Buffer	  selection	  
 Since	  H/D	  exchange	   is	  pH	  sensitive,	   the	   choice	  of	   an	  appropriate	  buffer	   is	  essential.	  Tris-­‐based	  buffer,	  TNC	  (50	  mM	  Tris-­‐HCl	  pH7.5	  (T)	  supplemented	  with	  150	  mM	  NaCl	   (N)	   and	  10	  mM	  CaCl2	   (C)),	   used	   in	  previous	   expriments	  was	  not	  suitable	   due	   to	   temperature	   dependent	   changes	   in	   pH	   and	   the	   presence	   of	  primary	   amino	   groups	   which	   could	   sequester	   D	   atoms.	   There	   was	   a	   need	   for	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alternative	  buffer,	  which	  would	  both	  be	  compatible	  with	  H/DXMS	  and	  preserve	  the	   collagenase-­‐collagen	   interactions.	   Free	   from	   primary	   amines	   and	  temperature	   stable	   buffers,	   HEPES	   and	   MOPS	   (25	   mM,	   pH7.5),	   were	  supplemented	  with	  sodium	  and	  calcium	  salts	  as	  above,	  and	  tested	  with	  respect	  to	  collagen	  binding	  and	  unwinding	  activity	  of	  MMP-­‐1(E200A).	  This	  was	  assessed	  by	  the	  SDS-­‐PAGE-­‐based	  collagen	  unwinding	  assay	  described	  in	  Chapter	  3,	  where	  3	  μM	   Cat	   domain	   of	   MMP-­‐1	   was	   used	   in	   the	   presence	   of	   1	   μM	   MMP-­‐1(E200A)	  providing	   triple	   helicase	   activity.	   Collagen	   cleavage	   in	   such	   pseudo-­‐first	   order	  conditions	  depends	  on	  the	  extent	  of	  the	  collagen	  unwinding,	  thus	  the	  unwinding	  activity	  of	  MMP-­‐1(E200A)	  can	  be	  evaluated.	  MMP-­‐1(E200A)	  exhibited	   identical	  collagen	  unwinding	   in	   both	   tested	  buffers	   compared	   to	  TNC	   (data	  not	   shown).	  From	  the	  two	  buffers	  potentially	  applicable	  in	  the	  study	  MOPS	  was	  chosen	  as	  it	  proved	  to	  be	  useful	  in	  a	  previously	  published	  H/DXMS	  project,	  involving	  MMP-­‐7	  (Garcia	  et	  al,	  2005).	  To	  aid	  desalting	   in	   the	  MS	  application	  the	  MOPS-­‐NC	  buffer	  contained	   reduced	  NaCl	   (100	  mM)	  compared	   to	  TNC,	  but	   this	  had	  no	  effect	  on	  MMP-­‐1(E200A)	  function	  (data	  not	  shown).	  Addition	  of	  formic	  acid	  to	  0.8%	  was	  required	  to	  lower	  the	  pH	  from	  7.5	  to	  2.5.	  	  	  
5.2.1.2.	  Selection	  of	  the	  protein	  fragmentation	  method	  
5.2.1.2.1.	  Solution	  digestion	  
 Porcine	  pepsin	  and	  a	  microbial	  acidic	  protease	  aspergillopepsin	  (Takahashi	  &	  Chang,	  1976)	  were	  tested	  for	  their	  effectiveness	  in	  cleaving	  MMP-­‐1(E200A)	  in	  solution	  under	  H/D	  exchange	  quenching	  conditions	  (MOPS-­‐NC	  pH2.5,	  0	  °C).	  Both	  proteases	   were	   expected	   to	   cleave	   MMP-­‐1(E200A)	   into	   many	   overlapping	  fragments.	  Time-­‐dependent	  digestion	  of	  MMP-­‐1(E200A)	  by	  the	  two	  acidic	  proteases	  is	  shown	   in	   Figure	   25.	   Aspergillopepsin	   at	   the	   concentration	   of	   100	   nM	   showed	  poor	   degradation	   of	   3	   μM	   MMP-­‐1(E200).	   Only	   one	   predominant	   cleavage	  product	   of	   approximately	   30	   kDa	   was	   observed	   after	   50	   min	   digestion.	  Increasing	   aspergillopepsin	   concentration	   to	   400	   nM	   did	   not	   significantly	  facilitate	   the	   digestion	   (data	   not	   shown),	   so	   the	   enzyme	   was	   excluded	   from	  further	  application.	  Pepsin,	  on	  the	  other	  hand,	  proved	  to	  be	  proficient	   in	  MMP-­‐
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1(E200A)	  fragmentation	  to	  small	  peptides	  (Figure	  25).	  As	  little	  as	  20	  s	  reaction	  	  of	  3	  μM	  MMP-­‐1(E200A)	  with	  100	  nM	  pepsin	  yielded	  a	  large	  number	  of	  fragments	  below	   10	   kDa.	   After	   20	   min	   under	   these	   conditions	   the	   MMP-­‐1(E200A)	  degradation	   significantly	   progressed,	   and	   after	   1h	   the	   protein	   was	   almost	  completely	   fragmented	   to	   peptides	   below	   10	   kDa	   in	   mass	   (Figure	   25,	   right	  panel).	  	  	  	  	  	  	  	  	  
	  	  
	  	  	  	  	  	  In	  the	  context	  of	  the	  H/DXMS	  experiment,	  the	  drawbacks	  are	  that	  the	  early	  time	  points	   of	   the	   digestion	   showed	   a	   large	   amount	   of	   long	   fragments	   which	   is	  disadvantageous	   for	   the	  mapping	   resolution	   of	   the	  method.	   Even	   after	   1	   hour	  digestion,	  which	  corresponds	  to	  the	  half-­‐life	  of	  the	  D	  label	  for	  an	  average	  peptide,	  there	  was	   still	   a	   detectable	   level	   of	   large	  MMP-­‐1(E200A)	   polypeptides.	   During	  this	   period,	   some	   of	   the	   peptide	   populations	   up	   to	   10	   kDa	  were	   being	   further	  digested,	  which	  may	  result	   in	  an	  underrepresentation	  of	  peptides	  derived	  from	  highly	  pepsin-­‐susceptible	  MMP-­‐1(E200A)	  regions.	  Most	  of	  the	  fragments	  over	  4	  kDa	  exceed	  the	  mass	  range	  of	  the	  MS/MS	  experiment	  and	  so	  cannot	  be	  analysed.	  Moreover,	   the	   domination	   of	   the	   long	   fragments	   has	   a	   negative	   influence	   on	  MS/MS	  analyses	  of	  fragments	  in	  the	  useful	  mass	  range,	  because	  of	  mass	  spectra	  crowding.	   Increasing	   the	   pepsin	   concentration	   to	   enhance	   the	   fragmentation	  
Figure	   25.	   Solution	   digestion	   of	   MMP-­‐1(E200A)	   with	   acidic	   proteases	   under	   H/D	  
exchange	   quenching	   conditions	   (pH2.5,	   0°C).	   Timecourse	   of	   MMP-­‐1(E200A)	  
degradation	  by	  aspergillopepsin	  (SDS-­‐Ammediol	  PAGE,	  10%	  gel)	  and	  pepsin	  (SDS-­‐Tricine	  
PAGE,	  15%	  gel).	  Proteolysis	  stopped	  by	  1:1	  addition	  of	   the	  reducing	  SDS-­‐PAGE	   loading	  
buffer	  and	  pH	  neutralisation.	  The	  gels	  were	  stained	  with	  silver.	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efficiency	  would	   compromise	   detection	   of	   the	  MMP-­‐1(E200A)	   peptic	   peptides,	  due	   to	   contamination	   by	   pepsin	   and	   its	   self-­‐digestion	   products.	   Another	  complication	  related	  to	  solution-­‐based	   fragmentation	  was	  control	  of	   the	  pepsin	  reaction	  time.	  Inhibition	  by	  pepstatin,	  a	  competitive	  inhibitor	  of	  pepsin,	  requires	  large	  excess	  of	  this	  inhibitor	  over	  the	  enzyme	  (Umezawa	  et	  al,	  1970;	  Marciniszyn	  et	   al,	   1976).	   In	   the	   nano-­‐LC-­‐MS/MS	   analyses	   of	   MMP-­‐1(E200A)	   fragments	  obtained	   by	   solution	   digestion	   of	   3	   μM	   MMP-­‐1(E200A)	   with	   100	   nM	   pepsin	  under	  H/D	  exchange	  quenching	  conditions,	  stopped	  by	  20	  μM	  pepstatin	  within	  the	  H/DXMS-­‐compatible	   time	   frame	  of	  5	  min,	   the	  peptide	   identification	  yielded	  only	  42%	  of	  the	  total	  MMP-­‐1(E200A)	  sequence	  coverage	  (data	  not	  shown).	  The	  poor	  level	  of	  identification	  coverage	  was	  likely	  due	  to	  insufficient	  fragmentation	  and	  the	  large	  quantity	  of	  pepstatin	  in	  the	  mixture,	  which	  affected	  the	  sensitivity	  of	  MMP-­‐1(E200A)	  peptides	  detection.	  	  	  In	   summary,	   pepsin-­‐dependent	   degradation	   of	  MMP-­‐1(E200A)	   in	   solution	  was	   slow,	   inefficient	  and	   the	   resultant	  peptide	  mixtures	  were	  contaminated	  by	  the	  enzyme	  and	  inhibitor.	  As	  this	  fragmentation	  method	  was	  far	  from	  ideal,	  the	  application	  of	  pepsin	  immobilised	  on	  a	  column	  was	  evaluated	  instead.	  
5.2.1.2.2.	  Solid	  phase	  pepsin	  digestion	  
 Pepsin	   columns	   (PCs)	   were	   prepared	   based	   on	   HPLC-­‐grade	   POROS	   AL20	  material	   from	  Applied	  Biosystems,	  which	   has	   been	   used	   in	   published	  H/DXMS	  applications	   (Hamuro	   et	   al,	   2002;	   Zawadzki	   et	   al,	   2003;	   Garcia	   et	   al,	   2005).	  POROS	  resins	  were	  designed	  as	  perfusion	  chromatography	  media.	  They	  produce	  low	  back-­‐pressure	  and	  can	  withstand	  high	  flow	  rates	  due	  to	  their	  porous	  nature.	  	  Apart	   from	   this,	   they	   are	   inert	   towards	   the	   D	   label.	   Alternative	   matrices	   for	  pepsin	  coupling	  have	  been	  shown	  to	  cause	  extensive	  D	  back	  exchange	  (Wu	  et	  al,	  2006).	   For	   the	   first	   column	   (PC1),	   8	   mg	   of	   pepsin	   were	   used	   in	   the	   coupling	  reaction	  per	  50	  mg	  of	  the	  POROS	  medium.	  	  Passing	   100	   μl	   of	   3	   μM	   MMP-­‐1(E200A)	   through	   the	   2.1	   mm	   internal	  diameter	  (id)	  and	  50	  mm	  long	  PC1	  with	  a	  flow	  rate	  of	  2	  ml/min	  at	  0	  °C	  produced	  exclusively	  short	  peptides	  (Figure	  26).	  This	  means	  that	  in	  about	  20	  sec	  residence	  time	   on	   the	   column	  MMP-­‐1(E200A)	  was	   completely	   fragmented	   to	   peptides	   of	  less	  than	  10	  kDa	  in	  mass.	  The	  same	  was	  true	  in	  the	  presence	  of	  4.5	  μM	  pepsin-­‐
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treated	  collagen	  I.	  	  This	  collagen	  lacks	  telopeptides.	  Thus,	  it	  was	  recovered	  from	  the	   column	   intact	   and	   it	   did	   not	   affect	   the	   fragmentation	   of	   MMP-­‐1(E200A)	  (Figure	  26).	  	  	  	  	  	  	  	  	  	  	  	  	  	  Clearly,	   this	   method	   of	   MMP-­‐1(E200A)	   fragmentation	   offered	   a	   great	  improvement	   over	   the	   digestion	   by	   pepsin	   in	   solution.	   Using	   a	   PC	   is	   fast	   and	  effective,	  highly	  reproducible,	  eliminates	  the	  presence	  of	  enzyme	  in	  the	  sample,	  and	  gives	  fine	  control	  over	  the	  extent	  of	  fragmentation.	  In	  addition,	  the	  digestion	  on	   the	   column	   can	  be	   regulated	  by	   flow	   rate,	   unless	   the	  PC	   exhibits	  maximum	  efficiency	  for	  the	  fastest	  possible	  flow	  rate.	  
 
5.2.1.3.	  Optimisation	  of	  MMP-­‐1(E200A)	  fragmentation	  and	  
identification	  of	  the	  fragments	  	  The	  quality	  of	  MMP-­‐1(E200A)	  fragmentation	  on	  the	  PC1	  was	  assessed	  by	  a	  nano-­‐LC-­‐MS/MS	   system,	  which	   automatically	   selected	   peptide	   ions	   for	  MS/MS	  analyses.	   Different	   flow	   rates	   (0.2-­‐2	  ml/min)	   through	   the	   column	  were	   tested	  (Figure	   27).	   The	   overall	   level	   of	   coverage	   was	   about	   50%	   for	   all	   tested	   PC1	  flowthroughs.	   The	   variations	   in	   coverage	   between	   the	   flowthroughs	   (43%	   –	  58%)	   were	   ascribed	   to	   the	   presence	   or	   absence	   of	   some	   single	   peptide	  identification	  hits,	   and	  were	   considered	   to	   be	   rather	   insignificant.	   Importantly,	  all	   the	  PC1	   flowthroughs	   returned	   a	   similar	   peptide	   identification	  pattern.	   The	  
Figure	  26.	  MMP-­‐1(E200A)	  fragmentation	  
by	  pepsin	  column.	  SDS-­‐Tricine	  PAGE	  (15%	  
gels)	   show	   peptic	   fragments	   of	   MMP-­‐
1(E200A)	   generated	   by	   passing	   3	   μM	  
MMP-­‐1(E200A)	   alone	   or	   in	   the	   presence	  
of	   4.5	   μM	  pepsin-­‐treated	   collagen	   I	   (col)	  
over	   the	   pepsin	   column	   (PC1)	   with	   2	  
ml/min	   flow	   rate.	   100	  μl	   of	   each	   sample	  
was	   loaded	   on	   the	   column	   and	   30	   μl	   of	  
each	   resultant	   flowthrough	   were	   loaded	  
on	   the	   gel.	   Undigested	   MMP-­‐1(E200A)	  
load	   is	   shown	   on	   the	   left	   (1	   μl	   of	   3	   μM	  
solution).	  Gels	  were	  stained	  with	  silver.	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  The	  level	  of	  MMP-­‐1(E200A)	  sequence	  coverage	  with	  fragments	  identified	  in	  the	  tested	  PC1	  flowthroughs	  was	  not	  satisfactory	  for	  the	  purpose	  of	  mapping	  MMP-­‐1(E200A)	  interactions	  with	  collagen.	  No	  data	  would	  be	  available	  from	  the	  large	  unmapped	  middle	  region	  of	  MMP-­‐1(E200A),	  which	  spans	  a	  half	  of	  the	  Cat	  domain	   most	   likely	   involved	   in	   those	   interactions.	   The	   reason	   for	   the	   lack	   of	  coverage	  in	  that	  particular	  segment	  was	  unclear.	  The	  possibilities	  were	  that	  this	  region	  was	  either	  relatively	  resistant	  or	  hyper-­‐susceptible	  to	  pepsin,	  although	  no	  sequence	   characteristics	   would	   support	   either	   possibility.	   It	   is	   highly	   unlikely	  
Figure	   27.	   Peptide	   identification	   coverage	   of	  MMP-­‐1(E200A)	   sequence	   obtained	   using	  
different	  pepsin	  column	  (PC)	  digests	  and	  the	  lack	  of	  coverage	  in	  the	  middle	  region.	  On	  
the	   right,	   schematic	   representations	   of	   the	   MMP-­‐1(E200A)	   sequence.	   Each	   black	   bar	  
stands	   for	   10	   amino	   acids	   (aa),	   except	   the	   first	   ones	   which	   stand	   for	   11	   aa.	   Regions	  
mapped	  via	  peptide	  identifications	  by	  nano-­‐LC-­‐ESI-­‐MS/MS	  performed	  on	  MMP-­‐1(E200A)	  
samples	  obtained	  after	   the	  PC	  are	   indicated	  with	  red	  bars.	  Flow	  rates	  over	  the	  PC1	  and	  
the	  mapping	   coverage	   of	   each	   run	   are	   shown.	  On	   the	   left,	   ribbon	   structure	   (smoothed	  
loops)	  of	  MMP-­‐1	  (pdb	  code:	  2CLT)	  showing	  the	  highest	  mapping	  coverage	  (58%	  obtained	  
with	  1ml/min	  flowthrough)	  in	  3D	  (red).	  The	  largest	  unmapped	  region	  including	  the	  lower	  
part	  of	  the	  Cat	  domain,	  with	  the	  active	  site	  cleft,	  and	  the	  linker	  peptide	  is	  circled.	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that	   the	   unmapped	   region	   remained	   undigested,	   since	   no	   fragment	   of	   the	  corresponding	  size	  was	  detected.	  Nonetheless,	  before	  excluding	  this	  possibility,	  extremely	  slow	  flow	  rates	  (0.02	  –	  0.1	  ml/min)	  through	  the	  PC1	  were	  examined,	  but	  no	   further	   improvement	  was	  seen.	  The	  second	  possibility	   is	   that	   the	  peptic	  fragments	  from	  that	  region	  were	  too	  small,	  or	  their	  absolute	  concentrations	  were	  diminished	   due	   to	   additional	   cleavages.	   This	   is	   highly	   probable,	   since	   pepsin	  cleavages	  are	  characterised	  by	   low	  specificity	  (Smith	  et	  al,	  1997;	  Hamuro	  et	  al,	  2008)	   and	   different	   sites	   in	   MMP-­‐1(E200A)	   could	   be	   cleaved	   with	   different	  efficiencies.	  To	   address	   the	   possibility	   of	   overdigestion	   of	   the	   unmapped	   MMP-­‐1(E200A)	  region	  on	  PC1,	   three	  weaker	  PCs	  were	  made	  (Table	  6).	  For	  PC1/100	  and	  PC1/1000,	  the	  amount	  of	  pepsin	   in	  coupling	  reaction	  was	  reduced	  by	  100-­‐	  and	   1000-­‐fold	   in	   relation	   to	   PC1,	   respectively.	   These	   columns	   had	   the	   same	  dimensions	   as	   PC1.	   The	   PC1/1000S	   was	   one	   fifth	   of	   the	   length	   of	   the	   other	  columns.	  	  
Table	  6.	  Pepsin	  columns	  	  	  	  	  	  	  	   	  	  	  MMP-­‐1(E200A)	  digested	  at	  0.2,	  2	  and	  6	  ml/min	  flow	  rates	  through	  each	  of	  four	  different	  PCs	   (12	   samples)	  were	   subjected	   to	  nano-­‐LC-­‐MS/MS	  analyses	   as	  before.	   None	   of	   the	   flowthroughs	   showed	   significantly	   improved	   coverage	   of	  MMP-­‐1(E200A)	  sequence	  with	  identified	  fragments.	  It	  became	  apparent,	  that	  the	  underrepresentation	  of	  MMP-­‐1(E200A)	  peptides	  mapping	   to	   the	  middle	   region	  of	   the	   protein	   in	   the	   MS/MS	   analyses	   may	   not	   result	   from	   uncontrolled	  proteolysis,	  but	  from	  poor	  ionisation	  of	  fragments	  from	  that	  region.	  This	  is	  likely	  in	  case	  of	  the	  peptic	  peptides,	  as	  they	  contain	  various	  N-­‐	  and	  C-­‐termini,	  and	  some	  
Pepsin	  
column	  ID	  
Amount	  of	  pepsin	  	  
per	  50	  mg	  POROS	  AL20	  resin	  
in	  the	  coupling	  reaction	  [mg]	  
Column	  dimensions	  
id	  x	  length	  [mm]	  
PC1	   8	   2.1	  x	  50	  
PC1/100	   0.08	   2.1	  x	  50	  
PC1/1000	   0.008	   2.1	  x	  50	  
PC1/1000S	   0.008	   2.1	  x	  10	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residues	   are	   more	   readily	   protonated	   than	   others.	   In	   the	   automated	   data-­‐dependent	  MS/MS	  rounds	  running	  simultaneously	  with	  the	  MS	  survey	  scan	  some	  parent	  ions	  are	  omitted	  from	  the	  MS/MS	  analyses,	  due	  to	  their	  low	  abundance.	  A	  manual	  inspection	  of	  the	  unprocessed	  MS	  spectra	  indeed	  indicated	  the	  presence	  of	   a	   vast	   number	   of	   peptide	   ions	   which	   did	   not	   trigger	   an	   MS/MS	   event	  (unassigned	   precursor	   mass	   peaks)	   of	   low	   or	   medium	   intensity.	   Since	   the	  dominating	  high-­‐intensity	  ions	  are	  picked	  by	  the	  system	  with	  higher	  preference,	  it	   was	   concluded	   that	   pre-­‐fractionation	   of	   the	   digests	   may	   help	   to	   reduce	   the	  crowding	  of	  the	  MS	  spectra	  and	  aid	  the	  identification	  of	  poorly	  ionizing	  peptide	  species.	   For	   the	   purpose	   of	   establishing	   an	   exhaustive	   fragmentation	   map	   of	  MMP-­‐1(E200A)	  such	  fractionation	  of	  the	  digest	  was	  a	  promising	  approach.	  This	  additional	   fractionation	   cannot	   be	   applied	   in	   the	   actual	   H/DXMS	   procedure,	  where	   the	  speed	  of	  analyses	   is	  essential.	  However,	  once	  a	  complete	  map	  of	   the	  MMP-­‐1(E200A)	   peptic	   digest	   is	   in	   place,	   peptide	   identification	   during	   the	  H/DXMS	   experiment	   is	   not	   necessary,	   unless	   the	   digestion	   produces	   isobaric	  peptides.	  The	  catalogue	  of	  peptide	  masses	  with	  assigned	  sequences	  can	  serve	  as	  a	   reference	   for	   all	   detected	   changes	   in	   peptide	   masses	   upon	   H/D	   exchange,	  provided	   that	   the	  MS	   spectra	   after	   the	   exchange	   are	   not	   too	   complicated.	   The	  confidence	   in	   the	   assignments	   will	   also	   depend	   on	   the	   accuracy	   of	   the	   mass	  measurement	   in	   the	   absence	   of	   MS/MS.	   Another	   advantage	   of	   the	   off-­‐line	  mapping	  is	  that	  the	  Q-­‐TOF	  instrument	  can	  record	  continuous	  MS	  spectra	  during	  the	  H/DXMS	  experiment	  and	  no	  information	  is	  lost	  by	  switching	  to	  MS/MS	  mode	  during	  the	  run.	  	   	  Further	  digests	  of	  MMP-­‐1(E200A)	  were	  generated	  using	  each	  of	  the	  four	  different	   PCs	   with	   three	   flow	   rates,	   0.2,	   2	   and	   6	   ml/min.	   In	   MMP-­‐1(E200A)	  flowthroughs	   from	   different	   PCs	   the	   abundances	   of	   different	   peptides	   were	  expected	  to	  vary,	  which	  could	  facilitate	  the	  mapping	  of	  certain	  peptides.	  The	  12	  resultant	   flowthroughs	  were	   subjected	   to	  RP-­‐HPLC	  on	   a	   2.1	  mm	   id	   and	  25	   cm	  long	   C18	   column	   with	   an	   acetonitrile	   (ACN)	   gradient	   adjusted	   for	   optimal	  peptide	  separation,	  as	  shown	  in	  Figure	  28.	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   Figure	   28.	   RP-­‐HPLC	   separations	  	  of	  MMP-­‐1(E200A)	  peptic	  peptides.	  
The	   fragmentations	   were	   carried	  
out	   by	   passing	   3	   μM	   MMP-­‐
1(E200A)	   over	   the	   four	   different	  
pepsin	   columns	   (PCs)	   using	   3	  
different	  flowrates	  on	  each	  PC.	  The	  
PC	   flowthrough	   samples	   with	  
digested	   MMP-­‐1(E200A)	   were	  
fractionated	  on	  the	  C18	  (2.1	  mm	  x	  
25	   cm;	   Vydac)	   column	   for	   off-­‐line	  
MS/MS	  peptide	   identification.	   The	  
eluate	   was	   monitored	   at	   214	   nm	  
(black	   trace)	   and	   230	   nm	   (grey	  
trace)	  wavelengths.	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The	   peptides	  were	   eluted	   from	   the	   column	   between	   12%-­‐48%	  ACN	   in	   4.5	  ml.	  Twenty	   fractions	   of	   200	   μl	   volume	   were	   collected	   from	   each	   run	   for	   peptide	  identification	   by	   nano-­‐LC-­‐MS/MS	   and	   MALDI-­‐MS/MS.	   For	   MALDI,	   each	   C18	  fraction	   was	   dried	   using	   a	   vacuum	   concentrator	   so	   the	   concentration	   of	   the	  analyte	  was	  greatly	  increased,	  compared	  to	  other	  MS	  experiments.	  The	  combined	  outcome	  of	  the	  MMP-­‐1(E200A)	  peptic	  peptide	  mapping	  is	  presented	  in	  Figure	  29	  and	  Table	  7.	  After	  the	  nano-­‐LC-­‐MS/MS	  analyses	  of	  all	  the	  fractions	  from	  each	  PC	  digest	  the	  peptide	  identification	  coverage	  of	  MMP-­‐1(E200A)	  sequence	  increased	  substantially	  compared	  to	  unfractionated	  digests,	  and	  a	  number	  of	  peptides	  from	  the	  previously	  unmapped	  middle	  region	  were	   identified.	  However,	  as	  shown	  in	  Table	   7,	   some	   peptides	   were	   only	   identified	   by	   MALDI	   experiments,	   in	   which	  peptides	   were	   manually	   selected	   for	   MS/MS.	   In	   each	   analysis	   cycle	   the	  previously	  identified	  peptides	  were	  ignored	  and	  only	  the	  unassigned	  peaks	  were	  subjected	   to	  MS/MS.	   By	   such	   iterative	   user-­‐directed	   procedure	   and	   due	   to	   the	  large	   amount	   of	  material	   used	   in	   the	  MALDI	   experiments,	   some	  most	   difficult	  peptides	  were	  identified.	  A	  total	  of	  311	  out	  of	  370	  amino	  acid	  residues	  of	  MMP-­‐1(E200A)	   sequence	   were	   covered	   by	   peptide	   identifications	   in	   the	   combined	  MALDI/ESI	  dataset.	  This	  translates	  to	  84%	  sequence	  coverage	  (Figure	  29).	  Still	  a	  fragment	   of	   27	   amino	   acid	   residues	   (A258-­‐F284)	   in	   the	   middle	   region	   (4	  residues	   of	   the	   C-­‐terminal	   region	   of	   the	   Cat	   domain,	   the	   linker	   region	   and	   7	  residues	  of	  the	  N-­‐terminal	  region	  of	  the	  Hpx	  domain)	  of	  MMP-­‐1(E200A)	  and	  a	  C-­‐terminal	   segment	   of	   25	   amino	   acids	   (Y445-­‐N469)	   remained	   unmapped.	   These	  two	   regions	   form	   a	   disulphide	   bond	   via	   Cys278	   and	   Cys466	   and	  may	   adopt	   a	  compact	   solution	   structure	   less	   accessible	   to	   pepsin.	   A	   molecular	   ion	   of	  disulphide-­‐bonded	  peptides	  cannot	  be	  identified	  by	  MS/MS,	  due	  to	  the	  mixing	  of	  product	  ions	  from	  those	  two	  peptides.	  Therefore,	  this	  piece	  of	  the	  protein	  cannot	  appear	  in	  the	  peptic	  peptide	  sequence	  map	  unless	  it	  is	  reduced.	  In	  the	  H/DXMS	  study	  of	  MMP-­‐1(E200A)	  interaction	  with	  collagen	  no	  reducing	  agent	  can	  be	  used,	  as	   it	   might	   influence	   this	   interaction.	   This	   means	   that	   the	   peptic	   peptide	  identification	  coverage	  of	  MMP-­‐1(E200A)	  reached	  its	  methodological	  limit.	  In	   this	   set	   of	   experiments	   an	   exhaustive	   map	   of	   MMP-­‐1(E200A)	   peptic	  peptide	   sequences	  was	   established.	  Due	   to	   extensive	   overlapping,	   the	  peptides	  provide	  high	  redundancy	  in	  the	  protein	  sequence	  coverage.	  This	  map	  can	  serve	  
Chapter	  5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Mapping	  of	  collagen	  binding	  sites	  in	  MMP-­‐1	  
 136	  
for	   comprehensive	   mapping	   of	   collagenase-­‐collagen	   interaction	   sites.	   Only	   a	  relatively	   small	   part	   of	   MMP-­‐1(E200A),	   inlcuding	   the	   linker	   region	   and	   a	   C-­‐terminal	   peptide	   of	   the	   Hpx	   domain,	   cannot	   be	   covered	   in	   H/D	   exchange	  analyses.	   These	   regions	   are,	   however,	   unlikely	   to	   be	   involved	   in	   the	   collagen	  binding,	  as	  they	  reside	  at	  the	  back	  of	  the	  enzyme	  (facing	  the	  side	  opposite	  to	  the	  catalytic	  cleft).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   The	   analyses	   of	   MMP-­‐1(E200A)	   digests	   by	   4	   different	   PCs	   enabled	  determination	   of	   the	   optimal	   fragmentation	   conditions	   for	   the	   H/DXMS	  experiment.	   The	   original	   PC1	   returned	   the	  most	   uniform	  peptide	   intensities	   in	  MS	   spectra	   for	   all	   tested	   flow	   rates,	  which	   is	   advantageous	   in	  monitoring	  H/D	  exchange-­‐induced	  changes	  throughout	  the	  whole	  protein	  structure.	  The	  PC1	  was	  chosen	  to	  be	  employed	  in	  the	  H/DXMS	  setup.	  
Figure	   29.	   MMP-­‐1(E200A)	   peptic	   peptide	   sequence	   map.	   Mapping	   of	   the	   MMP-­‐1(E200A)	   peptic	  
peptides	  onto	  the	  MMP-­‐1(E200A)	  sequence	  was	  obtained	  by	  nano-­‐LC-­‐Q-­‐TOF-­‐MS/MS	  and	  MALDI-­‐Q-­‐
TOF	   MS/MS.	   Only	   residues	   at	   the	   start	   of	   each	   line	   are	   numbered	   (grey).	   The	   red	   bars	   indicate	  
identified	   peptides.	   Each	   of	   them	   is	   numbered	   at	   the	   beginning	   and	   the	   peptides	   continuing	   to	  
another	  lane	  are	  indicated	  with	  arrowheads.	  The	  peptide	  IDs	  are	  listed	  in	  Table	  7	  with	  corresponding	  
numbers.	  The	  active	  site	  E	  to	  A	  mutation	  is	  boxed.	  The	  yellow	  boxes	  indicate	  sequences	  not	  covered	  
by	  peptide	  identifications.	  The	  S-­‐S	  bond	  between	  C278	  and	  C466	  is	  indicated.	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Table	  7.	  MMP-­‐1(E200A)	  peptic	  peptides	  identified	  by	  nano-­‐LC-­‐Q-­‐TOF	  or	  MALDI-­‐Q-­‐TOF	  MS/MS.	  
 









Peptide	   numbers	   (No.)	   refer	   to	   the	   scheme	   shown	   in	   Figure	   29.	   Many	   peptides	   were	   identified	   in	  
differently	  charged	  forms,	  especially	  in	  the	  case	  of	  electrospray	  ionisation	  (ESI)	  method.	  Several	  ions	  were	  
detected	  multiple	  times	  with	  various	  accuracies,	  and	  the	  ranges	  of	  their	  observed	  mass-­‐over-­‐charge	  (m/z)	  
values	  are	  shown.	  M,	  peptide	  mass;	  M	  (experimental)	  is	  calculated	  as	  follows:	  M	  =	  ((m/z)	  z)	  -­‐	  z.	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5.2.1.4.	  Construction	  and	  optimisation	  of	  the	  H/DXMS	  apparatus	  	  
 After	  the	  MMP-­‐1(E200A)	  fragmentation	  map	  was	  in	  place,	  an	  apparatus	  for	  the	   H/D	   exchange	   analyses	   was	   built.	   To	   achieve	   short	   analyses	   time,	   and	  therefore	  minimise	  the	  D/H	  back	  exchange,	  a	  two-­‐valve	  system	  was	  designed	  for	  automated	   in-­‐line	   protein	   digestion,	   peptide	   separation	   and	   peptide	   mass	  determination	  (Figure	  30).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  30.	  Schematic	   illustration	  of	  the	  H/DXMS	  setup.	  The	  quenched	  H/D	  exchanged	  samples	  are	  
injected	  into	  the	  sample	  loop	  (Sample	  loading)	  with	  the	  Injection	  Valve	  (IV)	  set	  to	  position	  0	  (Pos	  0).	  
They	  are	  next	  passed	  over	  the	  PC	  and	  the	  Trap	  column	  equilibrated	  in	  solvent	  A	  with	  the	  IV	  and	  the	  
Flow	  Direction	  Valve	  (FDV)	  set	  to	  Pos	  1.	  The	  MOPS-­‐NC	  buffer	  leaves	  the	  system	  from	  the	  FDV	  position	  
4	  and	  the	  peptides	  are	  retained	  on	  the	  Trap	  column.	  The	  valves	  are	  then	  switched	  to	  Pos	  2	  and	  the	  
gradient	  of	  buffer	  B	  is	  applied.	  The	  peptides	  are	  separated	  on	  the	  RP-­‐HPLC	  columns	  and	  sprayed	  into	  
the	  Q-­‐TOF	  spectrometer	  via	  the	  capillary	   inlet.	  The	  Q-­‐TOF	   instrument	  combines	  a	  quadrupole	  mass	  
filter	   (MS1,	  Q),	  a	  hexapole	  collision	  cell,	  and	  a	  TOF	  mass	  analyser	   (MS2).	  The	  peptide	  collision	  with	  
argon	   and	  MS/MS	   identification	   was	   not	   carried	   out	   during	   the	   H/DXMS	   run.	   Pusher,	   orthogonal	  
acceleration	   electrode;	   Detector,	   microchannel	   plate	   collector;	   Reflectron,	   a	   stack	   of	   lenses	  
generating	  electric	  field	  which	  reverses	  the	  ion	  flight	  trajectory	  (ion	  mirror).	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Also,	  to	  prevent	  the	  loss	  of	  the	  label	  the	  Ettan	  microLC	  HPLC	  instrument	  with	  all	  the	   solutions	   and	   columns	   was	   placed	   in	   the	   cooling	   cabinet,	   where	   the	  temperature	  was	  maintained	  at	  0.5-­‐1	  °C.	  Tubing	  from	  the	  last	  (C18)	  column	  was	  connected	  to	  the	  MS	  probe	  outside	  the	  cabinet.	  The	  eluant	  from	  the	  RP	  columns	  was	  sprayed	  directly	  into	  the	  Micromass	  Q-­‐TOF	  spectrometer	  via	  the	  micro-­‐LC-­‐MS	  inlet	  for	  fast	  flow	  rates	  (up	  to	  1	  ml/min).	  	  Particular	   elements	   from	   this	   setup	   were	   tested	   and	   tuned	   for	   the	   best	  performance	   (see	   below).	   The	   challenge	   was	   the	   trade-­‐off	   between	   resolution	  and	   analysis	   time.	   Thirty	   minutes	   after	   quenching	   the	   H/D	   exchange	   was	  targeted	  as	  the	  maximal	  analyses	  time.	  Within	  that	  time	  the	  protein	  needed	  to	  be	  digested	   and	   the	   resultant	   fragments	   separated	   to	   the	  highest	   possible	   degree.	  According	   to	   the	   flow	  path	  scheme	  shown	   in	  Figure	  30,	   the	  sample	  (containing	  MMP-­‐1(E200A)	   alone	   or	   complexed	  with	   collagen)	   first	   passes	   through	   the	   PC	  and	   the	   outflowing	   peptides	   are	   trapped	   on	   the	   short	   column	   with	   reversed-­‐phase	   resin	   (Trap).	   Next,	   the	   acetonitrile	   gradient	   (see	   below)	   elutes	   the	  peptides	  from	  the	  Trap	  column	  and	  separates	  them	  on	  the	  2.1	  mm	  id	  and	  50	  mm	  long	   analytical	   C18	   column	   which	   terminates	   in	   the	   ESI	   source	   of	   the	  spectrometer.	  	  The	  PC	  selected	  was	  the	  PC1,	  as	  described	  previously.	  For	  the	  Trap	  column	  two	  resins	  were	  tested,	  C18	  and	  POROS	  R1	  20.	  The	  resins	  were	  self-­‐packed	  into	  2.1	  id	  and	  20	  mm	  long	  column	  cases	  and	  each	  such	  column	  was	  attached	  in-­‐line	  with	  the	  PC1	  to	  capture	  the	  MMP-­‐1(200A)	  peptides	  generated	  on	  the	  latter.	  From	  the	  ACN	  elution	  profiles	  compared	  in	  Figure	  31A	  it	  is	  clear	  that	  R1	  is	  a	  weaker	  RP	  resin	  than	  C18,	  as	  the	  peptides	  started	  eluting	  earlier	  from	  the	  R1	  Trap.	  Despite	  a	  slightly	  poorer	  peptide	  recovery	  compared	  to	  the	  C18	  material,	  the	  R1	  material	  was	  more	  suitable,	  as	  it	  allowed	  a	  better	  peptide	  separation	  on	  the	  downstream	  analytical	  C18	  column.	  The	  ACN	  gradient	   for	   the	  R1	  Trap	  and	  the	  C18	  columns	  connected	   in	   tandem	   also	   required	   optimisation.	   In	   Figure	   31B	   the	   gradient	  profile	   for	   the	   maximal	   level	   of	   peptide	   separation	   in	   the	   H/DXMS	   system	   is	  presented.	  The	  total	  RP-­‐HPLC	  run	  time	  was	  set	  for	  less	  than	  25	  min	  with	  the	  flow	  rate	  of	  50	  μl/min.	  The	  PC1	  run	  with	  peptide	  trapping,	  together	  with	  a	  desalting	  wash	  on	  the	  Trap	  column	  was	  performed	  at	  a	   flow	  rate	  of	  200	  μl/min	  within	  4	  min.	  The	  applied	  flow	  rates	  enabled	  high	  speed	  analyses,	  so	  the	  overall	  H/DXMS	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run	  time	  was	  kept	  under	  30	  min.	  At	  the	  same	  time,	  these	  flow	  rates	  produced	  an	  optimal	  MMP-­‐1(E200A)	  digestion	  on	  the	  PC1,	  as	   tested	  before	  (Figure	  28),	  and	  sufficient	  sensitivity	  of	  the	  MS	  analyses.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5.2.2.	  Mapping	  of	  the	  interaction	  sites	  between	  MMP-­‐1(E200A)	  	  
and	  collagen	  I	  
 MMP-­‐1-­‐(E200A)	   was	   subjected	   to	   H/D	   exchange	   measurements	   in	   the	  presence	  or	  absence	  of	  collagen,	  using	  the	  optimised	  H/DXMS	  setup.	  The	  enzyme	  was	  labeled	  in	  80%	  D2O	  with	  or	  without	  collagen	  and	  the	  labeling	  was	  quenched	  at	  various	  timepoints	  (5s	  –	  5h)	  indicated	  in	  Figure	  33.	  	  In	  Figure	  32	  is	  presented	  a	  summarised	  global	  view	  on	  the	  H/D	  exchange	  in	  MMP-­‐1(E200A),	  including	  the	  changes	  caused	  by	  collagen	  binding.	  Raw	  H/DXMS	  spectra	   of	   example	   peptides	   representing	   various	   modes	   of	   H/D	   exchange	  indicated	  in	  this	  summary	  are	  shown	  in	  Figure	  33.	  	  	  	  	  
Figure	   31.	   Optimisation	   of	   RP-­‐HPLC	  
components	  of	  the	  H/DXMS	  setup.	  (A)	  
MMP-­‐1(E200A)	   peptic	   fragments	   were	  
trapped	  on	  the	  C18	  and	  the	  POROS	  R1	  
reversed-­‐phase	   Trap	   columns	   (2.1	  mm	  
x	   2	   cm)	   and	   eluted	   with	   the	   same	  
gradient	  of	  buffer	  B	   (80%	  ACN	   in	  0.1%	  
formic	   acid).	   The	   R1	   material	   shows	  
weaker	   binding	   of	   the	   peptides	  
compared	   to	   the	   C18	   resin.	   (B)	  
Analytical	   C18	   column	   of	   the	   H/DXMS	  
setup	   (2.1	   mm	   x	   5	   cm;	   Vydac)	   was	  
connected	   after	   the	   POROS	   R1	   Trap	  
column.	  The	  buffer	  B	  gradient	  returning	  
the	   highest	   degree	   of	   peptide	  
separation	   in	   this	   column	   setup	   is	  
shown.	  The	  eluates	  in	  (A)	  and	  (B)	  were	  
monitored	  at	  214	  nm	  wavelengths.	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   Figure	  32.	  Characteristics	  of	  H/D	  exchange	  in	  MMP-­‐1(E200A)	  and	  changes	  in	  H/D	  exchange	  upon	  collagen	  binding.	  Site-­‐specific	  H/D	  exchange	   in	  MMP-­‐1(E200A)	   is	   shown	  with	  different	  colours	   in	  the	   primary	   and	   3D	   structure.	   The	   analysed	  peptides	   are	   indicated	  with	   the	   relevant	   colour	   and	  
numbered	  according	  to	  Figure	  29	  and	  Table	  7.	  Regions	  covered	  and	  not	  covered	  by	  the	  analyses	  are	  
shown	   on	   the	   Van	   der	   Waals	   surface	   and	   in	   the	   ribbon	   3D	   structure	   of	   MMP-­‐1(E200A).	   The	  
magnifying	  elipse	  shows	  a	  solvent-­‐exposed	  region	  where	  the	  peptide	  amide	  H	  exchange	  to	  D	  was	  
not	  observed.	  This	  may	  be	  due	  to	  tight	  hydrogen	  bonding	  in	  this	  segment	  (dotted	  lines).	  H/DXMS	  
spectra	  of	  the	  example	  peptides	  are	  shown	  below	  (Figure	  33).	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Figure	   33.	   	   H/DXMS	   spectra	   of	   selected	   MMP-­‐1(E200A)	   peptic	   peptides.	   The	   spectra	   from	  
different	  H/D	  exchange	  timepoints	  are	  stacked	  on	  one	  another	  so	  as	  to	  compare	  the	  differences	  
in	  isotopic	  pattern	  deviations	  upon	  H/D	  exchange	  in	  the	  free	  and	  collagen-­‐bound	  MMP-­‐1(E200A)	  
(top	   and	   bottom	   stacks,	   respectively).	   The	   experiments	   were	   repeated	   3	   times	   with	   a	   similar	  
outcome.	  (A	  and	  B)	  Example	  peptides	  showing	  impaired	  D	  incorporation	  upon	  collagen	  binding.	  
The	   shift	   in	   isotopic	   distribution	   at	   20	   s	   H/D	   exchange	   is	   indicated	   by	   dashed	   and	   red	   elliptic	  
shapes	  for	  the	  MMP-­‐1(E200A)	  alone	  and	  the	  MMP-­‐1(E200A)	  bound	  to	  collagen,	  respectively.	  The	  
perpendicular	  lines	  show	  the	  respective	  deviation	  in	  the	  isotopic	  distribution	  symmetries.	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(C)	   Example	   peptide	   showing	   impaired	   D	   incorporation	   upon	   collagen	   binding	   detected	   and	  
analysed	  in	  two	  ionic	  forms,	  doubly	  charged	  (top	  stacks)	  and	  singly	  charged	  (bottom	  stacks).	  The	  
shift	  in	  isotopic	  distribution	  at	  1	  min	  H/D	  exchange	  is	  indicated	  by	  dashed	  and	  red	  elliptic	  shapes	  
for	   the	   MMP-­‐1(E200A)	   alone	   and	   the	   MMP-­‐1(E200A)	   bound	   to	   collagen,	   respectively.	   The	  
perpendicular	  lines	  show	  the	  respective	  deviation	  in	  the	  isotopic	  distribution	  symmetries.	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(D)	  Peptide	  showing	  delayed	  impairement	  of	  D	  incorporation	  upon	  collagen	  binding.	  The	  shift	   in	  
isotopic	  distribution	  at	  10	  min	  H/D	  exchange	  is	  indicated	  by	  dashed	  and	  red	  elliptic	  shapes	  for	  the	  
MMP-­‐1(E200A)	  alone	  and	  the	  MMP-­‐1(E200A)	  bound	  to	  collagen,	  respectively.	  The	  perpendicular	  
lines	  show	  the	  respective	  deviation	   in	   the	   isotopic	  distribution	  symmetries.	   (E)	  Peptide	  showing	  
enhanced	   H/D	   exchange	   upon	   collagen	   binding.	   The	   perpendicular	   red	   lines	   indicate	   the	  most	  
abundant	  mass	  peaks	  (base	  peaks)	  in	  the	  isotopic	  distributions.	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(F	  and	  G)	  Example	  peptides	  showing	  no	  change	  in	  D	  incorporation	  upon	  collagen	  binding.	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(H	  and	  I)	  Example	  peptides	  showing	  no	  detecable	  D	  incorporation	  in	  our	  experimental	  setup.	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(J)	  Peptide	  showing	  dynamic	  changes	  in	  D	  incorporation	  upon	  collagen	  binding	  detected	  and	  
analysed	  in	  two	  ionic	  forms,	  doubly	  charged	  (top	  stacks)	  and	  triply	  charged	  (bottom	  stacks).	  
The	  most	  abundant	  peaks	  in	  each	  isotopic	  distribution	  are	  boxed.	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A	   time-­‐dependent	   mass	   increment	   was	   observed	   in	   most	   of	   the	   sites	   of	  MMP-­‐1(E200A),	   but	   the	   rate	   and	   the	   extent	   of	   H/D	   exchange	   varied	   between	  them.	  The	  majority	   of	   these	   sites	   showed	   identical	  H/D	  exchange	  pattern	  with	  and	  without	  collagen,	  suggesting	  that	  they	  were	  not	  participating	  in	  the	  collagen	  binding	   (Figure	   33F	   and	   G).	   A	   marked	   reduction	   of	   D	   incorporation	   was	  observed	   in	   the	  285-­‐316	  region	  of	   the	  Hpx	  domain	  at	  early	   time	  points	  of	  H/D	  exchange	   of	   the	   collagen-­‐bound	   enzyme.	   This	  was	  most	   reliably	   confirmed	   for	  the	   302-­‐313	   site	   by	   different	   overlapping	   fragments	   (Figure	   32).	   Example	  H/DXMS	   spectra	   of	   302-­‐YMRTNPFYPEVE-­‐313	   (peptide	   39),	   302-­‐YMRTNPFYPEVELNF-­‐316	   (peptide	   41)	   and	   285-­‐DAITTIRGEVMF-­‐296	   (peptide	  33)	  fragments	  are	  shown	  in	  Figure	  33A,	  B	  and	  C.	  The	  285-­‐295	  and	  302-­‐316	  sites	  were	   reported	   to	   interact	  with	   a	  THP	   in	  H/DXMS	  experiments	   by	  Lauer-­‐Fields	  (2009),	  as	  discussed	  in	  the	  previous	  chapter.	  Here,	  the	  involvement	  of	  the	  285-­‐316	  Hpx	  domain	  segment	  in	  collagen	  binding	  was	  confirmed	  with	  native	  collagen	  I.	  A	  collagen-­‐dependent	  reduction	  in	  the	  rate	  of	  D	  incorporation	  was	  also	  seen	  in	  the	   349-­‐WAVQGQNVLHGYPKDIY-­‐365	   region	   (peptide	   51),	   but	   at	   later	   time	  points	   of	   H/D	   exchange	   (1-­‐10	  min)	   (Figure	   33D).	   This	   site	  may	   participate	   at	  some	   stage	   of	   collagenase-­‐collagen	   interaction,	   perhaps	   collagen	   unwinding,	  which	  is	  indeed	  a	  multistep	  event	  ((Chung	  et	  al,	  2004)	  and	  R.	  Visse	  &	  H.	  Nagase,	  in	  preparation).	  One	  MMP-­‐1(E200A)	  region	  represented	  by	  an	  unidentified	  2.66	  kDa	  peptide	  showed	  enhanced	  H/D	  exchange	  in	  the	  presence	  of	  collagen	  (Figure	  33E),	  which	   points	   to	   increased	   solvent	   exposure	   in	   that	   region	   upon	   collagen	  binding.	   This	   suggests	   that	   significant	   structural	   changes	   in	  MMP-­‐1	  may	   occur	  during	   the	   interaction	   with	   collagen.	   Poor	   or	   no	   H/D	   exchange	   after	   5h	  incubation	  in	  D2O	  buffer	  was	  observed	  in	  relatively	  few	  sites,	  including	  the	  213-­‐HRVAAHALGHS-­‐223	   part	   of	   the	   α-­‐helix	   at	   the	   back	   of	   the	   catalytic	   site	   cleft	  (Figure	  32).	  Example	  MS	  spectra	  of	  peptides	  mapping	  to	  two	  other	  unexchanged	  regions	   are	   shown	   in	   Figure	   33H	   and	   I.	   The	   polypeptide	   backbone	   of	   such	  regions	   is	   either	  buried	   in	   the	   core	  of	   the	  protein	  and	  poorly	  accessible	  by	   the	  solvent	   or	   rigidly	   stabilised	   by	   intra-­‐chain	   hydrogen	   bonds,	   as	   seen	   from	   the	  solvent-­‐exposed	   334-­‐FADRDEVRF-­‐342	   site	   in	   the	   Hpx	   domain	   (Figure	   32,	  magnified	   ellipse).	   Interestingly,	   the	   N-­‐terminal	   100-­‐FVLTEGNPRWEQTHLTY-­‐114	  site	  of	   the	  protein,	  which	  contributes	   to	   the	  hypothesised	  collagen-­‐binding	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cavity	   in	   the	   Cat	   domain,	   showed	   slightly	   reduced	   D	   incorporation	   for	   the	  collagen-­‐bound	   enzyme	   at	   certain	   time	   points	   of	   H/D	   exchange	   reaction,	  compared	   to	   the	   enzyme	   alone	   (Figure	   32	   and	   33J).	   This	   may	   result	   from	   a	  dynamic	  interaction	  of	  that	  region	  with	  collagen,	  which	  may	  be	  associated	  with	  collagen	  unwinding.	  	  
5.3.	  Discussion	  
 A	   considerable	   amount	   of	   effort	   was	   required	   to	   set	   up	   the	   H/DXMS	  technique	  in	  the	  laboratory	  and	  optimise	  various	  steps	  of	  its	  complex	  procedure	  for	   mapping	   the	   interaction	   sites	   between	   MMP-­‐1	   and	   collagen.	   An	   H/DXMS	  setup	  containing	  a	  pepsin	  column	  followed	  by	  an	  LC-­‐MS	  system	  was	  established,	  as	  recommended	  by	  Zhu	  et	  al	  (2004).	  A	  similar	  setup	  was	  successfully	  employed	  by	   a	   number	   of	   H/DXMS	   studies,	   including	   that	   of	   MMP-­‐7	   interactions	   with	  doxycycline	  (Garcia	  2005).	  This	   is	   the	   first	   H/DXMS	   approach	   to	   elucidation	   of	   collagenase-­‐collagen	  interaction	   sites	   using	   native	   collagen.	   The	   study	   by	   Lauer-­‐Fields	   (2009)	  employed	  H/DXMS	  to	  characterise	  the	  binding	  of	  MMP-­‐1(E200A)	  to	  a	  collagen-­‐like	  peptide.	  In	  that	  study	  no	  data	  from	  the	  lower	  half	  of	  the	  MMP-­‐1(E200A)	  Cat	  domain	   were	   available	   as	   that	   region	   remained	   unmapped.	   Here,	   the	   lack	   of	  peptide	   identification	  coverage	  of	  that	  region	  was	  tackled.	  Thorough	  HPLC	  pre-­‐fractionation	  of	  MMP-­‐1(E200A)	  peptic	  peptides	  combined	  with	  ESI-­‐MS/MS	  and	  MALDI-­‐MS/MS	  peptide	   identifications	   led	   to	   the	  determination	   of	   an	   extensive	  MMP-­‐1(E200A)	   fragmentation	   map,	   covering	   the	   whole	   Cat	   domain	   and	   the	  majority	  of	  the	  rest	  of	  the	  molecule.	  However,	  for	  several	  reasons,	  only	  a	  part	  of	  the	  peptides	   identified	  by	   this	  mapping	  strategy	  could	  be	  evaluated	   in	   the	  H/D	  exchange	  experiment.	  Firstly,	   the	  micro-­‐LC-­‐MS	  system	  used	   for	  H/DXMS	   for	   its	  robustness	   has	   a	   lower	   sensitivity	   than	   the	   nano-­‐LC-­‐MS	   used	   for	   peptide	  identification.	  Secondly,	  some	  peptides	  were	  identified	  only	  using	  MALDI,	  which	  may	  ionise	  different	  peptides	  than	  the	  ESI	  method,	  and	  the	  H/DXMS	  experiment	  was	   performed	   exclusively	   using	   the	   ESI.	   Furthermore,	   a	  manual	   inspection	   of	  the	   raw	   mass	   spectra	   is	   highly	   inefficient	   for	   this	   type	   of	   analyses	   and	   no	  H/DXMS	  data	  processing	  software	  was	  available.	  The	  spectra	  of	  H/D	  exchanged	  peptide	  mixtures	  are	  complicated,	  difficult	  to	  deconvolute	  and	  quantify.	  Isotopic	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patterns	  may	  be	  superimposed	  or	  smeared	   to	   the	  background	  by	  neighbouring	  high-­‐intensity	   peaks.	   Those	   signals	   cannot	   be	   efficiently	   separated	   unless	   the	  third	   dimension	   of	   the	   LC-­‐MS	  data,	  which	   is	   the	  HPLC	   retention	   time,	   is	   taken	  into	   account.	   Such	   multidimensional	   analysis	   combined	   with	   the	   global	  quantification	  and	  statistical	  validation	  of	  the	  H/D	  exchange	  in	  a	  protein	  can	  be	  done	  only	  using	  specific	  H/DXMS	  analysis	  software.	  Despite	   the	  difficulties,	   the	  final	   coverage	  of	  H/D	  exchange	  analyses	   in	  MMP-­‐1(E200A)	   reached	  79%	  of	   its	  sequence,	   which	   is	   only	   5	   %	   less	   than	   assumed	   from	   the	   established	   MMP-­‐1(E200A)	   fragmentation	  map.	   This	   was	   due	   to	   a	   large	   number	   of	   overlapping	  fragments	   contained	   in	   that	   map,	   which	   provided	   highly	   redundant	   MMP-­‐1(E200A)	  sequence	  coverage.	  Only	   the	   regions	   of	  MMP-­‐1(E200A)	  which	   showed	   reduced	  H/D	  exchange	  kinetics	   upon	   collagen	   binding	   are	   considered	   as	   candidates	   for	   the	   sites	   of	  collagen	  binding.	  Peptides	  mapping	  to	  the	  285-­‐316	  segment	  of	  the	  Hpx	  domain	  of	   MMP-­‐1(E200A)	   showed	   reduced	   D	   incorporation	   upon	   collagen	   binding	   at	  early	   time	   points	   of	   the	   H/D	   exchange	   reaction,	   which	   suggest	   that	   collagen	  binding	   sites	   are	   located	   in	   that	   segment,	   consistent	   with	   the	   THP-­‐MMP-­‐1	  binding	  study	  by	  Lauer-­‐Fields	  (2009).	  Nevertheless,	  the	  solvent	  protection	  time	  seem	   to	   be	   relatively	   short	   for	   the	   302-­‐YMRTNPFYPEVE-­‐316	   region	   as	   no	  difference	  in	  D	  incorporation	  to	  this	  region	  is	  seen	  after	  1	  min.	  Longer	  protection	  (up	  to	  10	  min)	  was	  observed	  for	  the	  285-­‐DAITTIRGEVMF-­‐301	  region.	  It	  may	  be	  concluded,	   that	   the	   285-­‐301	   site	   exhibits	  more	   stable	   binding	   to	   collagen	   than	  the	  302-­‐316	  site.	  The	  latter	  site	  may	  interact	  with	  collagen	  in	  a	  transient	  fashion	  during	   the	   unwinding	   of	   the	   helix.	   An	   additional	   349-­‐WAVQGQNVLHGYPKDIY-­‐365	   region	   in	   the	   Hpx	   domain	   manifested	   a	   reduced	   D	   incorporation	   in	   the	  presence	   of	   collagen,	   but	   only	   after	   10	   min	   of	   H/D	   exchange.	   This	   could	   be	  explained	  by:	  (i)	  a	  transient	   interaction	  with	  collagen,	  requiring	   longer	   labeling	  time	   for	   the	   difference	   in	   H/D	   exchange	   to	   be	   detected,	   (ii)	   relatively	   stable	  collagen	  binding	  at	  some	  relatively	  slowly	  exchanging	  site	  of	  that	  region,	  or	  (iii)	  an	   allosteric	   effect	   of	   collagen	   binding,	   causing	   stabilisation	   of	   some	   structural	  state	   ‘A’	   and	   preventing	   spontaneous	   transition	   to	   a	   state	   ‘B’,	   where	   this	   site	  becomes	  more	  solvent-­‐exposed.	  It	  is	  therefore	  possible	  that	  the	  349-­‐365	  region	  plays	  a	  role	  in	  collagen	  unwinding,	  which	  likely	  involves	  structural	  movements.	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Such	   conformational	   fluctuations	   were	   indicated	   by	   an	   unidentified	   region	  showing	   increased	   solvent	   exposure	   upon	   collagen	   binding,	   and	   the	   100-­‐FVLTEGNGNPRWEQTHLTY-­‐114	   site	   at	   the	   start	   of	   the	   Cat	   domain	   showed	  somewhat	  slower	  D	   incorporation	  upon	  collagen	  binding	  at	  certain	   time	  points	  of	  H/D	  exchange	  reaction.	  This	  region	  of	  the	  Cat	  domain	  forms	  a	  side	  of	  a	  cavity	  in	  the	  Cat	  domain,	  in	  which	  collagen	  is	  expected	  to	  bind	  according	  to	  the	  collagen	  binding	  model	  of	  MMP-­‐1	  presented	  in	  the	  previous	  chapter.	  Such	  H/D	  exchange	  behaviour	   represented	   by	   the	   100-­‐114	   region	   in	   the	   presence	   of	   collagen	  may	  suggest	  a	  dynamic	  nature	  of	  the	   interaction	  of	  this	  region	  with	  collagen.	  Such	  a	  mode	  of	  interaction	  between	  the	  Cat	  domain	  and	  collagen	  was	  concluded	  earlier	  (Chapter	  3)	  from	  the	  inability	  of	  the	  Cat	  domain	  to	  stably	  bind	  to	  collagen.	  	  	  It	   is	  worth	  reiterating	  that	  the	  N-­‐terminal	  Phe100	  forms	  a	  salt	  bridge	  with	  Asp252	  in	  fully	  activated	  MMP-­‐1.	  Any	  longer	  or	  shorter	  N-­‐terminus	  is	  unable	  to	  form	   that	   salt	   bridge	   and	   the	  N-­‐terminal	   segment	   remains	   unstructured.	   Then	  the	   collagenolytic	   activity	   of	  MMP-­‐1	   is	   reduced	  by	  80%.	  An	   analogous	   effect	   is	  seen	   in	   the	   case	   of	   MMP-­‐8.	   However,	   it	   is	   not	   necessarily	   required	   for	   the	  expression	  of	  maximal	   collagenolytic	   activity	   by	  MMP-­‐13,	   so	   the	   role	   of	   the	  N-­‐terminus	   anchoring	   by	   the	   salt	   bridge	   is	   not	   understood.	   In	   theory,	   this	  anchoring	   may	   be	   broken	   upon	   collagen	   binding	   and	   the	   N-­‐terminus	   may	  extensively	   interact	   with	   thermally	   fluctuating	   collagen	   chains,	   facilitating	   the	  unwinding	   process.	   Different	   effects	   of	   the	   presence	   or	   absence	   of	   the	   N-­‐terminus-­‐anchoring	   among	   MMP	   collagenases	   may	   be	   explained	   by	   distinct	  substrate	  specificities	  of	   these	  enzymes.	  For	  MMP-­‐1	  and	  -­‐8	   it	  may	  aid	  a	  correct	  positioning	  of	  the	  N-­‐terminus	  around	  collagen	  chains,	  whereas	  for	  MMP-­‐13	  such	  aid	  may	  not	  be	  needed.	  	  None	   of	   the	   observed	   changes	   in	   H/D	   exchange	   of	   MMP-­‐1(E200A)	  associated	  with	  the	  presence	  of	  collagen	  are	  strongly	  pronounced.	  This	  is	   likely	  due	  to	  a	  relatively	  weak	  affinity	  of	  the	  MMP-­‐1(E200A)	  interaction	  with	  collagen.	  At	  the	  applied	  collagen	  concentration	  a	  large	  portion	  of	  the	  enzyme	  is	  probably	  dissociated	   from	   the	   collagen	  during	   the	   rapid	  H/D	  exchange	   reaction.	  At	   later	  H/D	   exchange	   time	   points	   the	   changes	   of	   D	   incorporation	   to	   the	   collagen-­‐protected	   sites	   of	   MMP-­‐1(E200A)	   can	   no	   longer	   be	   resolved,	   because	   of	   the	  ongoing	   dissociation	   and	   re-­‐association	   of	   the	   MMP-­‐1(E200A)-­‐collagen	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Since	  the	  discovery	  of	  collagenase	  in	  tadpole	  tissues	  48	  years	  ago	  (Gross	  &	  Lapiere,	   1962)	   and	   the	   first	   purification	   of	   human	   collagenase	   35	   years	   ago	  (Woolley	  et	  al,	  1975)	  tremendous	  progress	  in	  the	  field	  of	  the	  metalloproteinases	  and	  collagen	  catabolism	  has	  been	  realised.	  	  Gradually,	   it	   has	   become	   apparent	   that	   collagenase	   has	   many	   relatives,	  which	   collectively	   digest	   the	   supportive	   framework	   of	   collagen	   and	   other	   ECM	  molecules.	   In	   the	   post-­‐genomic	   era	   all	   23	   members	   of	   the	   matrix	  metalloproteinase	   family	   in	   humans	   are	   known.	   Most	   of	   them	   are	   well	  characterised	   in	   terms	   of	   three-­‐dimensional	   structure,	   multistep	   activation,	  biochemical	   properties,	   regulation	   and	   localisation	   of	   expression	   in	   the	   body,	  substrate	   specificity,	   activity	   control	   by	   tissue	   and	   blood	   inhibitors,	   and	   the	  plethora	   of	   roles	   they	   play	   in	   health	   and	   disease.	   Nevertheless,	   the	   precise	  structural	   features	   by	   which	   substrate	   specificity	   is	   governed	   have	   not	   been	  elucidated	  to	  date.	  Complications	  in	  this	  area	  of	  metalloproteinase	  research	  arise	  from	   the	   frequent	   involvement	   of	   exosites	   and	   their	   crucial	   roles	   in	   substrate	  recognition	   and	   processing	   by	   MMPs.	   Moreover,	   conformational	   dynamics	   of	  metalloproteinases	   are	   considered	   key	   characteristics	   of	   their	   mechanisms	   of	  action.	   Thus,	   crystal	   structures	   cannot	   fully	   explain	   the	   structural	   cross-­‐talk	  between	  MMPs	  and	  their	  substrates.	  	  The	   aim	   of	   this	   work	   was	   to	   gain	   insight	   into	   the	   interaction	   between	  human	  collagenases	  and	  triple-­‐helical	  collagens,	  with	  emphasis	  on	  identification	  of	  the	  sites	  of	  interaction,	  and	  to	  improve	  our	  understanding	  of	  the	  mechanism	  of	  collagenolysis,	   focusing	  on	  human	  MMP-­‐1	  as	  a	  prototype.	  This	  was	  approached	  using	   two	   complementary	   approaches,	   the	   solid	   phase	   binding	   assay	   and	   the	  H/DXMS	  technique.	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6.1.	  New	  clues	  to	  human	  collagenase-­‐collagen	  interaction	  	  
and	  the	  mechanism	  of	  collagen	  processing	  	   The	   investigation	   presented	   herein	   revealed	   new	   insights	   into	   the	  mechanism	   by	   which	   collagenase	   interacts	   with	   interstitial	   fibril-­‐forming	  collagens	   to	   catalyse	   their	   hydrolysis.	   These	   results,	   future	   challenges	   and	  potential	  applications	  are	  discussed	  below.	  	  	  
6.1.1.	  Conclusions	  and	  perspectives	  from	  cooperative	  and	  heat-­‐
dependent	  collagen	  binding	  and	  unwinding	  by	  MMP-­‐1	  	   In	   Chapter	   3	   it	   has	   been	   demonstrated	   that	   the	   Cat	   and	   Hpx	   domains	   of	  MMP-­‐1	  enable	  effective	  collagen	  binding	  only	  when	  they	  are	  linked	  together	  and	  act	  jointly.	  This	  binding	  may	  lead	  to	  the	  collagenolyticaly	  relevant	  unwinding	  of	  the	   triple	   helix,	   as	   evidenced	   through	   the	   Cat-­‐stimulated	   binding	   of	   the	   full-­‐length	  MMP-­‐1(E200A),	  but	  it	  depends	  on	  the	  heat	  in	  the	  system.	  Based	  on	  these	  results	  and	  studies	  of	  unwinder	   and	  cutter	   activities	  of	   collagenase	  mutants	   (R.	  Visse	   &	   H.	   Nagase,	   unpublished	   results)	   it	   is	   postulated	   that	   the	   structural	  fluctuations	  in	  collagen	  are	  necessary	  but	  not	  sufficient	  for	  collagenolysis	  to	  take	  place,	   contrary	   to	   the	   theory	   by	   Stultz	   and	   coworkers	   (Nerenberg	   et	   al,	   2008)	  (Figure	  34B).	  The	  thermal	  energy	  contributes	  to	  the	  correct	  structural	  change	  in	  collagen	  when	   it	   is	   bound	   to	   collagenase,	   resulting	   in	   its	   cleavage,	   but	   is	   not	   a	  sole	   factor	   determining	   the	   cleavage	   site	   recognition	   and	   processing.	   The	  cooperative	  binding	  of	  the	  full-­‐length	  enzyme	  is	  needed	  to	  facilitate	  the	  specific	  collagen	  unwinding	  which	  takes	  advantage	  of	  thermal	  plasticity	  of	  the	  substrate.	  Moreover,	  using	  low	  molecular	  weight	  active	  site-­‐directed	  inhibitors,	  it	  has	  been	  shown	   that	   the	   catalytic	   site	   cleft	   of	   the	   enzyme	  does	  not	  only	  have	   a	   cleaving	  function,	  but	  also	  participates	   in	   the	  high-­‐affinity	   interaction	  with	   the	  resulting	  unwound	  collagen.	  This	  process	   requires	  extended	  strings	  of	   substrate-­‐binding	  (S)	   subsites,	   which	   are	   important	   determinants	   of	   MMP	   substrate	   specificity	  (Nagase	  &	  Fields,	  1996),	  but	  how	  the	  unwound	  α	  chain	   fits	   to	   the	  active	  site	  of	  the	   enzyme	   is	   not	   known.	   The	   collagen	   binding	   of	   MMP-­‐1,	   albeit	   weaker,	   is	  retained	  when	  the	  active	  site	  cleft	  is	  blocked,	  or	  at	  low	  temperatures,	  where	  the	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unwinding	  is	  essentially	  not	  possible.	  	  This	  mode	  of	  binding	  involves	  sites	  other	  than	  the	  active	  site	  cleft,	  and	  perhaps	  constitutes	   the	   initial	  contact	  sites	  of	   the	  enzyme	  with	  the	  substrate.	  	  Those	  initial	  contact	  sites	  could	  be	  elucidated	  by	  analysing	  MMP-­‐1(E200A)	  interactions	   with	   collagen	   at	   low	   temperature	   (10	   °C)	   using	   an	   improved	  H/DXMS	  methodology.	  Employment	  of	   the	  recombinant	  bacterial	  collagen	  (Bcl)	  instead	   of	   the	   native	   mammalian	   collagen	   could	   be	   especially	   helpful	   for	   this	  purpose.	   Identification	   and	   comparison	   of	   initial	   collagen	   binding	   sites	   with	  those	   of	   the	   transition	   complex	   of	   MMP-­‐1(E200A)	   with	   unwound	   collagen,	  strongly	  promoted	  at	  30-­‐37	  °C,	  would	  ultimately	  solve	  the	  structural	  enigma	  of	  collagen	   unwinding	   by	   collagenase.	   In	   the	   H/DXMS	   analyses	   presented	   in	  Chapter	   5,	   the	   collagenase-­‐collagen	   complex	   was	   formed	   at	   25	   °C,	   which	   also	  represents	  the	  interaction	  with	  unwound	  collagen.	  	  	  
6.1.2.	  Determination	  of	  the	  collagenase	  binding	  motif	  in	  collagen	  and	  
the	  model	  of	  collagenase-­‐collagen	  interaction	  	  	   All	   MMP	   collagenases	   cleave	   collagens	   I,	   II	   and	   III	   in	   the	  (Q/L)G#(I/L)(A/L)	  site	  (#	  indicates	  the	  scissile	  bond),	  located	  approximately	  ¾	  away	   from	   the	   N-­‐terminus	   of	   each	   α	   chain,	   but	   it	   has	   never	   been	   clear	   what	  guides	  them	  to	  this	  particular	  cleavage	  site.	  	  The	  results	  described	  in	  Chapter	  4	  explain	  the	  principle	  that	  guides	  fibrillar	  collagen	   binding	   of	   MMP-­‐1.	   The	   collagenase	   binding	   motif	   consists	   of	   two	  hydrophobic	  rings	  at	  P1’	  and	  P10’	  subsites	  in	  collagen,	  formed	  by	  Leu	  and/or	  Ile	  containing	   tripeptides	   separated	   by	   two	   other	   tripeptides,	   as	   follows	  G#(L/I)(A/L)-­‐GXY-­‐GXY-­‐GL(O/A)	   (O	   is	   hydroxyproline	   and	   underlined	   residues	  are	   considered	   key).	   Another	   requirement	   for	   efficient	   collagenase	   binding	  seems	   to	   be	   a	   local	   thermolability	   of	   the	   triple	   helix	   in	   the	   vicinity	   of	   the	  hydrophobic	  rings.	  	  Based	  on	  these	  results	  and	  the	  results	  presented	  in	  Chapter	  5,	  we	  propose	  our	  model	  of	   collagenase-­‐collagen	  binding	  which	   involves	   the	  P1’	   and	   the	  P10’	  hydrophobic	   residues,	   and	  we	   further	   consider	   that	   the	  P10’	   ring	  perturbs	   the	  hydrophobic	   interaction	   between	   the	   Cat	   and	   Hpx	   domains,	   allowing	   flexible	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alignment	   of	   the	   Cat	   domain	   to	   collagen	   at	   the	   cleavage	   site	   region.	   This	   two-­‐point	   hydrophobic	   interaction	   is	   a	   likely	   mechanism	   for	   displacing	   the	   water	  shell	   surrounding	   the	   collagen	   helix,	   which	   may	   in	   turn	   break	   the	   interchain	  hydrogen	  bonds	  and	  facilitate	  the	  unwinding	  process.	  To	   fully	   validate	   the	   postulated	   collagenase-­‐collagen	   binding	   model,	  crystallisation	   of	   MMP-­‐1(E200A)	   with	   a	   THP	   or	   the	   bacterial	   collagen	   (Bcl)	  would	  be	  ideal.	  Peptides	  II-­‐44	  and	  III-­‐44	  from	  collagen	  Toolkits	  could	  be	  sutiable	  high-­‐affinity	   binding	   candidates.	   Alternatively,	   II-­‐44	   derivative	   peptides	   that	  have	  shown	  enhanced	  affinity	  upon	  mutations	  (DB138,	  DB143	  and	  DB145)	  may	  be	   tried,	   as	   they	   are	   slightly	   shorter	   and	   possibly	   more	   prone	   to	   co-­‐crystallisation	  with	  MMP-­‐1(E200A).	  	  Another	   way	   to	   test	   the	   model	   is	   mutagenesis,	   which	   has	   already	   been	  initiated	   in	   our	   laboratory.	   By	   introducing	   point	  mutations	   to	   specific	   surface-­‐exposed	   residues	   that	   may	   provide	   collagenase-­‐collagen	   interaction	   sites	  according	  to	  the	  3D	  docking	  model	  presented	  in	  Chapter	  4,	  it	  should	  be	  possible	  to	   precisely	   pinpoint	   the	   sites	   of	   MMP-­‐1	   engaging	   in	   this	   interaction.	   In	   this	  approach	   we	   have	   selected	   residues	   which	   do	   not	   engage	   in	   intra-­‐molecular	  interactions,	  according	  to	  the	  available	  crystal	  structures	  (Li	  et	  al,	  1995;	  Iyer	  et	  al,	  2006)	  to	  avoid	  structural	  perturbation	  in	  the	  mutant	  enzymes.	  	  
6.2.	  Reappraising	  the	  molecular	  mechanism	  of	  collagenolysis:	  focus	  on	  
mammalian	  collagenases.	  
 It	  is	  easy	  to	  appreciate	  that	  large	  macromolecules	  are	  difficult	  substrates	  for	  enzymes.	  Triple-­‐helical	  collagen	  is	  one	  of	  the	  extreme	  examples	  as	  collagenolysis	  is	  one	  of	   the	  slowest	  known	  enzyme-­‐catalysed	  reactions	  (Welgus	  et	  al,	  1981b).	  Outside	   the	   vertebrates	   there	   are	   several	   proteinases	   with	   a	   collagenolytic	  activity,	  and	  bacterial	  as	  well	  as	  crab	  collagenases	  have	  been	  studied	  (Welgus	  et	  al,	  1982;	  Welgus	  &	  Grant,	  1983;	  Jung	  et	  al,	  1999;	  Matsushita,	  1999;	  Matsushita	  et	  al,	  2001;	  Matsushita	  &	  Okabe,	  2001;	  Toyoshima	  et	  al,	  2001;	  Wilson	  et	  al,	  2003).	  Only	   a	   few	  MMPs	   and	   cathepsin	   K	   effectively	   degrade	   interstitial	   collagens	   in	  mammals	  (Garnero	  et	  al,	  1998;	  Nagase	  et	  al,	  2006).	  Apart	   from	  the	  trypsin-­‐like	  
Chapter	  6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  General	  Discussion	  and	  Future	  Prospects	  
 
 158	  
crab	  collagenase,	  the	  common	  element	  of	  the	  collagenolytic	  mechanism	  of	  these	  enzymes	   is	   the	   use	   of	   multiple	   independent	   domains	   or	   multiple	   enzyme	  molecules.	   Collagenolytic	   MMPs	   use	   the	   Hpx	   domains	   and	   MT1-­‐MMP	   and	  cathepsin	   K	   use	   more	   then	   one	   enzyme	   molecule	   for	   collagenolytic	   activity.	  Apparently,	   in	   vertebrates	   no	   single-­‐domain	   enzyme	   can	   unwind	   the	   collagen	  helix	   alone,	  without	  which	   the	   scissile	   bonds	   cannot	   be	   accessed	   by	   the	   active	  site	  of	  the	  enzyme.	  	  Mammalian	   collagenases	   act	   in	   solution	   and	   do	   not	   need	   to	   cluster	   to	  effectively	   cleave	   collagen.	   As	   discussed	   in	   Chapter	   3,	   there	   is	   a	   controversy	  whether	   local	   collagen	   unwinding	   that	   results	   in	   the	   cleavage	   of	   α	   chains	   is	  promoted	   by	   enzyme	   binding	   (collagenase-­‐dependent	   collagen	   unwinding	  (Chung	  et	  al,	  2004),	  Figure	  34A)	  or	  precedes	  enzyme	  binding	  (Nerenberg	  et	  al,	  2008)(Figure	   34B).	   A	   recent	   study	   of	   Han	   et	   al	   (2010)	   supporting	   the	   first	  possibility,	   included	   a	   comparative	   analysis	   of	   collagen	   I	   homo-­‐	   ([α1(I)]3)	   and	  heterotrimer	   ([α1(I)]2,	   α2(I))	   interactions	   with	   MMP-­‐1	   and	   their	   cleavage	  kinetics	   at	   25	   °C.	   The	   homotrimer	   is	   relatively	   resistant	   to	   collagenolysis	   by	  MMPs	   (Makareeva	   et	   al,	   2010),	   but	  MMP-­‐1	   binds	   to	   homo-­‐	   and	   heterotrimers	  with	  the	  same	  affinity	  (Kd	  =	  1.3	  ±	  0.3	  μM	  and	  Km	  =	  0.9	  ±	  0.2	  μM),	  and	  it	  hydrolyses	  the	  unwound	  α1(I)	  and	  α2(I)	  chains	  with	  the	  same	  efficiency	  (Han	  et	  al,	  2010).	  The	  latter	  was	  shown	  using	  the	  MMP-­‐1Cat	  domain	  as	  a	  cutter	  proteinase	  in	  the	  presence	  of	  MMP-­‐1(E200A)	  unwinder	  enzyme,	  the	  method	  of	  Chung	  et	  al	  (2004)	  (Chapter	   3).	   A	   slower	   cleavage	   of	   homotrimers	   can	   therefore	   be	   explained	   by	  their	   resistance	   to	   local	   triple	   helix	   unwinding	   at	   the	   cleavage	   site	   and	   not	   by	  impaired	   enzyme	   binding	   or	   impaired	   cleavage	   of	   unwound	  α	   chains	   at	   25	   °C.	  This	  suggests	  that	  the	  enzyme	  may	  be	  responsible	  for	  inducing	  the	  catalytically	  relevant	  unwound	  state	  and	  not	  only	  accepting	  a	  pre-­‐existing	  unwound	  state	  of	  collagen.	   It	   does	   not	   answer,	   however,	   if	   the	   unwound	   state	   promoted	   by	   the	  enzyme	  binding	   is	   unique	   compared	   to	   the	  partially	  unwound	   states	  occurring	  naturally	   in	   higher	   temperatures.	   In	   the	   study	   of	   Han	   et	   al	   (2010),	   the	   initial	  cleavage	   rate	   (V0)	   for	   homotrimers	   was	   ~17-­‐times	   slower	   than	   that	   of	  heterotrimers	  at	  25	  °C,	  but	  at	  35	  °C	  it	  was	  only	  ~6-­‐times	  slower,	  suggesting	  that	  MMP-­‐1	   binding	   promotes	   the	   stochastic	   helix	   unwinding	   by	   destabilising	   the	  compact	   helical	   state,	   and/or	   stabilising	   the	   unwound	   state.	   In	   Chapter	   3,	   we	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showed	   that	   the	   MMP-­‐1Cat	   domain	   alone	   cleaves	   collagen	   at	   25	   °C,	   but	   very	  slowly.	  Twenty	  percent	  of	  5	  μM	  collagen	  I	  was	  cleaved	  by	  3	  μM	  MMP-­‐1Cat	  over	  30	  h.	  Dr.	  Robert	  Visse	  in	  this	  laboratory	  found	  that	  this	  activity	  is	  1/60000	  of	  that	  of	   full-­‐length	   MMP-­‐1.	   So	   the	   vulnerable	   state	   of	   collagen	   can	   be	   sampled	  spontaneously,	  but	  it	  alone	  is	  not	  sufficient	  for	  effective	  catalysis	  of	  triple-­‐helical	  collagen	   cleavage.	   More	   importantly,	   Dr.	   Visse	   has	   shown	   that	   mutants	   of	   the	  MMP-­‐1Cat	   domain	   that	   have	   relatively	   similar	   collagenolytic	   activities,	   exhibit	  marked	   variability	   in	   cutter	   activities	   upon	   addition	   of	   MMP-­‐1(E200A)	  (unpublished	  results).	  The	  collagen	  unwinding	  upon	  MMP-­‐1	  binding	  is	  therefore	  associated	  with	  distinct	  structural	  change	  within	  the	  substrate	  and	  not	  only	  the	  stabilisation	   of	   the	   naturally	   occurring	   vulnerable	   state.	   In	   other	   words,	   the	  enzyme	   must	   enhance	   collagen	   unwinding	   for	   the	   effective	   cleavage	   to	   take	  place.	  	  The	  two	  key	  attributes	  of	  MMP-­‐1	  interaction	  with	  collagen	  characterised	  in	  this	  thesis	  are:	  (1)	  temperature	  dependence	  of	  MMP-­‐1-­‐collagen	  binding;	  and	  (2)	  two-­‐point	  hydrophobic	  interactions	  as	  the	  basis	  of	  this	  binding.	  When	  combined,	  those	  insights	  indicate	  that	  the	  high-­‐affinity	  interaction	  between	  collagenase	  and	  collagen,	   which	   represents	   collagen	   unwinding,	   requires	   rearrangement	   or	  displacement	  of	  water	  molecules	  by	  the	  two-­‐point	  hydrophobic	  interaction,	  and	  is	   facilitated	   by	   heat,	   which	   confers	   inter-­‐chain	   mobility	   to	   the	   imino-­‐poor	  collagenase	  cleavage	  site.	  In	  the	  light	  of	  this	  work,	  supported	  by	  other	  available	  data	  mentioned	   above,	   the	   stepwise	  molecular	  mechanism	   of	   collagenolysis	   in	  mammals	   can	  be	   reinterpreted,	   as	   shown	   in	   Figure	  34C.	  This	   schematic	  model	  combines	   the	   previous	   hypotheses	   (Figure	   34A	   and	   B)	   and	   the	   currently	  advanced	   knowledge,	   resolving	   the	   controversy	   between	   different	   models	   of	  collagenase	  action.	  	  	  





 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  34.	  Schematic	  models	  of	  collagen	  cleavage	  by	  MMP	  collagenase.	   (A)	  A	  collagenase-­‐induced	  
collagen	  unwinding	  and	  subsequent	  cleavage	  of	  the	  unwound	  collagen	  chains	  (Chung	  et	  al,	  2004)	  (B)	  
The	   passive	   recognition	   of	   the	   spontaneously	   occurring	   collagenase-­‐susceptible	   unwound	   state	   of	  
collagen	  by	  collagenase	  (model	  by	  Stultz	  and	  coworkers).	  (C)	  The	  model	  proposed	  in	  this	  thesis,	  which	  
combines	   elements	   of	   the	   previous	  models.	   The	   steps	   involved	   in	   this	   model	   are:	   (1)	   collagenase	  
initial	  binding	  to	  collagen,	  where	  the	  loose	  conformation	  of	  the	  substrate	  is	  preferentially	  recognised	  
by	  the	  enzyme;	  (2)	  positioning	  of	  the	  strand	  to	  be	  cleaved	  in	  the	  active	  site	  cleft	  of	  the	  enzyme;	  (3)	  
sequential	  cleavage	  in	  all	  individual	  strands.	  All	  the	  models	  assume	  high	  temperature	  dependence	  of	  
collagenase	  action.	  E,	  enzyme	  (MMP	  collagenase);	  S,	   substrate	   (triple-­‐helical	  collagen);	  ES,	  enzyme-­‐
substrate	   complex;	   P,	   collagenase	   cleavage	   product;	   T,	   temperature.	   The	   square	   brackets	   indicate	  
molar	  concentration.	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One	   important	   aspect	   of	   the	   collagenolysis	   mechanism	   that	   awaits	  investigation	  is	  the	  thermodynamics	  of	  the	  collagenase-­‐collagen	  interaction.	  This	  will	   be	   a	   task	   for	  biophysical	  methods	   such	  as	   isothermal	   titration	   calorimetry	  (ITC).	  If	  collagen	  unwinding	  is	  contributed	  by	  destabilisation	  of	  hydrogen	  bonds	  in	  the	  triple	  helix	  due	  to	  enzyme-­‐substrate	  hydrophobic	  interactions,	  it	  should	  be	  observable	  by	  a	  change	  in	  entropy.	  It	   also	   remains	   unclear	   how	   collagen	   assembled	   in	   fibrils	   is	   processed	   by	  MMP	   collagenases.	   This	   thesis	   work	   was	   focused	   on	   the	   cleavage	   of	   soluble	  collagen	  molecules.	  Enzyme	  functions	  such	  as	  nonspecific	  binding	  and	  migration	  along	   the	   collagen	   fibril	   (Saffarian	   et	   al,	   2004)	   has	   not	   been	   investigated	   here.	  What	  degree	  of	  backbone	  motility	  does	  a	  collagen	  molecule	  have	  within	  a	  native	  fibril?	  How	  does	  the	  enzyme	  penetrate	  into	  the	  native	  fibril,	  in	  which	  collagenase	  cleavage	  sites	  are	  thought	  to	  be	  concealed	  (Perumal	  et	  al,	  2008).	  Are	  the	  fibrils	  in	  the	   body	   normally	   resistant	   to	   proteolysis	   and	   cleaved	   only	   at	   the	   sites	   of	  damage	   or	   injury?	  Are	   additional	   enzymes	  with	   telopeptidase	   activities	   crucial	  for	  collagen	  fibril	  degradation?	  These	  important	  aspects	  of	  collagenolysis	  in	  vivo	  still	  await	  investigation.	  	  	   	  
6.3.	  Prospective	  outcomes	  of	  continued	  collagenase-­‐collagen	  
interaction	  studies	  	   Many	   researchers	   have	   been	   stimulated	   to	   advance	   the	   understanding	   of	  mechanisms	   of	   collagenolysis	   to	   develop	   effective	   treatments	   for	   arthritis,	  atherosclerosis	  or	  cancer.	  In	  disease	  states	  unwanted	  collagenolysis	  results	  from	  a	   MMP	   and	   TIMP	   imbalance	   (Murphy	   &	   Nagase,	   2008a;	   Murphy	   &	   Nagase,	  2008b).	  The	  design	  of	   selective	  MMP	   inhibitors	   for	   therapeutic	  application	   is	   a	  challenge	  due	  to	  the	  similarities	  in	  MMP	  active	  site	  architecture.	  Besides	  MMPs,	  other	   metzincins	   such	   as	   ADAMs	   (a	   disintegrin	   and	   metalloproteinase)	   and	  ADAMTSs	   (a	   disintegrin	   and	   metalloproteinase	   with	   thrombospondin	   motifs)	  display	  a	  very	  similar	  architecture	  of	   their	  catalytic	  machinery	   to	  MMPs.	  Those	  subfamilies	   contain	   a	   number	   of	  metalloproteinases	   serving	   various	   important	  functions	   in	   the	   organism.	   The	   danger	   of	   side-­‐effects	   associated	   with	   cross-­‐reactivity	  of	   synthetic	  active	   site-­‐directed	   inhibitors	   is	   serious,	   especially	  when	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administered	   systemically.	   Elucidation	   of	   structural	   determinants	   of	   substrate	  specificity	   among	   MMPs,	   ADAMs	   and	   ADAMTSs	   and	   determining	   the	   exact	  mechanisms	  of	  their	  interactions	  with	  biological	  substrates	  would	  greatly	  aid	  the	  design	  of	   selective	   inhibitors	  of	   therapeutic	  potential.	  Targeting	  specific	  exosite	  interactions	  is	  believed	  to	  be	  one	  of	  the	  most	  promising	  strategies	  for	  achieving	  selective	   inhibition	  of	   disease	   effectors.	   This	  may	  permit	   a	   design	  of	   inhibitors	  not	  only	  specific	  among	  metalloproteinases,	  but	  also	  selectively	  blocking	  only	  a	  certain,	  undesired	  activity	  of	  the	  enzyme.	  	  Here,	  one	  major	  exosite	  for	  collagen	  I	  binding	  has	  been	  identified	  in	  blade	  1	  of	  the	  Hpx	  domain	  of	  human	  MMP-­‐1	  and	  a	  second	  exosite	  in	  the	  blade	  2	  has	  been	  proposed.	   The	   H/DXMS	   analyses	   combined	   with	   the	   studies	   of	   immobilised	  collagen	   binding	   by	   the	   Cat	   domain	   of	   MMP-­‐1	   also	   indicated	   other	   potential	  characteristics	   of	   the	   collagenase-­‐collagen	   interaction,	   such	   as	   dynamic	  behaviour	   of	   the	   MMP-­‐1	   N-­‐terminal	   region.	   Based	   on	   this	   and	   other	   evidence	  gathered	   in	   this	  work,	   a	   putative	  mode	   of	   collagen	   binding	   by	   collagenase	   has	  been	  deduced	  and	  will	  soon	  be	  tested	  by	  mutagenesis	  studies.	  Such	  insights	  may	  vitally	   facilitate	   the	   rational	   design	   of	   inhibitors	   preventing	   excessive	  collagenolysis	   associated	  with	  pathological	   conditions.	  MMP-­‐1	  may	  be	  a	  potent	  therapeutic	  target	  in	  vascular	  disease	  (Lim	  et	  al,	  2010).	  Collagenases	  other	  than	  MMP-­‐1	  may,	  however,	  be	  more	  relevant	  therapeutic	  targets	  in	  different	  diseases,	  e.g.	   MMP-­‐13	   in	   arthritides	   (Takaishi	   et	   al,	   2008)	   or	   MT1-­‐MMP	   in	   cancer	  (Strongin,	  2010;	  Seiki	  et	  al,	  2003;	  Poincloux	  et	  al,	  2009).	  Similar	  studies	  on	  MMP-­‐8	   and	   MMP-­‐13	   should	   be	   conducted	   in	   future,	   but	   many	   aspects	   of	   the	  mechanism	   of	   MMP-­‐1-­‐dependent	   collagenolysis	   may	   be	   valid	   for	   MMP-­‐8	   and	  MMP-­‐13,	   given	   the	   structural	   similarity	   of	   these	   enzymes.	   Unfortunately,	  knowledge	   on	   the	   various	   substrate-­‐binding	   exosites	   in	   the	   majority	   of	  metalloproteinases	   is	   still	   poor	   and	   a	   great	   deal	   needs	   to	   be	   learned	   about	  metalloproteinase	  mechanisms	  of	  action.	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